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Abstract 
 
An increasing amount of attention is being focussed on the physiological and 
pathological functions of kainate receptors (KAr), in mediating synaptic currents and 
presynaptically controlling transmitter release at excitatory and inhibitory synapses. 
The aims of this thesis were to determine the role of KAr in layer III of the rat 
entorhinal cortex (EC). 
 
I have provided electrophysiological evidence for involvement of two types of KAr in 
excitatory glutamatergic neurotransmission in layer III: 1. A GluR5-containing 
presynaptic KAr, which facilitates glutamate release at these synapses and 2. A non-
GluR5-containing postsynaptic KAr mediating synaptic currents. I have also 
demonstrated that several types of KAr act to increase synaptic inhibition in layer III. 
There appears to be a presynaptic facilitatory KAr on interneurone terminals, which 
acts to increase GABA release, and which may contain the GluR6 subunit. There is 
also a GluR5-containing KAr located on the soma/dendrites of interneurones, which 
drives GABA release, via direct excitation.  
 
Slow wave oscillations (SWO) can be reliably generated in the EC by reducing 
[Mg2+]o. Cunningham et al. (2006b) have recently shown that GluR5 receptors are 
involved in the initiation and/or maintenance of SWO in the EC as they are blocked 
by UBP 302. I have shown that reducing [Mg2+]o increases excitatory and inhibitory 
neurotransmission in layer III. A large part of the increased glutamate release was 
GluR5 KAr-dependent. Effects of GluR5 blockade suggest that the presynaptic GluR5 
receptors on glutamatergic terminals become tonically activated in low Mg . In 
addition, the increase in GABA release caused by reducing 
2+
[Mg2+]o is likely to be 
partly due to increased KAr activation of postsynaptic GluR5 receptors on 
interneurones. Layer V of the EC does not show pronounced SWO, and in preliminary 
experiments I have shown that KAr play a much less prominent role in glutamatergic 
transmission in this layer. Overall, my results provide good support for the suggestion 
that GluR5-containing KAr play an important role in SWO in layer III of the EC 
(Cunningham et al, 2006b).  
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CHAPTER 1 
 
GENERAL INTRODUCTION 
1.1. Introduction 
 
This laboratory has been studying the role of ionotropic (iGlur) and metabotropic 
glutamate receptors (mGlur) in excitatory transmission and in the control of glutamate 
and GABA release in the entorhinal cortex (EC) for a number of years (e.g. Jones, 
1987; 1994; Jones and Heinemann, 1989; Berretta and Jones, 1996a, b; Woodhall et 
al., 2001a; Evans et al., 2000; 2001). The EC is an essential structure in the temporal 
lobe, where it actively processes information entering and leaving the hippocampus, 
thus controlling the interactions between the hippocampus and the neocortex, and 
other areas of the limbic system (Witter et al., 1989a; Delatour and Witter, 2002; 
Witter and Moser, 2006). The EC has been implicated in a number of neurological 
disorders including Alzheimer’s disease, Parkinson’s disease and schizophrenia (e.g. 
Van Hoesen et al., 1991; Gomez-Isla et al., 1996; Prasad et al., 2004; Kövari et al., 
2003; Pennanen et al., 2004). In addition it is also known to play a vital role in the 
initiation and propagation of temporal lobe epilepsy (TLE; see Jones and Woodhall, 
2005; Tolner et al., 2007).  
 
Kainate receptors (KAr), like NMDA and AMPA receptors (NMDAr, AMPAr) are 
ligand-gated ion channels responsive to glutamate, the major excitatory 
neurotransmitter in the central nervous system (CNS). Postsynaptic KAr were initially 
found to mediate EPSCs much smaller and slower than AMPAr at hippocampal mossy 
fibre synapses (Castillo et al., 1997; Vignes and Collingridge, 1997), and have since 
been found at various other synapses (Frerking et al., 1998; DeVries and Schwartz, 
1999; Kidd and Issac, 1999; Li et al., 1999; Ali, 2003; Gryder and Rogawski, 2003). 
Presynaptic KAr exist at both excitatory (Agrawal and Evans, 1986; Frerking et al., 
2001; Schmitz et al., 2001) and inhibitory synapses (Rodriguez-Moreno et al., 1997; 
Cossart et al., 2001) where, depending on the particular study, they act to increase or 
decrease transmitter release. Acute administration of kainate acid (KA) is frequently 
used to generate a chronic animal model of TLE, as it produces seizures and 
neuropathological changes closely reminiscent of those observed in patients (Ben-Ari, 
1985). Epileptic activity induced by KA appears to arise initially in the EC before 
propagating to the hippocampus and other limbic areas (Ben-Ari et al., 1981) 
indicating a role for KAr in the synchronisation leading to epileptogenesis. The 
chronic recurrent seizures that develop after a latent period are associated with 
substantial cell loss in the EC (Tolner et al., 2005; 2007), although whether this is a 
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direct effect of KAr activation or as a consequence of hypersynchrony is still to be 
determined. What is becoming clear is that KAr are also important for other forms of 
network synchrony in the EC. Gamma frequency oscillations can be elicited in the EC 
by non-selective KAr agonists (Cunningham et al., 2003; 2004). These were blocked 
by both AMPAr and GABAAr antagonists suggesting AMPAr-mediated inputs to the 
GABAergic interneurones are involved in KAr driven rhythmogenesis. More recently 
it has been suggested that this gamma activity is largely dependent on GluR5-
containing KAr (Stanger et al., 2008). These KAr induced gamma oscillations have 
also been found to be markedly decreased in layer III in animal models of 
schizophrenia (Cunningham et al., 2006a). Other oscillations may also depend on KAr 
in the EC. Slow wave oscillations (SWO), localised primarily to layer III, can be 
induced by a moderate reduction in extracellular magnesium ([Mg2+]o) and are 
abolished by a GluR5 selective KAr antagonist (Cunningham et al., 2006b). 
 
Thus, KAr seem to be involved in the generation of network rhythmicity in the EC at 
both physiological and pathological levels, but surprisingly little is known of the 
physiological roles that these receptors play at excitatory and inhibitory synapses in 
this area. A recent paper (West et al., 2007) demonstrated a slow, KAr-mediated 
component of the glutamate EPSC in neurones in layer II and III of the rat EC, 
although it was more prominent in layer III. However, this is the only study of 
physiological role of KAr in the EC. 
 
Thus, the aims of this thesis were to determine the role of KAr in layer III of the EC. 
In particular the work has: 
 
- Characterised spontaneous inhibitory and excitatory synaptic transmission in 
layer III of the EC. 
- Determined the role of presynaptic KAr in controlling spontaneous glutamate 
release at excitatory synapses. 
- Examined the contribution of postsynaptic KAr at glutamate synapses. 
- Defined the role of presynaptic KAr in the release of GABA in layer III. 
- Determined how manipulations that elicit slow oscillatory activity may alter 
pre- and postsynaptic KAr function. 
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1.2. The entorhinal cortex 
 
The EC is located in the temporal lobe and is a pivotal part of the limbic system. Due 
to its proximity to the hippocampus it has also been referred to as part of the 
parahippocampal region, together with the hippocampus itself, the DG (DG), the peri- 
and postrhinal cortices and the subiculum. The EC is uniquely positioned to serve as 
an interface between the neocortex and hippocampal formation and, as such, it acts as 
a gateway, actively pre-processing and selecting information directed afferent and 
efferent to the hippocampus. These structures are thought to be vital in memory and 
cognition (Zola Morgan and Squire, 1993; Myhrer, 1989). The cognitive and memory 
deficits seen in many dementias, including Alzheimer’s disease, Parkinson’s disease 
and Pick’s disease, have been attributed to neuropathological changes in this region, 
particularly the EC (Braak and Braak, 1992; Braak et al., 2000). In addition, 
dysfunction of the EC is commonly associated with TLE. Atrophy of the EC has been 
seen both in animal models (Wozny et al., 2005; Du et al., 1995) and in patients 
(Bartolomei et al., 2005) and removal of the EC is vital for control of TLE when 
surgical intervention is required due to pharmaco-resistance (Goldring et al., 1992). 
 
1.2.1. Anatomy of the EC 
 
The area was first described by Cajal in 1901, although it was not termed the EC until 
1909, when Brodmann referred to Area 28 as area entorhinalis. It resides in the 
medial temporal lobe, specifically within the rhinal sulcus in the rostral ventromedial 
surface. The rat brain does not contain a medial temporal lobe and the EC is located at 
the most caudal, ventral, and lateral aspect of the brain (Figure 1.1A). The EC curves 
around the rostral surface of the hippocampus as is indicated in Figure 1.1B. The EC 
is traditionally subdivided into the medial and lateral cortices, although more recently 
these have been subdivided further into six sub-regions (Insausti et al., 1997). The 
medial and lateral divisions of the EC have strikingly different afferent and efferent 
connections (Kerr et al., 2007) and are thought to have distinct information processing 
functions (Hargreaves et al., 2005). This laboratory is principally concerned with the 
medial EC of the rat, which is where all of the experiments for this thesis have taken 
place.  
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Figure 1.1. Schematic diagrams of the location of the EC. A. Schematic diagram of 
a lateral view of the rat brain showing the position of the EC. Also identifies the 
cerebellum (CB), parietal lobe (PL), temporal lobe (TL), frontal lobe (FL) and the 
olfactory bulb (OB). B. Schematic diagram of an EC-hippocampal slice indicating the 
position of the medial and lateral EC in relation to the CA1 and CA3 regions of the 
hippocampus and the dentate gyrus (DG). 
 
1.2.2. Intrinsic connectivity and morphology of the EC 
 
The EC can also be divided into six layers (I-VI) as proposed originally by Ramon y 
Cajal (1901-02). Although many neuroanatomists maintain that there are only 5 layers 
as layer IV (otherwise known as lamina dissecans) is mostly acellular and is 
sometimes referred to as a plexiform layer (Insausti et al., 1997). It separates layers III 
and V and is used as the demarcation between deep and superficial layers. In some 
species it can only be found in the more caudal regions of the EC, and therefore it may 
be considered a cell free subdivision of layer V. It has been suggested that the EC may 
be a transitional cortex, phylogenetically younger than the three layered hippocampus 
but older than the clearly 6 layered neocortex (Insausti et al., 1997). Although termed 
the lamina dissecans, layer IV may contain large pyramidal cells with apical dendrites 
which send collaterals to the white matter and small cells which project locally (Witter 
et al., 1989b). Layer I, which contains mostly fibres and few neuronal cell bodies, is 
also sometimes referred to as a plexiform layer (Insausti et al., 1997), and represents 
the molecular layer of the EC. The neurones in this layer comprise spinous multipolar 
cells and horizontal cells (Germroth et al., 1989) that ramify locally. 
 
The remaining four are cellular layers. Layer II contains mostly large stellate 
neurones, with a smaller population of pyramidal cells. These are often grouped 
together in ‘cell islands’ although the layer becomes more continuous further caudally. 
This is less obvious in the rat than other species (Insausti et al., 1997). The spiny 
stellate cells of layer II, with many diverse and far-reaching projections, form the 
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main output from the EC to the hippocampus. A single layer II cell has been shown to 
project axonal branches towards the entire transverse DG (suprapyramidal and 
infrapyramidal blades, and the DG crest), the CA2-3 fields of the hippocampus, and 
the subiculum (Tamamaki and Nojyo, 1993). Their dendritic trees branch extensively 
throughout layers I and II and the superficial part of layer III, and many of the 
afferents in these layers will synapse with these cells. There is also limited evidence in 
some species to suggest that layer II stellate cells also project to layers V and VI of the 
EC (Ino et al., 2000; Buckmaster et al., 2004). Layer II also contains horizontal cells, 
differentiated from stellate cells by their horizontally orientated somata, dendrites and 
axons, which are restricted to the layer (Jones and Buhl, 1993; Germroth et al., 1989). 
Finally, small pyramidal like cells can be found in layer II that ramify in the 
superficial layers.  
 
Layer III is a broad layer containing large pyramidal neurones. These neurones have 
been broadly separated into two types depending on whether they project towards the 
angular bundle, ultimately to CA1 and the subiculum, or remain within the EC 
(Gloveli et al., 1997). Within the EC, layer III neurones seem to collaterilise most 
abundantly within layer III, but may also project into both the deeper (V and VI) and 
the more superficial layers (I and II; Gloveli et al., 1997). Collectively, layers I, II and 
III are often referred to as the superficial layers of the EC.  
 
Layer V is a fairly dense cell layer containing mostly pyramidal neurones, with some 
horizontal and polymorphic neurones (Hamam et al., 2000), and is thought to be the 
main origin of projections to the cortex (Dugladze et al., 2001; Insausti et al., 1997; 
Witter et al., 1989a, b; Sorensen , 1985). Layer VI contains mainly pyramidal, bipolar 
or multipolar neurones (Gloveli et al., 2001) and is less dense than layer V. This layer 
is also less distinct and often merges with both layer V and the white matter (Insausti 
et al., 1997). In both layer V and VI by far the most abundant cell type are the 
pyramidal neurones. They are the principal neurones which project to various cortical 
and subcortical structures as discussed in the next section. These cells may also 
project to the DG, to relay information to the hippocampus, or to the superficial layers 
to influence network activity of the EC (Gloveli et al., 2001). Other cells within layers 
V and VI also send collaterals to the superficial layers and the dentate granule cells or 
remain localised to the deeper layers. A summary diagram of the morphology and 
basic intrinsic connectivity can be seen in Figure 1.2. 
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Figure 1.2. Schematic representation of structure and connectivity of the medial EC 
including information on cell type and morphology in each layer.  
 
1.2.3. Extrinsic connectivity  
 
The EC is closely linked to the hippocampus and is considered to act as a gateway 
between the hippocampus and the neocortex. The main input to the hippocampus from 
the EC is known as the perforant pathway and predominantly arises from stellate 
neurones in layer II of the EC. Although these also synapse with neurones of 
Ammon’s horn (one of the two interlocking gyri composing the hippocampus) and the 
subiculum (Lopes da Silva et al., 1990), the axons of the perforant pathway primarily 
target the molecular layer of the DG, where 85% of the total synapses are from the EC 
(Matthews et al., 1976). Axons from the medial EC in rats primarily innervate 
neurones located in the middle third of the molecular layer of the DG. Axons from the 
lateral EC terminate in the outer third of the DG (Wyss, 1981). Additionally, the EC 
also projects to the contralateral hippocampus via the hippocampal commisure 
(Amaral et al., 1984).  
 
The perforant pathway is the first step of the trisynaptic loop. This refers to the 
polysynaptic circuit consisting of: 1. Axons primarily from layer II EC neurones that 
make excitatory synapses onto granule cells in the outer molecular layer of the DG 
(although there is some evidence for input to the DG from layer V neurones; Deller et 
al., 1996; Witter et al., 1988; Köhler, 1985). 2. Axons from the dentate granule cells, 
which form the mossy fibre pathway that synapse onto CA3 pyramidal cells. 3. The 
Schaffer-collateral commissural pathway, which consists of axons from CA3 
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pyramidal neurones (and contralateral CA1 pyramidal neurones, via the fornix) 
synapsing on CA1 pyramidal cells (Witter et al., 1993). All projections in the 
perforant pathway are glutamatergic and excitatory (Andersen 1975; Misgeld, 1988), 
although in each region there are local GABAergic interneurones that provide 
feedforward and feedback inhibition (Freund and Buzsáki, 1996; Lacaille et al., 1987; 
Ribak and Seress, 1983; Woodson et al., 1989). Most of the outputs from the 
hippocampus return to the EC from CA1 via the subiculum, where they terminate 
mainly in the deeper layers of the medial EC (Lopes da Silva, 1990). In the rat the 
output to the EC is strictly ipsilateral (Köhler, 1986), whereas there is a contralateral 
component in monkeys (Amaral et al., 1987).  
 
Not all inputs to the hippocampus from the EC are via the DG. There is also a 
monosynaptic pathway that terminates directly in the CA1 region, bypassing the first 
two stages of the trisynaptic loop. This is known as the temporoammonic (TA) 
pathway (Maccaferri and McBain, 1995), or the direct perforant pathway/entorhinal 
projection. The TA pathway primarily originates from the pyramidal cells of layer III 
of the EC (Steward and Scoville, 1976), and terminates on CA1 neurones. Greater 
than 90% of the axons terminate on pyramidal cells. However, they have also been 
shown to synapse onto inhibitory basket and chandelier neurones (Kiss et al., 1996) 
and interneurones of the stratum lacunosum-moleculare (Lacaille and Schwartkroin, 
1988). The direct projection from layer III neurones is also accompanied by a direct 
projection from layer II neurones to CA3 (Hjorth-Simonsen and Jeune 1972; Steward, 
1976; Steward and Scoville, 1976). There is some debate as to whether the TA 
pathway is primarily excitatory or inhibitory (Soltesz and Jones, 1995). Initially it was 
thought the primary function of the direct TA pathway was to modulate information 
processed via the trisynaptic pathway (Yeckel and Berger, 1990). However, evidence 
has accumulated to suggest that the TA pathway actually transmits the information 
required for some hippocampal-dependent functions (Jarrard et al., 1984; 
McNaughton et al., 1989; Brun et al., 2002). 
 
The EC is also reciprocally connected to various association cortices (prefrontal, 
limbic and parieto-occipital-temporal) either directly or via the perirhinal cortex 
(Witter and Groenewegen, 1984). The EC sends and receives direct and strong inputs 
from the olfactory bulbs (Van Groen et al., 1987). Other cortical regions with which 
the EC has strong connections include the prelimbic, infralimbic, dorsal peduncular 
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and the orbitofrontal and olfactory cortices. Weaker connections have also been found 
between the EC and the insular, cingulate, retrosplenial and area Fr2 of the medial 
frontal cortices (Insausti et al., 1997; Condé et al., 1995). In addition, sparse 
connections exist between the EC and somatosensory, auditory, visual and motor 
cortices (Insausti et al., 1997). The majority of these outputs to the neocortex have 
been found to originate in layer V of the EC (Dugladze et al., 2001; Insausti et al., 
1997; Witter et al., 1989a, b; Sorensen, 1985). Afferents from neocortical layer V 
terminate mainly in layers I and II of the EC (Insausti et al., 1997; Witter, 1993; 
Felleman and Van Essen, 1991). Subcortical regions, including the basal forebrain, 
thalamic nuclei, raphé nuclei, locus coeruleus, ventral tegmental area and amygdala 
also innervate various layers of the EC (Insausti et al., 1997).  
 
In summary, visual, auditory and somatosensory information, acquired and processed 
in polymodal association cortices, is conveyed via the parahippocampal and perirhinal 
cortices to the EC, DG, hippocampus and subiculum in a serial manner. Hippocampal 
output is then directed back to the EC, which sends reciprocal efferents to 
parahippocampal and perirhinal cortices to feed back information to the neocortical 
association areas. Thus, the EC is a relay station between the hippocampal and 
neocortical areas, acting as both an input and output processor. A summary diagram of 
the extrinsic connectivity of the EC is presented in Figure 1.3. 
 
1.2.4. The EC and memory  
 
The hippocampus has long been considered to be intimately involved in learning and 
memory and since the connectivity between the hippocampus and the EC is extensive 
it has also been suggested that the EC must also be involved. Together with other 
regions of the medial temporal lobe, the EC appears to be of particular importance for 
establishing long-term memory for facts and events (declarative memory; Squire and 
Zola-Morgan, 1991). The importance of the role of the EC in memory is supported by 
EC lesion studies, in which deficits in various learning and memory tasks have been 
identified (Roof et al., 1993; Glasier et al., 1995; Cho and Jaffard, 1995; Kopniczky et 
al., 2006). In addition, studies in which entorhinal afferents from the presubiculum 
(Liu et al., 2001) or from the perirhinal cortex (Liu and Bilkey, 1998) are selectively 
removed, suggest that the EC may serve a more critical function in the acquisition of 
declarative memory than was previously assumed. 
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Figure 1.3. Simplified diagram showing the connectivity of the EC with both the 
neocortex and the hippocampus (and related structures), highlighting the perforant 
and temporoammonic pathways. 
 
The role of the EC in memory is also frequently examined in humans and animals 
with medial temporal lobe damage, including Alzheimer's disease patients, whose 
early cognitive impairments can be traced to lesions in the EC (Van Hoesen et al., 
2000), and TLE patients. Recently, important evidence has come to light that has 
helped to elucidate how the EC contributes to hippocampal function and memory. Fell 
et al. (2001) showed that successful memory formation is accompanied by an 
enhancement in gamma frequency synchronisation between the rhinal cortex and the 
hippocampus. This led them to suggest that formation of declarative memories 
requires a direct entorhinal-hippocampal interaction. Frank and Brown (2003) 
investigated sustained activity in layer V of the EC, which they believe may be 
involved in maintaining representations to allow time for synaptic plasticity to occur, 
thus enabling the hippocampal-cortical circuit to form memories. Hafting et al. (2005) 
showed that the dorsal medial EC contains a directionally orientated topographically 
organised neural map of the spatial environment made up of what they referred to as 
“grid cells”. They suggested that these grid cells may be responsible for aspects of 
spatial learning that had previously been attributed to the hippocampus.  
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1.3. The EC and CNS disorders 
 
The EC has been implicated in a number of pathological conditions. Disruption of EC 
function is thought to be involved in the cognitive decline in various dementias 
including Alzheimer’s disease, Parkinson’s disease and Pick’s disease (Braak and 
Braak, 1992; Braak et al., 2000). Most strikingly, the morphological changes 
associated with Alzheimer’s disease occur in the EC in the earliest stages of the 
disease, before symptoms have even begun to occur (Braak and Braak, 1992). In 
addition, it has been suggested that neuropathological changes in the EC may underlie 
a vulnerability to schizophrenia (Kurachi, 2003). However, the disease most 
commonly associated with dysfunction of the EC is TLE, which is the cause of 
seizures in 40% of adult epilepsies (McNamara, 1992; Schwartz et al., 2000; Jones 
and Woodhall, 2005). The evidence for linking EC dysfunction with both 
schizophrenia and TLE is discussed in further detail below. It is interesting to note 
that there is a close association between schizophrenia and TLE. There is a higher 
prevalence of schizophrenia-like symptoms in epilepsy patients compared to the 
general population (Bredkjaer et al., 1998; Sachdev, 1998; Schwartz and Marsh, 2000; 
Gaitatzis et al., 2004), and people with a history of epilepsy have nearly 2.5 times the 
risk of developing schizophrenia (Qin et al., 2005). Thus, schizophrenia and TLE may 
well share dysfunction of the same neuronal networks. 
 
1.3.1 The EC and schizophrenia 
 
Schizophrenia is a chronic, debilitating psychiatric illness affecting approximately 1% 
of the general population. It is characterized by two kinds of symptoms; positive 
psychotic symptoms - thought disorder, hallucinations, delusions, and paranoia - and 
negative symptoms – impairment in emotional range, energy, and enjoyment of 
activities. It has been suggested that disruption of the interactions between prefrontal 
and entorhinal/hippocampal areas may underlie many of the symptoms of the disease 
(Grace, 2000). Structural magnetic resonance imaging has identified changes in EC 
volume associated with schizophrenia, with volume positively correlating with 
severity of delusions (Prasad et al., 2004). In addition, diffusional anisotropy 
(measuring myelination) suggests large-scale disruption of entorhinal connectivity 
(Kalus et al., 2005). Displacement or absence of stellate cell clusters in layer II is 
common in post-mortem tissue (Beckmann and Senitz, 2002; Falkai et al., 2000; 
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Kovalenko et al., 2003). At the cellular level, changes in mRNA for synaptic markers 
such as GluR3, NR1 and synaptophysin, have been reported in post-mortem EC from 
schizophrenic patients (Arnold, 2000; Hemby et al., 2002). Cholecystokinin (CCK) 
mRNA levels are reduced in layers III and V, where a decrease in inhibitory 
interneurones was also seen (Bachus et al., 1997). 
 
Significant learning and memory deficits are also seen in patients with schizophrenia 
(Aleman et al., 1999; Rushe et al., 1999; Paulsen et al., 1995). Changes in dentate 
granule cell morphology and genetic markers indicative of changes in input from the 
EC have been reported (Lauer et al., 2003; Austin et al., 2004), and it has been 
suggested that these changes may underlie episodic memory deficits (Talamini et al., 
2005). In addition, sensorimotor gating deficits are common in schizophrenia (Geyer 
and Braff, 1987) and the severity of deficits correlates with the severity of psychosis 
(Meincke et al., 2004). Importantly, the EC has been implicated as a key area involved 
in sensorimotor performance (Swerdlow et al., 2001; Davachi and Goldman-Rakic, 
2001).  
 
The cognitive and affective symptoms of schizophrenia have been suggested to arise 
from an inability to integrate or synchronise activity in neuronal networks. The 
disorder is increasingly being viewed as arising from abnormal neuronal synchrony in 
cortical networks. Specifically, a number of studies have shown disruption of gamma 
rhythmogenesis in cortical networks in schizophrenic patients (e.g. Spencer et al., 
2003; Symond et al., 2005). Harrison et al (2003) developed Lysophosphatidic acid 1 
receptor (LPA1R) knock-out mice as a possible model for schizophrenia. LPA1R is a 
G-protein coupled receptor for the bioactive phospholipid, lysophosphatidic acid. The 
role of LPA1R is unclear, although it is thought to be involved in neurogenesis or 
neuroblast migration during development due to its embryonic expression profile 
(Harrison et al., 2003). LPA1R knockout mice show a deficit in prepulse inhibition, 
widespread changes in the levels and turnover of the neurotransmitter 5-HT, region-
specific changes in levels of amino acids, and craniofacial dysmorphisms (Harrison et 
al., 2003; Roberts et al., 2005), changes which have been associated with 
schizophrenic-like pathology. Interestingly, in this model there is a selective loss of 
gamma frequency oscillations in superficial layers of the EC accompanied by a 
reduction in inhibitory control of principal cells (Cunningham et al., 2004). These 
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studies lend support to the idea that disruption of EC function may be an underlying 
factor in schizophrenia. 
 
1.3.2. The EC and epilepsy 
 
Epilepsy, characterised by recurrent spontaneous seizures, is the most common 
neuropathological disorder in the world. Of the 450 million people with mental and 
neurological disorders worldwide, an estimated 50 million have epilepsy (Shorvon, 
1990). There are over 40 different types of epilepsy, divided into symptomatic, 
idiopathic or cryptogenic categories and further subdivided into generalised or partial 
seizures (McCormick and Contreras, 2001). TLE is the most common form of partial 
epilepsy in adults (McNamara, 1992). Although the major focus has been on the 
hippocampus as the main site of TLE (Bradford, 1995; McCormick and Contreras, 
2001), there is increasing evidence that the EC is heavily involved. Seizures can arise 
independently or preferentially in the EC (Rutecki et al., 1989; Spencer and Spencer, 
1994; Alarcon et al., 1997; Assaf and Ebersole, 1997; Assaf et al., 2003; Bartolomei 
et al., 2004, 2005). Focal seizures arising in the EC or the amygdala are more likely to 
result in clinical manifestations, whereas seizures originating in the hippocampus do 
not (Wennberg et al., 2002). It has long been accepted that epilepsy involves abnormal 
and excess synchronous activity within neuronal networks. In this case, extreme 
hypersynchrony results in a pathologically oscillating network, to the extent where it 
is incapable of meaningful information processing. Fast cortical/gamma oscillations 
(30-100 Hz) are commonly recorded in states of active alertness. They are thought to 
be important in sensory processing. Specifically evidence suggests that neurones 
which represent the same object or event fire in temporal synchrony which groups 
features (referred to as ‘sensory/feature binding’) allowing the formation of coherent 
object representations (for review see Tallon-Baudry and Bertrand, 1999). Intensified 
gamma activity has been detected in the EEG of epileptic patients (Hirai et al., 1999; 
Willoughby et al., 2003). This increased and extremely synchronous gamma activity, 
is though to represent a pathological state of excessive (beyond normal physiological 
limits) temporal binding in the neural networks or ‘over-binding’ (Medvedev, 2001) 
and is suggested to be a “prerequisite to the development of seizures” (Willoughby et 
al., 2003). In vivo studies in rats with chronically induced epilepsy have demonstrated 
increased high frequency events and oscillations in the EC, with a high degree of 
similarity to events recorded in human TLE patients (Bragin et al., 2002, 2004). 
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 In human epilepsy as many as 30% of patients are refractory to available drug 
treatments (Sander, 1993; Kwan and Brodie, 2000). Control of drug-resistant TLE by 
surgical resection involves a partial temporal lobectomy, which invariably removes 
the EC (Sperling et al., 1996). The success rate of this surgery appears to correlate 
with the amount of parahippocampus and EC removed during the resection (Siegel et 
al., 1990; Fried, 1993; Sperling et al., 1996). Goldring et al. (1992; 1993) have 
suggested that the removal of the EC is vital for surgical control of refractory TLE. 
One of the symptoms of TLE is temporal lobe atrophy, as seen in MRI studies with 
epileptic patients. Many MRI studies have shown that the EC is significantly reduced 
in volume in TLE patients, often without an accompanying loss of hippocampal 
volume (Bernasconi et al., 1999; 2001; Jutila et al., 2001; Bonilha et al., 2003). 
Lesions of the EC are mainly localised to layer III (Schwarcz and Witter, 2002; Du et 
al., 1993). EC atrophy is specifically associated with TLE, none is evident in 
epilepsies arising outside of the temporal lobe, or in generalised epilepsies of 
unknown aetiologies (Bernasconi et al., 2003). Research using surgically resected 
tissue has also shown atrophy (Du et al., 1993) and gliosis (Yilmazer-Hanke et al., 
2000) in the EC. In addition, a recent study has identified changes in several genes in 
the EC of patients which indicated that local dysregulation of neurotransmission in the 
EC is common in human TLE (Jamali et al., 2006). 
 
Epileptic activity in rats is characterized by electrographic seizure activity that may 
arise in the EC before the hippocampus (Ben-Ari et al., 1981; Collins et al., 1983; 
Stringer, 1994). Studies in various models have shown that long lasting ictal-like 
epileptiform discharges generated in the EC entrain hippocampal neurones via the 
trisynaptic loop (Du et al., 1995; Jones and Lambert, 1990a; Avoli et al., 2002). Such 
discharges are thought to originate in deep layers, particularly layer V (Jones and 
Lambert, 1990a, b; Avoli et al., 1996; Lopantsev and Avoli, 1998) as the deeper 
layers of the EC are more susceptible to seizures, whereas the more superficial layers 
appear to be seizure resistant (Jones, 1993). However, a recent study by Tolner et al. 
(2005) contradicts this idea. Their results suggest that epileptiform activity is more 
readily generated in the superficial layers of the medial EC, although they agree that 
this would lead to an increased excitatory drive onto the hippocampus. There is some 
evidence to support control by CA3 over the generation of spontaneous epileptiform 
activity in the EC (Avoli, 2001; Stoop and Pralong, 2000; Barbarosie and Avoli, 
 14
1997). The absence of control of ictal discharge generation in EC by CA3 may 
contribute to the higher seizure susceptibility in young animals (Calcagnotto et al., 
2000; Cavalheiro et al., 1987; Hablitz, 1987). Significant neuronal loss in the EC has 
also been seen in animal models (Wozny et al., 2005; Du et al., 1995), also mainly 
localised to layer III. The EC atrophy in animal models induced by injection of amino-
oxyacetic acid (AOAA) seems to cause neurones in the superficial layers of the EC to 
become hyperexcitable, perhaps due to synaptic reorganisation (Scharfman et al., 
1998). Recently, using laser scanning photostimulation it was shown that there is 
reduced recurrent inhibition of layer II stellate neurones in epileptic animals (Kumar 
et al., 2007). The hyper-excitability in layer II may be due to a loss of GABAergic 
interneurones in layer III (Kumar and Buckmaster, 2006). There is also thought to be 
decreased inhibition in layer V in pilopcarpine treated rats (de Guzman et al., 2008), 
which may contribute to network epileptic hyper excitability in this model of TLE. 
 
1.4. Physiology and pathophysiology of layer III 
 
Information on the normal physiology and pharmacology of cells in layer III is 
limited, particularly when compared to the wealth of information on layer II and, to 
some extent, layer V (Jones and Heinemann, 1988; Jones, 1993; Berretta and Jones, 
1996a; b; Heinemann et al., 2000; Jones and Woodhall, 2005; Evans et al., 2000; 
2001; Bailey et al., 2004; Woodhall et al., 2005). Gloveli et al. (1997) identified four 
cell types in layer III of the medial EC, using biocytin to study their morphology, and 
intracellular recordings to determine the basic electrophysiology. Neurones in layer III 
were largely pyramidal cells, differing in their dendritic arborisations and whether 
they projected outside of the EC, or were ‘local circuit’ neurones. Using various 
pharmacological agents they provided evidence for NMDAr and non-NMDAr-
mediated excitation and GABAAr and GABABr-mediated inhibition present in layer 
III neurones, although these were not present in all cell types. They put specific 
emphasis on the excitability of the network in the presence of bicuculline, suggesting 
that this indicated a strong GABAAr-mediated inhibition in this layer of the EC. 
Neurones in layer III of the lateral EC have been found to be similar to those in the 
medial EC (Tahvildari and Alonso, 2005). Van der Linden and Lopes da Silva (1998) 
also carried out intracellular current-clamp recordings in the medial EC to compare 
layer III neurones to those in layer II. They described two cell types according to the 
presence of a time-dependent inward rectification. This manifests as a depolarising 
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sag in the membrane back towards resting membrane potential in response to 
hyperpolarisation, which is caused by the activation of a mixed cation current called Ih 
or “SAG”. Neurones in layer III, in direct contrast to those in layer II, were found to 
be mostly of the “NO SAG” type, which may indicate that neurones in layer III are 
less excitable than layer II neurones (Van der Linden and Lopes da Silva, 1998). 
Dickson et al. (1997) found neurones in layer III to typically be regularly spiking 
cells, which, unlike layer II neurones, lacked subthreshold oscillations. However, they 
also found that layer III neurones showed pronounced excitability that they felt may 
be related to the degeneration that is seen in layer III in epilepsy (described in more 
detail below).  
 
Dhillon and Jones (2001) investigated recurrent EPSPs in layer III neurones. These 
were found to contain a fast component mediated by AMPAr/KAr and a slow 
component mediated by NMDAr. The recurrent EPSPs in layer III neurones were 
larger in amplitude than those found in layer V, whilst no recurrent EPSPs were seen 
in layer II (Dhillon and Jones, 2001). A number of presynaptic receptors have been 
found in layer III including dopamine receptors (Stenkamp et al., 1998) and serotonin 
receptors (5HT1A; Schmitz et al., 1998) on glutamatergic terminals and GABABr on 
GABAergic terminals (Gloveli et al., 2003). Finally, various frequencies of oscillatory 
activity have been induced in layer III neurones including gamma frequency induced 
by KA (Cunningham et al., 2003), theta frequency induced by physostigmine (Alonso 
and Garcia Austt, 1987) and SWO, at a frequency of < 1Hz, which can be induced in 
adult animals by reducing extracellular magnesium (Cunningham et al., 2006b). 
 
The relative lack of knowledge on the physiological properties of neurones in layer III 
is surprising in the light of increasing evidence for a role in TLE. In particular, it has 
been shown that there is a characteristic pattern of neuronal loss and gliosis in layer III 
in a number of animal models of the disease (Du and Schwarcz, 1992; Du et al., 1995; 
Tolner et al., 2005), where it has been shown that greater than 50% of the total 
neuronal population may be lost. A similar situation may occur in human patients with 
TLE (Du et al., 1993), although, a recent study (Dawodu and Thom, 2005) has 
suggested that selective laminar neuronal loss in the EC is less common in patients 
than animal models. Du and Schwarcz (1992) proposed that the loss of layer III 
pyramidal cells led to the destruction of the TA pathway to the CA1 region, whilst the 
perforant path from layer II to the DG was relatively preserved. As the TA pathway is 
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believed to primarily innervate interneurones, this would lead to decreased inhibition 
in CA1 and production of a ‘seizure prone’ circuit, as this would directly reactivate 
the EC (Denslow et al., 2001). A recent study of entorhinal-hippocampal pathways in 
pilocarpine-treated rats (Ang et al., 2006) also reported that the TA pathway was 
severely disrupted, with concurrent sparing of the perforant pathway to the DG. 
Although the TA pathway changed from primarily inhibitory to powerfully excitatory, 
the authors proposed that pyramidal cell loss from layer III (or indeed CA1) would 
actually dampen this effect. In agreement, Kumar and Buckmaster (2006) have 
provided evidence that the cells lost from layer III are GABAergic interneurones not 
pyramidal cells, and that loss of these neurones would decrease feed-forward 
inhibition of layer II, causing hyperexcitability in layer II stellate cells and hence the 
perforant path.  
 
1.5. Kainate receptors 
 
There are two main families of glutamate receptor, mGlur, which are made up of 
seven transmembrane domains and mediate their responses via G-proteins that initiate 
a chain of events inside the cell and iGlur, which are ion channels that open in 
response to the transmitter. iGlur are principally permeable to sodium (Na+), 
potassium (K+) and calcium (Ca2+) ions and belong to one of three families, NMDAr, 
AMPAr and KAr. There is a wealth of information available on the structure, location, 
properties and function of NMDA and AMPAr (for reviews see Wisden and Seeburg, 
1993; Jonas, 1993; Borges and Dingledine, 1998; Dingledine et al., 1999; Yamakura 
and Simoji, 1999; Cull-Candy et al., 2001, 2006; Gouaux, 2004; Mayer, 2005; Kohr, 
2006; Malinow and Malenka, 2002). Much less is known about the function and 
physiological roles of KAr in the CNS, and this has largely been due to the lack of 
pharmacological agents able to discriminate between AMPAr and KAr. 
 
KA was first isolated from seaweed more than 50 years ago. Davies and Watkins 
(1981) were the first to propose that KA activated a distinct class of iGlur, in 
agreement with the evidence of KA binding sites present in the rat CNS (London and 
Coyle, 1979). However, this was confused by the discovery that AMPAr could also be 
activated by KA (Hollmann et al., 1989). It was not until the early 1990s, after cloning 
of the KAr subunits, that they were unequivocally shown to exist (Bettler et al., 1990; 
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1992; Egebjerg et al., 1991, Herb et al., 1992; Sakamura et al., 1992; Werner et al., 
1991).  
 
1.5.1. Subunit composition and expression 
 
KAr are tetramers, consisting of four subunits, from a possible five (Hollmann and 
Heinemann, 1994), termed GluR5, GluR6, GluR7, KA1 and KA2. GluR5-7 share 
70% sequence homology with each other (Bettler et al., 1990; 1992; Egebjerg et al., 
1991; Sommer et al., 1992), as do KA1 and KA2. However, the KAr subunits show 
only 40% similarity to the GluR subunits (Werner et al., 1991; Herb et al., 1992; 
Sakimura et al., 1992). All five subunits also share some sequence homology with 
both AMPAr (~30%) and NMDAr (~10%) subunits. Like all iGlur subunits, the KAr 
subunits fold to form three trans-membrane domains and one p-loop, which enters the 
plasma membrane from the cytoplasm to form the receptor pore (Bennett and 
Dingledine, 1995; See Figure 1.4.). 
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Figure 1.4. Schematic representation of iGluR subunit topology. (The S1 and S2 
domains form the ligand binding domain) 
 
Expression studies in both Xenopus oocytes and HEK 293 cells have shown that the 
GluR subunits are capable of forming homomeric (Bettler et al., 1991; Egebjerg et al., 
1991; Sommer et al., 1992; Schiffer et al., 1997) and heteromeric (Bortolotto et al., 
1999; Cui and Mayer, 1999; Paternain et al., 2000), low affinity, ligand-gated ion 
channels. KA1 and 2 have been shown to form high-affinity homomeric binding sites 
(Werner et al., 1991; Herb et al., 1992), but they require partnership with at least one 
GluR subunit in order to become a functional receptor (Herb et al., 1992; Sakimura et 
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al., 1992). Both low and high-affinity binding sites have been found in the CNS of 
various species, including rat and human (London and Coyle, 1979). Contractor et al. 
(2003) proposed that higher-affinity binding sites contain a KA subunit whereas the 
lower affinity sites do not. However, expression studies have shown that GluR5/KA2 
heteromers actually have a lower binding affinity than either GluR5 or KA2 
homomers (Herb et al., 1992).  
 
Various groups have mapped the distribution of KAr mRNA expressing cells in the rat 
CNS (Wisden and Seeburg, 1993; Bahn et al., 1994; Tölle et al., 1993) and have 
shown that GluR5-7 and KA2 are prominently expressed throughout the CNS 
including in the cortex, the striatum, the cerebellum and the hippocampus, but that 
KA1 is not so widely expressed. In the rat neocortex all KAr subunits, with the 
notable exception of KA1, are expressed by E14 (Bahn et al., 1994). Although this 
generally remains true through to the adult, there are significant changes in expression 
levels through development. Specifically, expression of the GluR5 subunit tends to 
decrease after P12, although this subunit also has the largest variation, at any given 
age, between different regions of the cortex (Bahn et al., 1994).  
 
There is little information available concerning specific expression patterns of KAr or 
their subunits in the EC. Bahn et al (1994) indicated that KAr subunit expression in 
the EC is broadly the same as the rest of the cortex, with a couple of notable 
exceptions. Expression of KAr in the EC appears later than the rest of the cortex, with 
no expression seen until E19 (Bahn et al., 1994). Also, GluR5 subunit expression is 
never as high as is seen in other cortical regions (Bahn et al., 1994). Like all other 
areas of the cortex, KA1 is hardly expressed in the EC throughout development and in 
the adult rat, whereas KA2 is one of the more highly expressed subunits (Bahn et al., 
1994; Wisden and Seeburg, 1993). Kohama and Urbanski (1997) used a pan-
GluR5/6/7 antibody, and showed dense expression across the whole of the primate 
EC, with little indication of lamina selectivity. A recent in vitro hybridization study 
has suggested a considerable variation in expression of KAr subunits in the human EC 
(Beneyto et al., 2007). GluR7 showed the densest level of expression, with 
intermediate levels of GluR6, KA1 and 2, but only low levels of GluR5. GluR7 also 
showed the most prominent lamina-selectivity with particularly high levels in layers V 
and II/III. 
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1.5.2. RNA editing and alternative splicing 
 
KAr are mostly permeable to Na+ and K+ ions with a low conductivity for Ca2+ 
(Ferrer-Montiel and Montal, 1996). Ca2+ permeability is determined by mRNA 
editing. GluR5 and GluR6 are the only KAr subunits that have been shown to undergo 
mRNA editing. Editing of a glutamine (Q) residue in the pore of these subunits to an 
arginine (R) results in a change in permeation properties (Sommer et al., 1991). 
Unedited versions of the subunits display inwardly rectifying currents as the outward 
currents are blocked by the presence of intracellular polyamines. However, mRNA 
editing causes the I-V relationship to become linear (Bowie and Mayer, 1995; Kamboj 
et al., 1995; Bähring et al., 1997). Editing can also occur at the Q/R site of the trans-
membrane domain 2, which confers a change in single channel conductance and Ca2+ 
permeability i.e. unedited receptors exhibit higher Ca2+ permeability (Burnashev et al., 
1996) and a higher unitary conductance (Swanson et al., 1996) when compared to 
receptors that include one or more edited subunits. The GluR6 subunit also has two 
additional mRNA editing sites located in the trans-membrane domain 1, which also 
effect calcium permeability (Köhler et al., 1993), fully edited GluR6 subunits are left 
essentially impermeable to Ca2+. 
 
As well as mRNA editing, the GluR subunits can also be alternatively spliced to give 
further diversity (see Figure 1.5). All subunit diversity arising from alternative 
splicing of the KAr subunits has been found to play an important role in subunit 
trafficking (Ren et al., 2003b). The GluR5 subunit has been shown to be alternatively 
spliced in its long extracellular N terminus, giving the variants referred to as GluR5-1 
and GluR5-2, which differ in the inclusion of a sequence of 15 amino acids. In 
addition, there is also alternative splicing of the GluR5 C-terminal domain, which 
gives rise to a further three main variants termed GluR5a, b and c (Sommer et al., 
1992) and a further variant, GluR5d, which is only present in humans (Barbon et al., 
2001). GluR6 is also alternatively spliced in the C-terminus giving two main splice 
variants, GluR6a and b (Gregor et al., 1993). There is a further variant, GluR6c, which 
involves the insertion of 15 amino acids in the C terminal domain, and which is only 
found in humans (Barbon et al., 2001). GluR7 also has two functional splice variants, 
GluR7a and b (Schiffer et al., 1997). All variants of the GluR subunits have a 
conserved sequence of 16 amino acids in the C terminal domain, found close to the 
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last trans-membrane domain. As yet KA1 and KA2 have not been shown to undergo 
any splicing or RNA editing.  
 
In addition, several groups have provided evidence for the phosphorylation of KAr 
subunits, which may regulate function (Wang et al., 1993; Ghetti and Heinemann, 
2000). GluR6 has been shown to interact with the PDZ domain of several modulatory 
proteins (Garcia et al., 1998; Hirbec et al., 2003), and this is probably involved in 
receptor trafficking and targeting, as discussed below. 
 
1.5.3. KAr pharmacology 
 
As already mentioned, pharmacological investigation of KAr has been somewhat 
hampered by a lack of selective tools. Until recently, there was difficulty in 
distinguishing between KAr and AMPAr mediated currents, as even KA was found to 
activate AMPAr (Patneau and Mayer, 1991) and, similarly, AMPA was found to 
activate KAr (Herb et al., 1992). However, the development of AMPAr selective, 
non-competitive antagonists such as GYKI 53655 (Paternain et al., 1995), has allowed 
better examination of KAr function, although these antagonists have not been tested 
against all KAr subunits. Studies have shown that the various native KAr have very 
different physiological and pharmacological properties (Wilding and Huettner, 2001). 
KAr are activated by KA with an EC50 of 6–23 µM (Heuttner, 1990) and can be 
blocked by CNQX, the archetypal non-NMDAr antagonist, once AMPAr have been 
blocked (Wilding and Huettner, 1995; Paternain et al., 1996).  
 
Synaptic responses that are mediated by KAr share two main features; the synaptic 
current is smaller than that mediated by AMPAr (about 10% of the total peak current) 
and it has significantly slower deactivation kinetics (Castillo et al., 1997; Vignes et 
al., 1997; Frerking et al., 1998). The slow decay kinetics of these receptors has been 
shown to be an intrinsic property of the receptors (Bureau et al., 2000; Kidd and Issac, 
2001) and not due to an extrasynaptic location as previously suggested (Lerma, 1997). 
Activation of KAr is followed by either deactivation due to ligand unbinding or 
desensitization caused by closing of the ion channel pore while the ligand remains 
bound. KAr desensitize completely and rapidly in response to glutamate, with a time 
constant of approximately 5 ms (Dingledine et al., 1999). This profound 
desensitization, together with slow recovery, is thought to play an important role in 
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determining the frequency and amplitude of excitatory responses and may provide a 
mechanism to prevent excitotoxicity (Frandsen and Schousboe, 2003; Jones and 
Westbrook, 1996).  
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Figure 1.5. Alternative splicing and RNA editing of KAr subunits. RNA edit site 1: 
RNA editing of GluR6 at I/V and Y/C sites in TM1. RNA edit site 2: RNA editing of 
GluR5 (residue 591) and GluR6 (residue 590) at the Q/R site in M2. Splice site 1: 
alternative splicing of GluR5 in the N-terminal domain. Splice site 2: alternative 
splicing of GluR5, GluR6 and GluR7 giving rise to C-terminal splice variants. 
 
As with AMPAr, agonist binding to KAr involves the N terminus and the extracellular 
loop between the last two trans-membrane domains (Armstrong et al., 1998). 
However, the ligand binding cavity in GluR5 subunits is significantly larger than that 
of GluR2 (in AMPAr) or GluR6 subunits (Mayer, 2005). This has enabled the 
development of GluR5 selective ligands which are prevented from binding to other 
subunits by steric occlusion. These include the GluR5 selective agonist ATPA (which 
is also a partial agonist at GluR6/KA2 receptors; Clarke et al., 1997) and UBP 302, 
which is the active s enantiomer of UBP 296, a potent, selective, competitive 
antagonist of all GluR5 containing KAr (More et al., 2004). For a more 
comprehensive list of KAr ligands see Table 1.1. 
 
Several allosteric modulators for KAr have been identified. Plant lectins (e.g. 
concanavalin A) are proposed to block desensitisation of KAr (Partin et al., 1993). 
Also, some cis unsaturated fatty acids (e.g. arachidonic acid) block native KAr 
(Wilding et al., 1998), specifically acting at edited GluR6 and GluR6/5 but only 
weakly inhibiting edited GluR5 or unedited subunits (Wilding et al., 2005). 
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 1.5.4. Trafficking and synaptic targeting 
  
KAr are found both pre and postsynaptically in most regions of the CNS, and, as with 
the other iGlur, controlled, selective, subunit-specific synaptic targeting plays a 
critical role in modifying the strength of excitatory synapses. When compared to the 
trafficking of subunits of the NMDA and AMPAr, relatively little is known about 
KAr. However, recent studies have begun to shed light on distinct motifs that control 
the trafficking and expression of KAr at synaptic sites. 
 
The most studied of the KAr subunits is the KA2 subunit. As mentioned previously, 
these are capable of forming non-functional homomeric complexes. Ren et al. (2003a) 
determined that these KA2 complexes remain in the endoplasmic reticulum unless 
they are co-assembled with a GluR subunit. ER retention is dependent on a motif of 
positively charged arginine residues in the C terminal region. However, the KA2 C 
terminus has also been found to contain an endocytic motif that causes rapid 
endocytosis of the receptor, maintaining a low level of expression of receptors 
containing KA2 at the plasma membrane. It has now been shown that alternative 
splicing of the C terminal region of both GluR5 and GluR6 strongly affects their 
plasma membrane expression (Ren et al., 2003b; Jaskolski et al., 2004). However, 
when trafficking motifs in the C terminus are disrupted, plasma membrane expression 
still occurs once the subunit has assembled with non-modified subunits, therefore, it 
would appear that oligomerisation may be the most crucial element of synaptic 
targeting (Yan et al., 2004). Supporting this suggestion is evidence that GluR6a and 
GluR7a, which have high levels of plasma membrane expression due to forward 
trafficking motifs, can promote the expression of other subunits (Jaskolski et al., 
2004; 2005). 
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Compound Activity Selectivity Reference 
ATPA agonist GluR5, partial agonist at GluR6/KA2 Clarke et al., 1997 
(S)-5-
Iodowillardine agonist 
GluR5, partial agonist at 
GluR6/KA2 
Patneau et al., 1992 
Swanson et al., 1998 
LY 333494 
 
agonist GluR5 Small et al., 1995 
Dysiherbaine agonist GluR5 (but active at mGluR5) 
Sakai et al., 2001 
Swanson et al., 2002 
LU 97175 Competitive antagonist GluR7>GluR5>GluR6 Löscher et al., 1999 
LY 377770 Competitive antagonist GluR5 
O’Neil et al., 1998 
O’Neil et al., 2000 
LY 293884 Competitive antagonist GluR5 
O’Neil et al., 1998 
 
LY 382884 Competitive antagonist GluR5 Simmons et al., 1998
UBP 296 Competitive antagonist 
GluR5, GluR5/GluR6, 
GluR5/KA2 More et al., 2004 
NS 3763 Non-competitive antagonist GluR5 
Christensen et al., 
2004 
SYM 2081 antagonist GluR5, GluR6 (Blocks EEAT2 at high concs.) Zhou et al., 1997 
MSVIII – 19 
  
antagonist GluR5 Sanders et al., 2005 
 
Table 1.1. KAr pharmacology. Adapted from Pinheiro and Mulle (2006). 
 
Additionally, several KAr binding proteins have been found that have been implicated 
in trafficking and synaptic targeting, including PDZ domain-containing proteins. 
SAP97 and PSD 95 cause clustering of KAr (Garcia et al., 1998) and GRIP, PICK1 
and Syntenin associate with GluR5b, GluR5c and GluR6a regulating function and 
synaptic stability of KAr (Hirbec et al., 2003). GRIP and PICK1 are not specific to 
KAr (they are also involved with AMPAr), although they do appear to mediate 
distinct actions. For example, GRIP interactions increase AMPAr function whilst 
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decreasing KAr function (Hirbec et al., 2002). It has also been shown that KAr 
interact with cadherin/catenin complexes, which may not be surprising as these are 
also known to interact with PDZ domain containing proteins, which have been found 
to play an important role in the initial recruitment and stabilisation of receptors at 
newly formed synapses (Coussen et al., 2002). Coussen et al. (2005) have also shown 
that GluR6 interacts with other proteins involved in assembly and trafficking of the 
protein, including dynamin-1and NSF.  
 
1.5.5. Postsynaptic KAr 
 
Development of AMPAr selective antagonists such as GYKI 53655 has enabled the 
investigation into KAr to move forward, identifying them postsynaptically 
contributing to the synaptic current. Postsynaptic KAr were first shown to be present 
on CA3 pyramidal neurones (Castillo et al., 1997), where high frequency stimulation 
of the mossy fibre pathway (in the presence of GYKI 53655 and the NMDAr 
antagonist, 2-AP5), unveiled a CNQX-sensitive current with slow rise and decay 
times. These KAr were believed to be heteromers containing a GluR5 subunit (as the 
response was blocked by LY 29355; Vignes et al., 1997) and a GluR6 subunit (as the 
current was no longer present in GluR6 knockout mice; Mulle et al., 1998). However, 
lack of high quality subunit-selective antibodies still hampers the confirmation of 
these functional studies with immunohistochemistry. It was postulated that these 
postsynaptic KAr were present extrasynaptically, requiring large amounts of 
glutamate to be released in order to spill out of the synapse, reflected by the 
requirement for repetitive stimulation (Mayer, 1997). However, PDC, a glutamate 
uptake inhibitor, has no effect on the kinetics of the KAr mediated current (Castillo et 
al., 1997), suggesting that the slow kinetics are intrinsic properties of the receptors. 
 
Since their discovery in the mossy fibre pathway, postsynaptic KAr have also been 
identified at a variety of other synapses, including in the somatosensory cortex (Kidd 
and Isaac, 2001) and the perirhinal cortex (Park et al., 2006). They were also found on 
interneurones in the hippocampus, where there was no requirement to stimulate at 
high frequency, possibly indicating that the receptors are not extrasynaptic at these 
synapses (Cossart et al., 1998). Also, more recently, a postsynaptic KAr-mediated 
current could be evoked using low frequency stimulation in the superficial layers of 
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the EC (West et al., 2007). This study found that the current was significantly larger in 
the layer III cells than in layer II.  
 
In almost all of the studies where postsynaptic KAr mediated currents have been 
identified (except in the squirrel retina – DeVries and Schwartz, 1999), the time 
constants for activation and desensitization of the receptors have been considerably 
different to what would have been predicted from results in cell culture. Although the 
reasons behind this discrepancy have yet to be elucidated, it has been suggested that 
this could be due to differing subunit composition of native KAr (Lerma et al., 2001). 
In most cases it is assumed that postsynaptic KAr are present in the same synapses as 
other glutamate receptors, specifically AMPAr, although some synapses have been 
shown to solely contain KAr. For example, cortical cells were shown to express both 
AMPAr and KAr (Kidd and Isaac, 1999). However, this study also showed that 
although both KAr mediated slow responses and AMPAr fast responses were seen 
simultaneously, no slow KAr mediated tail was evident on the fast rising responses. 
This suggests that these receptors do not co-localise in single synapses. Kidd and Isaac 
(1999) also demonstrated that the ratio of synapse type changes during development, 
leaving less KAr synapses during the critical period for activity-dependent plasticity. 
 
There is a role for KAr in synaptic plasticity at several synapses. In the somatosensory 
cortex it has been shown that when presynaptic stimulation of thalamo-cortical axons 
is paired with a depolarisation of the postsynaptic cell, KAr-mediated EPSCs undergo 
long term depression (Kidd and Isaac, 2001). Also, in the perirhinal cortex KAr can be 
removed from the postsynaptic membrane in an activity-dependent manner by a 
mechanism involving the interaction between the KAr and PICK1 (Park et al., 2006). 
Finally, it has also been shown that NMDAr-independent synaptic plasticity in the 
mossy fibre pathway can be completely blocked following addition of a GluR5 
subunit selective antagonist (Bortolotto et al., 2004). It has been suggested that, due to 
their long decay times, a decrease in the KAr mediated EPSC would decrease the 
ability of the neurone to temporally summate inputs.  
 
1.5.6. Presynaptic KAr 
 
KAr are present on presynaptic terminals where they have been shown to be involved 
in the regulation of transmitter release. Both facilitation and inhibition of release, at 
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both excitatory and inhibitory synapses have been reported (Contractor et al., 2000; 
Lauri et al., 2001; Min et al., 1999; Rodriguez-Moreno et al., 1997). 
 
In CA3 neurones in the hippocampus, frequency-dependent facilitation of NMDAr-
mediated EPSCs (recorded in the presence of GYKI 53655) is inhibited in the 
presence of CNQX (Schmitz et al., 2001) or LY 382884, the GluR5 subunit selective 
antagonist (Lauri et al., 2001), without change in the response to a single stimulus. 
These results indicate that there is a presynaptic KA autoreceptor acting to facilitate 
the release of glutamate at these synapses. The presence of a presynaptic KAr was 
supported by initial transgenic knockout studies (Contractor et al., 2001; Contractor et 
al., 2003). However, GluR5 knockouts had no effect on paired pulse or frequency 
facilitation, implicating the GluR6 subunit, not GluR5, in direct contrast to the results 
using LY 382884. Subsequently, Pinheiro et al. (2005) have also implicated the 
GluR7 subunit, as GluR7 knockouts show severely disrupted paired pulse facilitation 
(PPF). Therefore, the most likely subunit composition of these autoreceptors is a 
GluR6/GluR7 heteromer.  
 
The mechanism underlying the facilitation by the presynaptic KA autoreceptor is 
likely to be depolarisation of the terminal or direct Ca2+ influx through the receptors 
rather than any metabotropic effect due to the speed of the effect in high frequency 
(100 Hz) trains (Schmitz et al., 2001). Ca2+ imaging supports depolarisation of the 
presynaptic terminals and activation of voltage-gated calcium channels (VGCC; 
Kamiya et al., 2002). However, as the action of presynaptic KAr can also be impaired 
by philanthotoxin (Lauri et al., 2003; Pinheiro et al., 2007), which selectively targets 
unedited Ca2+ permeable glutamate receptors, it is likely that there is some 
contribution of direct Ca2+ influx. Presynaptic KA autoreceptors acting to facilitate 
transmitter release have also been found at synapses of cerebellar stellate and Purkinje 
neurones. Interestingly, in the stellate cells, but not Purkinje, this becomes a 
depression in glutamate release at higher frequency stimulation. This may be due to a 
difference in subunit composition (Delaney and Jahr, 2002). There is also evidence for 
the presence of presynaptic KAr facilitating glutamate release in the olfactory bulb 
(Davila et al., 2007) and the neocortex (Campbell et al., 2007). 
 
Presynaptic KA autoreceptors also appear to inhibit glutamate release at some central 
synapses. For example, during early development, thalamocortical synapses in barrel 
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cortex show a depression of synaptic transmission at high frequency stimulation that is 
removed in the presence of the GluR5 selective antagonist, LY 382884 (Kidd et al., 
2002). Tonically active presynaptic KAr acting to depress glutamate release are also 
present at CA1-CA3 synapses in the hippocampus during early postnatal 
development, as LY 382884 increases the frequency of NMDA mediated mEPSCs in 
the presence of GYKI 53655 (blocking AMPAr). Unlike the KA autoreceptors that 
depress glutamate release in the barrel cortex, autoreceptors in the developing 
hippocampus appear to mediate their effects via a metabotropic action, as the effects 
of LY 382884 (and ATPA, the GluR5 agonist) were blocked by the addition of 
pertussis toxin (Lauri et al., 2006). This metabotropic action mediated by ionotropic 
KAr was first shown in the regulation of GABA release (Rodriguez-Moreno and 
Lerma, 1998), as discussed below. 
 
The first evidence for presynaptic KAr modulating GABA release was presented by 
Rodriguez-Moreno et al. (1997), who showed that in both cultured neurones and 
hippocampal slices, application of KA reduced the frequency and amplitude of 
mIPSCs. Rodriguez-Moreno and Lerma (1998) were the first to suggest a 
metabotropic action of ionotropic KAr because the ability of the receptor to inhibit 
GABA release in the hippocampus were dependent on the activation of a pertussis 
toxin (PTX)-sensitive G-protein, and suppressed by inhibitors of phospholipase C 
(PLC) and protein kinase C (PKC). Since then a wealth of evidence for a metabotropic 
action of presynaptic KAr, at both GABAergic and glutamatergic synapses, has been 
produced (reviewed in Rodriguez-Moreno and Sihra, 2007; see figure 1.6.).  
 
The question of how KAr can interact with G-proteins to mediate metabotropic 
actions has been the source of much debate, as the topology of KAr is unlike that of 
the 7-transmembrane domain G-protein coupled receptors. However, Rozas et al. 
(2003) showed that the GluR5 subunit, is also able to activate a G protein that 
depresses VGCC and, therefore, may be responsible for the ability of KA to depress 
transmitter release. In addition, Ruiz et al. (2005) observed that KAr in CA3 neurones 
associate with G-proteins, as they are precipitated by an anti-GluR6 antibody that co-
precipitates both GluR6 and KA2 subunits. Regardless of this, the mechanisms and 
functional significance of a KAr with both ionotropic and metabotropic modes of 
action remain elusive, although it is interesting to note that AMPAr have also been 
shown to mediate effects via G-proteins (Wang and Durkin, 1995; Wang et al., 1997). 
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 The ability of KAr to mediate both ionotropic and metabotropic actions may help to 
explain the proposed ability to facilitate transmitter release at low concentrations, but 
depress release at higher concentrations at the same synapse. This so called 
bidirectional regulation has been shown to occur at both glutamate (Schmitz et al., 
2001; Lauri et al., 2006) and GABA synapses (Jiang et al., 2001; Braga et al., 2003). 
In addition, Schmitz et al. (2000; 2001) have provided evidence that KAr are present 
at mossy fibre synapses and both facilitate and inhibit GABA release depending on 
the duration of the train. This effect, not evident in autoreceptors, has been suggested 
to be due to different subunit composition (Contractor et al., 2003), but could also be 
explained by the simultaneous metabotropic and ionotropic modes of action.  
 
1.5.7. KAr in synchronisation of neuronal networks 
 
There is increasing evidence that KAr may be involved in normal and pathological 
synchronisation of neuronal networks. KAr have been implicated in several types of 
oscillation, including reducing the frequency of theta oscillations in the hippocampus 
(Huxter et al., 2007). Cunningham et al. (2003) showed that nanomolar doses of both 
KA and domoic acid (the potent KAr agonist) induced gamma oscillations in the EC 
in the absence of input from the hippocampus. In a more recent paper, GluR5-
containing homomeric KAr have been shown to have a role in the maintenance of 
these KA-driven gamma oscillations, as UBP 302 and NS 3763 (the homomeric 
GluR5 selective KAr antagonist; Christensen et al., 2004) reduced peak amplitude and 
spectral power of the oscillations (Stanger et al., 2008). In addition, UBP 302 partially 
inhibited the generation of the oscillations, suggesting that GluR5 containing receptors 
are at least partly responsible for their induction. It is also interesting to note that 
gamma oscillations have been shown to occur in superficial layers of the EC in rats 
who show neuronal loss in layer III of the EC following KA induction of chronic 
epilepsy, but not in control (Tolner et al., 2005).  
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Figure 1.6. Metabotropic actions of KAr. A: Presynaptic KAr activation enhances 
GABA release from interneurone terminals onto CA1 pyramidal cell dendrites via a G 
protein coupled to PLC, which generates second-messenger DAG activating PKC 
(target unknown)B: Activation of presynaptic KAr on glutamatergic SC terminals 
decreases glutamate release onto CA1 neurone via presynaptic G-protein activation 
and regulation of voltage-dependent Ca2+ entry. Activation of postsynaptic KAr on 
CA1 pyramidal cells effects decrease of a Ca2+-activated K+ current via a G-protein-
mediated activation of PLC and downstream PKC. PKA and mitogen-activated 
protein kinases are also involved. C: KAr produce a bimodal effect on glutamate 
release from MFs depending on the agonist concentration;, [KA] > 100 nM decreases 
glutamate release following activation of a G protein and the modulation of AC and 
PKA activity, [KA] < 100 nM facilitates glutamate release following activation of AC 
and PKA. Postsynaptic KAr on CA3 pyramidal cells decrease IAHP current via G-
protein, PLC and PKC activation. D: Activation of postsynaptic KAr inhibits voltage-
dependent Ca2+ channels through a G-protein- and PKC-dependent mechanism. At 
DRGN–dorsal horn neurone synapses, activation of presynaptic KAr by ATPA 
decreases glutamate release in a potentially G-protein-dependent manner.  
 
1.5.7.1. Slow wave oscillations 
 
SWO are rhythmically repeating, large amplitude events, which occur at a frequency 
of less than 1 Hz and are a prominent feature of the EEG during sleep in mammals. 
They are very similar between species (Zhu et al., 2006) and, thus, are thought to have 
a relatively conserved function. The intracellular correlate in single neurones is 
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characterised by periods of irregular tonic firing and a membrane potential fluctuating 
around -60 mV (an ‘up’ state) interspersed by periods of hyperpolarisation (a ‘down’ 
state). They are often referred to as up-states, and occur in tandem with the SWO of 
the EEG. These were initially found in the thalamus, in both the thalamo-cortical and 
thalamic reticular nucleus (Steriade et al., 1993), where they are intrinsic (i.e. require 
no network input), and can be initiated by stimulating cortico-fugal fibres or 
application of mGlur agonists. SWO can also be generated in cortical neurones by 
decreasing Ca2+ concentrations, although, in contrast to thalamic neurones, they do 
require network input (Sanchez-Vives and McCormick, 2000). 
 
The ‘up’ state component is extremely similar in dynamics, almost indistinguishable, 
to the active or waking state. This similarity is easily observed both in EEG and 
extracellular recordings (for review see Destexhe et al., 2007), and has been 
confirmed by comparing membrane potential dynamics of excitatory and inhibitory 
conductances using intracellular recordings by Steriade et al. (2001) and indirectly 
through modelling studies (Alvarez and Destexhe, 2004). The relationship between 
the ‘up’ state and the waking state has been interpreted as being important for the 
transfer of memory traces from the hippocampus to the neocortex (Destexhe et al., 
2007). This theory is supported by studies in humans, which show that increases in 
average power density of SWO after a specific learning task are associated with an 
increased task performance (Huber et al., 2004). Additionally, artificially boosting 
slow oscillations by transcranial application of oscillating fields increases retention of 
declarative memories. 
 
1.5.7.2. SWO in the parahippocampal region 
 
An oscillation of less than 1 Hz has been shown to occur in the hippocampus in slow 
wave sleep and under anaesthetic, which corresponds with the neocortical SWO 
(Wolansky et al., 2006). Not surprisingly, taking into account the critical positioning 
of the EC between the neocortex and the hippocampus, they also found that it 
correlated with slow oscillatory field and multiunit activity in the superficial layers of 
the EC. This indicated that the hippocampal SWO may be coordinated with SWO 
from the neocortex via input from the TA pathway. This was confirmed by Isomura et 
al. (2006) who found that neocortical SWO engages neurones in prefrontal, 
somatosensory, entorhinal, subicular cortices and DG into synchronous transitions 
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between up and down states and affects the CA1 and CA3 regions of the 
hippocampus.  
 
This work has instigated the investigation into SWO in the EC. Spontaneous SWO 
were observed in layer II neurones in EC slices obtained from neonate (P9-13) rats, 
where they were shown to be NMDAr-dependent (Jones and Heinemann, 1989). 
Similar events have also been induced in adult rat EC slices by a moderate reduction 
in [Mg2+]o (from “normal” 2mM to 1.25 mM). In these experiments, SWO were 
abolished by the GluR5 antagonist, UBP 302 (Cunningham et al., 2006). However, 
although these experiments suggested that NMDAr were not involved (Cunningham et 
al., 2006), further work in this laboratory suggests that these SWO can be reduced or 
abolished by either the KAr antagonist or the competitive NMDAr antagonist 2-AP5 
(Greenhill and Jones, unpublished data). Thus, both KAr and NMDAr appear to 
contribute to SWO in the EC. 
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Figure 1.7. SWO in the EC. A: Concurrent recordings of the LIII field potential and 
a LIII pyramidal neurone showing the spontaneous generation of SWO in layer III 
when extracellular magnesium is reduced. B: Application of the GluR5 receptor 
antagonist UBP 302 (20 μM) abolished the SWO. At the asterisk, a depolarising 
current step demonstrates the continued ability to evoke neuronal responses. 
 
1.5.7.3. Pathophysiological roles of KAr 
 
Evidence supporting a role for KAr in various pathological conditions has begun to 
accumulate. The GluR6 allele has been associated with early onset Huntington’s 
disease (Macdonald et al., 1999) and GluR6 mediated excitotoxicity has been 
implicated in the pathology of the disease (Rubensztein et al., 1997). The GluR5 gene 
is located on chromosome 21q22.1 (Barbon and Barlati, 2000) which is a region 
triplicated in Down’s syndrome. A disruption in GluR6 transmission has also been 
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identified in both autism (Jamain et al., 2002) and schizophrenia (Bah et al., 2004). 
Also, in schizophrenia, a reduction in both GluR6 and KA2 mRNA in the 
hippocampus has been demonstrated (Porter et al., 1997). 
 
A large majority of the evidence has been for the possible involvement of KAr in 
epilepsy. It has been known for many years that systemic or local administration of 
KA produces seizures and patterns of neuronal damage that are closely reminiscent to 
those observed in patients with epilepsy (Ben-Ari, 1985). Thus, KA administration has 
become a common method to induce an animal model of the disease. But is it the KAr 
itself which is mediating these pathological actions of KA? Several authors have 
provided evidence in agreement with this hypothesis. GluR6 knockouts decrease 
susceptibility to KA induced epilepsy (Mulle et al., 1998), although this was more 
pronounced for lower concentrations of KA. KAr mRNA has been found to be altered 
in temporal lobe epilepsy patients (Mathern et al., 1998) and the GluR5 allele (Sander 
et al., 1997) but not the GluR6 allele (Sander et al., 1995) increases susceptibility to 
the development of juvenile absence seizures. These observations indicate that the 
KAr plays an important role not just in KA induced epilepsy but also in the epileptic 
disorder in general. 
 
Since KAr appear to mediate a decrease in GABA release in various brain regions 
(Rodriguez-Moreno et al., 1997; Braga et al., 2003), some authors have postulated 
that this may be responsible for the acute epileptogenic activity of KA, giving rise to 
the idea of KAr antagonists being a possible future therapy for epilepsy. There has 
been some evidence to support this theory. For example, Smolders et al. (2002) 
showed that selective GluR5 antagonists (LY 377770 and LY 382884) prevent the 
development of epileptiform activity induced by pilocarpine in hippocampal slices and 
also prevent limbic seizures provoked by both chemical and electrical stimulation in 
awake animals. In addition, the anticonvulsant, topiramate, has been shown to protect 
against seizures caused by a GluR5 specific KAr agonist (Kaminski et al., 2004). 
 
However, this does not reconcile well with the ability of KAr to increase GABA 
release in some brain regions (Cossart et al., 2001) or indeed take into account the 
varied actions of KAr at glutamatergic synapses. It may be that the traditional 
assumption that a collapse in inhibition is responsible for epileptic activity is 
incorrect. It is possible that an increase in GABA-mediated inhibition may lead to an 
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enhancement of hypersynchronous gamma activity and ‘over binding’ thus 
precipitating epileptogenesis (Medvedev, 2002; see Section 1.3.2.). In addition, it has 
also been recently suggested that an accumulation of chloride may lead to a change in 
the reversal potential of GABAergic currents causing a shift from inhibition to 
excitation, as is seen in development (Cossart et al., 2005). Therefore, it is possible 
that an decrease in GABA release could prove to be beneficial in epilepsy. 
 
Whilst a direct activation of KAr, whether to decrease or increase inhibition, may 
account for the acute actions of KA it does not explain the chronic epilepsy that is 
generated long after the KA treatment. However, recent evidence has also implicated a 
more long-term involvement of KAr in TLE, specifically in the sprouting of mossy 
fibres (Epsztein et al. 2005), a well known feature of the disease (Sutula et al., 1989). 
Mossy fibre axons reroute following epileptic cell death to synapse with granule cell 
dendrites in the inner molecular layer of the DG creating a hyper-excitable circuit. 
Epsztein et al., (2005) have shown that in pilocarpine treated rats a prominent KAr 
mediated current (blocked by SYM 2081) was present in dentate granule cells that 
was not seen in control and also that SYM 2081 also acted to reduce the epileptiform 
activity in the presence of high K+ artificial cerebrospinal fluid (aCSF). 
 
Collectively these results show that KAr are involved in several forms of oscillatory 
behaviour including oscillations occurring as a result of epileptogenesis and therefore 
possibly play a role in the synchronisation of cortical networks and that adaptive 
changes in receptor function or expression may be in part responsible for the 
pathological synchronisation underlying epilepsy. 
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CHAPTER 2 
 
METHODS 
2.1. Introduction 
 
In order to investigate the function of KAr in the EC I have utilised the 
electrophysiological technique of whole-cell voltage-clamp. In this technique a patch 
pipette is placed close to the cell body and negative suction is applied to form a high 
resistance electrical seal. The membrane contained within the tip of the electrode is 
then ruptured by application of further negative pressure so that the patch pipette then 
becomes electrically continuous with the inside of the cell. This allows currents to be 
measured in the whole cell enabling us to monitor the changes caused by the opening 
and closing of ligand gated ion channels on the postsynaptic membrane. These are 
excitatory or inhibitory post synaptic currents (E/IPSCs) depending on whether they 
are mediated by the amino acids glutamate or GABA, respectively. 
 
I have looked at the role of KAr in mediating both pre- and postsynaptic effects of 
glutamate. Analysis of the effects of the application of various agonists and 
antagonists for ligand gated ion channels, has allowed me to gain information about 
the presence and function of these receptors at postsynaptic sites on glutamatergic 
neurones, and on presynaptic terminals of both glutamate and GABA neurones. To 
look at the postsynaptic contribution of KAr to excitatory responses, I evoked EPSCs 
(eEPSCs) by stimulating presynaptic pathways electrically using an external electrode 
placed on the surface of the slice, and used antagonists of other receptors to 
pharmacologically isolate the KAr component.  
 
In order to study presynaptic KAr, we would ideally like to record directly from the 
presynaptic terminals themselves. However, with a few exceptions (e.g. Calyx of Held 
terminals, CA3 mossy fibre boutons), this is not feasible as terminals in cortical areas 
like the EC are too small to be visualised and patched directly. Presynaptic effects of 
KAr activation were therefore inferred from two approaches. Firstly, from alterations 
in eEPSCs and evoked IPSCs (eIPSCs) induced by agonists and antagonists. Secondly 
by monitoring changes in frequency of postsynaptic currents, resulting from the 
spontaneous release of glutamate or GABA from presynaptic terminals, which results 
in the spontaneous openings of postsynaptic channels. Thus the sEPSCs and sIPSCs 
can be used as a reporter or recorder of presynaptic transmitter release, which can give 
us information regarding the mechanisms that control the release of transmitter, such 
as the presence of presynaptic KAr. 
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2.2. Slice preparation 
 
Combined entorhinal-hippocampus slices were prepared from male juvenile Wistar 
rats (21-35 days old; 45-70 g), as described previously (Jones & Heinemann, 1988). 
All experiments were performed in accordance with the U.K. Animals (Scientific 
Procedures) Act 1986, European Communities Council Directive 1986 (86/609/EEC) 
and the University of Bath ethical review document. In initial experiments, rats were 
first anaesthetised using an i.m. injection of ketamine (120 mg/kg) plus xylazine (8 
mg/kg) and then decapitated. In later studies the animals were killed by cervical 
dislocation followed by decapitation without prior anaesthetic. Whilst the former 
approach produced better quality, longer lasting slices, there was no apparent 
difference in the results gained with either approach, so no distinction has been made 
between them.  
 
Following decapitation, the brain was rapidly removed and immersed in oxygenated 
aCSF (see below for composition) chilled to around 4 °C. The cerebellum was then 
removed and the brain bisected along the midline. A small slab of tissue was removed 
from the dorsal surface of the brain and this provided a flat surface on which the 
remainder of the brain was fixed, ventral surface upwards, to a Teflon slicing block 
using cyano-acrylate glue. The block plus brain was then immersed in the slicing 
chamber of a Campden Vibroslice (Campden Instruments), which was filled with 
chilled aCSF oxygenated with carbogen gas (95 % O2 / 5 % CO2). Slices were then 
cut through the brain from a caudal direction using a vibrating ceramic blade moved 
horizontally through the tissue at a slow speed. The frequency of vibration 
(intermediate) and speed (approximately 1.5 mm/min) at which the slices were cut 
were both chosen according to previous experience in the laboratory as providing the 
best structural preservation and viability of tissue as possible. Slices were discarded 
until the most ventral portion of the hippocampus and the rhinal fissure could be seen. 
From this point, slices (4-6; 350 µM thick) from each hemisphere, and containing the 
hippocampus, dentate gyrus, the subicular areas, and the entorhinal and perirhinal 
cortices, were dissected away from the rest of the brain (Figure 2.1). 
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Figure 2.1. Schematic diagram of the combined entorhinal-hippocampal slice 
showing the location of CA1 and CA3 pyramidal cells, dentate gyrus granule cells and 
the medial and lateral entorhinal cortex. 
 
These slices were then removed as they were cut and transferred to storage in a BSC-
PC chamber (Warner Instruments; figure 2:2) containing aCSF at room temperature. 
This allows up to 12 brain slices to be safely stored in vitro while maintaining 
excellent slice viability. Carbogen gas was bubbled into the chamber, and this initiates 
a circular flow of oxygen enriched aCSF, which continuously permeates the slices 
allowing them to remain viable for up to 8 hours while awaiting transfer to the 
recording chamber. 
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Figure 2.2. Schematic diagram of the BSC-PC slice holding chamber. 
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Slices were left to equilibrate in storage for at least one hour before being transferred 
individually, when required, to a recording chamber mounted on the stage of an 
upright Olympus BX50WI microscope. The chamber was perfused (2ml/min) with 
oxygenated aCSF and temperature was set at 31 ± 1 ºC using an inline heater (SH-
27B, Warner Instrument Corporation) and a thermostatically controlled feedback 
power supply (TC-324, Warner Instruments). Slices were allowed to further 
equilibrate in the recording chamber for 30 minutes before recording was attempted.  
 
Slices were visualised using a CCD infrared video camera (KP-M1E/K, Hitachi 
Kokusai Electric Inc.). All neurones for this study were recorded in the medial EC 
from layer III (unless otherwise indicated). Cells were selected based upon their 
appearance as healthy, undamaged neurones with clear pyramidal morphology. 
However, although the neurones studied were presumed to be glutamatergic 
pyramidal neurones, no attempt was made to retrospectively confirm this using dye 
injection techniques and post-hoc morphological identification. 
 
2.3. aCSF  
 
The standard artificial cerebrospinal fluid used for dissection, slicing and recording 
contained (in mM) NaCl (126), KCl (3) NaH2PO4 (1.4), NaHCO3 (19), MgSO4 (2), 
CaCl2 (2), and D-glucose (10). The dissection and slicing solution also contained 
ketamine (an NMDA receptor antagonist which at higher doses may also bind to 
opioid receptors that induces dissociative anaesthesia; 150 µM), indomethecin (a non-
steroidal anti-inflammatory drug which inhibits the production of prostaglandins; 45 
µM) and either n-acetyl-l-cysteine (NAC; derivative of the amino acid L-cysteine, and 
is a precursor in the formation of the antioxidant glutathione in the body and is able to 
reduce free radicals; 6 µM) or uric acid (Uric acid is the final product of purine 
metabolism in humans and there is increasing evidence showing that uric acid has an 
important role in vivo as an antioxidant (for review see Glantzounis et al., 2005); 300 
µM), all of which we have determined from experience in this lab can increase the 
survival and viability of neurons. In the experiments where reduced [Mg2+]o was 
employed, the storage and recording aCSF was modified to contain KCl at 3.75 mM 
and MgSO4 at 1.25 mM. 
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2.4. Recording 
 
Patch pipettes (open tip resistance 1–4 MΩ) were pulled from borosilicate glass 
(PG120T-10, 1.2 mm O.D. x 0.93 mm I.D., Harvard Apparatus) on a Flaming/Brown 
microelectrode puller. Pipette tips were coated with a layer of surf board wax (Mr. 
Zog’s Sex Wax) to minimise pipette-bath capacitance and electrical noise. Whole-cell 
voltage-clamp recordings were made of the EC using an Axopatch 200B amplifier. 
 
For EPSC recordings patch pipettes were filled with a Cs-gluconate-based patch 
solution containing the following (in mM): D-gluconate (100). HEPES (40), QX-314 
(1), EGTA (0.6), NaCl (4), MgCl2 (5), tetraethylammonium-Cl (1), ATP-Na (4), GTP-
Na (0.3). The solution was adjusted to 275 mOsm by dilution and set to pH 7.3 with 
CsOH. Using this patch solution and with membrane potential nominally voltage 
clamped at –60 mV, neurones continuously displayed sEPSCs which were primarily 
mediated by sodium ion entry through AMPA receptors activated by spontaneous 
glutamate release from presynaptic terminals (cf. Berretta and Jones, 1996a).  
 
For inhibitory recordings patch pipettes were filled with a Cs-based patch solution 
containing the following (in mM): CsCl (100), HEPES (40), QX-314 (1), EGTA (0.6) 
MgCl2 (5), tetraethylammonium-Cl (10), ATP-Na (4), GTP-Na (0.3). The solution 
was again adjusted to 275 mOsm by dilution and set to pH 7.3 with CsOH. Using this 
patch solution and with membrane potential again voltage clamped at –60 mV, 
neurones continuously displayed sIPSCs which were mediated by chloride (Cl-) ion 
entry through GABAAr activated by spontaneous GABA release from presynaptic 
terminals (cf. Woodhall et al., 2005). 
 
2.5. Evoked responses 
 
To investigate postsynaptic KAr at glutamate synapses and presynaptic KAr at both 
glutamate and GABA synapses we examined eEPSCs and eIPSCs. These studies 
involved electrically activating the presynaptic neurones/axons via a bipolar platinum 
electrode. Stimulating electrodes were positioned with the tips on the surface of the 
slice in layer V of the lateral EC close to the recording pipette in layer III (see figure 
2.3). Stimulus pulse duration was 0.05 ms with intensity (constant voltage: 1 - 10 mV) 
and stimuli controlled using a either a Grass S48 Stimulator or a Master-8 pulse 
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generator (A.M.P.I. Ltd, Jerusalem) coupled to a DS2 stimulus isolation unit 
(Digitimer Ltd.). The stimulus intensity was set to give an initial evoked response that 
was approximately 80% of maximal. Stimulation was delivered in trains of varying 
frequencies. Train parameters were set using the Grass S48 stimulator or Master 8. A 
number of different stimulation protocols were used and these will be described in 
detail in the relevant chapters. 
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Figure 2.3: Diagrammatic representation of the combined EC-hippocampal brain 
slice showing the positioning of the bipolar stimulating electrodes used elicit 
eI/EPSCs in layer III of the mEC. 
 
2.6. Activity-independent synaptic events. 
 
Spontaneous transmitter release is comprised of two components. Both glutamate and 
GABA can be released as a consequence of action potentials invading the presynaptic 
terminal, and subsequent Ca2+-influx through voltage-gated Ca2+-channels. The 
second component is action potential-independent, reflects random monoquantal 
release of transmitter, and is independent of extracellular Ca2+. Blocking voltage-gated 
Na+ channels and, thus, action potentials can abolish activity-dependent release. This 
allows isolation of the activity-independent events, so called “miniature” or mEPSCs 
and mIPSCs. These have been examined in a number of studies in this thesis by 
blocking presynaptic action potentials by bath perfusion with TTX (1 µM).  
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2.7. Data acquisition and analysis 
 
Whole-cell voltage clamp recordings were filtered at 2 - 5 kHz and digitised (Digidata 
1200B, Axon Instruments) at 20 - 50 kHz. Data were recorded to computer hard disk 
using Axoscope software. Series resistance compensation was not used, but access 
resistance (10–30 MΩ) was monitored at regular intervals throughout each recording, 
and cells were discarded from analysis if it changed by more than ± 10 %. Liquid 
junction potentials (LJP) were estimated using the calculator of pClamp 8 software. 
With the patch solution employed for EPSC recordings this was +12.6 mV, and with 
IPSC patch solution it was +10.13 mV. The junction potentials were not routinely 
compensated for in the holding potentials, but were in cases where current-voltage 
relationships were examined. 
 
Recordings were saved on-line to computer hard disc using AxoScope software (Axon 
Instruments). All data (spontaneous and evoked responses) were analysed off-line 
using Minianalysis software (Synaptosoft, Decatur). Analysis of evoked PSCs largely 
consisted of measuring peak amplitudes. However, in some experiments rise and total 
decay times of evoked potentials were also examined.  
 
Spontaneous events (either sEPSC/IPSCs or mEPSC/IPSCs) were detected 
automatically using a threshold-crossing algorithm and their interevent interval (IEI, 
inversely proportional to frequency), amplitude, rise (10-90%) and total decay times 
determined. Threshold was determined in order to detect the smallest spontaneous 
events above baseline noise and was maintained at a constant level, individually set 
for each neurone. When comparing s/mEPSCs or s/mIPSCs a minimum of two 
hundred events during a continuous recording period was sampled in control 
conditions and compared to the same number of events recorded in the drug perfusion 
periods. As noted, events were detected and marked automatically, but each event file 
was manually inspected in order to discard any events that were clearly non-biological 
from subsequent analysis. To compare pooled data under control and drug conditions, 
we determined mean values for event parameters in each cell and calculated the mean 
values for the population, using a paired t-test or one way analysis of variance 
(ANOVA) with Bonferroni Test, where appropriate, for statistical comparison. In 
addition, cumulative probability distributions of IEI were also determined and 
statistically compared using the non-parametric Kolmogorov-Smirnoff (KS) test.  
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 In a number of studies of evoked PSCs we also conducted a ‘before and after’ 
analysis. In these studies, the number of sEPSCs or IPSCs in a 1s time period 
immediately before a stimulus train was determined and compared (together with 
event amplitude) to the number in the 1s immediately after the train. Event number 
and amplitude were statistically compared using a paired t-test.  
 
For evoked EPSCs the mean amplitudes of the events in at least three consecutive 
trains were calculated for each condition (control vs drug).  
 
All error values stated refer to the standard error of the mean. 
 
2.8. Pharmacological studies 
 
All drugs were applied by inclusion in the bath perfusion medium. Specific 
application protocols are given in the relevant data chapters. Control recordings were 
conducted for periods of at least 10 minutes or more to ensure stability. Data sampling 
in the presence of drugs was conducted at least 10 minutes after the drug had reached 
the recording chamber. Bath volume was maintained at approximately 700 µl. Dead-
time after changing perfusion solutions was approximately 40 seconds, so with the 
perfusion rate employed exchange of drug solutions in the recording chamber was 
quite rapid. After completion of a successful pharmacological protocol on a recorded 
neurone, the slice was discarded and each new study performed on a naive slice 
transferred from the holding chamber. 
 
2.9. Drugs used. 
 
Drugs were made up as stock solutions (indicated below), aliquoted and stored at - 
20ºC. They were thawed immediately before use and diluted to the desired 
concentration in aCSF. 
 
2-AP5 (D-2-Amino-5-phosphonopentanoic acid), Tocris, UK. For stock solution 
dissolved in water. 
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ATPA ((RS)-2-Amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid), 
Tocris, UK. For stock solution dissolved in water. 
 
Bicuculline methiodide ([R-(R*,S*)]-5-(6,8-dihydro-8-oxofuro[3,4-e]-1,3-
benzodioxol-6-yl)-5,6,7,8-tetra-hydro-6,6-dimethyl-1,3-dioxolo[4,5-g]isoquinolinium 
iodide), Tocris, UK. For stock solution dissolved in water. 
 
CGP 55845A ((2S)-3-[[(1S)-1-(3,4-Dichlorophenyl)ethyl]amino-2-hydro 
xypropyl](phenylmethyl)phosphinic acid), Tocris, UK. For stock solution dissolved in 
DMSO. 
 
CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione), Tocris, UK. For stock solution 
dissolved in DMSO. 
 
GYKI 53665 (1-(4-aminophenyl)-3-methylcarbamoyl-4-methyl-3,4-dihydro-7,8-
methylenedioxy-5H-2,3-benzodiazepine) a kind gift from Dr Dick Evans, formerly of 
Bristol University. For stock solution dissolved in DMSO. 
 
MK 801 (Dizocilpine maleate), Tocris, UK. Dissolved in patch solution. 
 
NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione), Tocris, 
UK. For stock solution dissolved in DMSO. 
 
NS 3763 (4,6-Bis(benzoylamino)-1,3-benzenedicarboxylic acid), Tocris, UK. For 
stock solution dissolved in DMSO.
 
PDC (L-trans-Pyrrolidine-2,4-dicarboxylic acid), Tocris, UK. For stock solution 
dissolved in water. 
 
SR 95531/Gabazine (6-Imino-3-(4-methoxyphenyl)-1(6H)-pyridazinebutanoic acid 
hydrobromide), Tocris, UK. For stock solution dissolved in water. 
 
SYM 2206 ((±)-4-(4-Aminophenyl)-1,2-dihydro-1-methyl-2-propylcarbamoyl-6,7-
methylenedioxyphthalazine), Tocris, UK. For stock solution dissolved in DMSO. 
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TTX (Tetrodotoxin) with citrate, Alomone Labs., Israel. For stock solution dissolved 
in water. 
 
UBP 302 ((S)-1-(2-Amino-2-carboxyethyl)-3-(2-carboxybenzyl)pyrimidine-2,4-
dione), Tocris, UK, and also a gift from Dr Dave Jane, University of Bristol. For stock 
solution dissolved in 1 eq. NaOH. 
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CHAPTER 3 
 
SPONTANEOUS EXCITATION AND INHIBITION IN 
LAYER III PRINCIPAL NEURONES 
 
  47
3.1. Introduction 
 
As noted in Chapter 1, increasing attention is being focused on layer III of the EC, 
both in terms of physiological function (e.g. Erchova et al., 2004; Cunningham et al., 
2003; 2006) and pathological dysfunction (e.g. Du et al., 1993; 1995; Gloveli et al., 
2003). In contrast to neurones in other layers of the EC, less is known about basic 
properties of layer III neurones. Our laboratory has previously described in detail the 
characteristics the sEPSCs and sIPSCs in layers II and V of the rat EC in vitro 
(Berretta and Jones, 1996a; Woodhall et al., 2005) and shown clear differences 
between the two layers. During the course of the work described in this thesis I have 
made many recordings of spontaneous synaptic events in layer III neurones. 
Therefore, the aim of this chapter is to describe the properties of background 
spontaneous excitatory and inhibitory currents in layer III, to provide a more complete 
picture of layer III neurones and enable a comparison to what has been previously 
published for deeper and more superficial layers. 
 
Berretta and Jones (1996a) compared sEPSCs in layers II and V in the rat EC using 
whole cell patch clamp. They showed that the frequency of sEPSCs was similar in the 
two layers, but the events in layer V had a slightly larger mean amplitude, faster rise 
time, and were faster to decay. They attributed this to the presence of a population of 
larger events in the layer V neurones that were not present in layer II. They also noted 
that the frequency of sEPSCs in both layers was reduced by TTX to a similar extent 
(15-20%). However, the amplitude distribution was unchanged in layer II, whereas in 
layer V TTX blocked most of the larger amplitude sEPSCs. In terms of the 
pharmacology sEPSCs, most were abolished by addition of NBQX (or CNQX), 
indicating that the majority of sEPSCs in these layers were mediated by AMPAr. 
There was a small proportion of events left in NBQX that had a slower time course 
and were abolished by 2-AP5, indicating they were mediated by NMDAr. Although 
very infrequent, NMDAr-mediated events were more evident in layer V than layer II. 
 
Woodhall et al. (2005) compared the properties of sIPSCs in layers II and V in the rat 
EC. They showed that the sIPSCs were apparently exclusively mediated by GABAAr, 
as were abolished by gabazine. They had similar average amplitude and decay times 
but 10-90% rise times were slightly faster in layer V. However, the major difference 
between the layers was in frequency. The frequency of events in layer II neurones was 
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4-5 times greater than that seen in layer V. When recorded in the presence of TTX, 
the frequency of events was more than halved in layer V, whereas there was only a 
slight reduction in layer II, indicating that the large majority of events in layer II are 
action potential-independent. High frequency bursts of sIPSCs were seen in both 
layers but they occurred much more frequently in layer II than in layer V. Although, 
there was little difference in average decay or rise times in layers II or V, detailed 
analysis of the decay kinetics of individual sIPSCs indicated that they could be 
subdivided according to the relative decay and or rise times. It was suggested that this 
could indicate inputs from different subtypes of interneurones and/or inputs at 
different somatodendritic locations. 
 
Thus, this chapter aims to extend our knowledge of the properties of neurones in the 
EC by providing a characterisation of sEPSCs and sIPSCs in layer III and to compare 
these characteristics to those previously reported in other principal neurones of the 
EC. 
 
3.2. Methods 
 
In all experiments in this chapter, brain slices were prepared from juvenile animals 
aged from 3-5 weeks old (45 - 70 g). sEPSCs and sIPSCs were recorded from 
neurones in layer III of the medial division of the EC. In all recordings examining 
IPSCs, 2-AP5 and GYKI 53665 were included in the bath to block NMDAr and 
AMPAr respectively.  
 
Although recordings have been made from over 250 neurones, analysis in this chapter 
was limited to selected populations of high quality recordings i.e. cells with good 
access resistance (<15 MΩ; which was calculated from a 10 mV voltage step of 10 ms 
at a holding potential of -60 mV) which remains stable for the duration of the 
recording and high input resistance (>200 MΩ; calculated from the current shift at the 
end of the 10 ms pulse). Recordings were also only included in the analysis for this 
chapter if the holding current was less than 100 pA and if the holding current was 
remained unchanged throughout the experiment. For analysis, two hundred events 
during a continuous recording period were sampled for each neurone under each 
condition. Mean values for IEI, amplitude, rise and decay times were determined for 
each neurone from the 200 events. Pooled data were compared by averaging means 
  49
from the population and a Student’s t-test was used for comparison. Pooled data were 
also compared by constructing cumulative probability distributions and non-
parametric statistical analysis with the KS test. 
 
3.3. Results 
 
3.3.1. Characterisation of sEPSCs. 
 
3.3.1.1. Amplitude and frequency of sEPSCs 
The detailed analysis of sEPSC frequency and amplitude was conducted on 
representative whole-cell recordings made from a total of 15 neurones in layer III of 
the medial EC. At a holding potential of -60mV, neurones in layer III of the EC 
exhibited EPSCs as spontaneously occurring inward currents (Figure 3.1A). The mean 
IEI of sEPSCs was 217 ± 32 ms, which corresponds to a mean sEPSC frequency in 
the 15 neurones of 4.6 ± 1.0 Hz. This is considerably faster than that previously 
reported for either layer II and V cells (1.4 ± 0.1 Hz and 1.4 ± 0.1 Hz respectively; 
Beretta and Jones, 1996a; Figure 3.1B). Although sEPSC frequencies vary 
considerably from cell to cell and study to study, overall, layer III clearly shows a 
higher frequency of sEPSCs than either its deeper (V) or more superficial (II) 
counterparts (cf studies in Jones and Woodhall, 2005). 
 
The mean amplitude of sEPSCs in these neurones was 13.7 ± 0.9 pA. This is closer to 
that seen in layer II than layer V (13.24 ± 0.26 pA and 15.67 ± 0.52 pA respectively; 
Beretta and Jones, 1996a; Figure 3.1D). sEPSCs rarely exceeded 60 pA in amplitude. 
As in both layers II and V, the distribution of layer III sEPSCs was represented by a 
histogram with a single peak, skewed toward larger amplitude events. This is shown 
in Figure 3.1 together with the comparison with previous data from layers II and V. 
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Figure 3.1. Comparison of sEPSC amplitude and frequency in EC neurones. A: The 
traces are consecutive voltage clamp recordings from a typical layer III neurone. The 
downward deflections are sEPSCs. B: The graphs show the mean frequency of 
sEPSCs in layer III, compared to values for layers II and V (data from Berretta and 
Jones, 1996a). C: Frequency distribution of sEPSC amplitudes in layer III neurones 
(bin width = 1). The distribution shows a single peak, skewed toward larger 
amplitude events. D:  Comparison of average sEPSC amplitudes in layer III with 
layer II and V (data from Berretta and Jones, 1996a).  
 
3.3.1.2. sEPSC bursts 
 
In their analysis of sEPSCs, Beretta and Jones (1996a) described the presence of 
prominent bursts in layer V (see Fig 1A Beretta and Jones, 1996a), but these occurred 
infrequently in layer II. In layer III neurones, burst activity (defined as at least 3 
events in a 50 ms time frame) was seen in most neurons (13/15) although it was not 
particularly frequent (1.8 ± 0.3 bursts per neurone). Examples can be seen in Figure 
3.2. Analysis gave an inter-burst interval of 6.4 ± 2.4 s. The mean number of events 
per burst was 3.4 ± 0.1. Further analysis of these bursts revealed that the IEI of 
sEPSCs within bursts was 11.1 ± 1.5 ms and the mean duration was 38 ± 3 ms. 
Unfortunately, such detailed analysis of bursts was not presented by Beretta and Jones 
(1996a), so it is not possible to make any detailed comparisons. However, as it is 
likely that bursts in these neurones are driven by pyramidal neurones within the EC 
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(as excitatory inputs from outside the EC would have been largely removed during 
slice preparation) the increase propensity for bursting in layer III may be a reflection 
of high baseline firing rates in principal neurones connected by extensive recurrent 
excitatory collaterals in this layer compared to layers II and V. 
 
50 ms
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10
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Figure 3.2. Bursts of sEPSCs in layer III neurones. The traces are voltage clamp 
recordings showing bursts of sEPSCs (defined as at least three events within a 50 ms 
time frame) from typical layer III neurones. Bursts are indicated by the dotted line 
above the trace. Bursting activity was seen in most cells but within cells they were not 
particularly frequent. 
  
3.3.1.3. Effect of TTX on EPSCs 
 
Spontaneous transmitter release at synapses occurs in two ways. The first of these is 
caused by the opening of VGCC following an action potential that invades the 
terminal. This is often referred to as ‘true’ spontaneous (action potential-dependent) 
release. Random, monoquantal release can also occur, and this is held to be 
independent of action potentials and Ca2+ entry into the terminals, so called 
‘miniature’ events. Separation of the two can be achieved by blocking action 
potentials with TTX.  
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In 6 layer III neurones, TTX (1 µM) increased the IEI (decreased frequency) of events 
by more than six-fold from 217.4 ± 32 ms to 1359.6 ± 261 ms (n=6; KS test – P < 
0.0001; Figure 3.3A,B). This represents a decrease in frequency from 6.5 ± 1.0 Hz to 
0.9 ± 0.2 Hz, indicating that a very large majority of sEPSCs in this layer are action 
potential-dependent. This contrasts with the situation in both layers II and V where 
application of TTX only caused a 15-20 % reduction in the frequency of sEPSCs 
(Beretta & Jones, 1996a; Figure 3.4C) showing that the majority of events in these 
layers are action potential-independent. However, layer III shows some similarity to 
layer V in that TTX also caused a shift in the cumulative amplitude distribution (KS 
test – p < 0.0001; Figure 3.3D) towards smaller events, suggesting a loss of larger 
amplitude events, an effect not seen in layer II neurones (Beretta & Jones, 1996a). 
However, the mean amplitude of layer III sEPSCs remains unaffected (13.8 ± 0.9 pA 
vs. 12.5 ± 1.1 pA; Figure 3.3E). TTX also had no effect on the mean decay time (from 
5.4 ± 0.5 to 4.6 ± 0.4) or 10-90 % rise time (from 1.8 ± 0.1 to 1.8 ± 0.2). 
 
3.3.1.4. Kinetics of sEPSCs 
 
sEPSCs in layer III had a mean 10-90% rise time of 1.8 ± 0.1 ms and a decay time of 
5.4 ± 0.5 ms (n = 15). This is very similar to kinetic properties previously found for 
layer V (rise time = 1.9 ± 0.1 ms and decay time 5.7 ± 0.3 ms; Beretta and Jones, 
1996a). sEPSCs in layer II display comparatively slower rise and decay kinetics (rise 
time = 2.5 ± 0.1 ms and decay time 8.0 ± 0.4 ms; Beretta and Jones, 1996a; Figure 
3.4). Differences in kinetics may be due to differences in electrotonic properties of 
neuronal subtypes. Previously, electrotonic lengths have been estimated during 
whole-cell voltage-clamp recordings (Berretta and Jones, 1996a; Jones, unpublished). 
Electrotonic lengths in layer V and III were found to be similar, whereas layer II 
neurons were less compact. A similarity in electronic length between layer V and 
layer III neurones may reflect the similar sEPSC kinetics. It has been suggested by 
several studies that as a result of electrotonic filtering (the distortion of synaptic 
currents as a function of distance from the soma – Spruston et al., 1993), correlation 
of kinetic parameters may enable the identification of postsynaptic events arising from 
different cell surface domains (McBain and Dingledine. 1992). In view of this 
correlations were sought between rise time and decay time in layer III neurones, and 
also between rise time and amplitude for the pooled data of both sEPSCs and 
mESPCs. Figure 3.4D & E clearly shows that there were no significant correlations 
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for any of these parameters either for spontaneous or miniature EPSCs with r2 values 
all less than 0.1. This is perhaps unsurprising as Cs was included in the patch solution 
which would decrease space clamp errors by blocking potassium channels and 
therefore differences in kinetic parameters of events arising from various distances 
from the soma would be largely unapparent. 
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Figure 3.3. Comparison of sEPSCs and mEPSCs in EC neurones. A: The traces are 
consecutive voltage clamp recordings from a typical layer III neurone in the absence 
and presence of TTX (1 µM). B: Cumulative probability graph of IEI of sEPSCs 
compared to mEPSCs from layer III neurones (n=6). C: Graph of change in 
frequency after addition of TTX (frequency of sEPSC-frequency of mEPSC) in layer 
III neurones, compared to layer II and V neurones (data from Berretta and Jones, 
1996a). D: Cumulative probability graph of amplitude (n=6) of mEPSC and sEPSC 
amplitudes in layer III neurones. E: Comparison of sEPSC and mEPSC mean 
amplitudes in layer III. 
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Figure 3.4. Kinetics of sEPSCs and mEPSCs in EC neurones. A, B: The graphs 
shows mean decay time (A) and 10-90% rise time (B) of layer III sEPSCs, compared 
to layer II and V (data from Berretta and Jones, 1996a). C: Trace of average EPSC 
(n=60; scaled for amplitude) in the presence (red) and absence (black) of TTX (1 
µM). D, E: Graphs showing correlations between rise time and decay and also 
between rise time and amplitude for sEPSCs (D) and mEPSCs (E). 
 
3.3.1.5. Pharmacology  
 
Bath perfusion with NBQX (10 µM) completely abolished sEPSCs in layer III 
neurones (Figure 3.6) indicating that they are mediated primarily by non-NMDAr, 
most probably AMPAr. In confirmation of this, SYM 2206 (20 µM) or GYKI 53665 
(25 µM) also abolished the sEPSCs (not shown). In contrast, neither UBP 302 (20 
µM) nor 2-AP5 (50 µM) had any effect, indicating that GluR5 KAr or NMDAr  do 
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not contribute markedly to sEPSCs (further analysis included in Sections 4.3.1.2 and 
4.3.6.). However, unlike in layers II and V (Beretta and Jones, 1996a), there was no 
real evidence of slower, NMDA receptor mediated sEPSCs in the presence of NBQX 
at -60mV. However, when the holding potential was shifted towards positive values 
slow time course events (at +20 mV DT - 18.7 ± 3.2 and RT – 2.9 ± 0.6) did become 
apparent. These events reversed at around 0 mV and increased in amplitude at 
positive holding potentials. These are characteristics of NMDA receptor mediated 
events. In confirmation of this, they were abolished in the presence of 2-AP5 (50 µM; 
Figure 3.6C).  
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Figure 3.5. Pharmacology of sEPSCs in layer III neurones. The traces are voltage 
clamp recordings from 3 typical layer III neurones in control (A) and after addition of 
NBQX (B). NBQX (10 µM) effectively abolished sEPSCs. C: Consecutive traces from 
a typical layer III neurone in the presence of NBQX at -60, -40 and +40 mV and after 
the addition of 2-AP5 (50 µM). 
 
3.3.2. Characterisation of sIPSCs 
 
Woodhall et al. (2005) presented a detailed comparison of the properties of sIPSCs in 
layer II and layer V of the medial EC. I have now examined sIPSC properties in layer 
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III recorded under practically identical conditions. In the recording conditions 
employed (symmetrical Cl-) sIPSCs are manifest as fast inward currents at a holding 
potential of -60 mV (Figure 3.6A). These events reverse at 0 mV, to become outward 
currents at positive potentials. Again, recordings have been made in many neurones, 
but a sample of high quality neurones have been selected for use in this analysis. 
 
3.3.2.1. Amplitude and frequency of sIPSCs  
 
The detailed analysis of sIPSC characteristics were conducted on representative whole 
cell recordings made from a total of 19 neurones in layer III of the medial EC. The 
mean IEI of sIPSCs in the 19 neurones was 112 ± 21 ms which corresponds to a mean 
sIPSC frequency of 15.5 ± 2.8 Hz (Figure 3.6). This is of the same order that was 
previously reported for layer II cells (IEI – 87 ± 2 ms; Woodhall et al., 2005), but 
substantially faster than in layer V (IEI – 404 ± 10 ms; Woodhall et al., 2005). 
 
sIPSCs in layer II and layer V show an amplitude distribution represented by 
histograms with a single peak, skewed toward larger amplitude events (Woodhall et 
al., 2005). The same was seen in layer III (figure 3.6C). The mean amplitude of 
sIPSCs in the sample of 19 neurones in layer III was 30.9 ± 2.0 pA. This is larger than 
that reported for both layer II and layer V (24.0 ± 1.8 pA and 25.7 ± 3.9 pA, 
respectively; Figure 3.6D). 
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Figure 3.6. Comparison of sIPSC amplitude and frequency in EC neurones. A: The 
traces are consecutive voltage clamp recordings from a typical layer III neurone. The 
downward deflections are sIPSCs. B: The graphs show the mean frequency of sIPSCs 
in layer III, compared to values for layers II and V (data from Woodhall et al., 2005). 
C: Frequency distribution of sIPSC amplitudes in layer III neurones (bin width = 3). 
The distribution shows a single peak, skewed toward larger amplitude events. D:  
Comparison of average sIPSC amplitudes in layer III with layer II and V (data from 
Woodhall et al., 2005).  
 
3.3.2.2. IPSC bursts 
 
As with sEPSCs, sIPSCs can occur in bursts in EC neurones. In the previous analysis 
of sIPSCs in layers II and V a major difference was found to be in the frequency of 
bursts (defined as at least 3 events in a 50 ms time frame). These were found to occur 
at a much higher frequency in layer II than in layer V (inter-burst interval - 653 ± 79 
ms vs. 5447 ± 627 ms; Woodhall et al., 2005). I have examined the characteristics of 
sIPSC bursts in layer III neurones (Figure 3.7A). In the 19 layer III neurones, I found 
the inter-burst interval to be 574 ± 48 ms, a very similar frequency to that seen in 
layer II and much more frequent than V (Figure 3.7B). However, the number of 
events per burst was closer to that seen in layer V (3.5 ± 0.1 compared to 5.8 ± 0.7 in 
layer II and 3.7 ± 0.2 ms in layer V; Figure 3.7C). Further analysis of the bursts 
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revealed that the frequency of IPSCs within bursts was slightly faster in layer III than 
that seen in either layers II or V (15 ± 0 ms compared to 19 ± 1 ms in layer II and 19 ± 
1 ms in layer V) but that the mean duration of the bursts was less (37 ± 1 ms 
compared to 93 ± 9 ms in layer II and 80 ± 5 ms in layer V).  
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Figure 3.7. Bursts of sIPSCs in layer III neurones: Comparison to layer II and V. 
A: The traces are voltage clamp recordings showing bursts of sIPSCs (defined as at 
least three events within a 50 ms time frame) from typical layer III neurones. Bursts 
are indicated by the dotted line above the trace. B,C: Histograms showing mean 
inter-burst interval (B) and number of sIPSCs per burst (C)  for layer III, compared to 
layer II and V (data from Woodhall et al., 2005).  
 
3.3.2.3. Effects of TTX on sIPSCs. 
 
As with glutamate release, GABA release consists of spontaneous events (action 
potential driven) and miniatures (action potential-independent). The IEI of sIPSCs in 
the presence of TTX (1 μM) approximately doubled from 112 ± 21 ms to 238 ± 44 ms 
(n=10; KS test – P<0.0001; Figure 3.8). This represents a decrease in frequency from 
15.5 ± 2.8 Hz to 6.0 ± 1.1 Hz, indicating that approximately half of the IPSCs in layer 
III are action potential-dependent. This effect is similar to that seen in layer V where 
the IEI more than doubled (from 368.2 ± 13.1 ms to 979.9 ± 31.5 ms; Woodhall et al., 
2005). In contrast, in layer II, TTX had little or no effect (Woodhall et al., 2005) 
showing that action potential driven release is almost non-existent in layer II in the 
slice preparation. In terms of absolute numbers of sIPSCs, layer III neurones showed 
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a much greater decrease than layer V in the presence of TTX, as a result of their 
higher sIPSC frequency to begin with (Figure 3.8C).  
 
Neither layer II nor V showed any significant difference in amplitude comparing 
sIPSCs with mIPSCs (Woodhall et al., 2005). In contrast, in layer III, application of 
TTX also caused a shift in the cumulative amplitude distribution (KS test – P<0.0001; 
Figure 3.8D) towards smaller events, suggesting a loss of large amplitude events. This 
was also reflected by the decrease in mean amplitude of IPSCs in the presence of TTX 
(from 30.9 ± 2.1 pA to 23.7 ± 1.7 pA; n=10; t test – P<0.01; Figure 3.8E).  
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Figure 3.8. Comparison of sIPSCs and mIPSCs in EC neurones. A: The traces are 
consecutive voltage clamp recordings from a typical layer III neurone in the absence 
and presence of TTX (1 µM). B: Cumulative probability graph of IEI (n=10) of 
sIPSCs and mIPSCs in layer III neurones. C: Histogram showing the change in 
frequency after addition of TTX (frequency of sIPSC-frequency of mIPSC) in layer III 
neurones, compared to layer II and V neurones (data from Berretta and Jones, 
1996a). D: Cumulative probability graph of amplitude (n=10), comparing mIPSC and 
sEPSC in layer III. E: Comparison of sEPSC and mIPSC mean amplitudes in layer 
III. 
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3.3.2.4. Kinetics of sIPSCs 
 
sIPSCs in layer III had a mean decay time of 15.8 ± 1.5 ms, which is longer than those 
seen in the other layers (layer II – 10.5 ± 0.1 ms vs. 10.6 ± 0.11 in layer V; Figure 
3.8A). Mean 10-90% rise times (2.2 ± 0.2 ms) were broadly similar to those reported 
for both layer II and layer V (2.0 ± 0.03 ms and 1.9 ± 0.03 ms respectively; Woodhall 
et al., 2005; Figure 3.9B). Application of TTX, appeared to slightly alter time to 
decay time (from 5.9 ± 0.5 to 4.9 ± 0.3) and 10-90% rise time (from 2.2 ± 0.5 to 2.4 ±  
0.2) but the differences were not significant.  
 
As has been suggested for sEPSCs, correlation of kinetic parameters of postsynaptic 
inhibitory events may enable the identification of inputs to different cell surface 
domains (Maccaferri et al., 2000). I therefore looked for correlations between rise 
time and decay, and also between rise time and amplitude for the pooled data of both 
sIPSCs and mISPCs. Such analysis in layer II and layer V neurones failed to identify 
any significant correlations between rise time and amplitude, or rise and decay time in 
either population (Woodhall et al., 2005). Figure 3.9D and E clearly shows that there 
were also no significant correlations for these parameters in layer III either, with r2 
values less than 0.15. Again this is unsurprising due to the inclusion of Cs in the patch 
solution. Although Woodhall et al., (2005) could separate populations of neurones in 
both layer II and V on the basis of decay time, this analysis has not been attempted 
here due to the relatively small number of layer III cells available. 
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Figure 3.9. Kinetics of sIPSCs and mIPSCs in EC neurones. A, B: The graphs 
shows mean decay time (A) and 10-90% rise time (B) of layer III sIPSCs, compared to 
layer II and V (data from Woodhall et al., 2005). C: Trace of average EPSC (n=60) 
in the presence (red) and absence (black) of TTX (1 µM). D, E: Graphs showing 
correlations between rise time and decay and also between rise time and amplitude 
for sIPSCs (D) and mIPSCs (E). 
 
3.3.2.5. Pharmacology  
 
Bath application of gabazine (20 µM) rapidly abolished sIPSCs (Figure 3.10A,B) 
indicating that they are primarily mediated by GABA acting at GABAAr. It should be 
noted that addition of gabazine had no effect on the holding current. This indicates 
that the GABAA receptor mediated standing tonic current in a variety of other 
neurones (Brickley et al., 1996; Nusser and Mody, 2002) is not found in layer III.  
  62
These results are similar to those in layers II and III where gabazine abolished sIPSCs 
without affecting holding current (Woodhall et al., 2005). 
 
Bath application of strychnine (1 µM) appeared to slighty increase the IEI of sIPSCs 
in layer III neurones from 168 ± 117 ms to 198 ± 134 ms. This effect was marginal, 
but in the small sample of neurones tested (n=3) just reached significance when 
assessed by KS analysis of cumulative probability (P<0.01; Figure 3.10C). Thus, 
there may be a small contribution of glycine mediated sIPSCs in layer III (in contrast 
to layers II and V; Woodhall et al., 2005). Previous work from this laboratory has 
suggested that presynaptic NMDAr may facilitate GABA release in layer II but not 
layer V. However, there are not tonically active as 2-AP5 has no effect on sIPSC 
frequency (Jones and Woodhall, 2005). Similar results were found in layer III 
neurones where 2-AP5 (50 µM) had no effect on sIPSC frequency (Figure 3.10D). 
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Figure 3.10. Pharmacology of sIPSCs in layer III neurones. The traces are voltage 
clamp recordings from 3 typical layer III neurones in control (A) and after addition of 
gabazine (B). Gabazine (20 µM) effectively abolished sIPSCs. C: Cumulative 
probability graph of IEI (n=3) comparing control to strychnine conditions. D: 
Cumulative probability graph of IEI (n=4) comparing control to 2-AP5 conditions. 
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3.4. Discussion 
 
Examination of spontaneous synaptic activity in layer III revealed some interesting 
differences from the deeper and more superficial layers. This thesis has focused on 
layer III due to its involvement in TLE (e.g. Du and Schwarcz, 1992; Du et al., 1995; 
Tolner et al., 2005) and SWO (Cunningham et al., 2006). In view of the relative lack 
of physiological and pharmacological studies carried out in layer III in comparison to 
the other layers of the EC, it is interesting to consider how the properties of 
spontaneous activity may affect synaptic behaviour in relation to generation of 
synchronous behaviour. 
 
3.4.1. sEPSCs 
 
Neurones in layer III exhibited continuous spontaneous excitatory activity and the 
characteristics of sEPSCs were generally similar to those recorded in the other layers 
(Berretta and Jones, 1996a; Woodhall et al., 2001a; Jones and Woodhall, 2005) in that 
they were abolished by NBQX (and other AMPAr antagonists) and therefore are 
largely mediated by non-NMDAr, primarily AMPAr. However, more in depth 
analysis indicated that there are obvious differences between the spontaneous activity 
in layer III compared that in other layers of the EC. What is perhaps surprising is that 
there are substantial differences between layer III and layer II, which provide the 
afferent input to the hippocampus, and substantial similarities to layer V, which is the 
major relay of hippocampal output (Dugladze et al., 2001; Insausti et al., 1997; Witter 
et al., 1989a, b; Sorensen, 1985). 
 
The most pronounced difference between the sEPSCs in layer III compared to the 
other layers is the much higher frequency of events. It is also noteworthy that bursts 
of activity occurred frequently in layer III. Thus, the higher levels of spontaneous 
glutamate release in layer III may be due to a greater number of synaptic contacts onto 
these neurones. However, it seems more likely to be associated with an increased 
firing rate and/or connectivity of the neurones in layer III, since TTX had a 
pronounced effect (decreasing frequency five fold). Paired recordings of single axon 
connections have shown a high degree of connectivity between neurones in layer III, 
somewhat higher than layer V, and considerably higher than layer II (Dhillon and 
Jones, 2001). Thus, it could be postulated that the high frequency of sEPSCs in layer 
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III is a reflection of high baseline firing rates in principal neurones connected by 
extensive recurrent excitatory collaterals. There is also evidence for a high degree of 
electrical coupling between layer III principal neurones via gap junctions (Dhillon and 
Jones, 2001), which could further contribute to the high level of baseline glutamate 
release.  
 
The distribution of sEPSC amplitudes in layer III showed a single peak, skewed 
toward larger amplitudes, similar to that seen in layers II and V (Berretta and Jones, 
1996a). Also, similar to the other layers, it is unlikely that this variability is due to 
sEPSCs originating from different sites on the dendritic tree, as amplitudes showed no 
correlation with sEPSC kinetics, as would have been expected if synaptic location 
was a major factor (McBain and Dingledine, 1992). Therefore, it is more likely to be 
caused by variability at individual synapses. Although differences between layers 
were small, average peak amplitude, was similar to that in layer V neurones and larger 
than layer II (Berretta and Jones, 1996a). Berretta and Jones (1996a) suggested that 
the differences in amplitude of sEPSCs between layers II and V was most likely due 
to a greater activity-dependent presynaptic release in the latter. Activity-dependent 
sEPSCs in layer V are likely to be mediated by multi-quantal release of glutamate. In 
layer II there was no change in the amplitude distribution in TTX and therefore both 
the action potential-independent and dependent release are probably mediated by the 
release of single quanta. TTX does not completely abolish large amplitude events in 
layer V (Berretta and Jones, 1996a) and the same is true in layer III. These data 
suggest something else may be contributing to the difference in EPSC amplitude 
between layers in the EC. As there was no correlation between amplitude and rise 
time it seems unlikely that differences in electrotonic length are responsible for 
difference in amplitude of sEPSCs between layers. As noted above, recurrent 
excitatory connectivity is high in layers III and V but low in II (Dhillon and Jones, 
2001). It may be that the large amplitude, activity-dependent events reflecting release 
from other excitatory afferents. 
 
The kinetics of sEPSCs in layer III are very similar to layer V, rather than the much 
slower kinetics of layer II sEPSCs. Berretta and Jones (1996a) suggested that 
electrotonic filtering was a factor in the different kinetics of layers II and V, as they 
estimated superficial neurones have greater electrotonic length. The majority of 
principal neurones in layer III are spiny stellates (Alonso and Klink, 1993, Jones, 
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1993), which have relatively complex dendritic arborisations compared to the 
principal neurones in layer V, which are medium-size pyramidal neurones 
(Buckmaster et al., 2004; Hamam et al., 2002). Layer III neurones are also medium 
sized pyramidal neurones (Gloveli et al., 1997; Dhillon and Jones, 2001; Buckmaster 
et al., 2004; Tahvidori and Alonso, 2005). The similarity in morphology between 
layer III and V neurones probably means they are similar electronically, as has been 
estimated previously (Dhillon and Jones, 2001), and may explain similar kinetics of 
sEPSCs in the two layers. 
 
There may also be a difference in the contribution of NMDAr in layer III compared to 
layers II and V. When AMPAr mediated sEPSCs were blocked in layers II and V, 
residual pure NMDAr mediated sEPSCs occured even at negative holding potentials 
(Berretta and Jones, 1996a). The authors suggested that this indicated a strong 
NMDAr mediated excitation in these neurones (greater in layer V than layer II) 
compared to other brain regions where NMDAr mediated sEPSCs could only be 
detected at positive holding potentials (e.g. CA3 – MacBain and Dingledine, 1992). In 
layer III observation of NMDAr mediated sEPSCs required somewhat more positive 
holding potentials. The difference was small, and its significance unclear. One 
possibility is that there may be differences in subunit composition of postsynaptic 
NMDAr, and hence voltage sensitivity (see Cull-Candy et al., 2001), in layer III 
compared to II and V. It is also interesting that 2-AP5 reduces frequency in both layer 
II and V (Beretta and Jones, 1996a; Woodhall et al., 2001a) but did not in layer III. 
This may indicate that tonic facilitation of glutamate release by presynaptic NMDAr 
(Beretta and Jones, 1996b; Woodhall et al., 2001a) is not operative in layer III (see 
also Section 4.3.6.). 
 
The GluR5 KAr antagonist UBP 302, failed to alter sEPSC frequency, amplitude or 
kinetics of sEPSCs in layer III (or layer V, see Section 7.3.3.). Thus, it is clear that 
these receptors (either pre- or postsynaptically) are unlikely to be accessed by 
spontaneously released glutamate. In any case, sEPSCs were abolished by NBQX or 
GYKI 53665 indicating that KAr of any subunit composition were unlikely to 
contribute to spontaneous excitation. This contrasts with studies in CA3, where 
GYKI-resistant mEPSCs have been observed, which are presumed to result from KAr 
activation (Cossart et al., 2002). 
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3.4.2. sIPSCs 
 
Neurones in layer III also exhibited continuous spontaneous inhibitory activity. The 
characteristics of these sIPSCs were generally similar to those recorded in the other 
layers of the EC (Woodhall et al., 2005). They were completely abolished by 
gabazine, and therefore are mediated by GABAAr. Also, as in layer II and V, gabazine 
had no effect on holding current indicating an absence of the tonic background current 
that is a feature of GABAergic synapses in other brain regions (Brickley et al., 1996a; 
Nusser and Mody, 2002). It should be noted that strychnine did slightly reduce the 
frequency of sIPSCs in layer III. This could indicate that a few sIPSCs may be glycine 
receptor mediated. However, the difference was very small and it should be stressed 
that gabazine essentially abolished sIPSCs so any contribution of glycine receptors is 
likely to be insignificant in terms of total background inhibition. 
 
Interestingly, sIPSCs in layer III had clearly larger amplitudes and longer decay and 
rise times than the events previously described for the other layers of the EC. In the 
presence of TTX the amplitude of sIPSCs was reduced and was no longer different 
from the average amplitude seen in layers II and V. However, time to decay and rise 
time was still significantly larger. The change in amplitude in the presence of TTX, 
was not seen in layers II and V (Woodhall et al., 2005). It may be that activity-
dependent sIPSCs in layer III are the result of release of multiple quanta whereas in 
layers II and V they are mediated by the release of single quanta. This does not, 
however, explain the slower kinetics of sIPSCs in layer III as these are unaffected by 
the addition of TTX.  However, it has been shown in several brain areas, including the 
hippocampus (Pearce, 1993) that GABAAr can mediate much slower IPSCs (decay 
time 30-70ms) as well as the more typical fast IPSCs (3-8 ms) which may represent a 
different subunit composition of postsynaptic recptors. In layer III neurones, 
approximately 25% of the IPSCs recorded have decay times greater than 20 ms and 
therefore the longer average decay time in these neurones when compared to layers II 
and V may indicate a greater contribution of these slower GABAA mediated IPSCs. 
There has also been some recent evidence to suggest that the slower GABAA 
mediated IPSCs may result from the activation of specific types of interneurone 
(Szabadics et al., 2007) and it is possible that the difference in rise and decay times in 
the EC between layers may be due to the differential contribution from interneurone 
subtypes. 
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Woodhall et al. (2005) noted that the most pronounced difference between layers II 
and V was in frequency of sIPSCs, with layer II sIPSCs occurring four times faster 
than those in layer V. They suggested that it was likely that this was due to a greater 
number of interneurones and/or more synaptic contacts per interneurone in layer II. 
sIPSC frequency in layer III was if the same order as in layer II. My data would 
indicate that the same applies to layer III, with pyramidal cells receiving a large 
number of GABAergic inputs, similar to layer II and much more pronounced than 
layer V. This would fit with the general density of GABAergic interneurones revealed 
by immunohistochemical studies (Kohler and Chan-Palay, 1982, 1983; Lotstra and 
Vanderhaeghen, 1987; Rogers, 1992; Wouterlood et al., 1995; Fujimaru and Kosaka, 
1996; Miettinen et al., 1996, 1997; Mikkonen et al., 1997; Wouterlood and Pothuizen, 
2000; Wouterlood et al., 2000; Arellano et al., 2002). 
 
One of the major differences between layers was in the contribution of activity-
dependent vs. independent release. Thus, in layer II, TTX had little effect on sIPSC 
frequency whereas it reduced it by around 60% in layer V (Woodhall et al., 2005). In 
layer III, the very high initial frequency of sIPSCs was halved by TTX. Thus, layer V 
neurones undergo a low level of spontaneous inhibition which is primarily driven by 
interneurone firing. Layer II neurones have a very high level of background 
inhibition, that is largely independent of spontaneous firing in interneurones. 
Whereas, layer III has a high level of background inhibition but a large proportion of 
this results from spontaneous interneurone firing. It is apparent that oscillatory 
activity in networks can depend on interneurone-interneurone and/or principal-
interneurone interactions (Cunningham et al., 2003). The high level of action potential 
driven inhibition and excitation in layer III may indicate a high level of 
interconnectivity in the network of this layer. The pronounced burst activity in both 
excitatory and inhibitory activity may also reflect this interconnectivity. This may be 
associated with the susceptibility of layer III to synchrony and oscillations 
(Cunningham et al., 2003; 2006a; b). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 4 
 
LOCALIZATION AND FUNCTION OF KAR AT 
GLUTAMATERGIC SYNAPSES IN LAYER III 
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4.1. Introduction 
 
In the previous Chapter I described the properties of spontaneous excitatory events in 
layer III neurones. Pharmacogical data suggested that KAr were unlikely to contribute 
directly to mediating events occurring in response to spontaneous glutamate release. 
However, because KAr have been shown to be widely involved in excitatory 
transmission elsewhere, the aim of the work in this Chapter was to identify the 
presence and role of presynaptic KAr at glutamatergic synapses in layer III of the EC. 
A major role of KAr is to presynaptically control neurotransmitter release at 
excitatory synapses throughout the CNS (Kidd et al., 2002; Schmitz et al., 2001; 
Lauri et al., 2001; Jin et al., 2006; Lauri et al., 2006; Campbell et al., 2007). The 
nature of this control has been the subject of controversy, with evidence for both 
facilitation (Schmitz et al., 2001) and inhibition (Jin et al., 2006) of glutamate release. 
 
The area where presynaptic KAr have been most intensely studied is in the 
hippocampus (see review by Kullmann, 2001). The first evidence for the presence of 
presynaptic KAr came from studies investigating the effects of KA on synaptosomes 
isolated from the hippocampus. Malva et al. (1995) studied the effects of KA on 
intracellular free Ca2+ concentration in hippocampal synaptosomes and concluded that 
there were presynaptic KAr modulating Ca2+ levels in nerve terminals in the CA3 
region, as stimulation with KA caused an increase in intracellular Ca2+. Chittajallu et 
al. (1996) showed that, in hippocampal synaptosomes, brief exposure to KA inhibited 
Ca2+-dependent [3H]L-glutamate release, an effect that was reversed by KAr 
antagonists but not selective AMPAr antagonists. This provided the first evidence that 
presynaptic KAr could inhibit glutamate release. These authors took this further by 
showing that micromolar concentrations of KA, in the presence of an AMPAr 
selective antagonist, reduced NMDAr mediated EPSCs in CA1 neurones. Other 
evidence also suggests that presynaptic KAr act to depress glutamate release in other 
brain regions including the nucleus accumbens (Casassus and Mulle, 2002), in the 
cortex during early postnatal development (Kidd et al., 2002), and at primary sensory 
afferent synapses in the dorsal horn of the spinal cord (Kerchner et al., 2001).  
 
In contrast, presynaptic KAr have also been shown to facilitate glutamate release. 
This was demonstrated in both hippocampal (Malva et al., 1998) and cortical 
synaptosomes (Perkinton and Sihra, 1999). In agreement with Malva et al. (1995; 
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1998), Schmitz et al. (2001) provided direct evidence for a presynaptic KAr in CA3, 
which act to potentiate glutamate release. They suggested that it was KAr activation 
which was responsible for the frequency facilitation at this synapse, which was 
previously thought to be due to residual Ca2+. Subsequently, KAr have been found to 
facilitate glutamate release at many excitatory synapses throughout the CNS, 
including in the amygdala (Li et al., 2001), the cerebellum (Delaney and Jahr, 2002) 
and neocortex (Campbell et al., 2007). 
 
Interestingly, at many synapses where presynaptic KAr facilitates glutamate release 
they have also been found to have an inhibitory action at higher concentrations of 
agonist (Schmitz et al., 2001; Delaney and Jahr, 2002; Campbell et al., 2007). This 
bidirectional modulation of neurotransmitter release was first described at inhibitory 
synapses (Rodriguez-Moreno et al., 1997), but has now been shown to occur at 
excitatory synapses, both when high concentrations of exogenous agonists were 
applied, and also when endogenous glutamate levels are increased by higher 
frequency stimulation (Schmitz et al., 2001; Delaney and Jahr, 2002). However, not 
all glutamatergic synapses where KA autoreceptors facilitate transmitter release 
exhibit this bidirectionality. In some synapses increasing concentrations of agonist 
continue to potentiate release (Li et al., 2001).  
 
The subunit composition of presynaptic KAr located on glutamatergic terminals in 
different brain regions remains a source of much debate. At mossy fibre synapses 
alone GluR6 and 7 and KA1 and 2 have all been suggested to be present (Breustedt 
and Schmitz, 2004; Pinheiro et al., 2007; Darstein et al., 2003 respectively), whereas 
the GluR5 subunit is thought to be involved at excitatory synapses on layer II/III 
pyramidal neurones in the prefrontal cortex (Campbell et al., 2007) and cingulate 
cortex (Wei et al., 2005). 
 
KAr have also been found to contribute to the postsynaptic current at glutamatergic 
synapses in many areas of CNS, including the hippocampus (Castillo et al., 1997; 
Vignes and Collingridge, 1997), somatosensory cortex (Kidd and Isaac 2006), 
prefrontal cortex (Campbell et al., 2007), cingulate cortex (Wei et al., 2005) and 
perirhinal cortex (Park et al., 2006). Again, postsynaptic KAr mediated response were 
initially identified in the mossy fibre pathway, on CA3 pyramidal neurones (Castillo 
et al., 1997; Vignes and Collingridge, 1997). Synaptic responses mediated by KAr 
  71
share two main features, the synaptic current is smaller than that mediated by AMPAr 
(about 10% of the total peak current) and it has significantly slower decay kinetics 
(Castillo et al., 1997; Vignes et al., 1997; Frerking et al., 1998). In addition, KAr 
desensitize completely and rapidly in response to glutamate, with a time constant of 
approximately 5 ms (Dingledine et al., 1999).  
 
Postsynaptic KAr on CA3 neurones were initially thought to contain GluR5 since the 
eEPSC could be reduced by a number of GluR5 antagonists (Vignes et al., 1997). In 
addition, a contribution of GluR6 subunits was indicated as the EPSC is no longer 
present in GluR6 knockout mice (Mulle et al., 1998). However, there has been debate 
as to whether the postsynaptic receptors do contain the GluR5 subunit at this synapse 
as this does not fit with the mRNA expression pattern (Paternain et al., 2000) and the 
EPSC is still present in GluR5 knockout mice (Contractor et al., 2000). Contractor et 
al. (2003) have also suggested a role for the KA2 subunit at mossy fibre synapses, 
because in KA2 subunit deficient mice, although the KAr EPSC is still present, it has 
a significantly decreased decay time, indicating a change in affinity of KA for the 
receptor.  
 
Since their discovery in the mossy fibre pathway, postsynaptic KAr have also been 
identified at other synapses, including in the somatosensory cortex (Kidd and Isaac, 
2001). The KAr mediated EPSC at these synapses exhibited the slow decay kinetics 
seen in the mossy fibre synapse (Castillo et al., 1997). Kidd and Isaac (2001) 
determined that the slow decay is an intrinsic property of KAr and not due to an 
extrasynaptic location as previously suggested (Lerma, 1997), as neither inhibition 
nor facilitation of glutamate clearance has any effect on kinetics. KAr mediated 
synaptic responses have also been found in the superficial layers perirhinal cortex 
(Park et al., 2006), where they are regulated by tonically activated mGluR5. In 
addition, postsynaptic KAr have been found on hippocampal interneurones, where 
they are activated by single stimuli, possibly indicating that the receptors are not 
extrasynaptic at these synapses (Cossart et al., 1998).  
 
More recently, a KAr-mediated EPSC has been demonstrated in the superficial layers 
of the EC (West et al., 2007). It appears to be more pronounced in layer III neurones 
compared to layer II. The KAr eEPSC in the EC displays the same small amplitude 
and slow kinetics as noted in other regions (Castillo et al., 1997; Vignes et al., 1997; 
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Frerking et al., 1998). However, no information concerning the possible subunit 
composition of these receptors is currently available. 
 
Thus, the aims of this chapter were: 1) to determine if presynaptic KA autoreceptors 
are present in layer III of the EC; 2) if KAr autoreceptors are present what is their 
function; 3) to elucidate the possible subunit composition of presynaptic KAr in layer 
III; 4) to determine whether postsynaptic KAr contribute to the evoked EPSC; 5) to 
elucidate the possible subunit composition of the postsynaptic receptors. 
 
4.2. Methods 
 
General recording methods were as described in Chapter 2. To investigate the 
function of KAr specific use of the GluR5 selective antagonist, UBP 302, and the 
GluR5 selective agonist, ATPA, were made.  
 
Isolation of the postsynaptic KAr mediated synaptic current was achieved by using a 
cocktail of 2-AP5 (50 µM), SR 95531 (20µM), CPG 55845A (5µM) and either SYM 
2206 (20 µM) or GYKI 53655 (25µM) to block NMDAr, GABAAr, GABABr and 
AMPAr mediated currents. A stimulus train of either 50 or 100 Hz was used to evoke 
an EPSC large enough for analysis. The mean amplitude and time to decay were 
calculated for three consecutive KAr eEPSCs. 
 
4.3. Results 
 
4.3.1. Presynaptic effects 
 
4.3.1.1. Effects of ATPA on sEPSCs 
 
In the first set of experiments I determined the effect of activating GluR5 KAr with 
the specific agonist, ATPA (0.1 µM and 0.5 µM). In the presence of 0.1 µM ATPA, 
there was a decrease in IEI from 174 ± 32 ms to 78 ± 7 ms (KS test - P<0.001, n=7) 
reflecting a change in frequency from 5.8 ± 1.2 Hz to 9.9 ± 1.0 Hz. A further decrease 
to 60 ± 9 ms occurred (14.6 ± 2.8 Hz) after addition of 0.5 µM ATPA (KS test - 
P<0.001, n=5; Figure 4.1A). Thus, the KAr agonist induced a concentration-
dependent increase in frequency of sEPSCs, with the higher concentration eliciting a 
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3-fold rise. There was no change in the amplitude or kinetics. Averaged sEPSCs for 
control and in the presence of ATPA (n=60) can be seen in Figure 4.1B and table 4.1 
summarises IEI, amplitudes and kinetics of sEPSCs in control and in the presence of 
ATPA. The increase in frequency of sEPSCs with no effect on amplitude or kinetics 
may be an indication that the agonist was acting presynaptically to enhance glutamate 
release. 
 
To determine whether the effect of ATPA was on presynaptic GluR5 KAr on the 
glutamate terminals or was driven by excitation of neurones bearing GluR5 receptors 
on their soma and/or dendrites, I looked at the effect of ATPA on mEPSCs in the 
presence of TTX (1 µM), to block action potential-dependent release. The IEI of 
mEPSCs in control was 359 ± 91 ms. This decreased to 262 ± 82 ms in the presence 
of ATPA (0.1 µM; KS test – P<0.0001; n=4; Figure 4.1D) reflecting an increase in 
frequency from 3.4 ± 0.9 Hz to 5.2 ± 1.5 Hz. The effect of ATPA was completely 
reversed by UBP 302 (20 µM). IEI increased from 262 ± 82 in the presence of ATPA 
to 366.55 ± 111.59 ms after subsequent addition of UBP 302 (KS test – P<0.0001; 
n=4; Figure 4.1D). Neither ATPA nor UBP 302 had any effect on amplitude or 
kinetics of the events (Table 4.1). Thus, the increase in frequency induced by ATPA 
seems likely to be activation of GluR5 containing receptors on the glutamate 
terminals, rather than on cell bodies where activation would lead to an increase in 
action potential-dependent release. 
 
UBP 302 is non-selective in that it targets any KAr containing GluR5 subunits. In 
further experiments I examined the effect of NS 3763, an antagonist that is selective 
for homomeric GluR5 receptors (Christensen et al., 2004). In 3 neurones, ATPA 
decreased IEI from 604 ± 183 ms to 162 ± 65 ms (KS-test – P<0.00001; n=3), 
reflecting a change in frequency from 2.0 ± 0.6 Hz to 8.0 ± 2.4 Hz. Subsequent 
addition of NS 3763 (20 µM) increased IEI to 409 ± 145 ms (3.2 ± 1.2 Hz; KS-test – 
P<0.0001; n=3). However, IEI after addition of NS 3763 is still significantly 
increased from control (KS test – P<0.00001; n=3). NS 3763 had no significant 
effects on amplitude or kinetics of mEPSCs (Table 4.1). Thus, the studies with 
antagonists suggest that the presynaptic autoreceptor are likely to be a mixture of 
GluR5 homomers and heteromers in combination with another KAr subunit.  
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Table 4.1. Effects of GluR5 agonists/antagonists on IEI, amplitude and kinetics of 
sEPSCs and mEPSCs. *indicates a significant change when compared control (P 
<0.001 KS Test). ? indicates a significant change when compared to 0.1 µM ATPA (P 
<0.001 KS Test).  
 
4.3.1.2. Effects of UBP 302 on sEPSCs 
 
The next question I addressed was whether spontaneously released glutamate could 
tonically activate the presynaptic GluR5 receptors. To examine this I tested the effect 
of UBP 302 alone in 10 neurones. IEI in control conditions was 256 ± 512 ms. This 
remained unaltered in the presence of UBP 302 (20 µM; 274 ± 56 ms). Likewise, 
there was no change in amplitude or kinetics of events (Table 4.2). Thus, these 
experiments suggest that ambient glutamate release does not activate presynaptic 
KAr. In addition, the lack of effect of UBP 302 alone (see also Section 3.3.1.5.) 
suggests that GluR5-containing KAr do not contribute postsynaptically to sEPSCs, 
which are likely to be exclusively AMPAr-mediated. 
 
Table 4.2. Summary of IEI, amplitude and kinetics of sEPSCs with UBP 302 alone. 
 
  IEI (ms) Amplitude (pA) 
Decay time 
(ms) 
Rise time 
(ms) 
Control 174 ± 32 10.6 ± 0.7 5.8 ± 0.6 1.5 ± 0.1 
+ ATPA (0.1 µM) 80 ± 7* 11.4 ± 0.7 5.4 ± 0.5 1.4 ± 0.1 sEPSCs 
+ ATPA (0.5 µM) 60 ± 9*^ 11.3 ± 0.4 5.3 ± 0.5 1.4 ± 0.2 
Control 359 ± 91 12.3 ± 0.6 5.9 ± 0.2 1.5 ± 0.1 
+ ATPA (0.1 µM) 262 ± 82* 12.7 ± 0.8 5.5 ± 0.5 1.6 ± 0.1 
+UBP 302 (20 µM) 367 ± 112? 13.3 ± 1.4 5.5 ± 0.3 1.7 ± 0.1 
Control 604 ± 183 8.8 ± 1.3 6.7 ± 0.9 1.7 ± 0.2 
+ ATPA (0.1 µM) 163 ± 65* 10.0 ± 1.2 7.1 ± 0.3 1.4 ± 0.1 
mEPSCs 
+ NS 3763 (20 µM) 409 ± 145*? 8.6 ± 1.6 5.5 ± 0.6 1.7 ± 0.2 
  IEI (ms) Amplitude (pA) 
Decay time 
(ms) 
Rise time 
(ms) 
control 256 ± 52 15.5 ± 3.4 5.2 ± 0.6 1.7 ± 0.2 
sEPSCs + UBP 302 (20 274 ± 56 16 1 ± 1 6 5 9 ± 0 9 1 7 ± 0 1
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Figure 4.1. Effects of APTA on sEPSCs and mEPSCs. A: Concurrent recordings of 
sEPSCs recorded in control conditions and during perfusion of ATPA (100 nM) in a 
typical layer III neurone. B: Cumulative probability graph of sEPSC IEI in control 
conditions and during ATPA (100 and 500 nM) application (n=7). C: Average sEPSC 
for control and after application of ATPA (n=60). D: Concurrent recordings of 
mEPSCs recorded in control conditions and during perfusion of ATPA (500 nM) and 
UBP 302 (20 µM). E: Cumulative probability graph mEPSC IEI in control conditions 
and during ATPA and UBP 302 application (n=4). E: Cumulative probability graph 
of mEPSC IEI in control conditions and during ATPA and NS 3763 (20 µM) 
application (n=3). 
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Figure 4.2. Effects of UBP 302 on sEPSCs. A: Concurrent recordings from 2 
example layer III neurones of sEPSCs in control conditions and during UBP 302 (15 
µM) perfusion. B: Cumulative probability graph of sEPSC IEI in control conditions 
and after UBP 302 application (n=10). C: Averaged sEPSC in control conditions and 
after application of UBP 302 (n=60). 
 
4.3.1.3. eEPSCs in layer III 
 
Using a bipolar stimulating electrode positioned in layer V of the lateral EC a train of 
EPSCs could be evoked in layer III of the medial EC. In these experiments I evoked 
trains of responses with 5 shocks at 5, 10 or 20 Hz. In all stimulus protocols, paired 
pulse facilitation (PPF) could be seen between the first and second shocks. With the 
stimulation frequencies employed the inter-pulse intervals were 200, 100 and 50 ms at 
5, 10 and 20 Hz respectively. The paired pulse ratio seen with these 
frequency/intervals were constant at 1.3 ± 0.1 (n=4), 1.3 ± 0.1 (n=6) and 1.3 ± 0.2 
(n=6). With 5 Hz stimulation, facilitation remained relatively constant across the train. 
When 10 Hz was used response amplitudes became more variable but in some cells, 
facilitation was increased. In contrast, at 20 Hz, amplitudes of later responses in the 
train decreased until they reached a plateau of approximately half the amplitude of the 
first response. Graphs showing the normalised average peak amplitude for pooled data 
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are shown in Figure 4.3B. eEPSCs were abolished by SYM 2206 (20 µM), indicating 
they are mediated by AMPAr (Figure 4.3A). 
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Figure 4.3. Evoked EPSCs in layer III of the EC. A: Average trace of responses to 
trains of 5 shocks at 10 Hz recorded from an example cell in layer III in control 
conditions and after addition of SYM 2206 (20 µM). B: Graph of normalised 
amplitudes of responses to trains of 5 shocks for 5, 10, 20 Hz. C: Graph of PPR at 
different frequencies. 
 
4.3.1.4. Effects of ATPA on eEPSCs 
 
The effects of ATPA and UBP 302 on sEPSCs suggested the presence of a GluR5-
containing facilitatory KA autoreceptor on glutamate terminals in layer III. To look at 
this further I have tested the effect of ATPA (50 nM) on eEPSCs (5 pulses at 10 Hz; 
n=7; Figure 4.3A). As noted previously PPF of the amplitude of the second response 
in the train was observed under control conditions with peak amplitude increasing 
from 58.1 ± 11.6 pA to 67.3 ± 9.6 pA (P<0.01, n=7). Subsequent responses showed a 
gradual increase in facilitation (Figure 4.4). After the addition of ATPA (50 nM) the 
amplitude of the second response increased to 89.4 ± 20.3 pA, whilst the first 
response remained about the same (63.3 ± 16.6 pA; Figure 4.4B). The ratio of the 
paired pulse facilitation before and after the addition of ATPA (50 nM) increased 
from 1.2 ± 0.1 to 1.6 ± 0.2 (P<0.05, n=7). Subsequent perfusion with a higher 
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concentration of ATPA (100nM) greatly increased all responses in the train with the 
first and the second responses increased to 102.4 ± 21.4 pA and 105.3 ± 19.6 pA 
respectively. This meant that PPF was essentially eliminated and subsequent 
frequency-dependent facilitation throughout the train essentially disappeared (Figure 
4.4C). ATPA had no effect on decay times of any of the evoked responses (Table 4.3). 
These data supported the results from the analysis of sEPSCs in the proceeding 
sections and indicate the presence of GluR5 autoreceptors facilitating glutamate 
release. They also suggest that the receptors may be largely saturated at 100 nM as 
responses no longer showed frequency-dependent facilitation. 
 
 1 2  3 4 5 
control 5.9 ± 0.7 6.9 ± 0.2 6.7 ± 0.5 6.7 ± 0.8 6.2 ± 0.4 
+ ATPA 6.2 ± 0.9 6.3 ± 0.8 6.4 ± 0.4 6.6 ± 0.4 7.5 ± 1.0 
 
Table 4.3. Effects of ATPA on decay times of eEPSCs in a stimulus train of 5 
shocks at 10 Hz. 
 
 ‘Before and after’ analysis of sEPSCs was also conducted. There were no significant 
differences in the amplitude or kinetics for events recorded before or after the trains in 
either control conditions or after addition of ATPA (100 nM). However, under control 
conditions the number of events increased from 7 ± 1 before the train 9 ± 2 after each 
train (P<0.05, n=7). In the presence of ATPA, the number of events before the train 
increased to 9 ± 2 (P<0.001, n=7) in agreement with the general increase in sEPSC 
frequency described earlier. Now, however, the number of events after the train did 
not change (9 ± 2; Figure 4.4D,E). Therefore the increased frequency of sEPSCs 
before the train in the presence of ATPA obscured the rise resulting from endogenous 
activation of the KAr on the terminals seen in control. These results suggest that the 
glutamate released during the stimulation trains may transiently increase sEPSC 
frequency, possibly as a result of KAr activation on the terminals. During ATPA 
application the change was obscured suggesting that the GluR5 receptors on the 
terminals were not fully activated and thus, unable to support further increase. 
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Figure 4.4. Effects of ATPA on eEPSCs. A: Consecutive eEPSCs during 5 Hz train 
in control conditions and during perfusion of ATPA. B: eEPSCs mean amplitude 
graph in control conditions and after ATPA (50 and 100 nM) application (n=7) C: 
Graph of normalised amplitude of eEPSCs in control conditions and after ATPA 
application (n=7) D: Consecutive recordings of sEPSCs before and after stimulus 
train (5 Hz) in control conditions and after application of ATPA (100 nM) E: Graph 
of mean number of events before and after a stimulus train in control conditions and 
after perfusion of ATPA (n=7). 
 
4.3.1.5. Effects of UBP 302 on eEPSCs 
 
Having shown that exogenous activation of GluR5 receptors could presynaptically 
enhance spontaneous and evoked release, in the next set of experiments I examined 
whether these receptors may be activated by endogenous glutamate release. The 
failure of UBP 302 to alter the frequency of sEPSCs (Section 4.3.1.2.) suggests that 
ambient glutamate release does not activate the receptors. To look at this further, I 
now tested the effect of the antagonist on eEPSCs. In these experiments I used 20 Hz 
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trains for 1s, in order to gain a picture of how frequency-dependent changes in 
eEPSCs were altered over a longer time course. 
 
Again PPF of the amplitude of the second response in the train was observed with an 
average increase from 84.6 ± 36.0 pA to 102.3 ± 36.7 pA in 6 neurones (t-test – 
P<0.05, n=6). The facilitation persisted for the first 3-4 events in the train and was 
then succeeded by depression (Figure 4.5B). After the addition of UBP 302 (20 µM) 
the amplitude of first response was unaltered (82.8 ± 26.4 pA). However, the 
amplitude of the second response was now unchanged (79.5 ± 21.2 pA; Figure 4.5B) 
rather than facilitated. The decrease in PPR of the first two responses comparing 
control to UBP 302 was found to be statistically significant (t-test – 1.5 ± 0.2 to 0.9 ± 
0.1, p<0.05, n=6). Amplitudes of later responses in the train decreased until they 
reached a plateau of approximately half the amplitude of the first response in all 
conditions (average of last ten responses in control – 51.8 ± 24.5; UBP 302 – 42.4 ± 
17.1). Thus, UBP 302 effectively removed the early facilitation without altering the 
subsequent depression of eEPSCs. However, the antagonist had no effect on the 
kinetics of any of the evoked responses (average decay time in control – 7.3 ± 0.4 ms; 
UBP 302 – 6.8 ± 0.3 ms). Thus, the blockade of facilitation by UBP 302 clearly 
suggests that facilitation of glutamate release is dependent on a presynaptic GluR5 
KAr, in line with the conclusions from the previous studies. 
 
‘Before and after’ analysis with UBP 302 also supported this conclusion. In control 
conditions the number of events that occurred 1 s before the train of eEPSCs 
increased from 8 ± 2 to 11 ± 2 in the 1 s after (t-test – P<0.05, n=10). The addition of 
UBP 302 (20 µM) had no effect on the number of events before the train (7 ± 2), 
whereas the number of events after was no longer increased (7 ± 1, t-test – P<0.01, 
n=10; Figure 4.5D, E). There was no difference in the amplitude or kinetics for events 
recorded before or after the trains in either control or after addition of UBP 302. This 
analysis indicates that the GluR5 KAr autoreceptor is activated during repetitive 
stimulation and results in a subsequent brief increase in spontaneous events.  
 
Overall, the conclusion is that GluR5 autoreceptors can facilitate glutamate release 
but are not tonically activated by ambient glutamate levels. During high frequency 
activation of glutamate synapses, sufficient glutamate is available to access the 
receptors and boost transmission. 
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Figure 4.5. Effects of UBP 302 on eEPSCs. Consecutive eEPSCs during 5 Hz train 
in control conditions and during perfusion of UBP 302 (20 µM). B: sEPSC mean 
amplitude graph in control conditions and after UBP 302 application (n=6) C: Graph 
of normalised amplitude of eEPSCs in control conditions and after UBP 302 
application (n=6). D: Consecutive recordings of sEPSCs before and after stimulus 
train (20 Hz) in control conditions and after application of UBP 302. E: Graph of 
mean number of events before and after a stimulus train in control conditions and 
after perfusion of UBP 302 (n=6). 
 
4.3.1.6. Effects of 2-AP5  
 
The KAr mediated facilitation of AMPAr-mediated eEPSCs seen in these experiments 
is reminiscent of the presynaptic NMDAr-mediated facilitation of glutamate release 
seen in layers II and V (Berretta and Jones, 1996b; Woodhall et al., 2001a). I thought 
it worthwhile therefore to test the effects of the NMDAr antagonist, 2-AP5 (50 µM) 
on eEPSCs evoked within layer III (5 pulses at 10 Hz). Again, facilitation of the 
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amplitude of the second response in the train was observed, the average increase was 
from 52.2 ± 6.1 A to 71.6 ± 7.21 pA in these neurones (KS test – P<0.001, n=5). In 
this particular group of neurones facilitation was maintained for all 5 shocks. 
However, after addition of 2-AP5, whilst the amplitude of first response remained the 
same (53.7 ± 6.5 pA) the amplitude of the second response was again decreased to 
52.0 ± 5.8 pA (Figure 4.6A) with a consequent decrease in paired pulse ratio (1.5 ± 
0.1 to 1.0 ± 0.1, t-test – p<0.01, n=5; Figure 4.6B). There was no change in kinetics of 
any of the evoked responses in the presence of 2-AP5. Subsequent addition of UBP 
302 (20 µM) had no effect on the amplitude of the first response (50.5 ± 7.9 pA) and 
no further effect on the amplitude of the second response in the train (47.4 ± 4.9 pA) 
and therefore on PPR (1.1 ± 0.1). However, later responses in the train still showed 
some facilitation in the presence of 2-AP5 and this appeared to be blocked by UBP 
302. These results were very surprising as they indicated that blockade of either the 
presynaptic GluR5 receptor or an NMDA autoreceptor was capable of completely 
preventing facilitation. 
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Figure 4.6. Effects of 2-AP5 on eEPSCs. A: Graph of normalised amplitude of 
eEPSCs in control conditions and after 2-AP5 (50 µM) and UBP 302 (20 µM) 
application (n=5) B: Graph showing PPR in control conditions and during 2-AP5 
and UBP 302 perfusion (n=5). 
 
As mentioned above, presynaptic NMDAr are tonically activated by spontaneous 
glutamate release in layers II and V (Berretta and Jones, 1996b; Woodhall et al., 
2001a). However, this was not the case in layer III. Analysis of sEPSCs showed that 
there was no difference in frequency of sEPSCs, as shown by IEI (from 83.8 ± 13.4 to 
87.7 ± 13.5; Figure 4.7A), amplitude or kinetics (Figure 4.7B). However, the increase 
in sEPSCs seen after evoked release revealed by before and after analysis was again 
dependent on NMDAr activation. Under control conditions, the number of events 
increased from 9 ± 1 before the train to 14 ± 1 after (t-test – P<0.01, n=10). With the 
addition of 2-AP5 the number of events before the train was the same as in control 
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conditions (8 ± 1) whereas the number of events after the train did not increase (9 ± 1, 
t-test –  P<0.01, n=10; Figure 4.7C). There was no difference in the amplitude or 
kinetics for these events in the presence of 2-AP5. Subsequent addition of UBP 302 
(20 µM) had no effect on the number of events before the train (9 ± 1) and no further 
effect on the number of events after the train (9 ± 1). 
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Figure 4.7. 2-AP5 on sEPSCs. A: Cumulative probability graph of sEPSC IEI in 
control conditions and after 2-AP5 (50 µM) and UBP 302 (20 µM) application 
(n=10) B: Averaged sEPSCs in control and 2-AP5 (n=60). C: Graph showing mean 
number of events before and after a stimulus train in control conditions and after 
perfusion of 2-AP5 (n=10). 
  
One possible explanation for the above results is that UBP 302 may be non-selective 
and act as an NMDAr antagonist. To ensure that UBP 302 was having no direct 
effects on the NMDAr I tested its effects on evoked NMDAr mediated responses in 
five neurones. The NMDA responses were isolated by blocking AMPAr, GABAAr 
and GABABr using GYKI 53655 (25µM), SR 95531 (20µM) and CPG 55845 (5µM) 
respectively, and recording at a holding potential of +40 mV. Single responses were 
evoked and six successive NMDAr-mediated eEPSCs for each neuron were averaged. 
The eEPSCs had an average amplitude of 138.7 ± 14.4 pA and slow kinetics (decay 
time, 158.2 ± 42.0 ms; 10-90 % rise time, 2.5 ± 0.8 ms; n=5). They could be abolished 
by 2-AP5 (50 µM), indicating they were indeed mediated by NMDAr. However, 
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application of UBP 302 (20 µM) had no effect on amplitude (126.6 ±12.5 pA), time to 
decay (182.1 ± 59.3 ms) or 10-90% rise time (3.3 ± 0.3 ms). Thus, it is unlikely that 
the effects of UBP 302 on facilitation in layer III results from NMDAr blockade. 
 
I have also looked at the effects of 2-AP5 on eEPSCs and sEPSCs after the addition of 
ATPA. Addition of 50 nM ATPA increased PPF of evoked EPSCs from 1.14 ± 0.06 
to 1.41 ± 0.09 (n=5) as described earlier (Section 4.2.1.4). However, subsequent 
addition of 2-AP5 had no effect (1.40 ± 0.09; Figure 4.8A,B). ATPA also decreased 
IEI of sEPSCs from 352 ± 117 ms to 128 ± 28 ms. Subsequent addition of 2-AP5 did 
increase IEI to 226 ± 60 ms (KS test – P<0.001, n=5) but was still decreased when 
compared with control (KS test – P<0.01; Figure 4.8C). There was no change in the 
amplitude or kinetics of these events in the presence of 2-AP5. 
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Figure 4.8. Effects of 2-AP5 on KAR mediated facilitation. A: Graph of normalised 
amplitude of eEPSCs in control conditions and after ATPA (50 nM) and 2-AP5 (50 
µM) application (n=5). B: Graph of PPR for control conditions and after application 
of ATPA and 2-AP5 (n=5). C: Cumulative probability graph of sEPSC IEI in control 
conditions and after ATPA and 2-AP5 application (n=5). 
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4.3.2. KAr at postsynaptic sites 
 
The foregoing experiments have clearly indicated the presence of presynaptic GluR5 
KA autoreceptors in layer III. Recently, West et al. (2007) described a KAr eEPSC at 
these synapses. I now sought to confirm if KAr contributed to the eEPSCs at these 
synapses and to gain some idea of the KAr subunits involved. At other synapses KAr 
EPSCs are hard to detect and rely on observing a residual current when AMPAr and 
NMDAr are blocked. I used this approach here. I blocked NMDAr, GABAAr, 
GABABr and AMPAr receptor mediated currents using a cocktail of 2-AP5 (50 µM), 
SR 95531 (20µM), CPG 55845A (5µM) and either SYM 2206 (20 µM) or GYKI 
53655 (25µM) and used a stimulus train of either 50, 100 or 200 Hz increase to elicit 
the KAr eEPSC. In the presence of these antagonists, single shock stimulation evoked 
very little in the way of an eEPSC. However, with high frequency trains a small, slow 
KAr-mediated current was recorded in 57% of cells (8/14) following high frequency 
stimulation.  
 
4.3.2.1. Pharmacology of KAr eEPSC 
 
The KAr eEPSC showed a clear dependence on frequency of activation (see Section 
4.3.2.2 below). In my pharmacological analysis I used trains of 5 shocks at 100 Hz to 
evoke responses. In the presence of the antagonist cocktail there was a small, slow 
residual current. In the 8 neurones tested, the mean amplitude of the slow current was 
22.5 ± 1.2 pA and its decay time was 232.8 ± 26.2 ms. In the presence of UBP 302 
(20 µM) these parameters were unaltered at 20.3 ± 1.5 and 258.7 ± 26.3 ms (Figure 
4.9). Subsequent addition of CNQX (10 µM) completely blocked the eEPSC. This 
concentration is relatively selective for KAr over AMPAr, but does not discriminate 
between KAr subtypes. These results confirm those of West et al. (2007). Thus, my 
data indicate that this eEPSC is not mediated by KAr containing the GluR5 subunit 
but is likely to depend on other KAr subunit / subunits.  
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Figure 4.9. Pharmacology of KAr eEPSC A: Consecutive recordings of KAr eEPSC 
in control conditions and in the presence of UBP 302 (20 µM) and CNQX (10 µM). 
B,C; Graphs showing mean decay time (B) and peak amplitude (C) of KAr-mediated 
eEPSCs in control conditions and after addition of UBP 302 and CNQX (n=8). 
 
4.3.2.2. Frequency-dependence of KAr eEPSC 
 
The amplitude and decay time constants of the KAr EPSC were similar to those 
previously reported (West et al., 2007; Castillo et al., 1997). Both amplitude and 
decay time of the KAr eEPSC were dependent on the frequency and the duration of 
stimulus train.  
 
Increasing the frequency from 50 to 100 Hz but keeping train length constant resulted 
in an increase in amplitude from 20.9 ± 1.4 pA to 24.3 ± 1.2 pA (n=4). Decay time 
concurrently rose from 132.9 ± 23.2 ms to 189.9 ms. Increasing the stimulation 
frequency to 200 Hz again maintaining the same duration of train further increased 
both amplitude (to 35.7 ± 5.4 pA) and decay time (to 378.1 ± 35.2 ms; Figure 4.10A). 
The increase in both amplitude and decay time was found to be significant only after 
the increase to 200 Hz (P<0.05; One way ANOVA and Bonferroni Test). 
 
Similarly, increasing the length of the stimulus train but maintaining the frequency 
also increased the KAr eEPSC parameters. Thus, augmenting the number of shocks 
  87
from 5 to 10 at 50 Hz caused an increase in amplitude from 18.3 ± 1.5 pA to 25.5 ± 
1.5 pA (ANOVA – P<0.05, n = 7) and in the decay time from 183.5 ± 29.8 to 298.2 ± 
48.0 ms. 15 shocks at 50 Hz further increased the amplitude to 32.4 ± 2.3 pA 
(ANOVA – P<0.05, n = 7) and the decay time to 404.8 ± 61.5 ms (ANOVA – 
P<0.05; Figure 4.10B). Averages of the amplitude and decay times for all stimulation 
protocols are included in Table 4.4 and are illustrated in Figure 4.10. 
 
 Amplitude (pA) Decay time (ms) 
50 Hz 20.9 ± 1.4 132.9 ± 23.1 
100 Hz 24.3 ± 1.2 189.9 ± 19.8 
200 Hz 35.7 ± 5.4* 378.1 ± 35.2* 
5 shocks at 50 Hz 18.3 ± 1.5 183.5 ± 29.8 
10 shocks at 50 Hz 25.5 ± 1.5* 298.2 ± 48.0 
15 shocks at 50 Hz 32.4 ± 2.3*? 404.8 ± 61.5* 
 
Table 4.4 – Summary of KAr eEPSC amplitude and decay times at different 
frequencies and durations of stimulus train. * indicates a significant change when 
compared control (P <0.05 One way ANOVA and Bonferroni Test). ? indicates a 
significant change when compared to 10 shocks (P <0.001 One way ANOVA and 
Bonferroni Test). 
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Figure 4.10. Frequency-dependence of KAr eEPSC A: Concurrent recordings and 
graphs showing mean peak amplitude and decay time of KAr eEPSC after 50, 100 
and 200 Hz stimulation. B: Concurrent recordings and graphs showing mean peak 
amplitude and decay time of KAr eEPSC after 5, 10 and 15 shocks. 
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4.3.2.3. I-V relationships of KAr eEPSCs 
 
The I-V relationship of KAr can reflect the calcium permeability and the subunit 
composition of channels (Egebjerg and Heinemann, 1993; Ruano et al., 1995). Inward 
rectification is characteristic of KAr containing unedited GluR5 and GluR6 subunits 
(Bowie and Mayer, 1995; Kamboj et al., 1995). Thus, I also studied the current-
voltage (I-V) relationship of the KAr eEPSC. In the presence of the antagonist 
cocktail detailed above, KAr eEPSCs, induced by 100 Hz stimulation, were recorded 
at holding potentials ranging from –60 to +40 mV. KAr eEPSCs reversed at a 
potential of approximately 0 mV (-3.2 ± 4.7 mV, n = 4). The current recorded at the 
peak amplitude in relation to the holding potential was then plotted. Figure 4.9E 
illustrates the I-V curve (corrected for LJP) of KAr eEPSCs. It can be seen that the I-V 
relationship is relatively linear in the negative voltage range, but shows a pronounced 
inward rectification at positive holding potentials. Thus, this data combined with the 
observations that the eEPSC is blocked by CNQX and is unaltered by UBP 302 
suggests that there is a small, prolonged EPSC in layer III neurones likely mediated 
by KAr containing unedited GluR6 subunits. 
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4.11. I-V relationship of KAr eEPSC. A: Concurrent KAr eEPSCs recorded at 
holding potentials from – 60 to + 40 mV in an example layer III neurone. B: Current-
Voltage plot (n=4; corrected for LJP). 
 
4.4. Discussion 
 
These results provide strong electrophysiological evidence for the presence of two 
different types of KAr involved in glutamatergic neurotransmission in layer III of the 
EC. They confirm that layer III neurones receive excitatory inputs mediated by 
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postsynaptic KAr (West el al. 2007) but extend this to show that the receptors 
involved are not GluR5 containing, but may be homo- or heteromeric receptors 
containing the GluR6 subunit. In addition, I have shown that glutamate transmission 
is physiologically boosted by a KA autoreceptor, which is a homo- or heteromeric 
GluR5-containing receptor.  
 
Frequency-dependent facilitation of AMPAr-mediated eEPSCs was blocked by UBP 
302, the GluR5 selective antagonist, and enhanced by a low concentration of ATPA, 
the GluR5 selective agonist. Thus, it seems likely that this facilitation is mediated by a 
presynaptic KAr containing the GluR5 subunit. This conclusion was strongly 
supported by the observation that ATPA increased the frequency of sEPSCs without 
changing mean amplitude or kinetics. The lack of effect of UBP 302 on sEPSCs in 
these neurones indicates that the presynaptic GluR5 receptors are not tonically 
activated by spontaneous glutamate release and likely to be activated only in 
situations where higher levels of glutamate are present. This is shown by two 
observations. First during trains of AMPAr-mediated eEPSCs, the first event was 
unaltered by UBP 302, but the facilitation of succeeding events was blocked. Second, 
following a train of eEPSCs, the frequency of AMPAr mediated sEPSCs was 
transiently increased, and this effect was also blocked by UBP 302, without change in 
amplitude or kinetics of the spontaneous events. Thus, these studies provide evidence 
that the presynaptic KAR is activated during high levels of excitation, i.e. repetitive 
stimulation, and act to further boost excitation (see Figure 4.12). 
 
The precise mechanism for the facilitation is currently unknown. However, it seems 
likely to be an ionotropic response, not metabotropic as has been suggested for 
presynaptic KAr previously (Rodriguez-Moreno and Sihra, 2004), due to the speed at 
which it occurs, although, the possibility of a metabotropic effect cannot be 
completely ruled out. If it is ionotropic, the mechanism probably involves increased 
influx of Ca2+ into the glutamate terminal. This could occur by two mechanisms. 
Activation of the GluR5 receptor could depolarise the terminal and cause increased 
opening of VGCCs, leading to enhanced glutamate release. Alternatively, increased 
Ca2+ entry could occur directly via the receptor ionophore, as KAr do have a low Ca2+ 
permeability (Ferrer-Montiel and Montal, 1996), with unedited GluR5 and GluR6 
containing receptors having higher permeability than those that have undergone 
mRNA editing (Burnashev et al., 1996). This has been proposed for facilitation by 
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presynaptic NMDAr (Woodhall et al., 2001a). We do not yet know what the situation 
is with the presynaptic KAr in layer III. However, it is clear that the receptor is 
localised to the terminals, as ATPA caused an increase in mEPSC frequency as well 
as its effects of action potential driven release. This shows that the increase in 
glutamate release is unlikely to be (solely) dependent on increased firing in afferent or 
recurrent excitatory connections.  
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Figure 4.12. Schematic summary diagram of presynaptic KAr in glutamatergic 
transmission. Schematic diagrams showing what may be happening during 10 Hz 
stimulation in control conditions (A) and after application of UBP 302 (B). 
 
Previous studies in the EC have shown that there are a number of other presynaptic 
receptors at glutamatergic synapses (Woodhall et al., 2007; Thompson et al., 2006; 
Evans et al., 2000; Woodhall et al., 2001a; Berretta and Jones, 1996b) controlling 
transmitter release. NMDA autoreceptors are present in layers II and V where they act 
to facilitate glutamate release, and in contrast to the presynaptic GluR5 KAr are 
tonically active (Berretta and Jones, 1996b; Woodhall et al., 2001a; Yang et al., 
2006a).  
 
Because the effects of the NMDAr and KAr in causing facilitation show similarities, I 
felt it was important to determine any role of presynaptic NMDAr in layer III. Initial 
experiments with 2-AP5 showed no effect on sEPSC frequency (see also Section 
3.3.1.5.), suggesting that presynaptic NMDAr were not operative in layer III, in 
contrast to layers II and V. However, very surprisingly, I then found that 2-AP5 
blocked frequency facilitation of AMPAr-mediated eEPSCs. Even more surprising, 
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after blocking NMDAr UBP 302 no longer had any effect and vice versa. The fact 
that UBP had no direct effect on the isolated NMDAr-mediated evoked EPSC ruled 
out the possibility that UBP 302 itself is blocking NMDAr.  
 
These observations are difficult to explain. One possibility is that presynaptic KAr 
and NMDAr are acting synergistically on some terminals to facilitate glutamate 
release in layer III. However, this may only be the case during low levels of KAr 
activation, because when facilitation was increased by ATPA, blocking NMDAr no 
longer blocked the frequency facilitation. In the presence of ATPA, 2-AP5 did 
decrease sEPSC frequency slightly, although it was still much higher than that seen in 
control. It may be speculated that during repetitive stimulation, activation of the 
presynaptic KAr causes the necessary depolarisation of the terminal but not enough to 
facilitate glutamate release directly. However, the depolarisation of the terminal could 
then result in parallel activation of the presynaptic NMDAr by relieving Mg2+ block. 
These experiments with ATPA suggest that the KA autoreceptor is capable of causing 
facilitation without synergy with the NMDAr, if the levels of available glutamate are 
sufficiently high. At present then the basis of the KAr-NMDAr synergy remains 
unknown and the subject for future investigation. 
 
Positive feedback of the nature mediated by the KA autoreceptor described here could 
be considered a dangerous feature as it introduces inherent instability to a synapse. 
Such instability could possibly underlie the susceptibility of the EC to epileptiform 
activity, and in particular the vulnerability of layer III to degeneration in patients and 
animal models of TLE (Du and Schwarcz, 1992; Du et al., 1993; Du et al., 1995). As 
mentioned in Chapter 1, KA’s ability to cause acute epileptiform activity and a 
chronic epileptic condition, where cell loss seen is also similar to that seen in patients 
with TLE (Du et al., 1995), suggests that KAr may be possible future targets for 
pharmacological interventions. More recently, there has been direct evidence for the 
involvement of GluR5 subunit containing KAr in epilepsy, as antagonists of GluR5 
(LY377770 and LY382884) prevent pilocarpine induced limbic seizures (Smolders et 
al., 2002) and topiramate, an antiepileptic drug whose action was previously 
unknown, has been found to protect against seizures induced by ATPA (Kaminski et 
al., 2004). There has been a suggestion that GluR5 agonists could be used 
antiepileptic drugs by virtue of the fact that they can increase GABA release (Khalilov 
et al., 2002; see also Section 5.3.1.1.). However, the evidence I have presented for 
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GluR5-containing KAr producing a significant increase in excitation may directly 
challenge this idea. I have clearly demonstrated that, in layer III, a presynaptic GluR5 
containing KAr is capable of greatly increasing excitation, and therefore a GluR5 
agonist may exacerbate epilepsy in this region. It is noteworthy that, in these 
experiments, inhibition was not blocked and therefore this action of the KAr occurred 
regardless of whether there is also a GluR5 KAr acting to increase inhibition in the 
EC, although this will be discussed in more detail in Chapter 5. 
 
In addition to the facilitatory presynaptic GluR5 KAr, KAr also mediate postsynaptic 
effects in the EC. A KAr-mediated synaptic current has been identified in the EC by 
West et al. (2007). In the present study, neither UBP 302 nor ATPA had any effect on 
the average kinetics or amplitude of sEPSCs suggesting that the GluR5 subunit 
containing KAr did not contribute to the postsynaptic glutamate currents in layer III. 
However, KAr-mediated evoked synaptic currents could be isolated, when AMPAr, 
and NMDAr were blocked and repetitive stimulation was employed, an approach used 
by West et al. (2007) and others to study postsynaptic KAr responses. The KAr 
mediated eEPSC in my studies was very similar to that found by West et al. (2007). 
Most importantly time to decay, which is often used to separate KAr-mediated 
currents from much faster AMPAr-mediated currents, was very similar. The slow 
eEPSC could also be blocked by CNQX at concentrations selective for KAr. 
However, UBP 302 had no effect on this KAr-mediated eEPSC in my experiments. 
This clearly shows that the postsynaptic KAr responsible for the eEPSC does not 
contain the GluR5 subunit. In addition, the I-V curve for the KAr eEPSC showed 
significant inward rectification. The I-V relationship of KAr can reflect the calcium 
permeability and the subunit composition of channels (Egebjerg and Heinemann, 
1993; Ruano et al., 1995). Inward rectification is characteristic of KAr containing 
unedited GluR5 and GluR6 subunits (Bowie and Mayer, 1995; Kamboj et al., 1995) 
which are relatively impermeable to Ca2+. Together, these data indicate that the KAr 
responsible for these eEPSCs in layer III contain an unedited GluR6 subunit (Figure 
5.13.) 
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Figure 4.13. Schematic summary diagram of postsynaptic KAr on principal 
neurones in layer III. Schematic diagrams showing what may be happening during 
100 Hz stimulation in 2-AP5 and GYKI 53665 (A) and after application of CNQX (B). 
 
As discussed in Section 1.5.5., since KAr mediated synaptic transmission was first 
identified by (Castillo et al., 1997), it has been found throughout the brain (Frerking 
et al., 1998; DeVries and Schwartz, 1999; Kidd and Isaac, 1999; Li et al., 1999; Ali, 
2003; Gryder and Rogawski, 2003). A recent study in the anterior cingulate cortex in 
genetically modified mice showed that both GluR5 and GluR6 subunits contribute to 
the KAr EPSCs, with GluR6 being more prominent (Wu et al., 2005). As double 
knockouts completely abolished the current the authors concluded that it was unlikely 
that GluR7 was involved. We have no evidence to show which subunits are 
responsible for the postsynaptic KAr mediated current in the EC, only that GluR5 
does not appear to be involved, and they may contain an unedited GluR6 subunit. All 
of the KAR subunits are expressed in detectable levels (with exception of KA1) in the 
adult rat EC (Bahn et al., 1994), so any of them may be involved. As yet, the only 
subunit-selective ligands available are those for GluR5, therefore in order to 
determine which subunits are involved in the postsynaptic current in the EC either 
genetic knockouts must be tested or studies must wait for development of further 
useful antagonists. 
 
Importantly, the present study provides evidence for at least two KAr with different 
subunit compositions contributing to transmission at glutamatergic synapses in layer 
III of the EC, a presynaptic receptor acting to facilitate glutamate release, which 
contains the GluR5 subunit, and a postsynaptic receptor that contributes to synaptic 
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transmission but does not contain the GluR5 subunit. This suggests that, at least in the 
EC, KAr with different functions have different subunit compositions. Thus, the 
susceptibility of the EC to epileptogenesis and neuronal damage induced by KA, will 
likely involve enhanced glutamate release, coupled with direct activation of the 
postsynaptic receptors. This leads to the conclusion that therapeutic interventions for 
TLE may be most effective if they are selective for to receptors composed of specific 
subunits. Also, as subunit expression of KAr is thought to be altered in epilepsy 
(Porter et al., 2006), it will be of great interest to determine if there are obvious 
changes in KAr in the EC in animal models of TLE. 
 
Finally, the present results are of relevance to the generation of oscillatory activity in 
the EC. Both gamma oscillations (Cunningham et al., 2003; Stranger et al., 2008) and 
SWO (Cunningham et al., 2006) generation appear to involve GluR5 KAr. It is 
possible that exacerbation of glutamate transmission driven by GluR5 autoreceptors, 
together with a high degree of recurrent connectivity in layer III (Dhillon and Jones, 
2001) could be a factor in susceptibility to rhythmical network activity. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 5 
 
LOCALIZATION AND FUNCTION OF KAR AT 
GABAERGIC SYNAPSES IN LAYER III 
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5.1. Introduction 
 
In the previous Chapter I showed that presynaptic KAr are present at excitatory 
synapses in layer III acting to facilitate glutamate release. Presynaptic KAr also exist 
as heteroreceptors at inhibitory synapses throughout the CNS (Rodriguez-Moreno and 
Lerma, 1998; Min et al., 1999; Cossart et al., 2001; Frerking et al., 2001; Braga et al., 
2003; Crowder et al., 2006), where they have been show to both increase (Cossart et 
al., 2001) and decrease (Min et al., 1999) GABA release. Therefore, the aim of this 
chapter was to examine presynaptic KAr at GABAergic synapses, and to identify their 
role in layer III of the EC.  
 
Early evidence for KAr regulating GABA release came from studies showing that low 
doses of KA caused a reduction in the amplitude of sIPSCs and eIPSCs in 
hippocampal pyramidal cells (Fisher and Alger, 1984; Kehl et al., 1984). However, 
this work did not really progress until selective ligands were developed to distinguish 
between the AMPAr and KAr. In 1997, Clarke et al. (1997) showed that the GluR5 
selective KAr agonist, ATPA, caused a reduction in eIPSC amplitude in the 
hippocampus. In addition, the GluR5 selective KAr antagonist, LY294486, prevented 
the action of both ATPA and KA. In the same year, Rodriguez et al. (1997) showed 
that application of KA reduced the frequency of mIPSCs and the amplitude of 
eIPSCs, both in culture and hippocampal slices. These effects were blocked by 
CNQX. Since then KAr have been shown to inhibit GABA release at inhibitory 
synapses in other brain regions including in the globus pallidus (Jin and Smith, 2007) 
and in the amygdala (Braga et al., 2003).  
 
Initially, the ability of KAr to depress GABA release was difficult to reconcile with 
the ionotropic nature of the receptor. However, Rodriguez et al. (1997) provided 
evidence for a metabotropic action of KAr by showing that the effects of KA were 
blocked by pre-incubation with pertussis toxin, or PKC inhibitors such as 
staurosporine and calphostin C. In terms of the subunit composition of the KAr 
responsible, some evidence for the presence of GluR6/7 has been shown in the globus 
pallidus using immunoreactivity (Jin and Smith, 2007), whilst pharmacological 
evidence suggests the involvement of GluR5 in the hippocampus and in the amygdala 
(Clarke et al., 1997; Braga et al., 2003). It is thought that the metabotropic actions of 
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KAr underlie their ability to depress GABA release (Rodriguez-Moreno and Sihra, 
2007). 
 
KAr have also been shown to facilitate GABA release at a number of inhibitory 
synapses throughout the CNS, including CA1 (Cossart et al. 2001), the hypothalamus 
(Liu et al. 1999), the neocortex (Ali at al., 2001), the dorsal horn of the spinal cord 
(Kerchner et al. 2001), the nucleus accumbens (Crowder et al., 2006) and in the 
amygdala (Braga et al. 2003). Studies of subunit composition suggest that there are no 
obvious differences in the KAr that facilitate GABA release compared to those that 
inhibit it. Using confocal and electron microscopy, Lu et al. (2005) showed that 20-
35% of GAD67 positive terminals in the dorsal horn also show immunoreactivity for 
GluR5, GluR6/7 and KA1 and 2 KAr subunits. In CA1, use of subunit-specific 
knockouts have shown that the receptors facilitating GABA release are likely to be 
GluR5/GluR6 heteromers (Mulle et al., 2000).  
 
As presented in Section 1.5.6., presynaptic KAr at inhibitory synapses (as at 
excitatory synapses) may modulate GABAergic transmission in a bidirectional 
manner, with lower concentrations of agonist causing an increase in transmitter 
release, and higher concentrations a depression. This has been shown in both CA1 and 
CA3 (Jiang et al., 2001; Schmitz et al., 2000; 2001) and in the amygdala (Braga et al., 
2003). Interestingly, only one synapse has so far been identified, in the globus 
pallidus (Jin and Smith, 2007), where presynaptic KAr are capable of only depressing 
GABA release without bidirectional modulation. 
  
In addition to presynaptic KAr modulating GABA release, KAr have also been found 
to contribute to the EPSCs in interneurones in CA1 (Cossart et al., 1998; Frerking et 
al., 1998). Recently, these KAr have been shown to be more effective than AMPAr in 
increasing interneurone firing frequency, probably as a result of their long decay times 
(Yang et al., 2007). Yang et al. (2007) also noted that single synaptic KAr mediated 
currents were capable of shifting the phase of interneurone firing, which they 
suggested could mean that KAr may play an important role in the synchronisation of 
interneurones in CA1. However, as yet, the hippocampus is the only region in which 
direct evidence has been produced for the presence of KAr acting to drive 
interneurones (Frerking et al., 1998; Yang et al., 2006b; 2007; Goldin et al., 2007).  
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At present, nothing is known about the role of KAr at inhibitory synapses in the EC. 
Thus, this chapter had two main aims: 1) to determine if presynaptic KAr were 
present in inhibitory synapses in layer III of the EC and 2) if KA heteroreceptors are 
present, how do they act to modulate GABA release. 
 
5.2. Methods 
 
Most methods were as described in Chapter 2. In all recordings of IPSCs, 2-AP5 (50 
µM), GYKI 53665 (25 µM) or NBQX (1 µM), and CGP 55845 (5 µM) were included 
in the bath to block NMDAr, AMPAr and GABABr respectively. To investigate the 
function of KAr the GluR5 selective antagonist, UBP 302, and the GluR5 selective 
agonist, ATPA, were used.  
 
5.3. Results 
 
5.3.1. Effects of KAR ligands on sIPSCs 
 
5.3.1.1. ATPA increases spontaneous activity 
 
The effects ATPA (0.1 µM and 0.5 µM) on sIPSCs were assessed on 7 neurones. 
Addition of ATPA (0.1 µM) decreased IEI from 122 ± 14 ms to 98 ± 8 ms (KS test – 
P<0.0001, n=7), which reflects a increase in mean frequency from 7.3 ± 0.8 Hz to 
10.7 ± 1.1 Hz (+ 53.1 ± 17.5 %). ATPA (0.5 µM) further decreased the IEI to 73 ± 12 
ms (KS test – P<0.0001, n=7; Figure 5.1A,C), which reflects a mean frequency of 
16.6 ± 3.6 Hz, and therefore an increase of 65.3 ± 40.0 %. Concurrently, there was no 
change in amplitude or kinetics (Table 5.1; Figure 5.1B).  
 
Some studies have shown that higher concentrations of KAr agonist are capable of 
decreasing GABA release when lower concentrations facilitate release (Braga et al, 
2003). Therefore I tested the effects of a higher concentration of ATPA on sIPSCs in 
a further 7 neurones. ATPA (10 µM) also caused a decrease in inter-event interval 
from 126 ± 25 ms in control to 72 ± 24 ms (KS test – P<0.0001, n=7; Figure 5.1A,C), 
which reflects a mean increase in frequency from 10.8 ± 3.5 Hz to 22.7 ± 5.3 Hz (+ 
51.6 ± 14.2 %). There was no concurrent change in kinetics of the events (Table 5.1; 
Figure 5.1B). However, there was a tendency for mean amplitude to be increased in 
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the presence of this higher concentration of ATPA (Table 5.1). After the initial 
increase in frequency, prolonged exposure (> 15 minutes) to this higher concentration 
caused a subsequent decrease frequency, (16.7 ± 4.9 Hz; P<0.01, n=7). 
 
sIPSCs 
IEI  
(ms) 
Amplitude (pA) Decay Time (ms) Rise Time (ms) 
Control 122 ± 14 37.5 ± 2.4 4.8 ± 0.3 2.3 ± 0.1 
+ ATPA (0.1 µM) 98 ± 8 * 35.4 ± 2.6 4.8 ± 0.3 2.3 ± 0.2 
+ ATPA (0.5 µM) 73 ± 12 * ? 34.8 ± 3.2 5.4 ± 0.4 2.7 ± 0.3 
+ ATPA (10 µM) 72 ± 23 * 42.2 ± 6.1 4.7 ± 1.0 2.0 ± 0.5 
 
Table 5.1. Effects of ATPA on IEI, amplitude and kinetics of sIPSCs. * indicates a 
significant change when compared control (P <0.001 KS Test). ? indicates a 
significant change when compared to 0.5 µM ATPA (P <0.001 KS Test).  
 
5.3.1.2. Effects of ATPA on mIPSCs 
 
The results of these experiments indicate a role for KAr in the control of GABA 
release in the EC. The increase in frequency of sIPSCs without change in amplitude or 
kinetics is indicative of presynaptic receptors on the terminals acting to increase 
quantal GABA release. However, these results cannot rule out the alternative 
possibility that there are KAr postsynaptic to glutamate terminals on the soma and/or 
dendrites acting to drive GABA release by exciting the interneurones, increasing 
firing, and thus resulting in increased activity-dependent release from the inhibitory 
terminals on the recorded neurones.  
 
To further elucidate the location of these receptors I looked at the effect of ATPA (0.5 
µM) on mIPSCs recorded in the presence of TTX (1 µM) which effectively blocks 
action potential-dependent release. Under these conditions ATPA (0.5 µM) still 
caused a decrease in IEI of mIPSCs from 293 ± 31 ms to 240 ± 27 ms (n = 10, 
P<0.001) reflecting an increase in mean frequency from 4.0 ± 0.6 Hz to 4.9 ± 0.8 Hz 
(+ 23.3 ± 4.0 %). Proportionally this change was not dramatically different to that 
seen with sIPSCs, but in terms of overall increase in frequency it appeared much less. 
Again there was no change in mean amplitude, decay time or 10-90 % rise time 
(Table 5.2).  
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mIPSCs 
IEI  
(ms) 
Amplitude (pA) Decay Time (ms) Rise Time (ms) 
Control 293 ± 31 29.8 ± 2.0 5.2 ± 0.6 2.5 ± 0.4 
+ ATPA (0.5 µM) 240 ± 27 * 31.3 ± 2.8 5.3 ± 0.7 2.3 ± 0.4 
 
Table 5.2. Effects of ATPA on IEI, amplitude and kinetics of mIPSCs. * indicates a 
significant change when compared control (P <0.001 KS Test). 
 
In 4 of these neurones, I tested the effects of UBP 302 (20 µM) on the increase in 
frequency mediated by ATPA. In these neurones, the mean IEI in control conditions 
was 359 ± 91 ms and this decreased to 262 ± 82 ms in the presence of ATPA (KS test 
– P<0.001; n=4). Subsequent addition of UBP 302 had no significant effect (270 ± 68 
ms). This was unexpected as UBP 302 should be selective for GluR5 receptors and 
would be predicted to reverse the effects of the GluR5 agonist. Therefore, we repeated 
the experiments in a further 3 cells, but applied UBP 302 prior to ATPA. UBP 302 
(20 µM) had no significant effect on IEI (from 286 ± 135 ms to 239 ± 101 ms). 
However, ATPA (0.5 µM) still caused a decrease in IEI to 94 ± 29 ms, reflecting a 
mean increase in frequency from 7.4 ± 4.2 to 12.6 ± 3.3 Hz (137.0 ± 62.8 %). 
 
These results suggest that the KAr responsible for increasing GABA release are at 
least partly located on the GABA terminals. However, the effect of ATPA did appear 
to be proportionally less in the presence of TTX, so GluR5 receptors may also be 
present on the interneurone cell bodies or dendrites. 
 
The failure of UBP 302 to block the increase in mIPSCs evoked by ATPA could 
suggest the agonist is acting via a subtype of GluR5 receptor not sensitive to UBP 
302, or even via a receptor not containing the GluR5 subunit. 
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Figure 5.1. Effects of ATPA on sIPSCs and mIPSCs. A: Concurrent recordings 
showing sIPSCs in control conditions and in the presence of ATPA (0.5 µM and 10 
µM) in a typical layer III neurone. B: Average IPSC (n=60) in control conditions and 
after addition of ATPA. C: Cumulative probability graph of sIPSC IEI control 
conditions and after ATPA application (n=6). D: Concurrent recordings showing 
mIPSCs in an example cell in control conditions and in the presence of ATPA. E: 
Cumulative probability graph of mIPSC IEI control conditions and after ATPA 
application (n=4). 
 
5.3.1.3. UBP 302 and CNQX reduce sIPSC frequency 
 
In these experiments, as previously, sIPSCs were recorded in the presence of GYKI 
53665 and 2-AP5 to block AMPAr and NMDAr respectively. In 6 neurones the 
control IEI was 86 ± 23 ms. Addition of UBP 302 increased IEI to 119 ± 22 (KS test 
P<0.05, n=6; Figure 5.2B) which reflects a decrease in frequency from 15.4 ± 3.2 Hz 
to 10.1 ± 2.1 Hz (- 31.3 ± 5.8 %). Subsequent addition of CNQX (10 µM) to the same 
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neurones caused a further significant increase in IEI to 154 ± 24 (KS test P<0.0001, 
n=6; Figure 5.2B) which reflects a decrease in frequency from 10.1 ± 2.1 Hz to 7.1 ± 
0.9 Hz (20.11 ± 10.5 %). Neither antagonist had any effect on amplitude or kinetics 
(Table 5.3; Figure 4.2C). Unlike the sEPSC the train of evoked stimuli didn’t cause a 
short-term increase in the number of sIPSCs. Thus, the combined effect of CNQX and 
UBP 302 suggest that there may be more than one KAr controlling GABA release. 
The effects of ATPA on sIPSCs and mIPSCs (Section 5.3.1.1 and 5.3.1.2.) suggest 
that GluR5 KAr are present on both GABA terminals and the soma/dendrites or the 
GABAergic interneurones. UBP 302 decreases sIPSC frequency, but not mIPSCs 
(Section 5.3.1.2). This indicates that there may be KAr mediating a tonic excitatory 
drive onto interneurones but that GluR5 on the terminal are unlikely to be tonically 
activated by ambient glutamate. CNQX may be blocking a KAr on the interneurones 
as well, but until experiments have been done on mIPSCs in TTX we cannot rule out 
that this receptor may also be tonically activated on the terminals as well.  
 
sIPSCs 
IEI  
(ms) 
Amplitude 
(pA) 
Decay Time 
(ms) Rise Time (ms) 
Control 86 ± 23 34.6 ± 2.5 8.9 ± 1.3 1.7 ± 0.2 
+ UBP 302 (20 µM) 119 ± 22 * 32.1 ± 1.8 8.3 ± 1.4 1.6 ± 0.1  
+ CNQX (10 µM) 154 ± 24 ? 30.3 ± 2.2 9.0 ± 1.5 1.9 ± 0.2 
 
Table 5.3. Effects of UBP 302 and CNQX on IEI, amplitude and kinetics of sIPSCs. 
* indicates a significant change when compared to control (P <0.001 KS Test). ?  
indicates a significant change when compared to UBP (P <0.001 KS Test). 
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Figure 5.2. Effects of KAr antagonists on sIPSCs.. A: Concurrent recordings of 
sIPSCs in control conditions and in the presence of UBP 302 (20 µM) and CNQX (10 
µM) in a typical layer III neurone. B: Cumulative probability graph of IEI of sIPSCs 
in control conditions and after application of UBP 302 and CNQX (n=6). C: Average 
IPSC (n=60 in control conditions and after application of UBP 302 and CNQX 
 
5.3.2. Presynaptic KAr act via VGCC 
 
5.3.2.1. Effect of Cd2+ on the facilitation of GABA release mediated by KAr 
 
The preceding experiments on sIPSCs and mIPSCs suggested that the KAr that 
facilitate GABA release are located, both on the soma/dendrites of interneurones and 
on the GABAergic terminals. Activation of the receptors on the terminals could 
increase release by increasing presynaptic Ca2+ entry. KAr, depending on their subunit 
composition and post-translational editing (Burnashev et al., 1996), are permeable to 
calcium although they are normally more permeable to monovalent cations. Thus, 
Ca2+ entry through the receptors could increase GABA release. Alternatively, the 
receptors could depolarise the terminal and activate VGCC to enhance release. To try 
to determine which of these scenarios is most likely I looked at the effect of Cd2+, a 
non-selective blocker of VGCC. I assessed the effect of the divalent cation on the 
increase in frequency of sIPSCs induced by ATPA. In 8 neurones, ATPA (0.5 µM) 
decreased IEI from 121 ± 33 ms to 75 ± 16 ms (KS test – P<0.0001; n=8), which 
represents a increase in mean frequency from 13.1 ± 2.9 Hz to 19.4 ± 4.4 Hz (+ 55.9 ± 
14.8 %). Subsequent addition of Cd2+ (50 µM) partially reversed the decrease in IEI to 
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96 ± 20 ms (KS test – P<0.001; n=8) reflecting a mean frequency of 15.0 ± 3.4 
(decrease of 21.7 ± 3.5 %). Therefore, Cd2+ partially blocks the increase in frequency 
of sIPSCs mediated by ATPA. This suggests that VGCC are important for the 
increase in GABA release elicited by GluR5 activation. However, this doesn’t 
distinguish between action potential-dependent and independent release, as ATPA 
may also be activating KAr which are not located directly on the terminal. Thus, I 
repeated the experiments looking at mIPSCs. In these experiments I added Cd2+ 
before ATPA to ensure that it was having no direct effects on the mIPSCs. Indeed, 
Cd2+ had no effect on IEI, amplitude or kinetics of the mIPSCs (Table 5.4; Figure 
5.3A,B). When ATPA (0.5 µM) was now applied in the presence of Cd2+ (50 µM) it 
failed to increase IEI (from 252 ± 29 ms to 251 ± 31 ms; n=9; Figure 5.3A,B). Thus, 
these experiments strongly suggest that the main facilitatory effect on GABA release 
of the KAr on the terminals, due to depolarisation, presumably as a result of Na+ 
entry, and subsequent opening of VGCC. 
 
mIPSCs 
IEI  
(ms) 
Amplitude (pA) Decay Time (ms) Rise Time (ms) 
Control 283 ± 32 30.3 ± 2.2 5.3 ± 2.1 2.5 ± 1.4 
 + Cd2+ (50 µM) 252 ± 29 27.8 ± 3.2 4.5 ± 0.2 2.4 ± 0.7 
+ ATPA (0.5 µM) 251 ± 31 27.4 ± 2.0 4.4 ± 0.2 2.3 ± 0.4 
 
Table 5.4. Effects of ATPA and Cd2+ on IEI, Amplitude and kinetics of mIPSCs. 
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Figure 5.3. Effects of Cd2+ and APTA on mIPSCs. A: Concurrent recordings of 
mIPSCs in control conditions and after Cd2+ (50 µM) and ATPA (0.5 µM) application 
in a typical layer III neurone. B: Cumulative probability graph of mISPC IEI in 
control conditions and after addition of Cd2+ and ATPA (n=9). 
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5.3.3. Analysis of KAR ligands effects on eIPSCs 
 
5.3.3.1. eIPSCs in layer III 
 
Using a bipolar stimulating electrode positioned in layer V of the lateral EC a train of 
IPSCs can be evoked in neurones in layer III of the medial EC. In these experiments, 
AMPAr and NMDAr were again blocked, and the stimulating electrode was placed 
relatively close to the recording site. I evoked trains of 5 responses at 5 and 10 Hz. 
With both frequencies, the pattern and profile of responses was similar. There was a 
clear cut paired pulse depression (PPD), a decrease in the amplitude of the second 
response when compared to the first response in the train. Thereafter, the responses 
remained depressed throughout the train. At 5 Hz (equating to a paired pulse interval 
of 200 ms) the ratio of depression between the first and second response was 0.5 ± 0.1 
(n=8), this was very similar to the depression seen at 10 Hz (0.5 ± 0.1; n=7). Average 
amplitudes and decay times for the five responses in the 5 and 10 Hz trains can be 
seen in Table 5.5. Graphs showing the normalised average peak amplitude for pooled 
data and paired pulse ratios can be seen in Figure 5.4. I tested the effects of a GABAB 
antagonist, CGP 55845A, on the profile of the 5 Hz train of eIPSCs. There was no 
significant effect of the antagonist on either PPR (1.6 ± 0.1; n=3) or decay times of any 
of the responses in the train (Table 5.5), therefore in future experiments data with and 
without CGP 55845A (5 µM) in the aCSF was pooled. eIPSCs were abolished by 
bicuculline (5 µM), indicating they are mediated by GABAAr (Figure 5.4A). 
 
  1 2 3 4 5 
Amplitude  96.9 ± 13.1 49.7 ± 7.2 59.0 ± 10.7 65.9 ± 15.7 60.2 ± 1.0 
5 Hz 
Decay time 10.9 ± 1.4 9.8 ± 1.4 8.2 ± 1.1 8.4 ± 1.0 7.7 ± 1.4 
Amplitude 177.0 ± 21.0 98.5 ± 12.9 73.5 ± 4.5 120.9 ± 6.4 
149.1 ± 
42.7 
5 Hz + 
CGP 
55845A Decay time 11.9 ± 0.3 8.8 ± 1.7 8.9 ± 1.4 10.0 ± 1.5 9.6 ± 2.2 
Amplitude 128.6 ± 40.8 59.6 ± 9.4 62.0 ± 10.5 73.6 ± 14.4 61.2 ± 11.310 Hz 
Decay time 9.7 ± 1.0 11.8 ± 1.4 9.4 ± 1.3 10.0 ± 1.7 9.1 ± 1.2 
 
Table 5.5. Average amplitudes (pA) and decay times (ms) for eIPSCs.  
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Figure 5.4. Evoked IPSCs in layer III of the EC. A: Average trace of eIPSCs to 
trains of 5 shocks at 10 Hz recorded in a typical layer III neurone in control 
conditions and after addition of bicuculline (5 µM). B: Graph of normalised 
amplitudes of responses to trains of 5 shocks for 5 and 10 Hz and also 5 Hz in the 
presence of CGP 33845A (5 µM). C: Graph of PPR at different frequencies. 
 
5.3.3.2. ATPA increases amplitude of eIPSCs 
 
Results from experiments on spontaneous release suggest that KAr facilitate GABA 
release via receptors on terminals and the interneurone soma and/or dendrites. 
However, the pharmacology of these effects is not clear cut. To look further at the role 
of KAr in control of inhibition I examined eIPSCs recorded as above. The effects of 
ATPA (0.1 and 0.5 µM) on eIPSCs (5 pulses at 5Hz; Figure 5.3A) were assessed in 8 
cells. In these cells a concentration-dependent increase in the amplitude of all events 
across the train was seen in the presence of ATPA. After the addition of ATPA (0.1 
µM) the average eIPSC amplitude of the first response was increased from 163.7 ± 
10.2 to 204.2 ± 13.6 pA, (P<0.05, n=8). Likewise, the subsequent events in the train 
were also increased (P values ranging from <0.05 to 0.01), although the depression 
between the first and second responses and the overall train profile were largely 
unaltered (Figure 5.5A). When a higher concentration of ATPA was used there was 
little further increase in the first response (210.2 ± 13.1 pA; n=8). However there was 
a significant increase in the size of the second response (from 135.98 ± 10.71 pA to 
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186.33 ± 17.87 pA; P< 0.05; n=7). The subsequent responses in the train were also 
generally increased, such that all responses were approximately the same amplitude as 
the first, although these increases were not found to be significant when compared to 
the amplitudes in the lower concentration. The PPR increased in the presence of 0.5 
µM ATPA (from 0.66 ± 0.03 to 0.89 ± 0.08; P<0.05, n=8; Figure 5.5B) reflecting the 
relative overall increase in the amplitude of the second response. Thus, with lower 
concentrations of ATPA, the depressive profile of the repetitive trains was 
maintained, whereas the higher concentrations essentially eliminated frequency-
dependent depression. ATPA had no effect on decay time or 10-90% rise time of any 
of the evoked responses (Table 5.6). 
 
Figure 5.5. Effects of ATPA on eIPSCs. A: Consecutive eIPSCs during 10 Hz train 
in control conditions and during perfusion of ATPA (0.1 and 0.5 µM) in a typical 
layer III neurone. B: Graph of PPR in control conditions and in the presence of 
ATPA. C: eIPSC mean amplitude graph in control conditions and after ATPA 
application (n=10) D: Graph of normalised amplitude of eIPSCs in control 
conditions and after ATPA application (n=10). 
 
 
5.3.3.3. UBP 302 and CNQX have different effects on eIPSCs 
 
The previous results suggest that KAr can enhance GABA release at terminals in layer 
III. I have now looked at the effects of KAr antagonists to determine if these receptors 
control ATPA (0.1 µM) ATPA (0.5 µM)
Response No
0
1.5
1 2 3 4 5
N
or
m
al
is
ed
 e
IP
SC
am
pl
itu
de
D
0
250
1 2 3 4 5
eI
PS
C
am
pl
itu
de
 (p
A)
control ATPA (0.1 µM)
C
B
0
1
P
PR
10
0 
pA
200 ms
A control ATPA (0.1 µM) ATPA (0.5 µM)
Response No
ATPA (0.5 µM)
N
or
m
al
is
ed
 e
IP
SC
am
pl
itu
de
eI
PS
C
am
pl
itu
de
 (p
A)
P
PR
10
0 
pA
 108
could be activated during repetitive stimulation with AMPAr and NMDAr blocked, 
and thus alter evoked GABA release.  
 
The effects of UBP 302 (20 µM) on eIPSCs (5 pulses at 5 Hz; Figure 5.6A) were 
assessed in 6 neurones. As described above, in all cells there was a large decrease in 
amplitude of the second, and all subsequent responses in the train compared to the 
first. The average amplitude decreased from 163.5 ± 20.7 pA to 94.2 ± 18.8 pA 
(P<0.01, n=6) from the first to the second pulse. After the addition of UBP 302 the 
amplitude of first response was significantly decreased to 88.4 ± 7.4 pA (P<0.01; 
n=6). However, the amplitude of the second response increased to 121.8 ± 12.6 pA 
(Figure 5.1B). The change in the paired pulse ratio was highly significant (0.6 ± 0.1 to 
1.4 ± 0.2, P<0.01, n=6; Figure 5.1C). Although, subsequent responses declined 
slightly in amplitude, they remained above the amplitude of the first response. The 
change in profile of the responses meant that the original PPD was converted into a 
substantial PPF by the GluR5 antagonist. Because UBP 302 reduced the first response 
in the train, this would suggest that Glur5 receptors may be activated in the 
interneurones soma/dendrites by the stimulation causing excitation of glutamatergic 
afferents to the interneurones. Blockade of this KAr drive would then lead to a 
decrease in GABA release onto the recorded neurone. 
 
In all neurones, CNQX (10 µM) was then added. CNQX had no further effect on the 
amplitude of the first response (93.1 ± 11.9 pA). Now, however, the second and third 
responses remained approximately the same amplitude as the first (91.9 ± 9.1 pA; 
P<0.01, n=6). This meant that the paired pulse ratio (1.0 ± 0.1; P<0.05, n=6) was 
significantly different to both control and UBP 302 and was essentially at unity, 
reflecting the lack of frequency dependence. Neither UBP 302 (15 µM) nor CNQX 
(10 µM) had any effect on the decay times of any of the evoked responses (Table 5.6). 
 
This would suggest again that two different KAr may be involved in modulating 
GABA release. The lack of effect on the first response indicates that the CNQX 
sensitive receptors are not involved in the excitatory input to the interneurones. The 
block of PPF may suggest that it is located on the terminals. This is speculated on 
further below. 
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  1 2 3 4 5 
Amplitude 163.7 ± 10.2 92.9 ± 13.3 97.7 ± 10.7 96.4 ±11.3 94.6 ± 5.4 control 
Decay time 11.4 ± 2.3 10.0 ± 2.2 10.7 ± 2.5 10.7 ± 2.6 9.9 ± 1.9 
Amplitude 204.2 ± 13.6* 
136.0 ± 
13.6** 
154.0 ± 
13.3ˆ** 
144.2 ± 
25.2* 
146.6 ± 
21.1* + ATPA 
Decay time 10.6 ± 1.8 11.1 ± 2.1 10.8 ± 1.8 11.2 ± 1.4 10.7±2.0 
Amplitude 88.4 ± 7.4* 121.8 ± 12.6 
102.9 ± 
12.0 
106.7 ± 
16.5 98.2 ± 11.9 + UBP 302 
Decay time 12.6 ± 3.0 11.7 ± 2.2 11.0 ± 2.3 11.2 ± 3.0 9.1 ± 2.4 
Amplitude 93.1 ± 11.9* 91.9 ± 9.1
? 87.7 ± 6.9*? 71.9 ± 5.5
* 86.8 ± 15.1* + CNQX 
Decay time 10.2 ± 2.3 11.9 ± 2.6 13.5 ± 3.2 11.7 ± 2.2 10.7 ± 2.1 
  
Table 5.6. Amplitudes (pA) and Decay times (ms) for eIPSCs. * indicates a 
significant change when compared to control (*P<0.05 **P<0.01; One way ANOVA 
and Bonferroni Test). ? indicates a significant change when compared to UBP 302 (P 
< 0.01; One way ANOVA and Bonferroni Test). 
 
 
Figure 5.6. Effects of UBP 302 and CNQX on eIPSCs. A: Consecutive eIPSCs 
during 10 Hz train in control conditions and during perfusion of UBP 302 (20 µM) 
and CNQX (10 µM). B: Graph of PPR in control conditions and in the presence of 
UBP 302 and CNQX. C: Graph of mean amplitude of eIPSCs in control conditions 
and after UBP 302 and CNQX application (n=10) D: Graph of normalised amplitude 
of eIPSCs in control conditions and after UBP 302 and CNQX application (n=10).  
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5.4. Discussion 
 
GABAergic transmission in the EC is modulated by a number of different receptors 
including NMDAr, mGluR and GABABr (Jones and Woodhall, 2005). In other brain 
regions, particularly the hippocampus, presynaptic KAr have proven to be very 
important in the regulation of GABA release (Cossart et al., 2001; Frerking et al., 
2001; Min et al., 1999; Rodriguez-Moreno et al., 2000). The aim of this study was to 
determine whether KAr are present on interneurones in layer III of the EC and, if so, 
what role they play in GABAergic transmission.  
 
ATPA increased sIPSC frequency in layer III, and this facilitation partly persists in 
the presence of TTX. This, together with the lack of effect of the agonist on amplitude 
and kinetics of sIPSCs or mIPSCs strongly indicates that KAr act to facilitate 
spontaneous GABA release from interneurones in layer III of the EC. The effect of 
ATPA was reduced, but not abolished, by TTX, suggesting that KAr are active at two 
sites: 1. on the soma or dendrites of the interneurones where their activation could 
increase neuronal firing and hence activity-driven GABA release. 2. On the 
GABAergic terminals, where they could directly enhance glutamate release. As 
ATPA shows good selectivity for receptors containing the GluR5 subunit (Hoo et al., 
1999; Stensbøl et al., 2001; Nielsen et al., 2003), this could suggest that these are the 
receptors most likely to be involved at both sites. However, recent evidence suggests 
that ATPA has some activity at GluR6 receptors when they also contain the KA2 
subunit (Paternain et al., 2000). Both of these subunits are also present in the EC 
(Bahn et al., 1994). Thus, it is possible that ATPA could be activating different 
receptors at the two sites. Although, the increase in sIPSC frequency elicited by 
ATPA was partially reduced by a GluR5 antagonist, and the increase in frequency of 
mIPSCs caused by ATPA was not blocked by UBP 302 (the GluR5 selective 
antagonist). This may indicate the presence of presynaptic KAr on the terminals 
acting to facilitate GABA release and containing the GluR6/KA2 subunits, and that 
there are also somatic KAr driving the interneurones, which contain the GluR5 
subunit. It’s also interesting there is no increase in events directly after a 5 Hz 
stimulus train, as seen for EPSCs. The results of studies with eIPSCs generally 
support the conclusion from studies on sIPSCs that there are excitatory GluR5 KAr on 
the interneurone soma/dendrites and a different, possibly GluR6/KA, receptor on the 
terminals. These are discussed further below.  
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These results are unlike what has been found in the hippocampus, in that presynaptic 
KAr in CA1 act to depress GABA release. Rodriguez et al. (1997) showed that 
application of kainate reduced the frequency of mIPSCs and the amplitude of eIPSCs, 
in culture and hippocampal slices. The KAr responsible for this depression are 
thought to contain the GluR5 subunit, as ATPA has been shown to cause a reduction 
in eIPSC amplitude which can be reversed by application of the GluR5 selective 
antagonist, LY 294486 (Clarke et al., 1997). KAr have been found to contribute to the 
EPSCs in interneurones in the hippocampus (Cossart et al., 1998; Frerking et al., 
1998), similar to what I have proposed may be the case in the EC. KAr have are 
thought to be more effective than AMPAr in increasing interneurone firing frequency, 
due to their long decay times (Yang et al., 2007). These KAr present on the 
soma/dendrites of hippocampal interneurones are also thought to contain the GluR5 
subunit, as they can be activated by ATPA and blocked by the GluR5 antagonist, LY 
293558 (Cossart et al., 1998).  
 
Presynaptic KAr have been shown to bidirectionally modulate both glutamate release 
(Schmitz et al., 2000; 2001; Lauri et al., 2006) and GABA release (Braga et al., 2003; 
Jiang et al., 2001). This intriguing ability allows them to facilitate transmitter release 
at low concentrations, but depress release at higher concentrations at the same 
synapse. It appears unlikely that this phenomenon occurs for GABA release in layer 
III of the EC, as both low and higher concentrations of ATPA (10µM) only caused an 
increase in sIPSC frequency. In the amygdala the same high concentration causes a 
decrease in the frequency of mIPSCs and increases the number of synaptic failures. I 
did see a decrease in the frequency of spontaneous events after prolonged exposure to 
the higher concentrations of ATPA, however, this was preceded by a pronounced 
increase in frequency. It could be that the increase in frequency resulted from low 
concentrations of ATPA as it washed into the bath and that the decrease was the result 
of the high concentration, when it had reached equilibrium in the slices. A biphasic 
effect similar to this was seen in the hippocampus (Jiang et al., 2001) where success 
rate of unitary IPSCs increased for the first few minutes of KA application before 
decreasing after 3-5 minutes. However, unlike in the hippocampus, in my experiments 
the increase in sIPSCs often persisted for up to 15 minutes, when equilibrium would 
have already been attained. Also, not all cells displayed a decrease. An alternative 
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explanation is that the decrease was due to a depletion of the GABA stores in these 
terminals and not a direct effect of the activation of KAr. 
 
I have attempted to determine the mechanism by which KAr facilitate GABA release. 
In my studies, Cd2+ completely prevented the increase in frequency of mIPSCs caused 
by ATPA. This suggests that VGCC are involved in the mechanism of GABA 
facilitation in these synapses. A likely scenario is that the KAr are acting to depolarise 
the terminal, thus activating VGCC and causing a subsequent influx of calcium and 
enhancement of release. Other studies have also looked at the mechanisms of KAr 
effects on GABA release (Cossart et al, 2001., Braga et al., 2003; Mathew and 
Hablitz, 2008). The effects of Cd2+ on facilitation of release have been investigated in 
the hippocampus and in the amygdala, where KA/ATPA-induced increase of the 
frequency of mIPSCs in the presence of Cd2+ was not significantly different from that 
in the absence of Cd2+ (Cossart et al., 2001; Braga et al., 2003; Mathew and Hablitz, 
2008). Therefore, it seemed unlikely that VGCC were involved in these brain regions. 
In addition, further studies have suggested that extracellular Ca2+ was necessary, as 
exposure to solutions containing no added extracellular Ca2+ inhibited the KAr-
mediated facilitation. In addition, KA was unable to induce facilitation in the presence 
of an inhibitor of Ca2+ permeable AMPA/KAr, suggesting that Ca2+ entry via Ca2+-
permeable KAr is involved (Mathew and Hablitz, 2008). Facilitation was also blocked 
after inhibition of endosomal Ca2+-ATPase-mediated Ca2+uptake, suggesting a role for 
intracellular stores. Inhibition of IP3 receptor, but not ryanodine receptor, induced 
Ca2+ release blocked KAr-induced changes, therefore the authors concluded that Ca2+ 
entering through Ca2+-permeable presynaptic KAr results in Ca2+ release from 
intracellular stores through IP3 receptors, which causes an increase in GABA 
transmission (Mathew and Hablitz, 2008). I cannot rule out the possibility that the 
KAr is acting via a metabotropic pathway in layer III, as has been suggested 
previously for the down-regulation of GABA (Rodriguez-Moreno and Lerma, 1998) 
and the facilitation of glutamate (Rodriguez-Moreno and Sihra, 2004) in the 
hippocampus and the bidirectional modulation of GABA in the amygdala (Braga et al, 
2003), particularly as the GluR5 subunit appears to be able to activate a G-protein, 
which could modulate VGCC (Rozas et al., 2003). This will require further 
investigation. 
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The results with eIPSCs are somewhat more complicated than those for the eEPSCs in 
Chapter 4. Evoked sIPSCs in control conditions showed a clear PPD of approximately 
50 %, a common feature at central GABAergic synapses. This has often been 
attributed to activation of presynaptic GABAB receptors (Davies et al., 1990; Deisz 
and Prince, 1989; Mott et al. 1993; Nathan and Lambert, 1991). However, GABAB 
blockade had little effect on PPD in my studies in layer III. Other mechanisms 
suggested to be involved include depletion of transmitter in the presynaptic terminal 
(Stevens and Tsujimoto, 1995; Debanne et al., 1996; Stevens and Wesseling, 1998), 
decreased calcium influx in response to action potential invasion (Brody and Yue, 
2000), inactivation of presynaptic calcium channel (Patil et al., 1998) and post pulse 
hyperpolarisation due to activation of calcium activated potassium and/or chloride 
channels (Marrion and Tavalin, 1998). In principle, any of these could be involved in 
PPD seen in these cells in layer III but this requires further experimentation to 
elucidate the mechanism involved. What is very interesting is the modification of 
frequency dependence of GABA transmission by KAr at EC synapses. UBP 302 
caused a depression in the amplitude of the first response to stimulation. By itself this 
would result in a reduction in PPD. However, UBP 302 also appeared to cause an 
increase in the second and subsequent events in the train, thus causing a shift in the 
PPR to facilitation. What are the mechanisms involved in this effect? A number of 
factors could account for the effect of UBP 302 on the amplitude of the initial 
response. It could be due to blockade of presynaptic GluR5 KAr on GABA terminals. 
In this scenario, the assumption would be that the first shock activated GABA inputs 
and simultaneously activated a parallel glutamate pathway. Glutamate released from 
this pathway would spillover to the GABA terminals, activating GluR5 receptors and 
instantaneously enhancing GABA release. Blocking these receptors would cause a 
decrease in the eIPSC to the first shock. The second possibility is that the GluR5 KAr 
are located on the interneurone soma/dendrites. Here, the first shock would activate 
both the GABA interneurones directly, but also feedforward glutamate pathways onto 
the interneurone. The amplitude of the first IPSC would depend on both pathways. 
UBP 302 would block the drive on to the interneurone and thus reduce the amplitude 
of the response. As earlier experiments showed that UBP 302 reduced sIPSC but not 
mIPSC frequency, and ATPA has a greater effect on sIPSCs than mIPSCs, this data 
seems to agree with the second proposal, and that there are GluR5 KAr driving 
excitation in interneurones in layer III. To determine whether or not there are 
postsynaptic GluR5 KAr located on the interneurones themselves, as has been found 
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in the hippocampus (Cossart et al., 1998; Frerking et al., 1998), we would need to 
record from the interneurones directly. These experiments should form part of future 
investigations.  
 
If GluR5 receptor blockade reduces the amplitude of the first response, what is 
responsible for the switch from PPD to PPF? This could arise because less GABA is 
released during the first event, leaving more in a readily available pool for the second 
and subsequent events. However, addition of CNQX on top of UBP 302 prevented the 
facilitation without affecting the amplitude of the first eIPSC. This could indicate the 
involvement of a second KAr acting as in the first scenario above. Glutamate could be 
spilling over from excitatory synapses and activating a UBP 302-insensitive, CNQX-
sensitive receptor on the GABA terminal. The change in eIPSCs induced by ATPA 
support this picture. Low concentrations of ATPA caused an increase in the amplitude 
of all events in the train (including the first), without affecting PPD. A higher 
concentration of ATPA increased the later events to a greater extent, resulting in 
elimination of PPD or PPF. As mentioned earlier, ATPA can act at GluR5 containing 
KAr as well as at GluR6/KA2 KAr (Paternain et al., 2000). These effects could reflect 
a differential, concentration-dependent increase in activation of somatic GluR5 and 
terminal GluR6/KA2r (see Figure 5.7). Overall, the data from studies of sIPSCs, 
mIPSCs and eIPSCs could support this spatial segregation of facilitatory KAr on 
GABA interneurones. However, it would perhaps be prudent to investigate the effects 
of mGluR ligands on the PPD and subsequent shift to PPF seen in these experiments. 
As group III mGluR have been found to depress spontaneous inhibition in layer V of 
the EC (Woodhall et al, 2001b), it would be necessary to rule out the possible 
involvement of mGluR in these observations. 
 
One of the elements motivating the investigation of KAr in the EC is the possible 
therapeutic potential of KAr agonists/antagonists in TLE. KA itself has been long 
linked to epilepsy because KA treatment is a common method to induce animal 
models of TLE, with systemic or local application of KA inducing seizures and 
neuropathological changes closely reminiscent of those in TLE patients (Ben-Ari, 
1985). This, in itself, suggests a possible role for KA antagonists as anti-convulsants, 
and is supported by evidence that KAr activation causes an overall disinhibition of the 
hippocampus (Rodriguez-Moreno et al., 1997). More recent research has provided 
direct evidence for the importance of GluR5 containing KAr. It has been shown that a 
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GluR5 selective antagonist, LY382884, protects against pilocarpine induced limbic 
seizures (Smolders et al., 2002). Also topiramate blocks EPSCs mediated by GluR5 
KAr (Gryder and Rogawski, 2003) and selectively protect against seizures induced by 
ATPA (Kaminski et al., 2004). It is difficult to resolve how the facilitation of GABA 
release by KAr seen in this study may relate to this evidence for the benefits of KAr 
antagonists in epilepsy since GluR5 blockade would be expected to reduce GABA 
release and exacerbate epileptic activity. It is also worth noting that the old view, that 
epilepsy results from impaired inhibition and that anti-convulsants simply enhance or 
restore inhibition, is no longer tenable. GABAergic interneurones are now 
increasingly seen to be drivers and initiators of network synchrony (Cobb et al., 1995; 
Traub et al., 2004; Klausberger et al., 2005). In addition, pathological changes in 
interneuronal synchronisation of principle neurones (Macloczky and Freund, 2005; 
Cossart et al., 2005) could be involved in TLE. Thus, alteration of the KAr-mediated 
facilitation of GABA release could very well be an important therapeutic target in 
epilepsy. However, a perhaps more relevant study showed that ATPA can have an 
anti-epileptic effect, stopping the spread of seizures, and this was believed to be due 
to the increase in frequency of sIPSCs (Khalilov et al., 2002).  
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Figure 5.7. Schematic summary diagram of roles of KAr in control of GABAergic 
transmission. Schematic diagrams showing what may be happening during 10 Hz 
stimulation in the presence of A: 2-AP5 (50 µM) and GYKI 53665 (25 µM) and B: 
after application of UBP 302 (20 µM) and C: CNQX (10 µM). 
 
Finally, related to this is the role of KAr in oscillations discussed in Chapter 1. It is 
clear that GluR5 KAr are involved in initiation and/or maintenance of both gamma 
oscillations and SWO (Cunningham et al., 2003; Stranger et al., 2008; Cunningham et 
al., 2006). During SWO, both excitatory and inhibitory transmission appear to be 
increased (Sanchez-Vives and McCormick, 2000; Shu et al., 2003). Thus, activation 
of KAr could be driving increased network synchrony by simultaneously elevating 
GABAergic and glutamatergic transmission and the interactions between them. 
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Whether or not KAr prove to be a new therapeutic target for epilepsy, it is clear that 
they play an important role in the modulation of GABAergic transmission layer III of 
the EC.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 6 
 
EFFECTS OF REDUCING [Mg2+]o ON EXCITATION 
AND INHIBITION IN LAYER III 
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6.1. Introduction 
 
In Chapter 1, I described recent work by Cunningham et al. (2006b) that has indicated 
that KAr containing the GluR5 subunit are involved in the initiation and/or 
maintenance of SWO in the EC. In the previous data chapters I have now shown that 
GluR5 containing KAr are present in the EC. These are involved at both excitatory 
and inhibitory synapses acting to enhance release of glutamate and GABA. In 
addition, KAr also contribute to postsynaptic excitation at glutamate synapses. 
Indirect evidence also indicates that postsynaptic GluR5 KAr mediate, at least in part, 
an excitatory input to GABAergic interneurones. 
 
SWO can be generated in the EC in response to reducing [Mg2+]o from 2 mM to 1.25 
mM (Cunningham et al., 2006b; Greenhill and Jones, unpublished observations). 
Most researchers are familiar with the ability of Mg2+ to block most cation channels, 
particularly Ca2+ channels. Mg2+ is often referred to as a physiological calcium 
channel blocker, as small decreases in Mg2+ plasma levels can lead to a significant 
increase in evoked Ca2+ currents and in resting Ca2+ (Altura and Altura, 1995). Thus, 
the effect of reducing [Mg2+]o would be to increase activity at VGCC and potentially 
increase the release of both glutamate and GABA.  
 
A second, very important ion channel blocking activity of Mg2+ in the CNS is at the 
NMDAr, where the cation exerts a voltage-dependent block of the receptor ionophore. 
It has been accepted that neurones need to be depolarised to remove the Mg2+ block 
before the NMDAr can be activated by glutamate (Mayer et al., 1984). This role of 
Mg2+ in the function of NMDAr has long been thought to be associated with the 
underlying mechanism for LTP and therefore vital for learning and memory (for 
review see Brown et al., 1988; Collingridge and Bliss, 1995; Bennett, 2000). Thus, 
lowering [Mg2+]o should lead to enhanced activation of NMDAr and this could also be 
involved in generation of SWO. It is well established that more profound reductions 
in [Mg2+]o lead to highly synchronised and prolonged epileptiform activity in the EC, 
which is dependant on NMDAr activation (Walter et al., 1986; Jones and Heinemann, 
1988; Jones and Lambert, 1990a,b). Although the experiments of Cunningham et al. 
(2006b) reported that SWO were not altered by NMDAr antagonists, further studies in 
this laboratory (Greenhill and Jones, unpublished observations) have shown that SWO 
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induced by lowering [Mg2+]o from 2.0 to 1.25 mM, can be reduced by 2-AP5 (see 
Figure 6.1 and below).  
control
UBP 302 (20 µM)
wash (10 min)
2-AP5 (50 µM)
wash (15 min)
2 s
20 m
V
20 m
V
 
Figure 6.1. Effects of UBP 302 and 2-AP5 on SWO. Consecutive intracellular 
recordings of SWO induced in the EC by reducing [Mg2+]o showing the effects of 
UBP 302 (20 µM) and 2-AP5 (50 µM ) and after washout (Greenhill and Jones, 
unpublished). 
 
Rhythmic electrical activity or oscillations of various frequencies are seen in many 
areas of the CNS and are important in many different processes, including memory 
(for review see Axmacher et al., 2006). SWO, in particular, have been suggested to 
underlie the transfer of memory traces from the hippocampus to the neocortex during 
sleep (for review see Hoffman et al., 2007), partly due to their prominence during 
slow wave sleep. As previously mentioned, KAr are thought to play a role in SWO 
generation in the EC, as these can be blocked by UBP 302 (Cunningham et al., 2006b; 
Figure 6.2A). sEPSPs with noticeably long decay times are present in intracellular 
recordings just before and during the onset of the SWO (Cunningham et al., 200b6; 
Figure 6.2B). These EPSCs have a significant KAr component as UBP 302 reduces 
the decay times of the events (Figure 6.1C), indicating the importance of the GluR5 
containing KAr in SWO. As mentioned above, NMDAr may also be important in the 
generation of SWO. Experiments in this laboratory have shown the SWO in the EC 
can be blocked by UBP 302, but that they can also be reduced or blocked by 2-AP5 in 
the same neurone. Thus, KAr are involved although it is not a straightforward story. 
KAr have also been shown to play a role in other oscillations including gamma 
oscillations in the hippocampus (Brown et al., 2006) and the EC (Cunningham et al., 
2003), theta oscillations in the hippocampus (Huxter et al., 2007) and beta oscillations 
in the motor cortex (Yamawaki et al., 2008). 
 
In this chapter I have attempted to begin a clarification of the role of KAr in the 
generation of SWO by studying how circumstances that generate SWO may alter KAr 
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transmission. The work has had two main aims: 1) to investigate the effects of 
reducing Mg2+ on synaptic transmission at both glutamatergic and GABAergic 
synapses in the EC and 2) to identify how these changes are linked to KAr and their 
role in SWO. 
control
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Figure 6.2. SWO in the EC. A: Extra- (exc) and intracellular (ic) recordings of 
spontaneous SWO induced by lowering [Mg2+]o (from 2 to 1.25 mM) in control 
conditions and after addition of UBP 302. B. Expansion of the ic record shows a 
flurry of spontaneous EPSPs during initiation of the SWO. C. Individual sEPSPs in 
control conditions and after addition of UBP 302. (adapted from Cunningham et al., 
2006b). 
 
6.2. Methods 
 
As in previous Chapters, brain slices were prepared from juvenile animals aged from 
4 to 6 weeks old (45 - 70 g) and general methods are the same (Chapter 2). The 
normal aCSF employed contained 3 mM KCl and 2 mM MgSO4. In the experiments 
where reduced [Mg2+]o was required, the storage and recording aCSF was modified 
with slightly higher KCl (3.25 mM) and lowered MgSO4 (1.25).  
 
6.3. Results 
 
6.3.1. Effects of reducing [Mg2+]o on glutamatergic transmission. 
 
6.3.1.1. Effect on sEPSCs. 
 
In the first set of experiments I determined whether spontaneous glutamate release 
was altered by reducing [Mg2+]o. In 5 neurones, reducing [Mg2+]o from 2 mM to 1.25 
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mM resulted in a substantial decrease in IEI from 180 ± 31 ms to 89 ± 16 ms (KS test 
– P<0.0001; n=5; see Figure 6.3). This reflects an increase in frequency from 6.2 ± 
1.0 Hz to 12.7 ± 2.1 Hz. Analysis of the kinetics of the sEPSCs showed that there 
were no significant changes in the rise or decay times, although both tended to be 
faster in low Mg2+. In addition, amplitudes were slightly, but not significantly smaller. 
All IEI, amplitudes and kinetics are recorded in Table 6.1. Thus, the general picture 
was an increase in frequency of events with little change in amplitude or kinetics. 
These results strongly suggest an overall increase in release without increased 
postsynaptic receptor activation. In particular, there was no suggestion for an increase 
in duration of events as a result of increased postsynaptic NMDAr or KAr activation. 
 
sEPSC 
IEI 
(ms) 
Amplitude 
(pA) 
Decay time 
(ms) 
Rise Time 
(ms) 
2.0 mM Mg2+ 180 ± 28  14.3±0.5 11.3±0.5 1.9±0.1 
1.25 mM Mg2+ 89 ±15 * 12.8±1.2 8.3±0.6 1.4±0.2 
 
Table 6.1. IEI, Amplitude and kinetic data for sEPSCs in ‘normal’ and reduced 
[Mg2+]o.. * indicates a significant change when compared control (P <0.001 KS Test).  
 
Figure 6.3. Effect of reduced [Mg2+]o on sEPSCs in layer III. A: Concurrent 
recordings from a typical layer III neurone in ‘normal’ (2 mM) and low (1.25 mM) 
Mg2+. B: Cumulative probability graph of IEI of sEPSCs in layer III in ‘normal’ and 
low Mg2+. C: Frequency distribution of sEPSC amplitudes in layer III neurones (bin 
width = 3). The distribution shows a single peak, skewed toward larger amplitude 
events. 
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6.3.1.2. Effect on eEPSCs. 
 
I next looked at the effects of lowering Mg2+ on AMPAr-mediated EPSCs in 7 
neurones. eEPSCs were evoked using a stimulation train of 5 pulses at 10 Hz. As in 
the studies in Sections 4.3.1.3, 4, 5 and 6, there was a facilitation of eEPSCs between 
the first and the second responses, which was maintained or decreased slightly across 
the subsequent events in the train. Reducing [Mg2+]o caused an increase in amplitudes 
of all events in the train (Figure 6.4C). The mean amplitude of the first eEPSC in low 
Mg2+ was 176.2 ± 15.2 pA compared to 99.3 ± 9.9 pA in control (ANOVA – P<0.01; 
n=6). During the subsequent train, amplitudes decreased slightly, but not significantly, 
compared to the first response. All eEPSCs remained larger than the corresponding 
events in control. Thus, the increase in amplitude was found to be significant at every 
point in the train (P values ranging from < 0.05 to < 0.01). Analysis of the PPR in the 
two conditions showed that reducing Mg2+ eliminates frequency-dependent facilitation 
between the first two responses (PPR from 1.35 ± 0.07 to 0.94 ± 0.07; Figure 6.4D) 
and across the rest of the train. 
 
I carefully compared the decay kinetics of the eEPSCs to determine if slow KAr or 
NMDAr components were evident in low Mg2+. Decay times of the first events in the 
trains were 51.5 ± 7.2 ms in control vs. 47.3 ±12.4 ms in low Mg2+, so there was no 
indication that the eEPSCs were prolonged. Likewise no differences were found when 
comparing events at later points in the train (see Table 6.2). If anything decay times 
were decrease rather than prolonged. ‘Before and after’ analysis was also conducted 
in these neurones. There was no difference in the amplitude, decay times or 10-90% 
rise times for events recorded before or after the 10 Hz trains in either control or in 
low Mg2+. However, under control conditions the number of events increased from 5 
± 1 before the train to 7 ± 1 after each train (P<0.05, n=7). In 1.25 mM Mg2+ the 
number of events before the train increased to 8 ± 1 (P<0.05, n=7), with no concurrent 
change in the number of events after the train (7± 1). 
 
Overall, the effect of reducing [Mg2+]o on excitatory transmission was very similar to 
the effect of applying ATPA (see Section 4.3.1.4.). sEPSC frequency but not 
amplitude was enhanced, and evoked responses were increased in amplitude with an 
overall loss of the frequency facilitation profile. Likewise, low Mg2+ eliminated 
sEPSC differences in the ‘before and after’ analysis, in a similar fashion to ATPA. 
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  1 2  3 4 5 
Amplitude 99.3 ± 9.9 132.0 ± 10.5 
127.0 ± 
14.9 123.8 ± 8.9 
125.0 ± 
13.8 Control 
Decay time 51.5 ± 7.3 60.9 ± 12.6 52.4 ± 8.3 59.2 ± 11.6 57.5 ± 10.7
Amplitude 176.2 ± 15.2† 
165.8 ± 
17.6* 
164.8 ± 
16.6* 
160.5 ± 
16.6* 
152.3 ± 
10.4* Low  
Mg2+ 
Decay time 47.3 ± 12.4 43.8 ± 11.6 45.3 ± 10.0 44.5 ± 11.3 39.6 ± 9.8 
 
Table 6.2. Amplitude (pA) and decay times (ms) of eEPSCs in ‘normal’ and low 
Mg2+.* indicates a significant difference when compared to control (P<0.05 One 
way anova and Bonferroni test) † indicates a significant difference when compared 
to control (P<0.01 One way anova and Bonferroni test). 
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Figure 6.4. eEPSCs in ‘normal’ and reduced [Mg2+]o. A: Consecutive recordings of 
eEPSCs during a 5 shock 10 Hz train in ‘normal’ (2 mM) and low (1.25 mM) Mg2+ B: 
PPR graph for ‘normal’ and low Mg2+ (n=6). C: eEPSC mean amplitude graph in 
‘normal’ and low Mg2+. D: Graph of normalised amplitude in ‘normal’ and low 
Mg2+. 
 
6.3.1.3. Effects of reducing [Mg2+]o is not due to NMDAr 
 
In the next set of experiments I determined whether reducing [Mg2+]o removed Mg2+ 
block and increased activation of NMDAr could lead to the increase in sEPSC 
frequency and eEPSC amplitude. To do this I determined the effects of the NMDAr 
antagonist 2-AP5 on these effects. Reducing [Mg2+]o to 1.25 mM resulted in an 
increase in sEPSC frequency from 6.2 ± 1.0 Hz to 12.7 ± 2.1 Hz, reflecting a change 
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in IEI from 180 ± 31 ms to 89 ± 16 ms. After the addition of 2-AP5 (50 µM) there 
was a small but significant increase in IEI to 119 ± 24 ms (P<0.01; n=5). However, 
the change was not dramatic, and even in the presence of 2-AP5 the frequency of 
sEPSCs (10.9 ± 2.8 Hz) was still much higher than in 2 mM Mg2+ (Figure 6.5). There 
was, however, a significant decrease in the decay times of the sEPSCs from 8.3 ±0.6 
ms to 5.0 ± 0.2 ms. This may indicate that there is some contribution of postsynaptic 
NMDAr to the synaptic current which is blocked by 2-AP5. IEI, amplitude and 
kinetics of sEPSCs are presented in Table 6.3. 
 
sEPSC 
IEI 
(ms) 
Amplitude 
(pA) 
Decay time 
(ms) 
Rise Time 
(ms) 
1.25 mM Mg2+ 89 ± 15 12.8 ± 1.2 8.3 ± 0.6 1.4 ± 0.2 
+ 2-AP5 119 ± 24* 11.5 ± 0.7 5.02 ± 0.2 1.2 ± 0.1 
 
Table 6.3. IEI, amplitude and kinetics for sEPSCs in reduced [Mg2+]o and in the 
presence of 2-AP5.* indicates a significant difference when compared to control 
(P<0.01 KS Test). 
 
In addition, 2-AP5 had no significant effect on the amplitude of the evoked responses 
(average amplitude across the train from 163.44 ± 7.69 pA to 153.39 ± 5.82 pA). 
However, there was a tendency for the amplitude of the responses to be smaller in the 
presence of 2-AP5 (Table 6.4 and Figure 6.5). There was also a tendency for the 
decay time of the eEPSC to decrease in the presence of 2-AP5, however this was not 
significant (Table 6.4). 
 
  1 2  3 4 5 
Amplitude 168.7±17.8 169.0±11.7 169.5±17.7 153.6±13.6 156.4±33.1Low 
Mg2+ Decay time 20.8±4.3 20.4±0.4 21.0±0.9 24.2±6.2 20.7±2.5 
Amplitude 154.1±15.9 147.8±16.5 169.5±7.7 149.2±14.1 146.4±12.6
+ 2-AP5 
Decay time 18.9±1.2 18.1±0.2 19.3±0.6 19.6±0.4 18.9±0.6 
 
Table 6.4. Amplitude (pA) and decay times (ms) for eEPSCs in reduced [Mg2+]o and 
in the presence of 2-AP5. 
 
These results indicate that there may be a small contribution of NMDAr to the change 
in glutamate transmission induced by lowering [Mg2+]o. It should be remembered that 
2-AP5 does not alter sEPSC frequency in normal [Mg2+]o (Section 3.3.1.5. and 
  126
4.3.1.6.). The decrease seen in 1.25 mM may indicate that there is a weak activation 
of presynaptic NMDAr in this condition. However, this is not what is responsible for 
the large increase in spontaneous activity. In 2 mM Mg2+, frequency-dependent 
facilitation of eEPSCs was blocked by 2-AP5. There was a tendency for eEPSCs to be 
reduced in 1.25 mM Mg2+, but again this effect was small. Overall then, increased 
activation of NMDAr in 1.25 mM Mg2+ may contribute to the enhanced glutamatergic 
transmission but it is not responsible for the majority of the effect. 
 
Figure 6.5. Effects of 2-AP5 on sEPSCs and eEPSCs in low Mg2+. A: Cumulative 
probability graph of IEI for sEPSCs in ‘normal’ and low Mg2+ conditions and after 
addition of 2-AP5 (50 µM) B: Normalised amplitude graph for eEPSCs in low Mg2+ 
and after addition of 2-AP5 (50 µM). 
 
6.3.1.4. Reducing [Mg2+]o causes increased activation of GluR5 KAr 
 
The SWO produced by reducing Mg2+ in the EC (Cunningham et al., 2006b) can be 
blocked by UBP 302 so in the next set of experiments I examined the effects of the 
antagonist (20 µM) on the effects of lowering Mg2+. As before, reducing Mg2+ to 1.25 
mM resulted in a decreased IEI (from 192 ± 31 ms to 103 ± 19 ms; P<0.001; n=6) and 
reflecting an increase in sEPSC frequency (from 6.6 ± 0.9 Hz to 11.5 ± 2.0 Hz) 
similar to that described earlier. Addition of UBP 302 substantially reversed this 
effect, increasing inter-event interval from 103 ± 19 ms to 201 ± 37 ms (5.8 ± 1.0 Hz; 
KS test – P<0.01; n=6; Figure 6.6.), back to similar levels as in control. The data in 
Table 6.5 show that the event amplitudes, rise and decay times were unaltered 
throughout. The ability of UBP 302 to decrease sEPSC frequency in low Mg2+ 
contrasts with its failure to do so in 2 mM Mg2+ (Section 4.3.1.2.) i.e. this means that 
with the increased glutamate release seen in 1.25 mM Mg2+ they are now tonically 
activated. Thus, in this situation, the GluR5 KAr are either more sensitive to 
glutamate or more readily accessed by released glutamate. These possibilities are 
addressed below. 
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sEPSC 
IEI 
(ms) 
Amplitude 
(pA) 
Decay time 
(ms) 
Rise Time 
(ms) 
1.25 mM Mg2+ 102 ± 19 14.6 ± 0.4 7.6 ± 0.6 1.4 ± 0.1 
+ UBP 302 201 ± 37* 14.5 ± 1.0 7.8 ± 0.4 1.5 ± 0.1 
 
Table 6.5. IEI, amplitude and kinetics for sEPSCs in reduced [Mg2+]o and in the 
presence of UBP 302. * indicates a significant difference when compared to control 
(P<0.01 KS Test). 
 
I have also determined the effect of UBP 302 on eEPSCs in low Mg2+. As before 
lowering Mg2+ increased the amplitude of all events in a 10 Hz 5 pulse train, and 
essentially eliminated frequency-dependent facilitation. Figure 6.6 clearly shows that 
UBP 302 decreases the amplitude of all the events in the train which was significant 
for all positions in the train (P values ranging from 0.05 to 0.0001; n=3). Data for 
amplitudes and decay times are included in Table 6.6. It is also clear from Figure 6.6 
that the reversal of the effects of Mg2+ was also accompanied by a lack of the 
frequency facilitation also seen in 2 mM Mg2+ after the addition of UBP 302 (Section 
4.3.1.5.). 
 
  1 2  3 4 5 
Amplitude 154.1±15.9 147.8±16.5 169.5±7.7 149.2±14.1 146.4±12.6Low 
Mg2+ Decay time 18.9±1.2 18.1±0.2 19.3±0.6 19.6±0.4 18.9±0.6 
Amplitude 87.9±14.3† 89.1±7.5* 59.6±7.7^ 94.1±5.3† 92.0±10. † + UBP 
302 Decay time 17.1±1.5 19.1±0.5 18.7±0.8 18.9±1.2 17.2±1.9 
 
Table 6.6. Amplitude (pA) and decay times (ms) for eEPSCs in Low Mg2+ and UBP 
302. * indicates a significant difference when compared to control (P<0.05 ANOVA 
and Bonferroni test). † indicates a significant difference when compared to control 
(P<0.001 ANOVA and Bonferroni test).^ indicates a significant difference when 
compared to control (P<0.0001 ANOVA and Bonferroni test). 
 
I also conducted ‘before and after’ analysis in these neurones. There was no 
difference in the amplitude, decay times or 10-90% rise times for events recorded 
before or after the trains in either in low Mg2+ or in UBP 302. In low Mg2+ the number 
of events was 15.2 ± 4.4 before the train compared to 15.9 ± 4.3 after. After addition 
of UBP 302 the number of events before the train decreased to 7 ± 2, similarly the 
number of events after the train decreased to 9 ± 2. Both were significant compared to 
the number of events in control (P<0.05, n=4). Although, the number of events after 
the train in UBP 302 was slightly higher compared to before this was not significant. 
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Figure 6.6. Effect of UBP 302 on sEPSCs and eEPSCs in low Mg2+. A: Concurrent 
recordings of sEPSCs in reduced Mg2+ after the addition of UBP 302 (20 µM) in a 
typical layer III neurone. B: Cumulative probability graph of sEPSC IEI in ‘normal’ 
and low Mg2+ and after addition of UBP 302 (n=6). C: Mean peak amplitude graph 
of eEPSCs in ‘normal’ and low Mg2+ and after addition of UBP 302 (n=4). D: 
Normalised amplitude graph of eEPSCs in ‘normal’ and low Mg2+ and after addition 
of UBP 302 (n=4).  
 
In summary, the data in the previous sections show that the depletion of [Mg2+]o 
elevates transmission at glutamatergic synapses. However, these effects are only 
weakly ameliorated by blocking NMDAr but substantially reversed by blocking 
GluR5 KAr. 
 
6.3.2 Blocking glutamate uptake mimics the effects of reducing [Mg2+]o  
 
The reversal of enhanced glutamate transmission by UBP 302 suggests two main 
possibilities; 1, that glutamate release is increased by lowering [Mg2+]o and the 
increased transmitter present can access KAr that were not tonically activated before. 
Or 2, that KAr function is somehow directly increased by removing Mg2+ i.e. that the 
receptor is somehow gated by Mg2+. I have attempted to look at these possibilities. To 
investigate the first of these possibilities, I looked at the effects of the glutamate 
uptake blocker PDC. The rationale behind this is that by reducing uptake, PDC should 
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make more glutamate available at the synapses, which may then mimic the increased 
release seen with low Mg2+.  
 
6.3.2.1. Effect of PDC on sEPSCs 
 
In 6 neurones the IEI of sEPSCs was 178 ± 33 ms. Application of PDC (50 µM) 
significantly decreased this to 92 ± 17 ms (P<0.0001; n=6). These results reflect an 
average change in frequency from 6.8 ± 3.3 Hz to 14.3 ± 3.2 Hz. Kinetics of the 
events were unaltered (Table 6.7). However, PDC also caused a small increase in the 
amplitude of the sEPSCs from 14.4 ±1.9 pA to 17.1 ± 2.0 pA (P<0.05; n=6). Thus, 
blocking uptake resulted in an increase in frequency, which likely reflects an 
increased probability of release. At the same time the increased amplitude may 
indicate that the postsynaptic receptors may not be saturated, and each release event 
can now reach more receptors. Thus, the increase in glutamate release is similar to 
that elicited by lowering [Mg2+]o. I then tested the effects of UBP 302 on sEPSC. 
Addition of the antagonist largely blocked the change in frequency induced by PDC 
reducing the IEI back to 147 ± 21 ms (P<0.001; n=6; Figure 6.7.). However, it did not 
completely reverse it, and the frequency (7.6 ± 1.2 Hz) remained elevated over control 
levels. Average amplitude was decreased to 15.4 ± 1.4 pA, although this was not 
found to be significant.  
 
sEPSC 
IEI 
(ms) 
Amplitude 
(pA) 
Decay time 
(ms) 
Rise Time 
(ms) 
Control 178 ± 33 14.4 ±1.9  9.3 ± 1.0 1.9 ± 0.2 
+ PDC 92 ± 17* 17.1 ± 2.0† 9.7 ± 1.7 1.7 ± 0.3 
+ UBP 302 147 ± 21^ 15.4 ± 1.4 8.5 ± 0.6 1.6 ± 0.2 
 
Table 6.7. IEI, amplitude and kinetics for sEPSCs in PDC and UBP 302. *indicates 
a significant difference when compared to control (P<0.0001 KS Test). †indicates a 
significant difference when compared to control (P<0.05 ANOVA and Bonferroni 
test). ^ inidicates a significant difference when compared to UBP 302 ((P<0.001 KS 
Test). 
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Figure 6.7. Effects of PDC on sEPSCs. A: Consecutive recordings of sEPSCs in 
control conditions and after addition of PDC (50 µM) and UBP 302 (20 µM). B: 
Cumulative probability graph of IEI in control conditions and after the addition of 
PDC and UBP 302 (n=6). 
 
6.3.2.2. Effects of PDC on eEPSCs 
 
I also determined the effect of PDC on eEPSCs. As with lowering Mg2+, PDC (50 
µM) increased the amplitude of all events in a 5 Hz 10 pulse train, and essentially 
eliminated frequency-dependent facilitation. Figure 6.8 clearly shows that PDC 
increases the amplitude of all the events in the train and this was significant for all 
positions in the train (P values ranging from 0.05 to 0.01; n=4). Data for amplitudes 
and decay times are included in Table 6.8. It is also clear from Figure 6.8 that PDC 
also removes the PPF seen in control. I then tested the effects of UBP 302 (20 µM) on 
eEPSCs in these neurones. UBP 302 significantly reduced the amplitude of all events 
in the train (P values ranging from 0.05 to 0.01) without affecting decay times (Table 
6.8 and Figure 6.8). There is also no PPF in UBP 302, as was seen in Section 4.3.1.5. 
 
In ‘before and after’ analysis there was no difference in the amplitude, decay times or 
10-90% rise times for events recorded before or after the trains in either in PDC (50 
µM) compared to control. In control the number of events increased from 8.4 ± 1.6 
before the train to 11.4 ± 2.0 after each train (P<0.05, n=6). However, after addition 
of PDC the number of events before the train was increased overall to 10.7 ± 2.0 
(P<0.05, n=6), but there was no concurrent change in the number of events after the 
train (11.9 ± 1.9) when the blocker was present. 
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  1 2  3 4 5 
Amplitude 79.5 ± 13.9 116.5 ± 8.6 119.7 ± 11.4 137.7 ± 7.3 
151.3 ± 
13.0 control 
Decay time 10.2 ± 1.2 10.0 ± 1.3 9.9 ± 1.0 10.3 ± 0.9 10.3 ± 0.7 
Amplitude 201.5 ± 30.2* 
190.3 ± 
25.1† 
215.3 ± 
32.8† 
228.1 ± 
34.6† 
246.3 ± 
44.8† + PDC 
Decay time 9.4 ± 0.4 9.3 ± 0.5 9.2 ± 0.5 9.2 ±0.5 9.1 ± 0.5 
Amplitude 66 ± 14.5^ 63.6 ± 13.8†^ 
59.2 ± 
13.6+ 
74.3 ± 
14.6^ 
69.4 ± 
15.3^ + UBP 
302 
Decay time 9.8 ± 0.8 10.5 ± 0.7 10.8 ± 1.9 10.3 ± 0.7 10.8 ± 1.0 
 
Table 6.8. Effects of PDC on eEPSC amplitude (pA)  and decay time (ms).* 
indicates a signidicant difference when compared to control (P<0.01 ANOVA and 
Bonferroni test). † indicates a signidicant difference when compared to control 
(P<0.51 ANOVA and Bonferroni test). ^indicates a signidicant difference when 
compared to PDC (P<0.05 ANOVA and Bonferroni test). +indicates a signidicant 
difference when compared to PDC (P<0.05 ANOVA and Bonferroni test). 
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Figure 6.8. Effects of PDC on eEPSCs. A: Concurrent recordings average eEPSCs 
in control conditions (2 mM Mg2+) and in the presence of PDC (50 µM) and UBP 302 
(20 µM) in a typical layer III neurone. B: eEPSC mean amplitude graph (n=4) 
showing control conditions and after addition of PDC and UBP 302. C: eEPSC 
normalised amplitude graph (n=4) showing control and after addition of PDC and 
UBP 302. 
 
Thus, in essence, the effects of reducing [Mg2+]o were mimicked by blocking 
glutamate uptake. This included the ability of GluR5 receptor blockade to at least 
partially reverse the increase in spontaneous glutamate transmission. This strongly 
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suggests that the increased glutamate release is boosted by activation of KAr 
receptors, which are not normally accessed by ambient glutamate. 
 
6.3.3. Postsynaptic KAr in low Mg2+ and PDC 
 
The previous experiments suggested that presynaptic KAr function was increased in 
low Mg2+ and during application of PDC. In a further series of experiments I looked 
at changes in postsynaptic KAr eEPCSs induced by reducing [Mg2+]o or blocking 
uptake. In these experiments I used a stimulation protocol of 5 pulses at 100 Hz in the 
presence of GYKI 53665 and 2-AP5, which elicited a small amplitude, slowly 
decaying EPSC mediated by KAr (Section 4.3.2.). 
 
I found that reducing [Mg2+]o from 2 mM to 1.25 mM significantly increased the 
amplitude of the KAr eEPSCs from 60.5 ± 6.9 pA to 84.9 ± 6.5 pA (P<0.01; n=6; 
Figure 6.9A). The kinetics of the event were unaltered, however, with a decay time of 
675.4 ± 58.2 ms in control compared to 711.6 ± 50.6 ms in low Mg2+.  
 
There are a number of possible explanations for this increase in amplitude, including 
increased release of glutamate, or a change in the postsynaptic receptor. In Section 
4.3.2.1. I showed that the KAr eEPSC was likely to be mediated by a KAr subunit 
other that GluR5 as it wasn’t blocked by UBP 302. The I-V relationship of the EPSC 
suggested that it might be an edited version of a GluR6 containing receptor with low 
Ca2+ permeability (Section 4.3.2.3.). It has been shown that GluR6 receptors can be 
weakly blocked by Mg2+ (Fukushima et al., 2003). One possibility is that the 
reduction of [Mg2+]o increased current through the postsynaptic receptors. This might 
be expected to result in a change in I-V relationship, so I have examined whether 
there was any effect of reducing Mg2+ on the I-V curve of the KAr eEPSC. It is clear 
from Figure 6.9B that reducing [Mg2+]o had no effect on the I-V relationship of the 
receptor which supports the suggestion that there is no direct effect of Mg2+ on the 
postsynaptic KAr itself.  
 
Since the effects of low Mg2+ on sEPSCs and eEPSCs was reversed by UBP 302, 
another possibility is that the KAr EPSC is enhanced by additional contribution from 
GluR5 receptors. To test this I looked at the effects of UBP 302 on this increase in the 
eEPSC amplitude in all six neurones where the KAr eEPSC was enhanced in low 
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Mg2+. UBP 302 caused a decrease in the amplitude of the KAr eEPSC from 84.9 ± 6.5 
pA to 64.3 ± 3.9 pA (P<0.01; n=6), i.e. virtually the same as the amplitude in control 
(60.5 ± 6.9 pA). There was no change in kinetics of the eEPSC in the presence of 
UBP 302 (687.2 ± 96.5 ms). Thus, reducing [Mg2+]o appeared to induce a GluR5 
mediated component to the KAr EPSC that was not present under control conditions 
(see Section 4.3.2.1.). The results from studies on sEPSCs and AMPAr-mediated 
eEPSCs above suggest that the most likely explanation is that low Mg2+ increases 
release of glutamate to then tonically activate presynaptic autoreceptors. 
 
Results obtained from blocking glutmate uptake agree with this scenario. I examined 
the effects of PDC on the KAr eEPSC in 2 mM Mg2+. Application of PDC (50 µM) 
caused an increase in the amplitude of the KAr eEPSC from 65.9 ± 6.6 pA to 100.3 ± 
12.6 pA (P<0.05; n=7), with no concurrent change in decay time (from 529.2 ± 49.60 
ms to 541.5 ± 68.0 ms). Again this increase was largely, although not completely, 
reversed in the presence of UBP 302 (75.9 ± 6.8 pA; P<0.05; n=6; Figure 6.9C). 
Surprisingly perhaps, there was no change in kinetics of the eEPSC in the presence of 
UBP 302 (500.5 ± 48.4 ms). 
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Figure 6.9. Postsynaptic KAr EPSC in reduced [Mg2+]o. A: Consecutive recordings 
of KAr eEPSCs in ‘normal’ (2 mM) and low Mg2+ (1.25 mM) and after addition of 
UBP 302 (20 µM) and mean amplitude graph (n=6) in ‘normal’ Mg2+ and low Mg2+ 
and after addition of UBP 302. B: Current-Voltage plot (n=4; corrected for LJP). C: 
Mean amplitude graph (n=6) in ‘normal’ Mg2+ and after addition of PDC (50 µM) 
and UBP 302. 
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6.3.4 Effects of reducing [Mg2+]o on GABAergic transmission 
 
The foregoing experiments clearly indicate an enhanced level of excitatory 
transmission under conditions that induced SWO. This enhancement is at least partly 
mediated by GluR5 receptors. These receptors also control aspects of inhibition 
(Chapter 5) and increased GABAergic inhibition is important in SWO (Sanchez-
Vives and McCormick, 2000). Therefore, I also examined GABA transmission during 
the lowering of [Mg2+]o that can elicit SWO (Cunningham et al., 2006b). 
 
6.3.4.1. Effect on sIPSCs 
 
In 6 neurones (in the presence of GYKI 53665 and 2-AP5 to block AMPAr and 
NMDAr respectively) the mean IEI of sIPSCs was 167 ± 32 ms. As was the case with 
sEPSCs, reducing the [Mg2+]o from 2 mM to 1.25 mM caused a large decrease in IEI 
to 88 ± 11 ms (KS test – P<0.0001; n=6, see Figure 6.10) reflecting an increase in 
frequency from 7.5 ± 4.2 Hz to 12.1 ± 3.2 Hz. Concurrently, the amplitude of the 
sIPSCs was also increased. There was a tendency for the decay times to be longer, but 
this change was not significant. Rise times were unaltered.  
 
In view of the fact that UBP 302 reversed the effects of lowering Mg2+ on EPSCs, I 
next examined the effect of the antagonist on the increase in sIPSC frequency induced 
by low Mg2+ in a further 4 neurones. In these neurones IEI was 138 ± 31 ms in 2 mM 
Mg2+ and this showed a substantial decrease to 52 ± 5 ms when Mg2+ was reduced to 
1.25 mM. Addition of UBP 302 (20 µM) then increased IEI from this reduced level to 
78 ± 11 ms (KS test – P<0.0001; n=4). This was a partial reversal, as IEI did not 
return to control levels (KS test P<0.001; n=4; see Figure 6.10). This indicated that, as 
with sEPSCs, increased GluR5 receptor activation contributes to the increase in 
inhibition.  
 
However, as UBP 302 is specific for GluR5 receptors, I also wanted to determine 
whether other KAr may be involved. Thus, subsequent addition of CNQX (20 µM) 
was made. This resulted in a further increase in IEI to 86 ± 12 ms (P<0.05; n=4; see 
Figure 6.10) but again this was still significantly shorter than in control (P<0.001; 
n=4). Average amplitudes and kinetics of sIPSCs in ‘normal’ and low Mg2+ and after 
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addition of UBP 302 and CNQX is summarised in Table 6.9. It can be seen that the 
increase in amplitude elicited in 1.25 Mg2+ is also reversed in parallel with IEI. 
 
sIPSC 
IEI 
(ms) 
Amplitude 
(pA) 
Decay time 
(ms) 
Rise Time 
(ms) 
2.0 mM Mg2+ 138 ± 31 34.4 ± 2.4 8.6 ± 0.5 1.9 ± 0.4 
1.25 mM Mg2+ 52 ± 5* 38.5 ± 3.0 10.4 ± 1.7 1.6 ± 0.2 
+ UBP 302 78 ± 11†^ 37.1 ± 2.2 9.2 ± 0.7 1.8 ± 0.3 
+ CNQX 86 ± 12^+ 35.4 ± 4.4 10.0 ± 0.8 1.9 ± 0.3 
 
Table 6.9. IEI, Amplitudes (pA), decay and rise times (ms) for sIPSCs in high and 
low Mg2+ and in the presence of UBP 302 and CNQX. * indicates a signidicant 
difference when compared to control (P<0.0001 ANOVA and Bonferroni test). † 
indicates a signidicant difference when compared to low magnesium (P<0.0001 
ANOVA and Bonferroni test). ^indicates a signidicant difference when compared to 
control (P<0.001 ANOVA and Bonferroni test). +indicates a signidicant difference 
when compared to UBP 302 (P<0.05 ANOVA and Bonferroni test). 
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Figure 6.10. Effect of reducing [Mg2+]o on sIPSCs. A: Concurrent recordings of 
sIPSCs in ‘normal’ and low Mg2+ and after addition of UBP 302 and CNQX. B: 
Cumulative probability graph of IEI of sIPSCs in ‘normal’ (2 mM) and low Mg2+ 
(1.25 mM) and after perfusion with UBP 302 (20 µM) and CNQX (20 µM). 
 
6.4.3.2. Effects on eIPSCs 
 
I have also examined changes in GABAAr-mediated eIPSCs during lowering of 
[Mg2+]o. Again, I employed 5 pulse trains at 10 Hz to evoke the inhibitory responses. 
As before, there was a clear PPD between the first and second responses followed by 
a plateau (Section 5.3.3.1.). Reducing [Mg2+]o resulted in an increase in amplitudes of 
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all eIPSCs in the train. The average overall amplitude of eIPSCs across the train in 
low Mg2+ was 366.0 ± 32.7 pA compared to 209.4 ± 21.5 pA in control (P<0.0001, 
n=6). The increase in amplitude was found to be significant wherever the event was in 
the train (P values ranging from 0.05 to 0.01; Figure 6.11). Despite the elevated 
amplitudes the overall profile of eIPSCs in the train was little affected and this was 
shown by a lack of change in PPD (Figure 6.11). There was a tendency for the decay 
time of eIPSCs to increase but it was not significant (from 38.7 ± 14.0 ms to 53.3 ± 
12.3 ms).  
 
Thus, as with effects on eEPSCs, lowering [Mg2+]o results in a large increase in 
amplitude of all evoked responses, which bears a strong similarity to the effects of 
perfusing with ATPA (see Section 5.3.3.2.). For this reason I have also studied the 
effect of KAr blockade on low Mg2+-induced changes in eIPSCs. Again, low Mg2+ 
induced an increase in amplitude of all responses in a 5 Hz train, with no real change 
in the overall pattern of frequency-dependent depression. The average amplitude of all 
responses in the train increased from 217.6 ± 25.5 pA in control to 351.26 ± 21.2 pA 
in low Mg2+. UBP 302 then decreased the average amplitude of all evoked IPSCs in 
the train to 238.0 ± 16.0 pA (P<0.001; n=5), and this reduction was significant for all 
positions in the train except the second (P values ranging from <0.05 to <0.01; Figure 
6.11). Subsequent addition of CNQX (20 µM) further reduced the overall average 
amplitude of eIPSCs (to 153.9 ± 9.6 pA). However, only the second response in the 
train decreased significantly (from 260.6 ± 32.5 pA to 173.5 ± 13.2 pA; P<0.05; n-4).  
 
The effects of the two antagonists on the profile of eIPSCs in the train were quite 
complex, but remarkably similar to their effects in 2 mM (Section 5.3.3.2. and 3.). 
Thus, UBP 302 decreased the first response in the train to below control levels, and 
the second response became larger, converting PPD to PPF. This meant that UBP 302 
caused a significant shift on the PPR (from 0.7 ± 0.1 to 1.4 ± 0.1; P<0.05; n=5; Figure 
6.11D). When CNQX was also added the initial PPF now disappeared, and the 
response profile became flat, with a consequent PPR of 1.1 ± 0.1 (P<0.05; n=5; see 
figure 6.11D). The average amplitude of evoked responses after CNQX application 
was also significantly less than in 2 mM Mg2+ (217.2 ± 25.5; P<0.05; n=4), although 
the only IPSC in the train that was significantly decreased was the second response 
(from 281.2 ± 84.9 to 169.1 ± 29.4; P< 0.05; n=4; Figure 6.11). 
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Figure 6.11. Effects of reducing [Mg2+]o on eIPSCs. A: Consecutive recordings of 
eIPSCs at 10 Hz in ‘normal’ (2 mM) and low Mg2+ (1.25 mM) and after addition of 
UBP 302 (20 µM) and CNQX (20 µM). B: eEPSC mean amplitude graphs (n=5) in 
‘normal’ and low Mg2+ and after addition of UBP 302 and CNQX. C: Normalised 
amplitude graphs (n=5) of eIPSCs in ‘normal’ and low Mg2+ and after addition of 
UBP 302 and CNQX. 
 
6.3.3.3. Effect of PDC on IPSCS 
 
Previously, I have shown that blocking glutamate uptake, using PDC, mimicked the 
effects of reducing [Mg2+] on glutamatergic transmission. This supported the 
conclusion that lowering Mg2+ caused increased glutamate release, which increased 
activation of GluR5 KAr at glutamatergic synapses. For completeness, I also 
investigated the effects of PDC on sIPSCs and eIPSCs. In 5 neurones the IEI of 
sIPSCs was 117 ± 23 ms. Application of PDC (50 µM) significantly decreased this to 
76 ± 18 ms (P<0.0001; n=6; Figure 6.12A,B). These results reflect an average change 
in frequency from 10.3 ± 2.3 Hz to 16.9 ± 4.3 Hz. Amplitude and kinetics of the 
sIPSCs were unaltered (Table 6.10). Thus, blocking glutamate uptake resulted in an 
increase in sIPSC frequency similar to that caused by lowering [Mg2+]o. I then tested 
the effects of UBP 302 on sIPSC frequency in these neurones. Addition of the 
antagonist partially reversed the increase in frequency induced by PDC reducing the 
IEI back to 99 ± 18 ms (P<0.001; n=6; Figure 6.12A,B). However, it did not 
completely reverse it, and the frequency (11.8 ± 2.3 Hz) remained elevated over 
control levels.  
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sEPSC 
IEI 
(ms) 
Amplitude 
(pA) 
Decay time 
(ms) 
Rise Time 
(ms) 
Control 117 ± 23 22.5 ± 2.5 10.2 ± 2.3 2.8 ± 0.6 
+ PDC 76 ± 18* 21.5 ± 2.7  9.0 ± 3.4 2.3 ± 0.5 
+ UBP 302 99 ± 18^ 19.0 ± 4.9 9.7 ± 3.0 2.4 ± 0.2 
 
Table 6.10. IEI, amplitude  and kinetics  for sIPSCs in PDC and UBP 302.* 
indicates a significant difference from control (P<0.0001 KS Test). ^ indicates a 
significant difference from PDC (P<0.001 KS Test). 
 
I also determined the effect of PDC on eIPSCs. As with lowering Mg2+, PDC (50 µM) 
increased the overall average amplitude of eIPSCs in a 5 Hz 10 pulse train from 108.0 
± 11.1 pA to 180.4 ± 15.1 pA (P<0.0001; n=5) with no concurrent effect on PPD 
(from 0.52 ± 0.10 to 0.63 ± 0.06). Figure 6.12C clearly shows that PDC increases the 
amplitude of all the events in the train and this was significant for all positions in the 
train (P values ranging from 0.05 to 0.01; n=5). I then tested UBP 302 (20 µM) on 
eIPSCs in these neurones. UBP 302 significantly reduced the amplitude of the first 
event in the train (from 228.5 ± 48.2 pA to 116.1 ± 32.6; P<0.01; n=5). There was a 
tendency for all of the subsequent events in the train to decrease in the presence of 
UBP 302, however this was only significant for the fourth and fifth responses (Figure 
6.12C). UBP 302 had no effect on the decay times (Table 6.10). As in Section 5.3.3.3. 
UBP 302 also changed the profile of responses from PPD to PPF (Figure 6.12D). 
 
  1 2  3 4 5 
Amplitude 137.2 ± 30.6 
79.3 ± 
30.3 
96.0 ± 
15.6 
116.9 ± 
17.3 
110.5 ± 
28.7 control 
Decay time 14.5 ± 3.6 14.5 ± 3.5 15.1 ± 3.7 15.4 ± 3.3 15.3 ± 2.8 
Amplitude 228.5 ± 48.2^ 
161.2 ± 
37.9^ 
161.5 ± 
28.3^ 
188.9 ± 
21.9* 
161.7 ± 
30.6* + PDC 
Decay time 14.3 ± 0.8 14.1 ± 0.9 14.9 ± 1.0 14.1 ± 1.0 14.7 ± 0.7 
Amplitude 116.1 ± 32.6+ 
129.1 ± 
30.5 
123.2 ± 
20.0 
125.1 ± 
32.5† 
109.1 ± 
29.2† + UBP 
302 
Decay time 14.8 ± 1.9 14.1 ± 1.4 14.0 ± 2.3 14.4 ± 1.6 14.7 ± 3.5 
 
Table 6.11. Effects of PDC on eIPSC amplitude (pA) and decay time (ms) * 
indicates a significant difference from control (P<0.01 KS Test). ^indicates a 
significant difference from control (P<0.05 KS Test). +indicates a significant 
difference from PDC (P<0.01 KS Test). † indicates a significant difference from PDC 
(P<0.05 KS Test). 
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Figure 6.12. Effects of PDC on sIPSCs and eIPSCs. A: Concurrent recordings of 
sIPSCs in control conditions (2 mM Mg2+) and after PDC (50 µM) and UBP 302 (20 
µM). B: Cumulative probability graph of sIPSC IEI in control conditions and after 
application of PDC and UBP 302 (n=6). C: eIPSC mean amplitude graphs showing 
control conditions and after perfusion of PDC and UBP 302 (n=5). D: Graph of PPR 
(n=5). 
 
Thus, in essence, the effects of reducing [Mg2+]o were mimicked by blocking 
glutamate uptake. This included the ability of GluR5 receptor blockade to at least 
partially reverse the increase in spontaneous glutamate transmission. This strongly 
suggests that the increase in GABA transmission is at least partly due to the increase 
in glutamate release elicited by low Mg2+ which is boosting activation of the GluR5 
KAr receptors which control GABA release. 
 
6.4. Discussion 
 
SWO can be induced in layer III of the EC when [Mg2+]o is moderately reduced 
(Cunningham et al., 2006b; Greenhill and Jones, unpublished). The aim of this 
chapter was to determine what this manipulation does to excitatory and inhibitory 
transmission in layer III and to relate this to the role of KAr. The results clearly show 
that when [Mg2+]o is reduced there is a substantial increase in spontaneous release at 
glutamatergic synapses, and a concurrent increase in amplitude of the eEPSCs, both 
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those mediated by AMPAr and KAr. This may not be surprising as the ability of Mg2+ 
to block VGCC has long been known. A reduction in [Mg2+]o might be expected to 
reduce a “physiological” block of VGCC in terminals and lead to increased glutamate 
release (Lin et al., 2002; Zhang et al., 1996). This could occur by two mechanisms. 1,  
a direct reduction of Mg2+ block of the VGCC poor; 2, a surface charge screening 
effect, where depletion of Mg2+ allows more Ca2+ to move closer to the mouth of the 
VGCC (Muller and Finkelstein, 1974).  
 
In addition, presynaptic NMDAr are present in the EC and act to facilitate glutamate 
release (Berretta and Jones, 1996b; Woodhall et al., 2001a). As NMDAr are blocked 
by Mg2+, another possibility is that the increased glutamate release could be due to an 
increased activation of presynaptic NMDAr when [Mg2+]o is lowered. The 
contribution of presynaptic NMDAr proved to be minor however, as when I applied 
2-AP5, the frequency of events was reduced slightly. It was by no means abolished, 
therefore increased presynaptic NMDAr activation was not responsible for the large 
majority of the increased release observed in low Mg2+. In addition, 2-AP5 had no 
real effect on the amplitude of the eEPSCs. This leads to the conclusion that although 
reducing the Mg2+ may cause a slight increase in presynaptic NMDAr activation other 
mechanisms account for the increase in spontaneous excitatory activity seen in 1.25 
mM Mg2+. This could be accounted for simply by the increased Ca2+ entry via VGCC 
noted above. However, as the SWO induced by lowering [Mg2+]o (Cunningham et al., 
2006b) are blocked by UBP 302, the effect of the antagonist on the increased 
glutamate release was tested. It caused a substantial reversal of the increased sEPSC 
frequency and increase eEPSC amplitude seen in 1.25 mM Mg2+. Thus, a large part of 
the increased release was GluR5 KAr-dependent. It should be remembered from 
Chapter 4 that these receptors can presynaptically facilitate release at layer III 
synapses, but only during repetitive stimulation. However, in 1.25 mM Mg2+, the 
GluR5 receptors become tonically active, as UBP 302 now reduces sEPSC frequency. 
Thus, I suggest that glutamate release is increased by reduced blockade of VGCC and 
this increased release is then boosted by enhanced activation of the presynaptic GluR5 
receptors. 
 
An alternative possibility is that Mg2+ has a direct effect on the GluR5 KAr and that 
lowering Mg2+ increases intrinsic activity of the receptor. I checked whether this 
might be the case by examining the effects of PDC. Blocking glutamate uptake would 
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be expected to increase ambient extracellular glutamate, without having direct effects 
on cellular, terminal or channel excitability. PDC, like 1.25 mM Mg2+, caused an 
increase in sEPSC frequency and an increase in the amplitude of the AMPAr-
mediated EPSCs. This was expected as by blocking uptake of glutamate in the 
synapse it increases the availability of the transmitter to activate the postsynaptic 
receptors. What was interesting is that UBP 302 again substantially reversed this 
effect of PDC. This would indicate that the impairment of glutamate clearance from 
the synapse again leads to an increased activation of the presynaptic GluR5 receptors, 
which in turn causes even more glutamate to be released. There is a precedent for 
increased activation of presynaptic glutamate receptors caused by increased ambient 
glutamate levels after glutamate transporter blockade. In cultured hippocampal 
neurones, PDC actually reduced sEPSCs and this was suggested to result from 
increased glutamate access to presynaptic mGluR (Maki et al., 1994). In fact, Iserhot 
et al. (1999) also reported that PDC at very high concentrations (400 µM) reduced 
excitatory field potentials in layer III and layer V in EC slices. They speculated that 
this could be due to enhanced activation of high affinity KAr. These results are 
obviously at odds with my studies. However, the authors did use very high 
concentrations of the blocker, which may well have direct effects on ion channels and 
cause desensitisation of postsynaptic AMPAr.  
 
My studies clearly suggest that preventing glutamate uptake enhances, rather than 
reduces excitatory transmission and the increase in ambient glutamate boosts itself by 
activating presynaptic GluR5 receptors. As PDC had essentially the same effect on 
glutamatergic transmission as reducing Mg2+, it seems unlikely that Mg2+ has any 
direct effects on the presynaptic KAr. I cannot completely rule out the possibility that 
PDC and low Mg2+ increase glutamate release, which then accesses postsynaptic 
GluR5 KAr, not normally activated by ambient or evoked glutamate release. Both 
manipulations caused an increase in the KAr EPSC and PDC also slightly increased 
sEPSC amplitude, all effects reversed by some extent by UBP 302. However, the 
studies in 2 mM [Mg2+]o (Section 4.3.1.) strongly indicated a presynaptic GluR5 KAr. 
Also, low Mg2+ increase sEPSC frequency with no effect on amplitudes or kinetics. 
Thus, overall my conclusion is that the effects are almost certainly due to increased 
presynaptic GluR5 activity. 
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I also examined the consequences of reducing [Mg2+]o on GABAergic transmission. 
Reduction of Mg2+ in the aCSF caused a pronounced increase in sIPSC frequency and 
an increase in amplitude of the eIPSCs, although it had no effect on PPR. Application 
of UBP 302 partially reduced the frequency of sIPSCs, subsequent addition of CNQX 
caused a further reduction although still not to the frequency seen in control. So what 
is the basis of the increase in GABA release and how does this relate to KAr-mediated 
control? It seems likely that increased GABA will occur partly due to removal of a 
Mg2+ block on the presynaptic VGCC on the GABAergic terminal. However, as both 
UBP 302 and CNQX have reduced frequency of sIPSCs in ‘normal’ Mg2+ (Section 
5.3.1.3.), and then had a similar effect in low Mg2+ it is unclear from this data that 
there is increased activation of KAr at GABAergic synapses. However, both 
antagonists also reduced eIPSC amplitude, and although GABA release was greatly 
elevated, overall their effects were similar in both low and normal Mg2+. Thus, UBP 
302 decreased the amplitude of all evoked responses during repetitive stimulation, in 
addition to changing PPD to PPF. Importantly, the first response in the train was also 
reduced compared to control, whether 2 mM or 1.25 mM Mg2+ was used. This would 
indicate that in low Mg2+ there is an increased activation of the GluR5-containing 
KAr, which I suggested in the previous Chapter were postsynaptic KAr acting to drive 
the interneurons. Thus, low Mg2+ may partly increase GABA release at synapses on 
the interneurones where postsynaptic GluR5 receptors are located.  
 
CNQX also decreased eIPSC amplitude, but as in ‘normal’ studies (see Section 
5.3.3.3.) the first response in the train was not reduced compared to that seen in the 
presence of UBP 302. I suggested in Chapter 5 that the facilitation in eIPSCs seen in 
the presence of 2 mM Mg2+ and UBP 302 was mediated by glutamate activating 
presynaptic GluR6/KA2 receptors on GABA terminals. This mechanism is still active 
in 1.25 mM Mg2+, as evidenced by the effect of CNQX, but it unclear as to whether 
there is increased activity of the presynaptic KAr on GABAergic terminals when 
[Mg2+]o is reduced. 
 
Studies with PDC in IPSCs largely reflected what was seen with low Mg2+. The 
increase in sIPSC frequency and eIPSC amplitudes were partially reversed by UBP 
302. This would fit well with these effects being partly due to increased glutamate 
levels present at synapses on the interneurones, driving increased GABA release via 
GluR5 receptors. Vignes (2001) showed in cultured hippocampal neurones that 
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GABA release was driven partly by AMPAr and partly by GluR5 KAr on 
interneurones. However, the effect of GluR5 receptors was only really apparent when 
uptake was blocked with PDC. In my studies, it would have been interesting to see 
whether CNQX further reduced the increase in GABA release in PDC, which would 
also support the possibility of spillover of glutamate release to the GABA terminals. 
There is clearly a precedent for this at GABA synapses on CA1 interneurones 
(Kullman and Semyanov, 2002). 
 
Thus, reduction in [Mg2+]o causes an increase in frequency of excitatory and 
inhibitory spontaneous activity and increased amplitude of evoked responses, which 
are largely blocked by the presence of the GluR5-selective antagonist UBP 302. This 
provides support for the suggestion that GluR5-contain KAr are responsible for the 
induction and/or maintenance of SWO in the EC (Cunningham et al., 2006b). The 
latter studies suggested that there was an increased GluR5 KAr component to sEPSPs 
in low Mg2+. This was not seen in the sEPSCs recorded in my studies. However, there 
was an increase in amplitudes of the postsynaptic KAr eEPSC, which was blocked by 
UBP 302. Whilst my data point primarily to increased presynaptic GluR5 activity, I 
cannot rule out increased activation of postsynaptic GluR5-containing receptors at this 
stage. 
 
It is clear from the intracellular recordings of SWO that the upstate phase is associated 
with greatly increased excitatory and inhibitory activity (Cunningham et al., 2006b; 
Haider et al., 2006; Sanchez-Vives and McCormick, 2000). As the SWO can be 
blocked by UBP 302, this strongly suggests that the GluR5 driven effects on 
excitatory and inhibitory elements of the network are involved in SWO generation. It 
is not possible to speculate on the functional mechanisms of network interaction 
leading to SWO generation from my data. However, they do affirm a primary role of 
enhanced GluR5 activity. Finally, as noted in the Introduction (Section 6.1), 2-AP5 
may also prevent SWO generation. It is interesting that 1, NMDAr and GluR5 KAr 
may interact cooperatively in mediating autoreceptor facilitation in layer III (Section 
4.3.1.6.), and 2, that 2-AP5 may at least partly reduce the enhanced glutamatergic 
transmission seen in low Mg2+. Thus, interaction between these two presynaptic 
receptors may also be involved in initiation or maintenance of SWO. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 7 
 
PRESYNAPTIC KAR AT GLUTAMATERGIC 
SYNAPSES IN LAYER V. 
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7.1. Introduction 
 
The experiments detailed in the preceding Chapters of this thesis have been conducted 
in layer III of the EC (for reasons outlined in the Introduction). However, there is little 
information available from expression studies to define the laminar distribution of 
KAr subunits in the EC. Postsynaptic KAr-mediated EPSCs have been identified in 
layer II (West et al., 2007). But nothing is known about any possible role of KAr 
presynaptically in layer II and either pre- or postsynaptically in other layers. 
 
However, in terms of laminar related actions of KAr it is very interesting that the 
power of the gamma oscillations induced by KA in EC studies shows a peak in layer 
III which declines sharply in layer V and also towards layer II, suggesting that KAr in 
layer III are important for the generation of gamma oscillations (Cunningham et al., 
2003). Also, SWO oscillations in the EC are prominent in layer III (and II) but decline 
markedly in layer V (Cunningham et al., 2006b). Again, as these oscillations can be 
blocked by UBP 302 they are likely to be driven in part by GluR5 KAr particularly in 
layer III. Thus, there would appear to be a correlation between KAr activation and the 
presence of strong oscillations in this layer and this has been a major driving force 
behind the studies in this thesis.  
 
Having determined a role for KAr both pre- and postsynaptically in layer III, I now 
asked whether these receptors may be functional in transmission in layer V. Since, 
both gamma and SWO are much less pronounced in the deep layer and KAr appear to 
play a dominant role in their generation my starting hypothesis was that KAr may 
play less of a role here. Thus, in this Chapter I have performed preliminary 
experiments to examine the role of KAr in layer V. To date, these have been aimed at 
examining a possible presynaptic role at glutamate synapses. 
 
7.2. Methods 
 
Again, brain slices were prepared from juvenile animals aged from 4 to 6 weeks old 
(45 - 70 g). sEPSCs, mEPSCs and eEPSCs were recorded from neurones in layer V of 
the medial division of the EC.  
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No specific analysis of the type of neurone recorded was performed. However, visual 
observation showed that the majority of neurones were medium-sized pyramidal 
neurones. Recordings were essentially limited to neurones with this morphology, with 
the presumption that these were principal glutamatergic neurones. 
 
Frequency-dependent facilitation of AMPAr-mediated eEPSCs is a prominent feature 
of excitatory transmission in layer V but this is heavily dependent on presynaptic 
NMDAr activation (Woodhall et al., 2001a; Yang et al., 2006a). In order to compare 
the involvement of presynaptic NMDAr in layer V with a possible role of presynaptic 
KAr the protocol for evoking eEPSCs and repetitive stimulation was slightly modified 
compared to that used in previous Chapters and designed to match that used in layer V 
previously in this laboratory. Single stimuli were delivered continuously at 0.05 Hz. 
At 2 minute intervals these were replaced briefly with trains of stimuli (3 Hz, 5 s) 
before low frequency (0.05 Hz) stimulation was resumed. Frequency-dependent 
facilitation was quantified by averaging the largest 5 responses evoked during the 
train and comparing these to the amplitude of 5 low frequency responses directly 
before each train. Mean facilitation in a minimum of 3 trains was then compared in 
the presence and absence of the drugs.  
 
In all the experiments, MK 801 was included in the patch pipette solution. This has 
been shown to block the postsynaptic NMDAr on the recorded neurone (Berretta and 
Jones, 1996b; Woodhall et al., 2001a; Yang et al., 2006a) allowing examination of 
presynaptic NMDAr-mediated effects in isolation. I used this approach to ensure 
consistency in my comparisons between NMDAr and KAr actions. 
 
7.3. Results 
 
7.3.1. ATPA has no effect on frequency of mEPSCs in layer V 
 
I showed in Chapter 4 (Section 4.3.1.1.) that ATPA powerfully increased the 
frequency but not amplitude of sEPSCs and mEPSCs in layer III neurones, providing 
strong evidence for presynaptic KAr autoreceptors on glutamate terminals. I have now 
conducted similar experiments in layer V neurones. I restricted these experiments to 
examining mEPSCs as I wished to determine if KAr were present specifically on 
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terminals on layer V neurones without complication from network/activity driven 
effects on glutamate release. 
 
mEPSCs were recorded in layer V neurones in the presence of TTX (1 µM). In the 
presence of ATPA (0.5 µM) there was no discernible change in mEPSCs. The IEI in 
ATPA was 702 ± 37 ms compared to 652 ± 73 ms in control. The cumulative 
probability analysis of IEI showed completely overlapping distributions in the pooled 
data (Figure 7.1A). In addition, ATPA failed to alter the amplitude (11.8 ± 0.4 pA 
compared to 11.3 ± 1.4 pA in control), time to decay (7.0 ± 1.3 ms compared to 5.7 ± 
0.8 ms in control; Figure 7.1B) or 10-90% rise time (1.4 ± 0.3 ms compared to 1.1 ± 
0.2 ms in control). Thus, these data indicate that GluR5 receptors are not present on 
glutamate terminals in layer V, in contrast to layer III (Chapter 4). 
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Figure 7.1. Effects of ATPA on mEPSCs in layer V of the EC. A: Cumulative 
probability graph of mEPSC IEI in 3 neurones in control conditions and after 
application of ATPA (0.5 µM). B: Average mEPSC (n=60) in control and in the 
presence of ATPA. C: Graph of amplitude distribution for pooled data (n=3) in 
control conditions and in the presence of ATPA (bin size = 4). 
 
7.3.2. 2-AP5 blocks facilitation of glutamate release in layer V. 
 
Frequency-dependent facilitation of evoked glutamatergic responses has been shown 
to be a pronounced feature of excitatory transmission in layer V (Woodhall et al., 
2001a; Yang et al., 2006a). This occurs at frequencies as low as 2-3 Hz, and is 
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strongly dependent on presynaptic NMDAr activation (Woodhall et al., 2001a; Yang 
et al., 2006a; Yang et al., 2008). I repeated the protocol used by Yang et al. (2006a). 
MK801 was included in the patch solution in all experiments. 
 
In 4 neurones, average amplitude of the eEPSC during 0.05 Hz stimulation was 128.8 
± 43.6 pA. During the higher frequency (3 Hz) stimulation this increased significantly 
to 223.9 ± 61.5 pA (P<0.05, n=4; see Figure 7.2A), representing an average increase 
of 86 ± 27 %. In confirmation of previous studies (Woodhall et al., 2001a; Yang et 
al., 2006a), addition of 2-AP5 (50 μM) had no effect on the amplitude of the eEPSC 
at 0.05 Hz stimulation (138.8 ± 48.0 pA) but significantly decreased the amplitude of 
the eEPSC at 3 Hz stimulation to 139.9 ± 47.8 pA (P<0.05; n=4; Figure 7.2A) 
reflecting a decrease in percentage facilitation to 2 ± 3 %.  
 
sEPSCs were also analysed in the same 4 neurones. IEI increased in the presence of 2-
AP5 from 315 ± 90 ms to 455 ± 96 ms. This represented a decrease in frequency from 
4.0 ± 1.0 Hz to 2.7 ± 0.9 Hz. There was also no change in amplitude or kinetics of the 
sEPSCs in 2-AP5 (Table 7.1). Thus, 2-AP5 reduced frequency facilitation of eEPSCs 
and increased IEI of sEPSCs, confirming the tonic facilitatory role of presynaptic 
NMDAr in layer V (Woodhall et al., 2001a). 
 
7.3.3. UBP 302 has no effect on glutamate release in layer V 
 
I now examined whether there is any contribution of presynaptic GluR5 KARs to 
facilitation of glutamate release in layer V, as is the case in layer III. This protocol, as 
above, was repeated in the presence of UBP 302 in 5 neurones. Again in control there 
was a significant frequency-dependent facilitation of eEPSCs. Mean amplitude of 
eEPSCs was 79.8 ± 6.5 pA in 0.05 Hz stimulation compared to 181.8 ± 14.9 pA in 3 
Hz. This represented a mean facilitation of 128 ± 3 %. Addition of UBP 302 (20 µM) 
had no significant effect on the mean amplitude of the eEPSC either during low 
frequency stimulation (95.8 ± 10.8 pA) or during high frequency stimulation (203.2 ± 
21.4 pA), representing an increase in facilitation of 113 ± 6 %. The increase was 
significant (P<0.01, n=5; Figure 7.2) and was unchanged when compared with 
control. sEPSCs were also analysed in these four neurones. There were no significant 
changes, amplitude or kinetics of the events (Table 7.1). Most importantly there was 
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no significant change in IEI. If anything there was a very weak decrease, but no 
overall change in frequency. 
 
sEPSCs 
IEI 
(ms) 
Amplitude 
(pA) 
Decay time 
(ms) 
Rise Time 
(ms) 
control 315 ± 90 16.0 ± 2.8 4.7 ± 1.0 1.7 ± 0.4 
+ 2-AP5 455 ± 96 15.2 ± 3.0 5.3 ± 1.5 1.7 ± 0.4 
control 658 ± 165 15.2 ± 2.6 5.8 ± 1.2 1.8 ± 0.3 
+ UBP 302 581 ± 194 16.0 ± 3.1 5.9 ± 0.3 1.6 ± 0.2 
 
Table 7.1. IEI, amplitude, decay and rise times for sEPSCs in layer V.  
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Figure 7.2. Effects of 2-AP5 and UBP 302 on frequency facilitation in layer V. A: 
Average eEPSCs (n=6) during 0.5 Hz and 3 Hz stimulation in control conditions and 
after application of 2-AP5 (50 µM). B: Average eEPSCs (n=6) during 0.5 Hz and 3 
Hz stimulation in control conditions and after application of UBP 302 (20 µM). C: 
Graph of average facilitation from pooled data (n=5) at various time points before 
and after application of 2-AP5 (red) and UBP 302 (blue.) 
 
7.3.4. 2-AP5 vs. UBP 302 in layer III 
 
The data above show that facilitation of glutamate release is NMDAr dependent in 
layer V, but does not involve GluR5 receptors, at least at 3 Hz. The experiments in 
Sections 4.3.1.4. and 4.3.1.5., examining GluR5-mediated facilitation in layer III, 
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were all conducted using a frequency of 5 Hz or higher. For completeness, and to 
directly compare facilitation between layers III and V, I returned to layer III and 
repeated the experiments using the same protocol as I used in layer V.  
 
In 3 neurones, mean amplitude of the eEPSC increased from 77.6 ± 11.0 pA during 
0.05 Hz stimulation. Using this protocol, similar levels of facilitation were found in 
layer III neurones, with a mean amplitude of 154.3 ± 5.5 pA during high frequency (3 
Hz) stimulation (P<0.05, n=3; Figure 7.3). This represents an average increase of 109 
± 27 %. To examine the contribution of presynaptic NMDAr to the facilitation in 
layer III, we then added 2-AP5 (50 µM) to the bath. The mean amplitude of the 
eEPSC during 0.05 Hz stimulation was not significantly increased (87.6 ± 13.2 pA). 
In addition, during high frequency (3 Hz) stimulation mean amplitude remained in the 
presence of 2-AP5 (mean amplitude of 169.7 ± 17.1 pA; P<0.01, n=3; Figure 7.3). 
Therefore, there was no significant change in the average percentage facilitation when 
compared with control (to 99 ± 13 %). These data indicate that facilitation at 3 Hz in 
layer III does not involve post- or presynaptic NMDAr as facilitation is maintained 
with MK-801 (1mM) present in the patch pipette and after application of 2-AP5 (50 
µM). It should be noted here that experiments in Section 4.3.1.6. reported that 2-AP5 
did block facilitation at 5 Hz in layer III. Whether this is due to a difference in 
stimulation protocols remains to be determined. However, the major difference 
between the studies was that in the present ones, MK-801 was present in the patch 
pipette. This may indicate that postsynaptic NMDAr are involved in the facilitation 
noted earlier (Sections 4.3.1.4, 5 and 6) and that this acts cooperatively with 
presynaptic GluR5 KAr. This will be a very interesting avenue for future research. 
 
In a further 4 neurones, I repeated the previous experiments but used UBP 302 instead 
of 2-AP5. In control there was a significant facilitation of eEPSCs, from 81.8 ± 19.3 
pA in 0.05 Hz stimulation to 160.7 ± 41.0 pA in 3 Hz (P<0.05; n=4). This represented 
a mean facilitation of 102 ± 26 %. Addition of UBP 302 (20 µM) had no significant 
effect on the average amplitude of the eEPSC during low frequency stimulation 
(119.7 ± 30.47 pA). However, during high frequency stimulation the mean amplitude 
of the eEPSCs decreased to 129.4 ± 29.7 pA, representing a clear decrease in 
percentage facilitation to 10 ± 7 % (P<0.05; n=3). These results indicate that UBP 302 
but not 2-AP5 removes facilitation at 3 Hz in layer III, suggesting a predominant 
facilitatory role of GluR5 over NMDAr at excitatory synapses in layer III. 
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Figure 7.3. Effects of 2-AP5 on frequency facilitation in layer III. A: Average 
eEPSC (n=6) in 0.5 Hz and 3 Hz stimulation in control conditions and after 2-AP5 
(50 µM) application. C: Graph of average facilitation (n=3) before and after 2-AP5 
application. 
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Figure 7.4. Effects of UBP 302 on frequency facilitation in layer III. A: Average 
eEPSC (n=6) in 0.5 Hz and 3 Hz stimulation in control conditions and after UBP 302 
(20 µM) application. C: Graph of average facilitation (n=3) at various time points 
before and after UBP 302 application. 
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7.3.5. KA decreases inter-event interval of miniature EPSCs in layer V 
 
Thus, the experiments above strongly suggest that GluR5 receptors do not act as 
autoreceptors in layer V. However, they do not rule out any involvement of KAr 
containing other subunits. In preliminary studies to look at this possibility I 
determined the effects of a low concentration of KA itself on mEPSCs recorded in the 
presence of TTX. KA, at this concentration should non-selectively activate any KAr 
present on terminals. Application of KA (300 nM) caused a decrease in frequency of 
mEPSCs in 3 layer V neurones from 3.5 ± 3.3 Hz to 2.2 ± 2.4 Hz, reflecting a change 
in IEI from 511 ± 229 ms to 900 ± 407 ms. Although the change was not pronounced, 
KS analysis of cumulative probability distribution showed that it just reached 
significance (P<0.05; n=3; Figure 7.5.). There was no significant change in mean 
amplitude (from 11.21 ± 0.93 pA to 12.10 ± 1.07 pA), although there was a tendency 
towards increase. Likewise, there were no significant changes in kinetics (Figure 
7.5B; Table 7.2). 
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Figure 7.5. Effects of KA on mEPSCs in layer V of the EC. A: Cumulative 
probability graph of IEI of mEPSCs in 3 neurones in control conditions and after 
application of KA (300 nM). B: Average mEPSC (n=60) in control and in the 
presence of KA (300 nM). C: Graph of amplitude distribution for pooled data (n=3) 
in control conditions and in the presence of KA (bin size = 3). 
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mEPSCs 
IEI 
(ms) 
Amplitude 
(pA) 
Decay time 
(ms) 
Rise Time 
(ms) 
control 511 ± 229 11.2 ± 0.9 6.0 ± 1.4 1.1 ± 0.2 
+ KA 900 ± 407* 12.1 ± 1.1 7.8 ± 1.8 1.3 ± 0.2 
 
Table 7.2. IEI, amplitude and kinetics for mEPSCs in control and KA in layer V. * 
indicates significant change when compared to control (P < 0.01 KS Test). 
 
Thus, in complete contrast to layer III excitatory or inhibitory synapses, these studies 
provide an indication for a KAr that depresses release in layer V. 
 
7.4. Discussion 
 
In Chapter 4 I provided evidence for the presence of presynaptic GluR5 containing 
(both homomeric and heteromeric) KAr at excitatory synapses in layer III of the EC, 
where they act to facilitate glutamate release. In addition, in Chapter 6 we have shown 
that reducing extracellular magnesium from 2 mM to 1.25 mM led to an increase in 
glutamate release resulting in tonic activation of these presynaptic KAr. This may 
contribute to the apparent role of GluR5 containing KAr in SWO in layer III of the 
EC (Cunningham et al., 2006b). 
 
In contrast, I have now shown that there is little evidence for the presence of GluR5 
containing KAr at excitatory synapses in layer V, as the GluR5 selective agonist 
ATPA has no effect on the frequency of mEPSCs, and UBP 302 failed to alter 
frequency-dependent facilitation in this layer. However, the addition of a 
submicromolar concentration of KA, which is sufficiently low to assume little or no 
activation of AMPAr, altered the frequency of mEPSCs in layer V. This strongly 
suggests that there may be a presynaptic KAr present in this layer but in contrast to 
layer III, these receptors do not contain the GluR5 subunit. Also in marked contrast to 
layer III, application of KA decreased mEPSC frequency, so it seems likely that these 
presynaptic KAr act to depress glutamate release from these terminals. Similar 
depressant effects have been reported in the nucleus accumbens (Casassus and Mulle, 
2002), in the barrel cortex (Kidd et al., 2002) and in the dorsal horn of the spinal cord 
(Kerchner et al., 2001). Unfortunately without a specific antagonist it is difficult to 
investigate whether this receptor is tonically active at physiological conditions, like 
the presynaptic facilitatory NMDAr in this layer (Berretta and Jones, 1996; Woodhall 
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et al., 2001a). It is also impossible to determine what the relationship between the 
presynaptic NMDAr and a depressant KAr may be in the overall balance of activity-
dependent control of synaptic transmission. 
 
This crucial difference between the function of KAr in layers III and V may underlie 
some of the fundamental differences between these layers. Thus, whereas SWO are 
spontaneously generated in layer III by reducing [Mg2+]o, SWO appear virtually 
absent in layer V (Cunningham et al., 2006b). Likewise, gamma frequency 
oscillations, driven by KA or ATPA are much more pronounced in layer III compared 
to layer V (Cunningham et al., 2003). Indeed, it could be suggested that the 
depressant KAr that seems to be present in layer V could actively contribute to 
suppression of SWO and/or gamma in layer V. Obviously much more work is now 
required to determine the overall contribution of KAr to transmission in layer V, 
particularly with respect to postsynaptic effects and control of GABA inhibition. 
 
In Chapter 4 (Section 4.4.), I discussed how the facilitatory KAr might be considered 
a liability, especially if there is no provision for bidirectional modulation of 
transmitter release. A relatively small increase in glutamate release could lead to a 
profound and self sustaining excitation. Thus, it may be the presence of this receptor 
in layer III which underlies the susceptibility to neuronal death seen in TLE. The fact 
that this type of KAr is not present in layer V may lend support to this argument as the 
neuronal death in both patients and animal models is largely restricted to layer III and 
is much less pronounced in the deeper layers (Du et al., 1993; Du et al., 1995). 
 
It is clear that autoreceptor control of glutamate release is mediated by different 
mechanisms in neurones which provide hippocampal input (GluR5, layer III) and 
those that largely relay output (NMDAr, layer V). The functional significance of these 
differences is obviously unknown at present. However, it is interesting that facilitation 
is tonically active in layer V but not in layer III. It has been speculated, that layer V 
neurones represent an “excitable” or “seizure-sensitive” population, whereas the more 
superficial layers may be more “quiescent” or “seizure resistant” (Jones, 1993; Jones 
and Lambert, 1990). The differences in autoreceptor control could be a factor in this 
difference. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CHAPTER 8 
 
GENERAL DISCUSSION 
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The aims of this thesis were to determine the role of KAr in layer III of the EC using 
whole-cell patch recordings in rat brain slices. 
 
8.1. Excitation and inhibition in layer III. 
 
Neurones in layer III exhibited continuous spontaneous excitatory and inhibitory 
activity and the characteristics of sEPSCs and sIPSCs were generally similar to those 
recorded in the other layers of the EC (Berretta and Jones, 1996a; Woodhall et al., 
2001; Jones and Woodhall, 2005; Woodhall et al., 2005). sEPSCs were abolished by 
NBQX (and other AMPAr antagonists) and therefore are largely mediated by non-
NMDAr, primarily AMPAr. sIPSCs were completely abolished by gabazine, and 
therefore are mediated by GABAA receptors but there was effect on holding current 
indicating an absence of a tonic background current that is a feature of GABAergic 
synapses in other brain regions (Brickley et al., 1996; Nusser and Mody, 2002). In 
addition, there may be some contribution of glycine receptors in layer III, as 
strychnine slightly reduced frequency. This was not seen in layers II and V (Woodhall 
et al., 2005). However the effect of strychnine was small, and therefore any 
contribution of glycine receptors to total background inhibition is unlikely to be 
significant.  
 
More in depth analysis revealed some differences between layer III and layers II and 
V. What is perhaps surprising is that there are substantial differences between layer III 
and layer II, which provide the afferent input to the hippocampus, and substantial 
similarities to layer V, which is the major relay of hippocampal output. The most 
pronounced difference between the sEPSCs in layer III compared the other layers is 
the much higher frequency of events. This may be a reflection of a high baseline firing 
rate in glutamatergic principal neurones via extensive recurrent excitatory collaterals. 
This was supported by the fact that a large majority of sEPSCs in layer III were action 
potential-dependent,  as TTX decreased frequency of events by more than six times. 
There was also a very high level of action potential driven inhibition in layer III, 
Taken together with the high level of activity driven excitation, may indicate a high 
degree of interconnectivity between principal neurones and between principal 
neurones and interneurones in this layer. The pronounced burst activity in both 
excitatory and inhibitory activity may also reflect this interconnectivity. Currently 
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missing from this picture is an examination of spontaneous activity in the 
interneurones themselves, and future experiments should examine this. 
 
8.2. KAr at glutamatergic synapses 
 
Chapter 4 provided electrophysiological evidence for the presence of two different 
types of KAr involved in glutamatergic neurotransmission in layer III of the EC. 
Frequency-dependent facilitation of eEPSCs at excitatory synapses appeared to be 
mediated by a presynaptic KAr containing the GluR5 subunit, but the lack of effect of 
UBP 302 on sEPSCs indicated that these receptors are not tonically activated by 
spontaneous glutamate release, only becoming activated in situations where higher 
levels of glutamate are present. The studies on eEPSCs provide evidence that the 
presynaptic KAr is activated during repetitive stimulation and therefore act to further 
boost excitation. The precise mechanism for the facilitation is currently unknown, 
although, it seems likely to be ionotropic. Surprisingly, 2-AP5 also abolished 
frequency facilitation. Thus, it is possible that presynaptic KAr and NMDAr are acting 
synergistically on some terminals to facilitate glutamate release in layer III. One 
possibility is that repetitive stimulation activates the presynaptic KAr causing the 
depolarisation of the terminal, which then results in parallel activation of the 
presynaptic NMDAr by relieving Mg2+ block. However, exogenous activation of 
GluR5 containing receptors with ATPA suggested that the KA autoreceptor is also 
capable of causing facilitation without synergy with the NMDA receptor.  
 
In addition to identifying the facilitatory presynaptic GluR5 KAr, I also found that 
KAr can mediate postsynaptic effects in the EC. The KAr-mediated eEPSC I 
identified was similar to that previously reported by West et al. (2007). Most 
importantly, time to decay, which is often used to separate KAr-mediated currents 
from much faster AMPAr-mediated currents, were comparable. The I-V curve for 
KAr eEPSC in my studies showed significant inward rectification, which is 
characteristic of KAr containing unedited GluR5 and GluR6 subunits (Bowie & 
Mayer, 1995; Kamboj et al., 1995). These are relatively impermeable to Ca2+. 
However, although the KAr eEPSC was blocked by CNQX (see also West et al., 
2007) it was unaffected by UBP 302. Therefore, my data indicate that the postsynaptic 
KAr in layer III are unlikely to contain GluR5 subunits, but instead may comprise an 
unedited GluR6 subunit. Elucidation of the exact subunit composition of the 
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postsynaptic KAr at layer III excitatory synapses awaits the development of more 
selective subunit antagonists. 
 
Thus, KAr can directly mediate postsynaptic excitation at glutamate synapses, and 
also boost transmission by presynaptic facilitation. These effects, mediated by 
different subtypes both required repetitive activation, and thus support a role for both 
pre- and postsynaptic KAr as boosters or amplifiers of synaptic excitation in response 
to elevated afferent activity. 
 
8.3. KAr at GABAergic synapses 
 
In Chapter 5 I provided evidence for a role of KAr in enhancing inhibitory 
transmission in layer III. Again this appeared to occur at two levels. A presynaptic 
KAr located on the inhibitory terminals facilitated spontaneous GABA release. My 
pharmacological data suggested that in contrast to glutamate synapses, this was not 
GluR5 containing but may contain the GluR6/KA2 subunits. Studies with Cd2+ 
suggested that activation of VGCCs must be involved in the mechanism of this 
facilitation.  However, I cannot rule out the possibility that the receptor is also acting 
via a metabotropic pathway, as has been suggested previously (Rodriguez-Moreno 
and Lerma, 1998; Braga et al., 2003).  
 
Interestingly, UBP 302 caused a decrease in frequency of sIPSCs but not mIPSCs and 
this indicates that there is a second mechanism of KAr mediated facilitation of GABA 
release. This seems likely to be a GluR5 containing KAr located on the 
soma/dendrites of the interneurones, as has also been reported in the hippocampus 
(Cossart et al., 1998; Frerking et al., 1998). However, in order to confirm this I would 
need to record from the interneurones directly. Experiments with eIPSCs support this 
suggestion, because UBP 302 depressed the amplitude of the first response in the 
stimulus train and shifted the PPR from PPD to PPF. This PPF is blocked by 
concentrations of CNQX selective for KAr, supporting the suggestion that there is a 
presynaptic KAr on the inhibitory terminals facilitating GABA release that may not 
contain the GluR5 subunit. Thus, there is more than one type of KAr involved in 
increasing inhibition in layer III, presynaptic GluR6/KA2 receptors and also GluR5 
containing KAr driving interneuronal firing.  
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8.4. Reduction of [Mg2+]o – roles of KAr in SWO 
 
SWO can be generated in the EC by reducing [Mg2+]o from 2 mM to 1.25 mM and 
work by Cunningham et al. (2006b) indicated that KAr containing the GluR5 subunit 
are involved in the initiation and/or maintenance of these SWO.  
 
In Chapter 6 I showed that the same paradigm of reducing [Mg2+]o caused an increase 
in sEPSCs and an increase in amplitude of the eEPSCs (both those mediated by 
AMPAr and KAr). Increased activation of presynaptic or postsynaptic NMDAr was 
not responsible for the increased release observed in reduced Mg2+, and 
pharmacological experiments showed that a large part of the increased release was due 
to increased activation of the GluR5 KA autoreceptor. In low Mg2+ these GluR5 
receptors were tonically activated by ambient glutamate. Overall, my data suggest that 
glutamate release may be increased generally (probably by reduced blockade of 
VGCC by Mg2+) and this increased release is then boosted by enhanced activation of 
the presynaptic GluR5 receptors. This was supported by the evidence that blocking 
glutamate uptake had virtually identical effects to reducing [Mg2+]o. At present, I 
cannot completely rule out the possibility that PDC and low Mg2+ increase glutamate 
release, which can then access postsynaptic GluR5 KAr not normally activated by 
ambient or evoked glutamate release. Both manipulations caused an increase in the 
KAr eEPSC and PDC also slightly increased sEPSC amplitude, these effects were 
partially reversed by UBP 302. However, the studies in 2 mM [Mg2+]o (Section 4.3.1.) 
strongly indicated a presynaptic GluR5 KAr and low Mg2+ increases sEPSC frequency 
with no effect on amplitudes or kinetics. Therefore, overall my conclusion is that the 
effects are almost certainly due to increased presynaptic GluR5 activity. 
 
Reduction of Mg2+ in the aCSF also caused a pronounced increase in sIPSC frequency 
and an increase in amplitude of the eIPSCs. eIPSCs were also increased in amplitude 
although frequency-dependent depression was unaffected. Again, it seems likely that 
increased GABA release will occur at least partly due to removal of a Mg2+ block on 
the presynaptic VGCC on the GABAergic terminal. However, UBP 302 and CNQX 
were both able to reduce the effects of low Mg2+ in a way which supported the earlier 
conclusions regarding the role of KAr in control of inhibition. Thus, firstly, antagonist 
studies were consistent with a contribution of increased activation of GluR5 
containing KAr as a result of increased glutamate release at excitatory synapses on the 
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interneurones. Secondly, they suggested that there was increased activation of 
GluR6/KA2 receptors on the GABA terminals, again as a result of increased 
glutamate spillover.  Studies with PDC accorded well with these effects being partly 
due to increased glutamate levels present at KAr on the interneurones and their 
terminals. 
 
8.5 KAr in layer V of the EC 
 
Oscillatory activity involving KAr is much less pronounced in layer V of the EC 
compared to layer III (Cunningham et al., 2003; 2006b), so in Chapter 7, I attempted 
to identify a role for KAr at glutamatergic synapses in layer V. In contrast to layer III 
ATPA had no effect on mEPSCs, and UBP 302 failed to alter frequency-dependent 
facilitation suggesting that presynaptic GluR5 KAr are unlikely to facilitate glutamate 
release in layer V. However, KA itself reduced the frequency of mEPSCs in layer V 
strongly suggesting that there may be a non-GluR5 containing presynaptic KAr acting 
to depress glutamate release at these synapses. It would be interesting to determine 
whether this receptor is tonically active and what the relationship between the 
presynaptic NMDAr in layer V (Berretta and Jones, 1996b; Woodhall et al., 2001) and 
a depressant KAr may be in the overall balance of activity-dependent control of 
synaptic transmission. Unfortunately, without a specific antagonist it is difficult to 
investigate this receptor further. 
 
This crucial difference between the function of KAr in layers III and V may underlie 
some of the fundamental differences between these layers. Thus, whereas SWO are 
spontaneously generated in layer III by reducing [Mg2+]o, they are virtually absent in 
layer V (Cunningham et al., 2006b). Likewise, gamma frequency oscillations, driven 
by KA or ATPA are much more pronounced in layer III compared to layer V 
(Cunningham et al., 2003). Indeed, it could be suggested that the depressant KAr that 
seems to be present in layer V could actively contribute to suppression of SWO and/or 
gamma in layer V. Obviously much more work is now required to determine the 
overall contribution of KAr to transmission in layer V, particularly with respect to 
postsynaptic effects and control of GABA inhibition. However, it is clear that 
autoreceptor control of glutamate release is mediated by different receptors in 
neurones which provide hippocampal input (GluR5, layer III) and those that largely 
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relay output (NMDAr, layer V). The functional significance of these differences is 
obviously unknown at present.  
 
8.6. Perspectives 
 
As frequently noted, KAr have been shown to have roles in oscillatory activity. KAr 
have been shown to play a role in gamma oscillations in the hippocampus (Brown et 
al., 2006) and the EC (Cunningham et al., 2003), theta oscillations in the hippocampus 
(Huxter et al., 2007) and SWO in the EC (Cunningham et al., 2006; Stanger et al., 
2008).  
 
Is it possible to relate the observations in this thesis to mechanisms of rhythmicity in 
layer III? Generation of oscillatory activity in cortical networks is likely to depend on 
the dynamics of network interconnectivity and firing patterns in constituent neurones 
(see collected papers in “Structure/function correlates in neurones and networks” J. 
Physiol. 2005: 526(1)). The connectivity in layer III of the EC indicated by analysis of 
spontaneous activity in my studies, and by previous studies of recurrent excitation 
(Dhillon and Jones, 2001) could therefore be a factor in the susceptibility of this layer 
to generation of gamma oscillations and SWO (Cunningham et al., 2003; 2006b). It is 
also clear that KAr act to increase transmission at both excitatory and inhibitory 
synapses in layer III. Currently, it is not known whether the different sub-type specific 
KAr effects are further location-specific in terms of types of interneurones/principal 
neurones, or pathway specific (e.g. recurrent versus afferent connections, feed-
forward or feed back pathways), so it would be premature to speculate on precise 
mechanisms. However, it is clear that an end result of KAr stimulation can be to 
induce gamma oscillations in layer III (Cunningham et al., 2003b), and that blocking 
KAr can modify SWO (this thesis; Cunningham et al., 2006; Stanger et al., 2008). My 
experiments have begun to provide a framework for delineating site and function-
specific role of KAr in these phenomena.  
 
Rhythmic or synchronous electrical activity at various frequencies is seen all over the 
CNS and is thought to be important in many processes including memory (for review: 
see Axmacher et al., 2006). Gamma oscillations have been suggested to be 
responsible for long-term storage of consciously accessible information into memory 
(Fell et al., 2001, Gruber et al., 2004 and Sederberg et al., 2003) and lesion studies 
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have demonstrated that structures within the medial temporal lobe are necessary for 
this memory formation (e.g., Scoville and Milner, 1957). SWO, which are particularly 
prominent during slow wave sleep, are suggested to be important in the transfer of 
memory traces from the hippocampus to the neocortex during sleep (for review see 
Hoffman et al., 2007). If SWO are important for learning and memory, for underlying 
the transfer of memory traces from the hippocampus to the neocortex during sleep as 
has been suggested (Destexhe et al. 2007) and KAr are important in the generation of 
SWO in the EC, then changes in KAr function in the EC could be responsible for 
some of the deficits in memory that are seen in various diseases. There is some 
evidence for this. Di Paola et al. (2007) found that EC atrophy in Alzheimer’s patients 
was correlated with a decline in performance of episodic memory delayed recall tests. 
Takeda et al. (2007) found that, in postmortem studies, a number of amyotrophic 
lateral sclerosis patients with signs of dementia showed degeneration of the perforant 
pathway, and that this degeneration was more pronounced in patients who showed 
severe memory deficits. In addition, significant reductions in the size of the EC have 
been found in patients with both subjective memory and mild cognitive impairments 
(Jessen et al., 2006). There is also some evidence to suggest the involvement of 
GluR5-containing KAr in learning and memory. Barker et al. (2006) infused a GluR5-
selective antagonist into the perirhinal cortex in rats and found that it produced an 
impairment in recognition memory that was independent of the impairment produced 
by an NMDAr antagonist. GluR5 KAr have also been implicated in mossy fibre LTP 
(Bortolotto et al., 1999, 2005). 
 
An inability to integrate or synchronise activity in neuronal networks in increasingly 
thought to underlie the cognitive symptoms of schizophrenia. KAr have been repeated 
implicated in aspects of oscillatory activity both in the EC (Cunningham et al., 2003, 
2006; Stranger et al., 2008) and in the hippocampus (Brown et al., 2006; Goldin et al., 
2007; Huxter et al., 2007). Disruption of KAr function in schizophrenia may lead to 
abnormal neuronal synchrony in the EC and, thus, cause a number of these symptoms. 
There has been some evidence for the involvement of KAr, specifically the GluR5 
subunit, in schizophrenia. Woo et al. (2007) showed that in post-mortem studies of 
schizophrenic patients the density of the GAD(67) mRNA-containing neurones that 
co-expressed GluR5 mRNA was decreased in the anterior cingulate cortex. Scarr et al. 
(2005) have also shown that [3H]KA binding was significantly decreased in the cortex 
of patients with schizophrenia. By contrast, levels of [3H]MK-801 and [3H]AMPA 
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binding did not differ, suggesting that there is a change in KAr number but not 
NMDAr or AMPAr. In addition, GluR5 mRNA is decreased in the cortex of patients 
with schizophrenia whilst there is difference in levels of mRNA for the other KAr 
subunits (Scarr et al., 2005). In other post-mortem studies, a reduction of GluR5/6/7 
immunoreactivity has been observed on apical dendrites of hippocampal pyramidal 
neurones in schizophrenic brains (Benes et al., 2001).  
 
Changes in the ability to maintain normal network synchrony will also have obvious 
consequences in epilepsy. GluR5-containing KAr function has also been shown to be 
altered in epilepsy. GluR5 and GluR6 KAr mRNA has been shown to be reduced in 
hippocampal pyramidal cells post-mortem studies of TLE patients with hippocampal 
sclerosis (Mathern et al., 1998). Concurrently there was an increase in GluR5 and 
KA2 mRNA in dentate granule cells (Mathern et al., 1998). In addition, the allelic 
varients of GluR5 but not GluR6 confers genetic susceptibility to the development of 
juvenile absence seizures (Sander et al., 1997; Sander et al., 1995 respectively). It is 
possible that changes in KAr function in the EC may be involved in TLE, as the EC 
has repeatedly been implicated in TLE (Rutecki et al., 1989; Spencer and Spencer, 
1994; Alarcon et al., 1997; Assaf and Ebersole, 1997; Bernasconi et al., 1999, 2001; 
Jutila et al., 2001; Wennberg et al., 2002; Asaf et al., 2003; Bonilha et al., 2003; 
Bartolomei et al., 2004, 2005; Jamali et al., 2006).  
 
Finally, it is interesting to note that several studies have suggested that a reduction in 
CSF Mg2+ could be, in part, responsible for the clinical manifestation of several 
pathological conditions. Uitti et al. (1989) showed that there were decreased Mg2+ 
concentrations in the caudate nucleus in parkinsonian brains. In agreement with this, a 
more recent study has shown that there is decreased free Mg2+ in CSF of Parkinson’s 
disease patients (Barbiroli et al., 1999). Decreased plasma Mg2+ concentrations have 
also been found in patients with dementia of Alzheimer’s type (Lemke, 1995). 
Interestingly, Mg2+ content in specific regions associated with Alzheimer’s disease 
has also been found to be reduced, including in the EC where a 20% reduction was 
found on average (Andrasi et al., 2005). Intracellular Mg2+ concentration has been 
found to be increased in the prefrontal cortex of schizophrenic patients (Hinsberger et 
al., 1997). However, Levine et al. (1996) found that acute schizophrenic patients have 
significantly lower CSF Mg2+ concentrations than patients in remission. This study is 
in agreement with earlier findings that that blood plasma Mg2+ levels were decreased 
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in schizophrenic patients but increased back to control levels when clinical remission 
was achieved (Kirov and Tsachev, 1990). Finally, the induction of epilepsy by 
lowering/removing extracellular Mg2+ concentration is a widely used in vitro model of 
epilepsy (Jeffreys, 1998) and CSF Mg2+ concentration is decreased in children with 
epilepsy when compared to control (Miyamoto et al., 2004). In addition, low CSF 
Mg2+ positively correlated with increased frequency, poor control and longer duration 
of fits in patients with iodiopathic generalised tonic clonic seizures (Sood et al., 1993). 
 
My results have demonstrated several roles for KAr in layer III of the EC and have 
provided support for the suggestion that they are involved in SWO in this region. 
These findings could be relevant for the development of therapeutic interventions for 
pathological conditions where the EC, KAr and disruption in normal network 
synchrony has shown to be important. 
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Mobility of NMDA autoreceptors but not postsynaptic
receptors at glutamate synapses in the rat entorhinal
cortex
Jian Yang1, Sophie E. L. Chamberlain1, Gavin L. Woodhall2 and Roland S. G. Jones1
1Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK
2The Molecular Biosciences Research Group, School of Life and Health Sciences, Aston University, Birmingham B4 7ET, UK
NMDA receptors (NMDAr) are known to undergo recycling and lateral diffusion in
postsynaptic spines and dendrites. However, NMDAr are also present as autoreceptors on
glutamate terminals, where they act to facilitate glutamate release, but it is not known whether
these receptors are also mobile. We have used functional pharmacological approaches to examine
whether NMDA receptors at excitatory synapses in the rat entorhinal cortex are mobile at either
postsynaptic sites or in presynaptic terminals. When NMDAr-mediated evoked EPSCs (eEPSCs)
were blocked by MK-801, they showed no evidence of recovery when the irreversible blocker was
removed, suggesting that postsynaptic NMDAr were relatively stably anchored at these synapses.
However, using frequency-dependent facilitation of AMPA receptor (AMPAr)-mediated eEPSCs
as a reporter of presynaptic NMDAr activity, we found that when facilitation was blocked with
MK-801 there was a rapid (∼30–40 min) anomalous recovery upon removal of the antagonist.
This was not observed when global NMDAr blockade was induced by combined perfusion with
MK-801 and NMDA. Anomalous recovery was accompanied by an increase in frequency of
spontaneous EPSCs, and a variable increase in frequency-facilitation. Following recovery from
blockade of presynaptic NMDAr with a competitive antagonist, frequency-dependent facilitation
of AMPAr-mediated eEPSCs was also transiently enhanced. Finally, an increase in frequency of
miniature EPSCs induced by NMDA was succeeded by a persistent decrease. Our data provide
the first evidence for mobility of NMDAr in the presynaptic terminals, and may point to a role
of this process in activity-dependent control of glutamate release.
(Received 6 June 2008; accepted after revision 18 August 2008; first published online 21 August 2008)
Corresponding author R. S. G. Jones: Department of Pharmacy and Pharmacology, University of Bath, Claverton
Down, Bath BA2 7AY, UK. Email: r.s.g.jones@bath.ac.uk
Synaptic transmission is a dynamic and plastic process,
modified by short, intermediate and long-term regulatory
mechanisms. Synaptic strength can be modulated by
presynaptic receptors, which provide activity-dependent
control of transmitter release. Presynaptic ionotropic
receptors have received increasing attention recently (see
Engelman & Macdermott, 2004 for review). AMPA
receptors (AMPAr; Patel & Croucher, 1997; De Paola et al.
2003), NMDA receptors (NMDAr; Berretta & Jones, 1996;
Li&Han, 2007;Woodhall et al.2001) andkainate receptors
(Agrawal & Evans, 1986;Malva et al. 1995; Chittajallu et al.
1996; Negrete-diaz et al. 2006) can all act as autoreceptors
on glutamatergic terminals, and as heteroreceptors on
GABA terminals (Bureau & Mulle, 1998; Kullmann &
Semyanov, 2002; Duguid & Smart, 2004).
At postsynaptic sites, trafficking ofmembrane receptors
is a determinant of moment-to-moment and long-term
modulation of synaptic efficacy (see Carroll & Zukin,
2002; Bredt & Nicoll, 2003; Perez-Otano & Ehlers, 2005;
Triller & Choquet, 2005). Interest in receptor mobility
has been driven by the demonstration that AMPAr are
rapidly inserted or deleted at glutamate synapses during
long-term potentiation (LTP) and depression (LTD) (see
Ehlers, 2000; Malinow &Malenka, 2002; Song & Huganir,
2002; Bredt & Nicoll, 2003; Collingridge et al. 2004).
NMDAr were originally thought to be stably anchored at
the postsynaptic density (PSD; Ehlers, 2000; Scannevin
& Huganir, 2000; Bredt & Nicoll, 2003) but it is now
apparent that they also undergo regulated trafficking
and that this may be intimately involved in long-term
synaptic plasticity (Carroll & Zukin, 2002; Nong et al.
2004; van Zundert et al. 2004; Perez-Otano & Ehlers,
2005)
The focus regarding glutamate receptor mobility has
been on recycling of receptors between the synaptic
membrane and intracellular pools. However, diffusion
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of receptors within cell membranes may also regulate
synaptic efficacy. Glycine (Meier et al. 2001; Dahan et al.
2003), GABAA (Jacob et al. 2005; Thomas et al. 2005),
AMPAr (Borgdorff &Choquet, 2002; Groc et al. 2004) and
NMDAr (Groc et al. 2004) have all been shown to undergo
lateral diffusion in the postsynaptic membrane primarily
usingdirect imaging andoptical tracking. Lateral diffusion
of postsynaptic NMDAr has been demonstrated using
a pharmacological approach (Tovar & Westbrook, 2002;
Zhao et al. 2008), in which irreversible block of NMDAr
responses by MK-801 at synapses on hippocampal
neurones was followed by an anomalous recovery during
washout of the blocker. This suggested that receptors
that were use-dependently blocked following activation by
glutamate at the PSD could be replaced by non-blocked
receptors from a distal source. A number of experimental
approaches indicated that this replacement occurred by
lateral diffusion of receptors from extrasynaptic sites in
the postsynaptic membrane rather than by insertion of
new receptors from cytosolic stores (Tovar & Westbrook,
2002; Zhao et al. 2008).
In the entorhinal cortex (EC) presynaptic NMDAr
facilitate spontaneous release at glutamate synapses
(Berretta & Jones, 1996; Woodhall et al. 2001;
Yang et al. 2006). These receptors also mediate
short-term, frequency-dependent facilitation of excitatory
transmission (Berretta & Jones, 1996; Woodhall et al.
2001; Sjo¨stro¨m et al. 2003; Brasier & Feldman, 2008;
Chamberlain et al. 2008), and may play a role in LTP;
Humeau et al.2003; Samson&Pare, 2005), LTD; (Sjo¨stro¨m
et al. 2003; Bender et al. 2006; Corlew et al. 2007),
and activity-dependent signalling via astrocytes (Jourdain
et al. 2007). The role of presynaptic NMDAr in synaptic
plasticity could be modulated by mobility of receptors in
the terminal membrane. In the present study we used
physiological approaches to examine whether pre- or
postsynaptic NMDAr undergo lateral diffusion at
glutamate synapses in the EC. Some of these results have
been published in abstract form (Yang et al. 2008).
Methods
Ethical information
Experiments were performed in accordance with the
UK Animals (Scientific Procedures) Act 1986, European
Communities Council Directive 1986 (86/609/EEC) and
the University of Bath ethical review document.
Slice preparation
Slices containing EC and hippocampus were prepared
from male Wistar rats (3–5 weeks), which were
anaesthetized with an I.M. injection of ketamine
(120mg kg−1) plus xylazine (8 mg kg−1) and decapitated.
The brain was rapidly removed and immersed in
oxygenated artificial cerebrospinal fluid (aCSF) chilled to
4◦C. Slices (350–400μm) were cut using a Vibroslice, and
stored in aCSF bubbled with 95% O2–5% CO2, at room
temperature. Following recovery for at least 1 h, individual
sliceswere transferred to a recording chambermountedon
the stage of a Zeiss Axioskop FS or an Olympus BX50WI
microscope. The chamber was perfused (2.5 ml min−1)
with oxygenated aCSF (pH 7.4) at 31–33◦C. The aCSF
contained (in mM): NaCl (126), KCl (3), NaH2PO4
(1.25), NaHCO3 (24), MgSO4 (2), CaCl2 (2), and
D-glucose (10).Neuroneswere visualizedusingdifferential
interference contrast optics and an infrared video
camera.
Electrophysiological recordings
Patch pipettes were pulled from borosilicate glass on
a Flaming/Brown microelectrode puller. For recording
spontaneous (sEPSCs), miniature (mEPSCs) or evoked
(eEPSCs) EPSCs, pipettes were filled with a caesium
gluconate-based solution containing (inmM): D-gluconate
(100), Hepes (40), QX-314 (1), EGTA (0.6), NaCl (4),
MgCl2 (5), TEA-Cl (1), ATP-Na (4), GTP-Na (0.3),
MK-801 (2). Solutions were adjusted to 290mosmol l−1,
and to pH 7.25–7.3 with CsOH. Whole-cell voltage clamp
recordings (holding potential –60mV unless otherwise
stated) were made from neurones in layer V of the medial
division of the EC, using an Axopatch 200B amplifier.
Series resistance compensation was not employed, but
access resistance (10–30M) was monitored at regular
intervals throughout each recording and cells were
discarded from the analysis if it changed by more than
±10%. Liquid junction potentials were estimated using
the calculator of pCLAMP 8 software, and compensated
for in the holding potentials.
eEPSCs were elicited by electrical stimulation (bipolar
pulses, 10–50 V, 0.02 ms duration) via a bipolar tungsten
electrode placed on the surface of the slice in layer V
of the lateral EC. The stimulation intensity was
adjusted to give a submaximal (approx. 60% maximum
amplitude) response. Unless otherwise stated, MK-801
was included in the patch pipettes allowing us to record
AMPA-mediated responses in isolation and to monitor
activity at presynaptic NMDAr uncontaminated by post-
synaptic receptor effects, an approach that we (Berretta
& Jones, 1996; Woodhall et al. 2001; Yang et al. 2006,
2007), and others (Sjo¨stro¨m et al. 2003; Samson &
Pare, 2005; Bender et al. 2006; Jourdain et al. 2007;
Li & Han, 2007; Brasier & Feldman, 2008), have used
successfully to block postsynaptic NMDAr in recorded
neurones.
C© 2008 The Authors. Journal compilation C© 2008 The Physiological Society
J Physiol 586.20 Mobility of NMDA autoreceptors in entorhinal cortex 4907
Determination of receptor mobility
Postsynaptic. We used an approach described by Tovar
& Westbrook (2002) and used by others (Harris & Pettit,
2007; Zhao et al. 2008) to monitor postsynaptic NMDAr
mobility. Repeated stimulation delivered in the presence
of the channel blocker, MK-801 results in progressive
block of NMDAr accessed by glutamate released during
synaptic activation. As this block is essentially irreversible,
recovery of the synaptic response afterwashout ofMK-801
provides a reporter of receptor mobility. A modification
of this approach was used here to monitor the mobility of
postsynaptic NMDAr in the EC in two series
of experiments. Both were conducted with an
AMPAr antagonist (NBQX), and a GABAAr antagonist
(bicuculline) in the bath. In the first study, MK-801
was not included in the patch pipette solution. When
whole-cell access was achieved, neurones were held at
+40mV and isolated, long duration NMDAr-mediated
EPSCs were evoked at low frequency (0.05 Hz). These
vary in their deactivation kinetics from neurone to
neurone (see Fig. 1A) but can be abolished by NMDAr
antagonists (Chamberlain et al. 2008). When eEPSC
amplitudes were stable, MK-801 (10μM) was bath
applied for a period of 5 min. Four minutes after
MK-801 perfusion commenced, stimulation frequency
was increased to 5 Hz for 40–50 s, resulting in a rapid
decline in eEPSC amplitude to around 0–10% of
the amplitude recorded at low frequency. Stimulation
frequency was then restored to 0.05 Hz, and MK-801
was washed out of the bath. Responses to low frequency
stimulation were then monitored for the remaining
lifetime of the recording (e.g. Fig. 2). After 35min, all
stimulationwas halted for a period of 15min, before being
resumed at low frequency until the end of the recording.
In a second series of experiments, the same protocol
was followed, but MK-801 was omitted from the external
perfusion and included in the patch pipette. Again, when
whole-cell accesswas achieved,NMDAr-mediated eEPSCs
were recorded at low frequency (0.05 Hz). After 6 min,
stimulation frequency was increased to 5 Hz for 40–50 s
and this resulted in a rapid decrease of the eEPSCs due
to blockade of the postsynaptic NMDAr by intracellular
MK-801 dialysed into the cell via the patch pipette. When
the eEPSCs had reached a stable low level, stimulation
was returned to 0.05 Hz, and recovery of the responses
monitored for the lifetime of the patch recordings
(Fig. 2).
Presynaptic. Monitoring presynaptic receptor mobility
is more difficult. In addition to the electrophysiological
approach (Tovar & Westbrook, 2002; Harris & Pettit,
2007), optical tracking of quantum dot or fluorescent
antibody-labelled receptors has been used to study
postsynaptic receptor trafficking (e.g. Groc et al.
2004; Washbourne et al. 2004). These approaches are
complicated at presynaptic sites because the size of
terminals precludes direct electrophysiological access,
or sufficient visual resolution. Direct imaging of the
movement of receptors in spines and dendrites has been
largely conducted in cultured neurones and applying
this to terminals in native tissue would be technically
more difficult. It requires specific labelling of presynaptic
receptors without contamination by those at postsynaptic
sites, and a very high degree of visual spatial resolution
to visualize and track receptor movement in very small
terminals.
To overcome these limitations we have developed a
variation of the functional pharmacological approach
(Tovar & Westbrook, 2002; Harris & Pettit, 2007) to test
for the mobility of presynaptic NMDAr in EC slices. All
experiments were conducted with MK-801 in the patch
pipette. When whole-cell access was gained, neurones
were voltage clamped at 0 mV, and synaptic stimulation
delivered at 5 Hz for 30–40 s to allow blockade of
postsynaptic NMDAr by MK-801 dialysed into the cell
via the patch pipette solution. Membrane potential was
then clamped at –60mV and single shock stimulation
delivered at low frequency (0.05 Hz) to evoke isolated
AMPAr-mediated EPSCs. At intervals of 2 min, the single
shock was replaced with stimulation at 3 Hz for 5 s. Such
stimulation results in a frequency-dependent facilitation
of the AMPAr-mediated EPSC, which we have shown
previously to arise primarily from activation of
presynaptic NMDAr (Woodhall et al. 2001; Chamberlain
et al. 2008). We used the degree of frequency-dependent
facilitation of AMPAr-mediated eEPSCs as a quantitative
measure of presynaptic NMDAr activation. After a control
recording of 3–4 episodes of 3 Hz stimulation, with
single shock stimulation at 0.05 Hz restored between each
episode, MK-801 (10μM) was bath applied for 5min and
thenwashedout for the remaining lifetimeof the recording
(see Figs 3, 4, 5 and 7). The stimulationprotocol continued
uninterrupted during the period of MK-801 application
and during the remainder of the recording. The protocol
thus included at least 3–5 periods of stimulation at 3 Hz in
the presence of MK-801 (including those occurring when
the blocker was being washed from the bath, see Fig. 1A),
and this was sufficient to cause use-dependent block of
frequency-facilitation. In a second group of neurones the
stimulation protocol was completely halted for a period of
15min starting approximately 6min after the beginning of
the MK-801 wash. The rationale for this was to determine
if the stimulation, and subsequent evoked release of
glutamate, could elicit a use-dependent unbinding of
the blocker from the receptors and hence be responsible
for recovery. In a third group, the same experimental
protocol was employed except that MK-801 perfusion
was accompanied by bath perfusion withNMDA (25μM),
and both agents were subsequently washed out. The latter
C© 2008 The Authors. Journal compilation C© 2008 The Physiological Society
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studies aimed to determine the effects of global blockade
of NMDAr on the terminals.
Control studies
MK-801 washout. The majority of the studies involved
monitoring response parameters (pre- or postsynaptic)
after removal of MK-801 from the bath, and relied on
its ability to irreversibly block NMDAr. It was important
to attempt to monitor the rate of removal of the drug
from the bath after termination of perfusion. The period
of application (5min in all experiments) was timed
from the moment the drug solution reached the bath,
to the moment it was replaced by drug-free ACSF.
The recording chamber had a volume of approximately
500μl, so with a perfusion rate of 2.5 ml min−1 the
bath solution should be completely exchanged 4–5 times
per minute during washout. Since NMDAr blockade is
use dependent, we monitored the washout of MK-801
using the following protocol. Isolated NMDAr-mediated
eEPSCs were recorded as above. Control responses were
evoked every 15 s for 5–7min, and then stimulation
was halted prior to perfusion with MK-801 for 5 min.
Repetitive stimulation (2 Hz for 50 s) was then delivered
4min into the MK-801 perfusion (n= 8), or 2, 7, 12, or
17min (n= 3 in each case) after the start of washout,
followed by a return to low frequency stimulation.
Responses were averaged over the subsequent 2 min for
comparison.
Stability of NMDAr-mediated effects. Experiments on
postsynaptic NMDAr mobility rely on the stability of
the evoked responses over time. To control for this,
in seven neurones we employed the protocol used to
monitor postsynaptic mobility (see above) but without
the addition of MK-801 to the bath perfusion or the patch
pipette. Likewise, meaningful experiments on presynaptic
receptor mobility are dependent on frequency-dependent
facilitation of AMPAr-mediated EPSCs remaining stable,
without rundown over time. To monitor this, in eight
neurones we performed experiments designed to monitor
presynaptic mobility as described above, but again,
without addition of MK-801 to the bath perfusion.
Data analysis
Data were recorded to computer hard disk using Axoscope
software. Minianalysis (Synaptosoft, USA) was used for
analysis of EPSCs off-line. In experiments with post-
synapticNMDAr, themean peak amplitudes of at least five
NMDAr-mediated eEPSCs evoked at low frequency were
determined every 2min in the control period before the
high frequency stimulation, and subsequently throughout
the study. In the studies of presynaptic NMDAr, the
average peak amplitude of the 5–6 responses before each
episode of 3 Hz stimulation was determined. During the
period of 3 Hz stimulation the amplitude of the 5–6
largest events was determined and normalized to the
average amplitude of the preceding low frequency events
prior to it. Inter-event interval (IEI), amplitude, rise
(10–90%) and decay times of AMPAr-mediated sEPSCs
and mEPSCs were also determined in some studies of
presynaptic NMDAr. Events were detected automatically
using a threshold-crossing algorithm. Threshold varied
from neurone to neurone but was always maintained
at a constant level in any given recording. At least
200 events were sampled during a continuous recording
period for eachneuroneunder eachcondition.Cumulative
probability distributions of IEI were compared using
the Kolmogorov–Smirnoff (K–S) test. The statistical
significance of changes in amplitudes and frequencies was
determined with a paired t test or one-way ANOVA. All
error values indicated in the text and figures refer to S.E.M.
Materials
Salts used in preparation of aCSF were ‘Analar’ grade and
purchased fromMerck/BDH (UK). All drugs were applied
by bath perfusion. NMDA, MK-801 ((+)-dizocilpine
maleate), NBQX (2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione), D-2-AP5 (D-2-amino-5-
phosphonovalerate), Ro 25-6981 ((αR,βS)-α-(4-hydroxy-
phenyl)-β-methyl-4-(phenylmethyl)-1-piperidinepropa-
nol hydrochloride) and bicuculline methiodide were
obtained from Tocris (UK). TTX came from Alomone
Laboratories (Israel).
Results
Control studies
Studies of both pre- and postsynaptic receptor mobility
(see below) rely on monitoring recovery after blockade
of NMDAr with MK-801. Experiments to determine the
rate of washout of the blocker from the slices after a
brief period (5min) of bath perfusion are illustrated
in Fig. 1A. During perfusion with MK-801 (n= 4),
isolated NMDAr-mediated eEPSCs were blocked when
repetitive stimulation was applied at 2 Hz. A similar
stimulation protocol applied 2min after the start of
washout (n= 3) was equally effective, showing that
sufficient MK-801 was still available in the bath/slices to
exert a use-dependent block of the receptors. However,
when stimulation was delayed by 7min after the start of
washing (n= 3) responses were only reduced by around
50–60%. After 12min, repetitive stimulation was much
less effective (n= 3) and with a further 5 min delay
(17min, n= 3) blockade was virtually absent. The data
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indicate that MK-801 washes relatively rapidly (around
15min) from the bath/slices, following brief applications
at the perfusion rate and bath volume employed in all
experiments described below.
We also determined the stability of postsynaptic
NMDA-mediated responses in seven neurones (Fig. 1B).
During repetitive stimulation (MK-801 absent), the
slow eEPSCs decreased in amplitude by around
Figure 1. Washout of MK-801 and stability
of NMDAr-mediated responses
A, isolated NMDA EPSCs were recorded in the
presence of NBQX and bicuculline at a holding
potential of +40 mV. Responses were evoked
by repetitive stimulation (2 Hz, 40–50 s) before
the application of MK-801 (5 min), during its
application and at various time points after. The
bars show the average reduction in eEPSC
amplitude at each time point. The responses
below are averages of 6–7 responses recorded
in selected individual neurones at each
corresponding time point, before or after
application of MK-801. The time course of
recovery of events at the 7 and 12 min time
points is shown in Fig. 2C. B, stability of
postsynaptic NMDAr EPSCs in the absence of
MK-801. Each point is the average of 6–8
responses. During repetitive stimulation at 5 Hz
for 40–50 s, eEPSC amplitude decreased
overall, but recovered to control levels within
3 min. Thereafter, responses were stable. The
slight increase noted around 15–25 min was
consistent, but not significant. C, stability of
frequency-dependent facilitation of AMPAr
eEPSCs. Frequency-facilitation was quantified
as described in the text (low frequency
stimulation at 0.05 Hz interleaved with
episodes of stimulation at 3 Hz for 5 s) and
monitored at 3 min intervals. The graph shows
pooled data from 8 neurones. There was an
initial decline in facilitation after the first
episode but thereafter it remained stable.
Stimulation artefacts in the records shown here
and in all subsequent figures have been partly
blanked for clarity.
10–30%. Control amplitudes recovered within 3–4min.
Subsequently there was a weak but consistent increase
over the next 15–25min, although this did not reach
significance at any point.
Figure 1C shows the stability of the frequency-
dependent facilitation of AMPAr-mediated eEPSCs
used to monitor presynaptic NMDAr-mediated activity
(n= 8). MK-801 was present in the patch solution in
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four of these studies but absent in the remainder. As
there was no detectable difference between groups they
were pooled. There was a small but consistent decline
in facilitation between the first and second episodes of
repetitive stimulation, but thereafter it remained stable
throughout the 30min of recording.
Mobility of postsynaptic NMDAr
The pharmacological approach (see Tovar & Westbrook,
2002; Harris & Pettit, 2007; Zhao et al. 2008) used utilizes
the properties of blockade by MK-801 to assess mobility
of postsynaptic NMDAr. In our first set of experiments
we recorded isolated NMDAr-mediated eEPSCs. In these
experiments, MK-801 was not included in the patch
pipette. As noted above, these responses were stable when
evoked at low frequency, but rapidly reduced or abolished
when the stimulation frequency was increased to 5 Hz in
the presence of bath-applied MK-801.
The results from one experiment are shown in
Fig. 2Aa. The responses were recorded in the presence
of bicuculline and NBQX. Each trace is the average
of 5–6 responses. Stimulation at 5 Hz in the presence
of MK-801 dramatically reduced the NMDAr EPSC.
Responses recorded 2min and 35min after the start
of washout of MK-801 show that they remain blocked
and there is no evidence for recovery of the post-
synaptic NMDAr-mediated eEPSCs. The time course of
experiments in nine neurones is shown in Fig. 2Ab and
clearly shows the lack of recovery of responses at any
point during washout (up to 70min in some neurones).
The use-dependent nature of MK-801 antagonism means
that only receptors accessed by glutamate at the activated
synapses will be blocked. However, the failure of the
eEPSCs to recover during washout suggests that these
are not replaced by non-blocked receptors moving
into the synapses from distal extrasynaptic sites or by
receptors from cytoplasmic storage sites. Note also that
all stimulation was halted for a period of 15min during
washout (dotted line), but that responses remained at
close to zero when it was restarted. Although control
experiments (Fig. 1A) clearly show that there is little
MK-801 remaining in the bath/slices after 15min, we
wanted to check the possibility that failure to recover
was due to residual MK-801, or to rebinding of MK-801
recently dissociated from the receptors. The fact that
recovery was absent whether or not stimulation was
delivered indicates that this was not the case. Finally,
although our control experiments to monitor stability
of the NMDAr test responses (Fig. 1B) only extended to
30min compared to the 70min testedhere, itwas clear that
the lack of recovery could not be attributed to an extensive
or permanent rundown of the postsynaptic responses.
Thus, the experiments suggest that mobility of NMDAr
at these synapses in the EC is limited, or that if it does
occur, it may bemuch slower compared to CA1 (see Tovar
& Westbrook, 2002; Zhao et al. 2008). However, it should
also be noted that Harris & Pettit (2007) have conducted
similar experiments and found no evidence for receptor
mobility in CA1.
We performed a second set of experiments (n= 9)
with a slightly different approach and these are illustrated
in Fig. 2B. In these neurones MK-801 was included in
the patch pipette instead of being bath applied. Internal
dialysis with MK-801 via the patch pipette begins
following whole-cell access, but NMDAr EPSCs could still
be evoked over the control period of recording with the
stimulation at low frequency (0.05 Hz; Fig. 2B), although
there was a slow, progressive decline in amplitude. This
was rapidly accelerated when high frequency (5 Hz)
stimulation was applied, as a result of the use-dependent
block of the postsynaptic receptors. On average, the
reduction in amplitude of the slow eEPSC by internal
MK-801 (84± 7%) was slightly less than that seen with
bath-applied MK-801 (94± 4%), suggesting that some
postsynaptic NMDAr may have remained unblocked.
However, as was the case with bath-applied MK-801, a
return to low frequency stimulation was not associated
with recovery of the eEPSCs, whether stimulation was
applied or not (Fig. 2B). In these experiments we
confirmed that the small residual eEPSC was NMDAr-
mediated by application of 2-AP5. These data support
the suggestion that the mobility of postsynaptic NMDAr
is low. They also show that this lack of mobility is a
characteristic of the synapses on the layer V neurones
themselves, since only the NMDAr in the recorded
neurones will be blocked and anyNMDAr-mediated poly-
synaptic events will remain unaltered.
One possible explanation for the lack of mobility
could be that the repetitive stimulation is sufficient
to cause spillover of glutamate resulting in blockade
of both synaptic and extrasynaptic receptors. Harris &
Pettit (2008) showed recently that significant recruitment
of extrasynaptic NMDAr at synapses in CA1 required
stimulation at 25 Hz or above, although they utilized
much shorter trains of stimuli. Of course, the situation
may be different at layer V synapses, but by limiting the
stimulation frequency to 5 Hz in our experiments we
hoped to avoid blockade of extrasynaptic receptors and
so give ourselves the best chance of detecting receptor
mobility. It should be noted that, in the experiments
where MK-801 was present internally, there was a small,
NMDAr-mediated EPSC remaining after the period of
5 Hz stimulation, suggesting that some of the postsynaptic
receptors were not blocked. However, there was still
no evidence of recovery during the subsequent 60min.
In addition, in the experiments where we monitored
MK-801 washout (Fig. 1A) we used a lower stimulation
frequency (2 Hz). When stimulation was delayed until
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the blocker was already being removed from the bath the
residualNMDAr eEPSC clearly indicated that a substantial
proportion of the postsynaptic NMDAr (whether synaptic
or extrasynaptic) were unblocked, but still there was no
recovery (Fig. 2C). Finally, Scimemi et al. (2004) showed
that glutamate spillover could result in MK-801-induced
Figure 2. Lack of mobility of postsynaptic NMDAr
Aa, synaptic responses evoked at +40 mV in the presence of
NBQX (10 μM) and bicuculline (20 μM), but without MK-801
in the patch pipette. The NMDAr-mediated EPSC (0.05 Hz,
5 events averaged) was dramatically reduced by stimulation
at 5 Hz for 40–50 s (last 5 events of train averaged) in the
presence of bath-applied MK-801. After MK-801 was
washed out and stimulation restored to 0.05 Hz there was
no recovery of the responses (5 events averaged in each
case) in the short or long term. Ab, time course of
experiments pooled from 9 neurones. Each point is the
average of mean amplitudes of EPSCs at each time interval
in the 9 neurones. At some of the later time points (60 min
plus) not all neurones are included as some recordings were
lost at this stage. During the period indicated by the dotted
line, low frequency (0.05 Hz) stimulation was halted.
Ba, similar protocol to A, except that MK-801 was included
in the patch pipette and omitted from the bath perfusion.
The results were essentially the same. Bb, pooled data from
9 neurones. In these experiments there was usually a small
residual EPSC, which was blocked by 2-AP5. C, time course
data for the neurones at the 7 min (©, n = 3) and 12 min
(•, n = 3) time points illustrated in Fig. 1A. No recovery of
eEPSC amplitude was seen during the washout of MK-801.
blockade of NMDAr at synapses some distance apart,
even when stimulation was delivered at only 0.25 Hz.
We have found that if 5 Hz stimulation is replaced with
low frequency (0.05 Hz) stimulation at layer V synapses,
substantial blockade of postsynaptic NMDAr does not
occur within the 5min perfusion of MK-801 employed
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in our studies, and requires perfusion periods of around
20min, with the attendant problems of a much extended
period of washout. However, we have done this in two
neurones and found that even with the very low frequency
there is no suggestion of any recovery over a subsequent
35min of washout of MK-801 (not shown). Thus, we feel
confident that the lack of recovery of theNMDAr response
is due to a lack of mobility rather than due to a global
blockade of all postsynaptic receptors.
Mobility of presynaptic receptors
Unless otherwise indicated, MK-801 was included in the
patch pipette to block postsynaptic NMDAr in these
experiments.Under these conditions eEPSCs aremediated
primarily by postsynaptic AMPAr (Berretta & Jones,
1996; Woodhall et al. 2001). As noted above, we used
frequency-dependent facilitation of AMPAr-mediated
eEPSCs (Woodhall et al. 2001; Chamberlain et al. 2008)
as a reporter of the function of presynaptic NMDAr
in order to investigate their mobility. To quantify
frequency-facilitation, responses evoked at low frequency
(0.05 Hz)were interspersedwithperiods of high frequency
stimulation, and response amplitudes during the latter
normalized to the average amplitude of the preceding low
frequency events. When frequency-dependent facilitation
was stable, it was then blocked by bath perfusion of
MK-801 for 5 min, and the blocker then washed out.
Alternate periods of low and high frequency stimulation
were continued uninterrupted throughout the application
of MK-801 and washout period.
In the first set of experiments we examined changes
in facilitation, recorded uninterrupted, after a brief
application of MK-801 in 10 neurones. Averaged eEPSCs
from one neurone are illustrated in Fig. 3A. The
frequency-dependent facilitation of eEPSCs during 3 Hz
stimulation is readily apparent. During application of
MK-801 this was abolished but low frequency responses
were unaffected. However, in contrast to the postsynaptic
NMDAr-mediated responses, it is clear that after MK-801
was washed out, frequency-facilitation mediated by
presynaptic NMDAr progressively recovered towards
control levels over a period of 30–40min. The time course
of this recovery in 10 neurones is shown in Fig. 3B.
Initially, the average change in response amplitude during
3 Hz stimulation became slightly negative because a weak
frequency-dependent depression of eEPSCs was often
seen when facilitation was blocked. However, this was
quickly replaced by facilitation again, which progressively
increased after MK-801 was washed out. Facilitation was
more variable than prior to application of the blocker,
but had returned to control levels by 40–45min. Note
that these experiments, and those below employed the
same recording chamber, perfusion rate and period of
application of MK-801 employed in the experiments
on postsynaptic NMDAr EPSCs. Although we have not
conducted experiments using frequency-facilitation to
monitor MK-801 washout we would expect that the
blocker would have a similar time course of availability at
both the presynaptic receptors and postsynaptic receptors
and that washout of MK-801 would be complete after
about 15min. Frequency-facilitation was monitored in
the absence of any drugs (Fig. 1C) and was stable over at
least 30min, so state-dependent alterations in presynaptic
receptor sensitivity were unlikely to influence recovery.
Thus, anomalous recovery of frequency-dependent
facilitation provides a strong indication that NMDAr
in the presynaptic membrane may be relatively mobile,
particularly compared to their postsynaptic counterparts.
PresynapticNMDAr, close to the release sites and activated
by glutamate, will be use-dependently blocked byMK-801
during repetitive stimulation.They should remainblocked
during and after washout of MK-801, as its binding in the
channel is essentially irreversible. The anomalous recovery
of facilitation suggests that the blocked presynaptic
receptorsmay be replaced at the release sites by others that
were originally outside the range of the released glutamate,
did not undergo a use-dependent block, and were able to
move into the vicinity of the release sites.
Analternative possibility is that thepresynapticNMDAr
are stably anchored at release sites, and that recovery
of facilitation occurred as a result of use-dependent
unblocking of these receptors by glutamate released as
a result of stimulation in the washout period. If this were
the case we would expect that halting stimulation would
negate recovery during this period, and that recovery
wouldonlyoccurwhen the stimulationwas recommenced.
We examined this possibility in seven neurones. Results
from one neurone are illustrated in Fig. 4A. Facilitation
was again abolished by bath application of MK-801.
Shortly following the start of the washout period, all
stimulation (both high and low frequency) was halted for
15min. However, when stimulation was recommenced, it
was clear that recovery had occurred despite the hiatus.
Summary data for the seven neurones is shown in Fig. 4B.
Allowing for the period of no stimulation, the time course
of recoverywas remarkably similar to that seen inneurones
where the stimulus protocol was unchecked throughout
(Fig. 3). In these experiments we applied NMDAr
antagonists after recovery to confirm that the facilitation
seen during anomalous recovery was due to activation
of presynaptic NMDAr. In four neurones we used 2-AP5
(30μM) and this rapidly abolished facilitation. We have
recently shown that frequency-dependent facilitation in
layer V is mediated by NMDAr containing the NR2B
subunit (Chamberlain et al. 2008). In three further
studiesweused theNR2B-selective antagonist, Ro 25-6981
(500 nM), and this also abolished facilitation (see Fig. 7A),
showing that the presynaptic receptors that replace those
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following MK-801 blockade are likely to be the same as
those initially present at release sites. Because 2-AP5 and
Ro 25-6981 had the same effect these studies have been
pooled in Fig. 4B.
The use-dependent nature of MK-801 blockade means
that only receptors accessed by glutamate in the vicinity
of the release sites will be blocked. Recovery would then
result from non-blocked receptors moving from distal
inaccessible sites on or in the terminals. It follows then
that if we are able to globally block these receptors then
recovery should not occur. We investigated this in a
third set of experiments. We combined bath application
Figure 3. Mobility of presynaptic NMDAr
The responses are AMPAr-mediated eEPSCs
(with MK-801 in patch pipette, average of
5 responses) evoked with interleaved low
(0.05 Hz) and high (3 Hz, 5 s every 2 min)
frequency stimulation. A, there was a clear
frequency-dependent facilitation of the AMPAr
eEPSCs during 3 Hz stimulation (a). During, and
shortly following, bath application of MK-801
(b), the amplitude of low frequency responses
was unaffected, but the frequency-facilitation
was largely abolished. However, responses
recorded after 40 min (c) show a full recovery
of facilitation. B, time course of studies pooled
from 10 neurones. Blockade of
frequency-facilitation by MK-801 revealed a
brief, weak overall frequency depression of
eEPSCs followed by a progressive anomalous
recovery.
of MK-801 with concurrent bath application of NMDA
(25μM) to globally block surface-expressed NMDAr.
Results from one neurone, together with pooled data
from the seven neurones tested, are shown in Fig. 5. The
concurrent application of MK-801 and NMDA rapidly
abolished frequency-dependent facilitation. However,
prolonged washout of both agents was not accompanied
by anomalous recovery. Thus, these studies provide
strong evidence that the recovery of facilitation shown
in the previous experiments was due to the presence of
non-blocked receptors in the distal terminal membrane,
able to move into the proximity of the glutamate release
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sites. Receptors located in cytoplasmic storage sites would
not be accessible to either agonist or blocker so they
would remain unblocked during perfusion with the
two drugs. Thus, the fact that no recovery was seen
after the combined treatment strongly suggests that
the recovery seen with MK-801 alone reflects lateral
diffusion of NMDAr already inserted in the terminal
membrane.
We cannot completely rule out the possibility that
anomalous recovery of facilitation reflects MK-801
unbinding from a proportion of presynaptic NMDAr.
However, the experiments above suggest this is very
unlikely. Tovar & Westbrook (2002) investigated this
possibility by transiently applying the competitive
Figure 4. Anomalous recovery is not
dependent on continuous stimulation
The protocol was the same as in Fig. 2, where
low frequency-stimulation (0.05 Hz) was
interleaved with 3 Hz stimulation (3 Hz, 5 s,
every 2 min). A, frequency-facilitation of
AMPAr-mediated eEPSCs (a) is again blocked in
the presence of MK-801. Full recovery was seen
after 35 min (c) despite the fact that no
stimulation was delivered between 15 and
30 min. B, time course of the studies pooled
from 7 neurones. In these neurones, after
anomalous recovery, we applied either 2-AP5
(n = 4) or Ro 25-6981 (n = 3), either of which
blocked the recovered frequency-dependent
facilitation.
antagonist 2-AP5 during recovery from MK-801 to
preventuse-dependentdissociationof the channelblocker.
This manipulation did not alter the rate of recovery.
We considered a similar approach in our studies of
presynaptic NMDAr, but ruled it out because of technical
difficulties associated with our experimental situation.
Tovar & Westbrook (2002) used a highly reduced culture
preparation and a fast perfusion system for drug
application capable of solution exchanges in the vicinity
of the recorded cell in 30–40ms, allowing perfusion
of the competitive antagonist to be turned on and off
almost instantaneously. That is not possible in native
tissue with an extracellular perfusion system. Recovery
of responses from even a short period of perfusion with
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2-AP5 is gradual (see Fig. 7B), and in our experimental
set-up, recovery from competitive blockade would simply
be superimposed on the recovery due to (presumed)
receptor mobility, and would not confirm or deny the
possibility that unbinding of MK-801 was occurring.
However, we believe that the lack of anomalous recovery
following global blockade of facilitation with combined
application of MK-801 and NMDA, and the failure of
halting stimulation to alter the rate of recovery, strongly
suggest that use-dependent unbinding of the blocker is
unlikely to be responsible for recovery. This conclusion
is also indirectly supported by the lack of recovery of
postsynaptic NMDAr function after blockade with
MK-801.
Figure 5. Anomalous recovery does not
occur after global blockade of NMDAr
The protocol was the same as in Fig. 2, where
low frequency stimulation (0.05 Hz) was
interleaved with 3 Hz stimulation (5 s, every
2 min). A, the records in one neurone show
that frequency-facilitation is abolished by
combined application of MK-801 together with
NMDA, again with no detectable effect on low
frequency responses (b). However, now, despite
prolonged washing of both agents, there was
no evidence for anomalous recovery of
facilitation (c). B, time course of experiments
pooled from 7 neurones.
Activity-dependent changes in presynaptic
receptor function
We have shown previously that presynaptic NMDAr in
the EC are tonically activated by ambient glutamate, since
antagonists induce a decrease in spontaneous glutamate
release (Berretta & Jones, 1996;Woodhall et al. 2001; Yang
et al. 2006, 2007). Therefore, we predicted that changes
in frequency-facilitation of eEPSCs might be paralleled
by changes in spontaneous glutamate release. Thus, we
determined changes in glutamate-mediated sEPSCs in the
neurones illustrated in Figs 3 and 5.
In the neurones where MK-801 alone was bath applied,
blockade of frequency-dependent facilitation (Fig. 3) was
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accompanied by a substantial decrease in frequency of
sEPSCs (Fig. 6Aa). Mean IEI increased from a control
value of 306± 80ms to 615± 136ms at the start of the
washout period.When facilitation of eEPSCs had returned
to control levels 40min later, mean IEI decreased to
Figure 6. Anomalous recovery is paralleled
by changes in sEPSCs
A, sEPSCs were recorded in the 10 neurones
included in Fig. 3. The recordings from one
neurone shown in Aa were obtained before
application of MK-801, 5 min after washing the
drug from the bath, and 40 min after washout,
when recovery of frequency-dependent
facilitation was complete. Cumulative
probability analysis of pooled data of IEI from
all 10 neurones is shown in Ab and the
distribution of peak amplitudes of events at the
same time points is shown in Ac. Blockade of
frequency-dependent facilitation of eEPSCs by
MK-801 (Fig. 3) was accompanied by a
decrease in frequency of sEPSCs (rightward
shift in IEI cumulative probability distribution)
with little overall change in amplitude. Recovery
of frequency-facilitation of eEPSCs (see Fig. 3)
was accompanied by an increased sEPSC
frequency (leftward shift in IEI) with again little
overall change in amplitude although there was
a slight shift towards larger amplitudes during
recovery. B, analysis of sEPSCs in the
7 neurones illustrated in Fig. 5. Combined
application of NMDA and MK-801 shifted the
cumulative probability distribution of sEPSC IEI
to the right, reflecting a decrease in frequency
of events. However, after 40 min of washout of
both agents, there was no recovery of sEPSC
frequency. Again there was little change in
amplitude distributions. C, time course of
changes in sEPSCs in the two groups. For this
analysis, mean IEI of all events in 5 min blocks
was determined and converted to frequency
for each neurone. Changes in frequency were
determined as a percentage of the mean
control frequency at each time point, and
averaged across all neurones in each group.
264± 75ms, These changes reflect a decrease in frequency
of around 50% by MK-801 and an increase of about
15% associated with anomalous recovery. K–S analysis
of cumulative probability distributions of IEI showed that
both the increase after MK-801 (P < 0.001) and decrease
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after washout (P < 0.01) were significant compared to
control (Fig. 6Ab). There was no significant change
in mean amplitudes (control: 15.5± 3.1 pA; MK-801:
14.0± 3.1 pA; wash: 14.0± 2.9 pA), and little overall
change in frequency distribution of peak amplitudes
(Fig. 6Ac). Mean rise times (1.5± 0.1 versus 1.6± 0.1
versus 1.6± 0.3 pA) and decay times (control: 3.5± 0.5
versus 3.7± 0.3 versus 3.7± 0.2 ms) were not significantly
altered at any stage, suggesting that the changes in sEPSCs
occurred as a consequence of the blockade and recovery
of presynaptic NMDA receptors.
The effects on sEPSCs differed when MK-801 was bath
applied in conjunction with NMDA (same 7 neurones
as illustrated in Fig. 5). In this case, sEPSC frequency
was reduced but failed to recover during washout. In
the control situation, IEI was 251± 41ms. Five minutes
following the washout of the agonist and the blocker, IEI
was increased to 552± 76ms, again reflecting a decrease
in frequency of around 50%. After 40min of washing,
IEI remained elevated at 598± 91ms (Fig. 6Aa,b).
Thus, the failure of frequency-dependent facilitation of
eEPSCs to recover following global blockade of NMDAr
was paralleled by a reduction in tonic facilitation of
spontaneous release, which likewise failed to recover.
Again, mean amplitudes were unaffected throughout
(control: 12.8± 1.8 pA; MK-801: 12.5± 1.5 pA; wash:
13.3± 1.7 pA) and there was little change in amplitude
distributions (Fig. 6Bc). Mean rise (1.6± 0.2 versus
1.9± 0.2 versus 1.7± 0.1 pA), and decay times (control:
4.2± 0.5 versus 5.3± 0.6 versus 5.1± 0.5 ms) were again
unaffected.
Figure 6C shows the time course of changes in sEPSC
frequency in the two sets of experiments. It is clear that
recovery was not seen after global blockade of presynaptic
NMDAr, but did occur when only NMDAr accessible
to synaptically released glutamate were blocked. The
increase above control levels was small, but consistent
and persistent during the period of recording, although it
only reached significance at two time points. This increase
in spontaneous glutamate release during anomalous
recovery of frequency-dependent facilitation (Fig. 6Aa,b)
could be indicative of an activity-dependent increase in
trafficking of NMDAr when those receptors close to the
release sites are compromised. Facilitation of eEPSCs did
becomemuchmore variable after recovery fromMK-801.
Although there was no significant overall increase in
frequency-dependent facilitation of eEPSCs there was a
relatively clear increase in at least five neurones, three in
experiments when stimulation was uninterrupted (Fig. 3)
and two when it was halted during recovery (Fig. 4).
An example of the latter is shown in Fig. 7A. In this
neurone, frequency-facilitation was around 50% in
control, and this progressed to around 80%, 40min
after washout of MK-801. In this neurone facilitation
was abolished by Ro 25-6891, demonstrating that it was
likely to be mediated exclusively by NR2B-containing
receptors.
To look further at this enhancement of presynaptic
NMDAr activity after receptor blockade, we determined
the effect of a short period of competitive NMDAr
blockade in a group of 6 neurones using a similar
protocol to that used to monitor recovery from MK-801
blockade. In these experiments MK-801 was included in
the patch pipette but 2-AP5 was substituted for bath
application of MK-801 to abolish frequency-dependent
facilitation (n= 5). The results of these studies are
summarized in Fig. 7B. As expected, 2-AP5 abolished
frequency-facilitation and this recovered relatively rapidly
over 15–20min when the drug was washed out. However,
there was also an increase in frequency-facilitation beyond
control levels following recovery,which thendeclinedback
towards control over a further 20–30min. The increase in
facilitation was significant (P < 0.05) at several points.
As noted, frequency-facilitation is mediated primarily by
NR2B receptors (Woodhall et al. 2001; Chamberlain et al.
2008), and in preliminary experiments (n= 2, not shown)
we have shown that brief blockade with Ro 25-6891 is also
followed by aweak increase above control during recovery.
Thus, the data do suggest that an overall reduction of
activation of presynaptic NMDAr, presumably NR2B,
could initiate an accelerated diffusion of receptors towards
the release sites.
Finally, we have determined whether the opposite may
be true by applyingNMDAalone in the absence of external
MK-801. Application of NMDA (25μM) often resulted
in the generation of large recurrent bursts of oscillatory
activity, which appeared to be network driven, making
meaningful analysis of sEPSCs and eEPSCs problematic.
In addition, eEPSCs per se were increased in amplitude
as might be expected, but more importantly, the agonist
resulted in a change in profile of activity at 3 Hz from
facilitating to depressing, or a variable mix of facilitation
and depression. To avoid these complications, in the
current experiments we examined mEPSCs recorded in
the presence of TTX (1μM). A brief application of NMDA
(n= 4) resulted in a substantial decrease in IEI ofmEPSCs
from 213± 44ms to 125± 27ms, reflecting an increase
in frequency from around 4.5 Hz to 8 Hz. However, after
washout of the agonist, mEPSC frequency then declined
to below baseline levels where it remained for at least
45min. IEI at 25min was 320± 66ms and at 45min it
was 330± 66ms reflecting a frequency of approximately
3.0 Hz at both time points.
The results of these studies are summarized in Fig. 8.
Figure 8B shows analysis of IEI and peak amplitudes of
sEPSCs in the neurone illustrated in Fig. 8A. Both the
leftward shift in cumulative probability distribution
elicited by NMDA, and the subsequent rightward
shift during recovery, were highly significant (K–S
test, P < 0.001). The frequency distribution of event
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amplitudes was not greatly altered by NMDA, or
during recovery from it. Mean control amplitude in this
neurone was 23.3± 0.5 pA, 21.9± 0.4 pA during NMDA,
22.3± 0.4 after 25min recovery and 23.5± 0.5 after
45min. Pooled data from the four neurones tested are
Figure 7. Blockade of NMDAr may promote
presynaptic NMDAr mobility
A, results from one neurone included in the analysis of
Fig. 4. Stimulation at 3 Hz was delivered for 5 s every 2 min.
Again, each point represents the mean facilitation occurring
during these periods relative to the mean amplitude of
responses at 0.05 Hz in the intervening periods. Following
anomalous recovery, frequency-dependent facilitation
increased beyond control levels. The NR2B-selective
antagonist Ro 25-6981 abolished the enhanced facilitation.
B, in 5 neurones 2-AP5 was used to a block
frequency-dependent facilitation instead of MK-801.
Recovery was succeeded by a period where facilitation
exceeded that seen in control conditions followed by a
gradual decline towards baseline levels by 60–70 min.
shown in Fig. 8C, and these largely reflect those seen in the
neurone in Fig. 8A. However, overall therewas a small shift
towards slightly larger amplitude events in the presence of
NMDA, reflected by a small, but significant (P < 0.05)
increase in mean peak amplitude from 16.8± 0.4 pA in
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control to 18.5± 0.5 pA when NMDA was added. Peak
amplitudes declined again during recovery to 15.6± 0.3
at 25min and 15.9± 0.5 pA at 45min, slightly, but not
significantly, below baseline. The time course of the
changes in sEPSC frequency are shown in the graph
in Fig. 8D, which clearly illustrates the rise induced by
NMDA followed by the persistent decrease. Changes in
frequency were significant (P < 0.01) at all time points.
Figure 8. Activation of NMDAr may
decrease presynaptic receptor mobility
A, recordings from a layer V neurone showing
the effects of a brief (5 min) application of a
low concentration (25 μM) of NMDA on
mEPSCs recorded in the presence of TTX
(1 μM). The agonist caused a substantial
increase in mEPSC frequency, but following its
washout there was a sustained decrease in
frequency over the subsequent recording
period (up to 50 min). This is reflected by the
analysis of cumulative probability of IEI shown
in B. Each plot consists of 1500 mEPSCs. The
shift to the left in NMDA reflects the change to
shorter intervals and a higher frequency. During
recovery, the distributions are persistently
located to the right of control reflecting the
decreased frequency. Frequency histograms of
amplitudes of the same events show little
change in amplitude distribution at any time
point. C, IEI and amplitude analysis of data
pooled from 4 neurones. Each neurone
contributed 500 events to the pooled analysis.
The results mirror those in the neurone
illustrated in A and B except that there was a
slight shift in amplitude distribution towards
larger events in the presence of NMDA. D, time
course of the effects of NMDA. Mean IEI of all
events in 5 min blocks was determined and
converted to frequency for each neurone.
Changes in frequency were determined as a
percentage of the mean control frequency at
each time point, and averaged across all
neurones.
Discussion
Glutamate release at cortical synapses is facilitated by pre-
synaptic NMDAr (Berretta & Jones, 1996; Woodhall et al.
2001; Sjo¨stro¨m et al. 2003; Jourdain et al. 2007; Li & Han,
2007; Brasier & Feldman, 2008; Li et al. 2008). We have
now demonstrated that presynaptic NMDAr are likely to
be dynamically mobile, and able to exchange between
locations close to release sites and more distal sites in the
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terminalmembrane. In contrast, we found thatNMDAr in
the postsynapticmembrane are likely to reside in relatively
stable synaptic and extrasynaptic pools.
Mobility of postsynaptic NMDAr
There has been increasing interest in the movement
of receptors between synaptic and extrasynaptic
compartments. Most of this attention has focused on
the mobility of postsynaptic receptors as a basis for
long-term synaptic plasticity (see Carroll & Zukin, 2002;
Collingridge et al. 2004; Perez-Otano & Ehlers, 2005;
Lau & Zukin, 2007). Trafficking appears to occur in at
least two compartments. Receptors may cycle between
the synaptic membrane and intracellular sites (see Carroll
et al. 1999; Collingridge et al. 2004; Nong et al. 2004;
Groc & Choquet, 2006), or by lateral diffusion in the
cellmembranewithout internalization (Choquet&Triller,
2003; Groc et al. 2004; Triller & Choquet, 2005; Groc &
Choquet, 2006). Both forms of trafficking contribute to
functional mobility of NMDAr, and it seems likely that
the two probably interact, with receptors moving into and
out of the PSD by lateral diffusion, and then recycled via
endocytosis at more distal sites in spines (seeWashbourne
et al. 2004; Groc & Choquet, 2006; Lau & Zukin, 2007).
NMDAr were originally thought to be stably anchored
at the PSD, and that AMPAr receptors were more mobile,
However, evidence now suggests that both receptors canbe
exchanged between the synaptic membrane and internal
stores as well as between synaptic and extrasynaptic sites
(Collingridge et al. 2004; Groc et al. 2004; Nong et al. 2004;
Triller & Choquet, 2005; Groc & Choquet, 2006).
A number of studies have used biochemical,
immuno-fluorescence techniques, and direct imaging
to monitor postsynaptic receptor trafficking (e.g. Groc
et al. 2004; Washbourne et al. 2004). We have examined
functional mobility using the pharmacological approach
ofmonitoring anomalous recovery ofNMDArEPSCs after
blockade with MK-801 (Tovar &Westbrook, 2002; Harris
& Pettit, 2007; Zhao et al. 2008). Tovar & Westbrook
(2002) found that NMDAr couldmove by lateral diffusion
between synaptic and extrasynaptic compartments at
autaptic synapses in hippocampal cultures, and Zhao
et al. (2008) reported similar findings in CA1 synapses
in hippocampal slices. In contrast, Harris & Pettit (2007)
foundno exchange of synaptic and extrasynaptic receptors
in CA1 pyramidal neurones using the same approach.
Clearly our results are in agreement with the latter study,
as we found no indication of mobility of postsynaptic
NMDAr in theEC,where they appear tobe stably anchored
or only slowlymobile. Of course, we are studying different
synapses to those in previous studies and there is no
reason a priori to assume that mobility of postsynaptic
receptors is a common feature of all glutamate synapses.
However, this does not explain the differences between
studies in the hippocampus. One possible factor could
be a developmental decline in receptor mobility. There is
considerable evidence to suggest that subunit composition
of postsynaptic NMDAr changes during development,
particularly with respect to synaptic versus extrasynaptic
location and synaptic plasticity (e.g. Wenzel et al. 1997;
Rumbaugh & Vicini, 1999; Tovar & Westbrook, 1999;
Liu et al. 2004; Groc et al. 2006b). Mobility at cultured
autaptic synapses (Tovar &Westbrook, 2002) was studied
during earlydevelopment (6 days in vitro).Rapid exchange
of synaptic NMDAr from NR2B- to NR2A-containing
is pronounced at postnatal days (P) 2–9 but declines
markedly by P16–21 (Bellone &Nicoll, 2007). Our studies
were conducted at P21–35, so it is possible that receptor
mobility at EC synapses has already stabilized at this stage.
We have recently shown that postsynapticNMDAr at these
synapses may contain a high proportion of triheteromeric
NR1/NR2A/NR2B receptors (Chamberlain et al. 2008), a
situation suggested to represent a stable mature situation
(Tovar &Westbrook, 1999). Again, however, this does not
explain the contrasting results in hippocampus reported
by Harris & Pettit (2007; P14–21) and Zhao et al. (2008;
P21) in hippocampal slices.
Mobility of presynaptic NMDAr
In contrast to the lack of mobility of NMDAr at
postsynaptic sites, using a similar physiological approach
we found clear evidence that NMDAr in presynaptic
terminals in the EC are highly mobile. The data strongly
suggest that this mobility results from lateral diffusion of
receptors in the terminal membrane. We cannot entirely
dismiss the possibility of trafficking of NMDAr to and
from internal stores in the terminals. One scenario is that
receptors are translocated from cytoplasmic sites to the
terminal membrane at distal locations and subsequently
move into the proximity of the release sites and access
to synaptically released glutamate by lateral diffusion,
analogous to the situation that may occur in postsynaptic
spines (Groc & Choquet, 2006; Lau & Zukin, 2007).
Our results provide a first functional demonstration
of trafficking of NMDAr in presynaptic terminals.
Immuno-labelling studies of NMDAr subunits have
shown them located in proximity to the terminal
membrane of active zones (Wang & Pickel, 2000; Fujisawa
& Aoki, 2003; Adams et al. 2004; Kotak et al. 2005).
However, receptors have also been seen close to the
membrane at extra-junctional sites in terminals and axons,
as well in the cytoplasm distal to the active zones (e.g.
Aoki et al. 1994; Conti et al. 1999; Wang & Pickel, 2000;
Adams et al. 2004; Kotak et al. 2005; Jourdain et al.
2007). This provides physical evidence for the existence
of extra-junctional presynaptic NMDAr as a source of
receptors to be trafficked to the active zones. Interestingly,
immuno-labelling of NR2B subunits has been detected
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in association with vesicular organelles in hippocampal
terminals (Saldanha et al. 2004; Jourdain et al. 2007),
perhaps representing a storage/delivery mechanism for
trafficking of NMDAr to the terminal membrane.
Few previous studies have considered trafficking of
presynaptic NMDAr. Electronmicroscopy combined with
immuno-labelling indicated that thenumber ofNR2Aand
NR2B subunits in terminals in rat somatosensory cortex
in vivo appeared to increase and decrease, respectively,
during NMDAr-blockade (Aoki et al. 2003; Fujisawa &
Aoki, 2003). This was taken as evidence that presynaptic
NR2AandNR2B subunits undergo regulated trafficking in
these terminals. Presynaptic NMDAr may originate in the
somatic endoplasmic reticulum and be transported along
axons to terminals, analogous to the transport of NMDAr
to spines along dendrites (see Lau & Zukin, 2007). The
anterograde transport of NMDAr along vagal axons was
suggested to reflect trafficking of NMDAr into terminals
to act as autoreceptors (Cincotta et al. 1989). O’Donnell
et al. 2004) observed NMDAr receptors in the axoplasm of
spinal axons and suggested these were being transported
along microtubules to primary afferent terminals, where
they would also act as autoreceptors (albeit inhibitory;
Bardoni et al. 2004). Scaffolding proteins such as PSD-95,
and SAP-102 (Kornau et al. 1995; Niethammer et al. 1996;
Fujita & Kurachi, 2000) anchor postsynaptic NMDAr at
the PSD, and such proteins also occur in cortical terminals
(Valtschanoff et al. 1999; Aoki et al. 2001). Our studies
demonstrate a rather dynamic mobility of presynaptic
NMDAr, but the presence of scaffolding proteins
presynaptically could suggest that receptors that diffuse
from distal sites may be anchored near active zones by
mechanisms similar to those at the PSD.
We have not yet fully examined the functional role
of presynaptic NMDAr mobility. One possibility is a
role in activity-dependent plasticity. We found that
anomalous recovery from MK-801, or acute blockade
with 2-AP5 could be followed by a period of enhanced
frequency-dependent facilitation of AMPAr-mediated
transmission and of spontaneous glutamate release. These
effects could be explained by an increased trafficking
of NMDAr into the vicinity of release sites in response
to decreased activation of the existing receptors during
the period of block. In contrast, when we activated
presynaptic receptors with NMDA the frequency of
mEPSCs greatly increased (see also Woodhall et al.
2001), but this was succeeded by a persistent decrease.
Thus, we could postulate that mobility of the
presynaptic NMDAr receptors is involved in an inter-
mediate form of self-regulation of synaptic strength at
glutamate synapses.Weknowthat thepresynapticNMDAr
are likely to be exclusively NR2B-containing (Woodhall
et al. 2001; Chamberlain et al. 2008), so the level of
activity at the presynaptic NR2B receptors may control
an activity-dependent signal leading to accelerated or
decreased mobility, and increased or decreased numbers
of the same receptor close to release sites. As noted above,
blockade ofNMDArwith 2-AP5 in vivo appears to result in
trafficking of NR2B subunits out of synaptic terminals in
somatosensory cortex (Fujisawa & Aoki, 2003), but these
studies were conducted immediately following the 2-AP5
application, not after recovery so it is difficult to relate
these studies to ours. In the context of activity-dependent
mobility, it is also of interest that hearing loss induced by
cochlear ablation in young (P10) gerbils rapidly results in
an increase in the number of presynapticNR2B subunits at
synapses in the superficial layers of auditory cortex (Kotak
et al. 2005), and this could reflect increased trafficking of
receptors induced by reduced afferent input.
Further implications for synaptic plasticity
Considerable attention has been focused recently on the
role of trafficking of NMDAr in postsynaptic dendrites
as a basis for long-term potentiation (LTP) and long-term
depression (LTD) (Carroll&Zukin, 2002;Nong et al.2004;
van Zundert et al. 2004; Perez-Otano & Ehlers, 2005).
Both forms of enduring plasticity have been demonstrated
at layer V synapses (Yun et al. 2002; Solger et al. 2004;
Craig & Commins, 2007). However, our results suggest
that surface mobility of postsynoptic NMDAr is unlikely
to be involved in NMDAr-dependent changes in synaptic
strength at these synapses, although we cannot rule out a
contribution of NMDAr exchanging between membrane
and cytoplasmic stores.
There is increasing evidence that presynaptic NMDAr
are involved in LTP (Humeau et al. 2003; Samson & Pare,
2005) and LTD (Sjo¨stro¨m et al. 2003; Bender et al. 2006;
Corlew et al. 2007) at other glutamate synapses. We do
not yet know whether presynaptic NMDAr can act as
mediators or modulators of long-term plasticity in the
EC. If they do, the ability of NMDAr to alter synaptic
transmission by migration in the presynaptic membrane
could well play a role in plasticity or metaplasticity and
we now aim to investigate this possibility. Finally, we have
previously shown that presynaptic NMDAr function is
greatly enhanced in theEC inchronically epileptic animals,
and that some anticonvulsants may target presynaptic
NMDAr (Yang et al. 2006, 2007). Whether alterations in
presynaptic NMDAr mobility are a factor in the action of
anticonvulsant drugs and whether a pathological change
inmobilitymay contribute to chronic epileptogenesis, will
also be subjects for future investigation.
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We have previously shown that spontaneous release of glutamate in the entorhinal cortex (EC) is tonically facilitated via activation
of presynaptic NMDA receptors (NMDAr) containing the NR2B subunit. Here we show that the same receptors mediate short-
term plasticity manifested by frequency-dependent facilitation of evoked glutamate release at these synapses. Whole-cell patch-
clamp recordings were made from layer V pyramidal neurones in rat EC slices. Evoked excitatory postsynaptic currents showed
strong facilitation at relatively low frequencies (3 Hz) of activation. Facilitation was abolished by an NR2B-selective blocker (Ro 25-
6981), but unaﬀected by NR2A-selective antagonists (Zn2+, NVP-AAM077). In contrast, postsynaptic NMDAr-mediated responses
could be reduced by subunit-selective concentrations of all three antagonists. The data suggest that NMDAr involved in presynaptic
plasticity in layer V are exclusively NR1/NR2B diheteromers, whilst postsynaptically they are probably a mixture of NR1/NR2A,
NR1/NR2B diheteromers and NR1/NR2A/NR2B triheteromeric receptors.
Copyright © 2008 Sophie E. L. Chamberlain et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1. INTRODUCTION
A huge amount of research has been devoted to the study
of the physiology, pharmacology, function, and pathology
of NMDA receptors (NMDAr). This has been extensively
reviewed elsewhere (e.g., [1–6]). Native NMDAr are het-
eromeric structures, and consist of NR1 subunits, which
are obligatory, in combination with one or more of four
subtypes of NR2 subunit (NR2A-D). Functional receptors
are tetramers, comprising two NR1 subunits and two NR2
subunits, where the functional unit is probably an NR1/NR2
heterodimer. The functional properties of NMDAr, such as
single channel conductance, the degree of voltage-dependent
Mg2+ block, and deactivation kinetics depend on which
of the four NR2 subunits is assembled in the receptor.
For example, NR2A and NR2B-containing channels have a
high single channel conductance (40–50 pS) whereas NR2C
and NR2D are lower (15–35 pS). NR2A-containing recep-
tors display fast decay kinetics (around 100 milliseconds),
whereas NR2B and C are much slower (250 milliseconds),
and NR2D slower still (4 seconds) [5, 7]. In addition to
functional diﬀerences, various subunit combinations display
pharmacological diﬀerences in susceptibility to antagonists
and regulatory mechanisms (such as sensitivity to H+, Zn2+,
polyamines).
Synaptic transmission is a highly dynamic and plastic
process, modified on-demand by a myriad of instantaneous,
short, intermediate, and long-term regulatory mechanisms.
Much attention has been devoted to the study of the role
of NMDAr in synaptic plasticity, particularly in long-term
potentiation (LTP) and depression (LTD). These studies have
largely focussed on NMDAr at postsynaptic sites. However,
dynamic regulation of synaptic strength can also involve
receptors on presynaptic terminals, which provide a power-
ful, synapse-delimited control of transmitter release, and the
existence of presynaptic NMDAr (preNMDAr) is now firmly
established. Neurochemical [8–11] and immunolocalization
studies [12–15] provided early indications for preNMDAr.
We provided the first clear functional demonstration of
preNMDAr, showing that the competitive antagonist, 2-
AP5, could reduce the frequency of spontaneous excitatory
postsynaptic currents (sEPSCs) at glutamate synapse in the
rat entorhinal cortex (EC), indicating a tonic facilitatory
eﬀect of preNMDAr on glutamate release [16]. PreNMDAr
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are now known to modify both glutamate and GABA release
in a wide variety of locations and tissues [17–33].
Increasing attention is being paid to the role of
preNMDAr as mediators of both long-term alterations in
synaptic strength, and in moment-to-moment and short-
term activity-dependent changes in transmitter release. For
example, a role of preNMDAr in LTD has been demonstrated
in cerebellum [34], visual [22, 33], and somatosensory [17]
cortex. Conversely, involvement of preNMDAr in LTP has
been demonstrated in amygdala [26, 32]. More intermediate
forms of potentiation of glutamate [30] and GABA trans-
mission [23], over a time scale of minutes, may also involve
preNMDAr. As noted above, we found that preNMDAr
are tonically activated by ambient glutamate [17, 35],
providing instantaneous control over the level of glutamate
release at EC synapses. Similar results have been reported
for other areas [22, 27, 28, 33]. In addition, we found
that preNMDAr are activated after action potential-driven
synaptic release of glutamate, increasing the probability of
subsequent release and allowing them to mediate short-term,
frequency-dependent facilitation of glutamate transmission
[16, 35].
We have also demonstrated that the tonic facilitatory
eﬀect of preNMDAr on spontaneous glutamate release is
likely to be predominantly mediated by NR2B-containing
NMDAr, since the increase induced by 2-AP5 was mimicked
[35, 36] by relatively specific blockers of the NR2B subunit,
ifenprodil [37], and Ro 25-6981 [38]. In addition, an antag-
onist with some specificity (albeit weak) for the NR2A sub-
units, NVP-AAM077 [39] had little eﬀect. Others have also
concluded that preNMDAr are likely to be predominantly
NR2B-containing [27, 33, 40]. Postsynaptically, both NR2A
and NR2B contribute to glutamate transmission, although
there is controversy over whether diheteromeric NR1/NR2A
and NR1/NR2B coexist at the postsynaptic density, or are
segregated between synaptic and extrasynaptic locations,
or even in a synapse-specific way [3]. The contribution
of triheteromeric NR1/NR2A/NR2B receptors is also still a
matter of debate [3, 41].
In the present study, we have extended our studies in
the EC to examine the contribution of NR2A and NR2B
receptors to short-term plasticity of glutamate transmission,
by examining the eﬀects of relatively specific blockers on
the preNMDAr mediated, frequency-dependent facilitation
of evoked glutamate release. In addition, we have used the
same agents to determine whether postsynaptic NMDAr may
diﬀer from those on presynaptic terminals.
2. METHODS
2.1. Slice preparation
Experiments were performed in accordance with the U.K.
Animals (Scientific Procedures) Act 1986, European Com-
munities Council Directive 1986 (86/609/EEC), and the
University of Bath ethical review document. Slices containing
EC and hippocampus were prepared from male Wistar
rats (P28–35), which were anaesthetized with an intra-
muscular injection of ketamine (120 mg/kg) plus xylazine
(8 mg/kg) and decapitated. The brain was rapidly removed
and immersed in oxygenated artificial cerebrospinal fluid
(aCSF) chilled to 4◦C. Slices (350–400 μm) were cut using
a Vibroslice, and stored in aCSF bubbled with 95% O2/5%
CO2, at room temperature. Following recovery for at least
1 hour, individual slices were transferred to a recording
chamber mounted on the stage of a Zeiss Axioskop FS or an
Olympus BX50WI microscope. The chamber was perfused
(2.0 ml/min) with oxygenated aCSF (pH 7.4) at 31–33◦C.
The aCSF contained (in mM) NaCl (126), KCl (3), NaH2PO4
(1.4), NaHCO3 (19), MgSO4 (2), CaCl2 (2), and D-glucose
(10). Neurones were visualized using diﬀerential interference
contrast optics and an infrared video camera.
2.2. Electrophysiological recording
Patch pipettes were pulled from borosilicate glass on a
Flaming/Brown microelectrode puller. For recording sponta-
neous (sEPSCs) or evoked (eEPSCs) excitatory postsynaptic
currents, pipettes were filled with a Cs-gluconate-based
solution containing (in mM) D-Gluconate (100), HEPES
(40), QX-314 (1), EGTA (0.6), NaCl (2), MgCl2 (5), TEA-
Cl (1), phosphocreatinine (5); ATP-Na (4), GTP-Na (0.3),
MK-801 (2). Solutions were adjusted to 290 mOsmol, and
to pH 7.3 with CsOH. Whole-cell voltage clamp recordings
(holding potential −60 mV unless otherwise stated) were
made from neurones in layer V of the medial division
of the EC, using an Axopatch 200B amplifier (Molecular
Devices, Calif., USA). Series resistance compensation was not
employed, but access resistance (10–30 MΩ) was monitored
at regular intervals throughout each recording and cells were
discarded from analysis if it changed by more than ±10%.
Liquid junction potential (12.3 mV) was estimated using the
Junction Potential Calculator included in pClamp-8 software
(Molecular Devices, Calif., USA), and compensated for in the
holding potentials.
eEPSCs were elicited by electrical stimulation (bipolar
pulses, 10–50 V, 0.02 millisecond duration) via a bipolar
tungsten electrode placed on the surface of the slice in layer
V of the lateral EC. The stimulation intensity was adjusted
to give submaximal (approx. 50–60% maximum amplitude)
responses.
2.3. Monitoring presynaptic NMDAr activity
In all these experiments, MK-801 (2 mM) was included in the
patch pipette solution to block postsynaptic NMDAr. This
allowed us to record AMPA-receptor mediated responses
in isolation, and to monitor activity at preNMDAr uncon-
taminated by postsynaptic receptor eﬀects. This approach
was developed by us [16, 35, 42], and has been used
successfully by others to block postsynaptic NMDAr in the
recorded neurone [17, 27, 28, 32, 33, 40]. When whole-cell
access was gained, neurones were voltage clamped at 0 mV,
and synaptic stimulation was delivered at 2 Hz for 30–40
seconds to allow blockade of postsynaptic NMDAr by MK-
801 dialyzed into the cell via the patch pipette solution.
Membrane potential was then clamped at−60 mV and single
shock stimulation delivered at low frequency (0.05 Hz) to
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evoke AMPAr mediated EPSCs. At 2 or 3 minute intervals,
the single shock was replaced with stimulation at 3 Hz
for 10 seconds. Such stimulation results in a frequency-
dependent facilitation of the AMPAr-mediated EPSC, which
we have shown previously to be dependent on activation
of preNMDAr [35]. We used the degree of frequency-
dependent facilitation of AMPAr-mediated eEPSCs as a
quantitative measure of preNMDAr activation.
2.4. Monitoring postsynaptic NMDAr activity
In these experiments, MK-801 was omitted from the patch
pipette solution. When whole-cell access was gained, control
eEPSCs were recorded at a holding potential of −60 mV,
before addition of the AMPAr antagonist, NBQX, and the
GABAAr-antagonist, bicuculline to the bath perfusion. After
10–12 minutes, the holding potential was changed to +40 mV
to record isolated NMDAr-mediated EPSCs as positive going
currents. These were evoked at low frequency (0.05 Hz)
until stable amplitudes were recorded, before addition of
antagonists to the bath.
2.5. Data analysis
Data were recorded to computer hard disk using Axoscope
software. Minianalysis (Synaptosoft, Decatur, Ga, USA)
was used for analysis of EPSCs oﬄine. In the studies of
preNMDAr, the average peak amplitude of the 8 responses
before each episode of 3 Hz stimulation was determined.
During the period of 3 Hz stimulation, the amplitude of
the 8 largest events was determined and normalized to the
average amplitude of the preceding low-frequency events
to obtain a quantitative measure of frequency-dependent
facilitation in the presence and absence of antagonists. In
these studies, we also analyzed AMPAr-mediated sEPSCs, by
determining interevent interval (IEI), amplitude, rise (10–
90%), and decay times. sEPSCs were detected automatically
using a threshold-crossing algorithm. Threshold varied from
neurone to neurone but was always maintained at a constant
level in any given recording. At least 200 events were sampled
during a continuous recording period for each neurone
under each condition. Cumulative probability distributions
of IEI were compared using the Kolmogorov-Smirnoﬀ test.
In experiments on postsynaptic NMDAr, responses were
quantified by measuring mean peak amplitudes of at least 5
NMDAr-mediated eEPSCs evoked at low frequency at inter-
vals throughout the study. In these studies, the vast majority
of sEPSCs were blocked, as recordings were conducted in
the presence of NBQX. Occasional slow sEPSCs mediated by
NMDAr were recorded, their frequency was very low (2-3 per
minute) and precluded meaningful analysis.
2.6. Materials
Salts used in preparation of aCSF were “Analar” grade and
purchased from Merck/BDH or Fisher Scientific (Dorset,
UK). All drugs were applied by bath perfusion. MK-801,
NMDA, NBQX, D-2-AP5, bicuculline methiodide, and Ro
25-6981 ((αR,βS)-α-(4-hydroxyphenyl)-β-methyl-4-(phen-
ylmethyl)-1-piperidinepropanol hydrochloride) were ob-
tained from Tocris (Bristol, UK). TPEN (N,N,N′, N′-
Tetrakis-(2-pyridylmethyl)-Ethylenediamine) was obtained
from Sigma (UK). UBP302 ((S)-1-(2-amino-2-carboxy-
ethyl)-3-(2-carboxybenzyl) pyrimidine-2,4-dione) was a
kind gift from Dr. Dave Jane, University of Bristol, and
NVP-AAM077 ((R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-
(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-ph-
osphonic acid) was a gift from Dr. Yve Auberson at Novartis
(Basel, Switzerland).
3. RESULTS
3.1. Presynaptic NMDAar
Figure 1(a) shows eEPSCs evoked in a layer V neurone
at 3 Hz, with postsynaptic NMDAr blocked by internally
dialyzed MK-801. The first 6 responses evoked during a train
of 30 at 3 Hz are shown and demonstrate the facilitation seen
at this relatively low frequency. As reported previously [35],
the facilitation of the AMPAr-mediated eEPSCs was entirely
dependent on presynaptic NMDAar activation, since it could
be abolished by 2-AP5 (n = 5, Figure 1(b)). Likewise, the
NMDAr channel blocker, MK-801, also abolished frequency
facilitation (n = 10, Figure 1(b)). In some neurones, facil-
itation was replaced by a weak frequency-dependent depres-
sion of eEPSCs in the presence of the blockers. This can be
seen as a reduction in mean amplitude of eEPSCs in the
presence of the blockers (e.g., Figure 1(b)). In a further 5
neurones, we confirmed the specificity of the eﬀect by testing
the eﬀects of GluR5 subunit specific antagonist of kainate
receptors (UBP 302, 20 μM), since we have recently shown
that these receptors mediate a similar short-term facilitation
of glutamate transmission at 3–5 Hz in layer III of the EC
(Chamberlain S.E.L and Jones R.S.G. unpublished). UBP
302 had no eﬀect on facilitation in layer V (not shown)
confirming its dependence on NMDAar. Interestingly, 2-AP5
had no eﬀect on frequency facilitation in layer III of the EC
(not shown), so although similar short-term plasticity is seen
in both layers, its underlying mechanism is lamina-specific.
Since neither 2-AP5 nor MK-801 has selectivity for
NR2A v NR2B subunits [5], the data do not indicate the
subunit composition of NMDAr responsible for short-term
frequency-facilitation. To determine the receptor involved,
we have examined the eﬀect of more specific antagonists.
First, we tested the eﬀects of Ro 25-6981. This is an allosteric
inhibitor of NMDA receptors, which binds to a site on
the N-terminal domain of the NR2 subunit, with a high
degree of selectivity (>3000 fold) for NR2B over NR2A
[38]. Figure 2(a) shows that Ro 25-6981 at 500 nM abolished
the frequency facilitation of eEPSCs, again revealing a weak
depression. A lower concentration (200 nM, n = 3) of
Ro 25-6981 resulted in a mean maximal reduction in
frequency-facilitation of 69 ± 7%. At these concentrations,
the drug should have little or no eﬀect on NR2A subunits
[38], strongly suggesting that NR2B-containing receptors are
primarily responsible for this form of short-term plasticity
at layer V synapses. This would agree with previous studies
that have shown the tonic facilitatory eﬀect on spontaneous
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Figure 1: Short-term facilitation is mediated by presynaptic NMDA
receptors. (a) First 6 responses evoked by a train of stimuli (3 Hz,
20 seconds) averaged from 3 neurones. (b) Responses (n = 8)
were averaged at low frequency and during 3 Hz stimulation. In
the presence of 2-AP5, low-frequency responses were unaltered,
but facilitation was abolished. The bar graphs show the mean
results from 5 neurones. (c) Similar results were seen with MK-801.
Stimulation artifacts have been partially blanked for clarity.
release is likely to be NR2B-mediated [16, 35, 43]. Accord-
ingly, Ro 25-6981 resulted in a substantial increase in IEI
of sEPSCs from 277 ± 82 milliseconds (5.5 ± 1.9 Hz) to
764 ± 261 milliseconds (2.1 ± 0.7 Hz) recorded in the same
neurones (cf. [36, 43]). KS analysis of cumulative probability
distributions confirmed a highly significant change. There
was no concurrent change in mean amplitude, rise, or decay
time (not shown).
Next, we examined the eﬀect of NVP-AAM077 in 5
neurones. This is a competitive antagonist that shows some
selectivity for receptors containing the NR2A subtype. Initial
reports indicated a greater than 100 fold selectivity of the
compound for NR2A over NR2B [39, 44]. However, recently,
it has been suggested that the selectivity is closer to 10
fold when the aﬃnity of the two subtypes for glutamate
is accounted for ([41], see also [45, 46]). Thus, at the
concentration employed here (400 nM), we might expect
almost complete blockade of NR2A receptors, but it is
possible that substantial inhibition of NR2B would also
occur [41]. Nevertheless, NVP-AAM077 did not signifi-
cantly aﬀect the frequency-dependent facilitation of eEPSCs
(see Figure 2(b)). If anything, the facilitation was slightly
(although not significantly) increased. These data suggest
that NVP-AAM077 may have reasonable selectivity for the
NR2A receptor in our preparation, but that these receptors
are not involved in presynaptic short-term plasticity at layer
V synapses. Further support for this was obtained from
analysis of sEPSCs. The mean IEI in control was 443 ± 230
milliseconds (4.0 ± 0.9 Hz), and this decreased slightly to
377 ± 180 milliseconds (4.5 Hz) with the addition of NVP-
AAM077. Likewise, there was no change in amplitude, rise,
or decay times of sEPSCs (not shown).
In view of the controversy over the selectivity of NVP-
AAM077, we also tested (n = 5) the eﬀects of Zn2+,
which has been shown to discriminate between NR2A and
NR2B receptors. Like Ro 25-6981 at NR2B subunits, Zn2+
binds to the N-terminal domain of the NR2A subunit
to exert a voltage-independent inhibition with >100 fold
selectivity over NR2B [47–49]. However, as with NVP-
AAM077, a relatively high concentration of Zn2+ (300 nM)
failed to alter frequency-dependent facilitation of eEPSCs
(see Figure 2(c)). In addition, it had little eﬀect on the
IEI (200 ± 150 v 298 ± 170 milliseconds, see Figure 2(d)),
amplitude (17.7 ± 3.4 v 15.4 ± 2.2 pA), rise (1.9 ± 0.3 v
2.1±0.4 milliseconds), or decay times (24.6±1.6 v 27.3±1.3
milliseconds) of sEPSCs (cf. [43]). Thus, the data from both
NVP-AAM077 and Zn2+ studies militate strongly against a
role for NR2A receptors in presynaptic frequency-dependent
facilitation in layer V of the EC. The ability of Ro 25-
6981 to block facilitation strongly indicates that presynaptic
plasticity at these synapses is dependent only on NR2B-
containing receptors.
A recent paper [50] suggested that activation of post-
synaptic NR2B-containing receptors at a similar frequency
(3.3 Hz) to that employed by us to elicit frequency-
dependent facilitation induced a long-term depression of
the NMDAr-mediated currents themselves (primarily by
decreasing fractional Ca2+ currents carried by the receptors).
We were interested to see if the repetitive activation of the
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Figure 2: Eﬀects of subunit selective antagonists. (a) Ro 25-6981 abolished frequency-dependent facilitation. In contrast, neither NVP-
AAM077 (b) nor Zn2+ (c) had any significant eﬀect. (d) Zn2+ also had little eﬀect on sEPSCs. The records show consecutive sweeps of
baseline recording of sEPSCs and in the presence of Zn2+. The cumulative probability plots show pooled data from 6 neurones, with 200
events from each neurone in the presence and absence of the blocker. There was a small shift to the right in the presence of Zn2+, but this
failed to reach significance (KS test).
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Figure 3: Progressive changes associated with repeated episodes
of stimulation at 3 Hz in the absence of NMDAr blockers. Each
point is the degree of facilitation recorded during a 30-second
period of stimulation and is the average from 5 neurones. (a) After
an initial decline in the degree of facilitation, it remained stable
throughout the subsequent 30 minutes of recording. (b) Mean
amplitude of responses recorded at low and high frequency used
to assess the facilitation in the neurones shown in (a). There was
a progressive, albeit small increase in amplitude of responses in
both cases. Representative records from one neurone, sampled at
the times indicated, are shown below.
presynaptic NR2B-containing receptors would induce any
decrement in frequency facilitation at layer V synapses. In 5
neurones, we induced facilitation of eEPSCs and monitored
the degree of facilitation but without the addition of any
blockers. Overall there was an initial decrease in the degree
of facilitation of AMPAr-mediated eEPSCs from the first to
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Figure 4: Time course of the eﬀect of 2-AP5 on eEPSC amplitude
and facilitation. (a) The progressive increase in both low- and high-
frequency responses was prevented by the addition of 2-AP5 (n =
5 neurones). The responses at high frequency were progressively
reduced to control levels, in parallel with the degree of facilitation
(b). (c) Representative responses recorded in one neurone at the
times indicated.
second episode, but thereafter it was remarkably consistent
(see Figure 3(a)). However, when we looked at absolute
amplitude of eEPSCs, there was a small, but consistent,
increase over the course of the studies. This applied to events
evoked at both low and high frequencies (see Figure 3(b)).
We also examined the time course of these changes in the
neurones tested with 2-AP5 (see Figure 4). The antagonist
appeared to prevent the progressive increase in amplitude
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of the low-frequency events at the same time as blocking
the frequency-dependent facilitation. This limited protocol
may suggest the short-term frequency-dependent facilitation
could underlie a longer-term enhancement of glutamate
transmission. As the postsynaptic NMDAr were already
blocked (by internal MK-801), this is likely to involve the
presynaptic, NR2B-containing receptors.
3.2. Postsynaptic NMDAr
We now wished to determine the contribution of NR2A/B
subunits to NMDAr at postsynaptic sites in layer V of
the EC, so we tested the same antagonists used in the
presynaptic experiments for eﬀects on isolated NMDAr-
mediated eEPSCs. As expected, the nonspecific blockers 2-
AP5 (n = 5) and MK-801 (n = 9) both abolished the slow
eEPSCs recorded at +40 mV in the presence of NBQX and
bicuculline (not shown). Ro 25-6981 (n = 5) also elicited a
concentration dependent reduction in postsynaptic NMDAr
responses at concentrations that would be expected to retain
selectivity for NR2B-containing receptors (see Figure 5(a)).
The slow eEPSCs were essentially abolished by Ro 25-6981 at
500 nM. This suggests that NR1/NR2B receptors dominate
at postsynaptic sites as they do presynaptically. However,
when we tested NVP-AAM077 (n = 6), we again found
a concentration-related reduction in postsynaptic responses
with around 80% inhibition at 500 nM (see Figure 5(b)).
Comparison with the data of Neyton and Paoletti [41]
suggests that the eﬀect of NVP-AAM077 could be explained
by blockade of both NR2B and NR2A receptors since 500 nM
was suﬃcient to abolish NR2A responses in oocytes, but
also to exert around 60% block of NR2B. However, this
is at odds with its failure to alter preNMDAr-dependent
facilitation, which is clearly an NR2B-mediated response.
Studies with Zn2+ (n = 6) failed to substantially clarify the
situation. The divalent cation also elicited a concentration-
dependent reduction in slow eEPSCs (see Figure 5(c)). The
concentrations employed exert around an 80% voltage-
independent block of NR2A receptors expressed in oocytes,
but retain a considerable degree of selectivity with regard
to block of NR2B receptors [47, 49]. These data do suggest
a role for NR2A receptors at postsynaptic sites, but it is
puzzling that Ro 25-6981 essentially also abolished NMDAr
EPSC, when it would be expected to have little eﬀect on
NR2A receptors.
We performed two more sets of experiments to look at
this question further. In 5 neurones, we first perfused a low
concentration of Ro 25-6981 (200 nM), to partially block
the NMDAr EPSC. We then added a low concentration of
Zn2+ (100 nM). In these neurones, Ro 25-6981 resulted in
inhibition of around 45%, and with the addition of Zn2+
there was a further reduction to around 90–100%, which
clearly indicates a role of both NR2A and NR2B in mediating
the postsynaptic response (see Figure 5(d)). Finally, there is
evidence that under control conditions, NR2A-containing
receptors may be substantially blocked by Zn2+, present in
the ACSF as a result of contamination of other salts used in its
preparation [47]. Although addition of Zn2+ clearly reduced
slow eEPSCs in our experiments, we also examined whether
there was significant blockade of the NR2A receptor in
control recordings by testing the eﬀect of the Zn2+-chelator,
TPEN (2 μM), in 3 neurones. This had no eﬀect on the mean
amplitude of NMDAr eEPSCs (125.3±25.1 v 111.9±26.1 pA)
suggesting that our results with antagonists were unlikely to
be confounded by Zn2+-contamination.
Finally, as noted above, relatively low frequency, repeti-
tive activation of NR2B receptors has been shown to induce
a depression of postsynaptic NMDA responses per se [50].
In 7 neurones, we determined the eﬀects of a brief period
of repetitive stimulation (3 Hz, 40 seconds) on postsynaptic
NMDAr eEPSCs in 5 neurones. Overall, during the repetitive
stimulation there was a small (15%), progressive decrease in
the first 10–15 seconds, and thereafter the amplitude reached
a plateau (see Figure 6(a)). We then recorded NMDAr
eEPSCs at low frequency (0.05 Hz) over the subsequent 30
minutes. There was an initial period (5 minutes) where
responses appeared to be slightly depressed and thereafter
a recovery followed by a slight increase before recovery to
control levels (see Figure 6(b)). However, apart from a brief
period around 20 minutes there was no significant diﬀerence
compared to control.
4. DISCUSSION
We originally demonstrated that the presynaptic NMDAar
mediating facilitation of glutamate release in the EC was
likely to be predominantly NR2B-containing, as the fre-
quency of sEPSCs was decreased by the N2B antagonist,
ifenprodil [35]. Other work supports the conclusion that
preNMDAr that facilitate spontaneous glutamate release at
cortical synapses are primarily NR2B-containing. We found
that Ro 25-6981 but not NVP-AAM077 or Zn2+ reduced
sEPSC frequency ([36], present study), and similar results
with Ro 25-6981 and Zn2+ were reported for synapses in layer
II/III of the visual cortex [28]. Jourdain et al. [27] reported
that presynaptic NR2B receptors were responsible for the
increase in mEPSC frequency in dentate granule neurones
seen after stimulation of glutamate release from adjacent
astrocytes, as it was blocked by ifenprodil. We now show that
the same receptor is likely to mediate short-term plasticity
of evoked glutamate release in layer V of the EC. Thus,
the facilitation of eEPSCs at the relatively low frequency
of 3 Hz was blocked by Ro 25-6981. The lack of eﬀect
of NVP-AAM077 and Zn2+ suggests that NR2A receptors
do not contribute to facilitation of either spontaneous or
evoked glutamate release at EC synapses. We cannot rule
out a role of NR2A receptors at higher frequencies, although
Sjo¨stro¨m et al. [33] have reported that frequency facilitation
at 30 Hz at layer V synapses in visual cortex is greatly
reduced by ifenprodil, suggesting that NR2B dominate at
other presynaptic sites as well.
It is somewhat surprising that only presynaptic NR2B
receptors appear to modulate release. Postembedding
immunolabeling studies have shown the presence of NR1
subunits in presynaptic terminals in cortex and hippocam-
pus [12–14, 51–53]. Whilst a host of studies have demon-
strated NR2B subunits at presynaptic locations [15, 51, 54–
59], similar studies have also indicated the presence of NR2A
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Figure 5: Eﬀect of subunit selective antagonists on postsynaptic NMDAr-mediated eEPSCs. Slow eEPSCs were recorded at +40 mV in
the presence of NBQX and bicuculline. Each response is the average of at least 8 events. (a) The NR2B antagonist, Ro 25-691, induced
a concentration-dependent reduction in slow eEPSCs. They were essentially abolished at the higher concentration. (b) and (c) show that
NR2A selective blockers induced a very similar blockade of slow EPSCs. (d) A combination of NR2A and NR2B antagonists also abolished
slow EPSCs.
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Figure 6: Changes in slow eEPSC amplitudes during and after
repetitive stimulation at 3 Hz for 30 seconds. (a) shows the average
response amplitudes at low frequency (0.05 Hz) recorded during 35
minutes stimulation in 7 neurones. During the period indicated by
the arrow, stimulation was increased to 3 Hz for 30 seconds and
the average response amplitudes (first 37 only for clarity) recorded
during this period are shown in (b). The only significant diﬀerences
compared to the mean control value are indicated by the asterisks
in (a).
subunits [51, 52, 60–62] although, to date, there are no
similar studies specifically related to the EC.
The presence of all three subunits suggests that both
NR1/NR2A and NR1/NR2B diheteromeric receptors and
possibly also NR1/NR2A/NR2B triheteromers could be
expressed in cortical presynaptic terminals, and this may
well be the case. However, it is clear from the phar-
macological experiments presented here and elsewhere,
that NR1/NR2B receptors are predominantly responsible
for short-term NMDAr-mediated facilitation of glutamate
release (but see, [63]). The properties of NR2B subunits
diﬀer from NR2A, in a way that may make them more
suited to the task of presynaptic facilitation (see [6, 7,
64–66]). NR2B subunits have a higher aﬃnity for both
glutamate and glycine, and show less desensitization. The
two subunits confer similar single channel conductance to
diheteromeric receptors (around 50 pS), but they have very
diﬀerent deactivation kinetics, with NR1/NR2A receptors
having decay time constants of 50–100 milliseconds, and
NR1/NR2B receptors in the order of 200–400 milliseconds.
Both are Ca2+-permeable, but NR2B receptors exhibit a
higher fractional Ca2+-current than NR2A (see [66, 67]).
Both subunits also display Ca2+-dependent inactivation,
but this is more pronounced for NR2A. The presence of
NR2B subunits results in prolonged EPSPs compared to
those seen when NR2A subunits dominate (see [3, 7, 66]).
Thus, it seems likely that activation of presynaptic NR2B-
containing receptors would mediate a slowly deactivating
opening of the NMDAr channel and a greater Ca2+-influx
into the presynaptic terminals than any influx mediated by
NR2A receptors. Ca2+-influx via the NMDAr is responsible
for instantaneous control of spontaneous glutamate release
[35]. With a deactivation time of around 300 milliseconds,
repetitive activation of NR1/NR2B receptors would readily
result in temporal summation of presynaptic Ca2+-entry
leading to the short-term facilitation at even relatively low-
frequency stimulations seen here and previously [35].
It is interesting to speculate on a physiological or
pathological role for short-term plasticity mediated by preN-
MDAr. State-dependent rhythms and oscillatory activity
at various frequencies occur in the networks of the EC
including ripples and sharp waves (>100 Hz), gamma (30–
80 Hz), theta (4–8 Hz), and slow waves (0.1–0.5 Hz) [68–
71], and these may be involved in mnemonic processing in
temporal lobe structures. There is a consensus that theta
oscillations are intimately involved in declarative memory
and spatial navigation (see [72–74]), and it is possible
that information encoding involved in these processes is
reliant on an increase in entorhinal-hippocampal delta/theta
coherence [73]. The facilitation of glutamate transmission
mediated by preNMDAr that we describe is readily elicited at
frequencies in the low theta range. Thus, we could speculate
that these receptors may be involved in the generation of
theta activity in the EC, and the proposed role of this activity
in short-term memory and coding of spatial information
(e.g., [72, 74]).
At a pathological level, it is noteworthy that, oscillations
at delta (1-2 Hz) and theta frequency may be associated with
epilepsy. In patients with temporal lobe epilepsy, there is a
generalized increase in EEG activity in the delta/theta range,
and the most common pattern of discharges after the initi-
ation of ictal events is a rhythmic delta/theta activity (e.g.,
[75, 76]). Also, in rats made chronically epileptic following
kainic acid injection, epileptiform events in superficial
layers of the EC were sometimes followed by spontaneous
theta oscillations in layer V [77]. We recently showed that
preNMDAr function declines in adulthood, but is markedly
enhanced in age-matched, chronically epileptic rats [36]
and there is evidence for a similar increased function in
human temporal lobe epilepsy [78]. We could speculate that
this increased preNMDAr function could result in enhanced
generation of delta/theta activity in epileptic conditions.
Of further interest in this regard is the observation that
increased delta/theta EEG activity (albeit in patients with
generalized absence/myoclonic seizures) is normalized by the
anticonvulsant drugs, valproate, and lamotrigine [79–81].
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We have also shown that at least one anticonvulsant drug
(felbamate) can block the preNMDAr [42]. This raises the
possibility that some anticonvulsants could alter delta/theta
oscillations by targeting preNMDAr.
Whatever the function of short-term plasticity, and the
involvement of preNMDAr in it, there is increasing evidence
that these receptors may also contribute to longer term
forms of plasticity, apparently mediating both LTD [17,
22, 33, 34] and LTP [26, 32] at a variety of synapses. In
at least one case, LTD appears to be mediated by NR2B-
containing receptors [33], so both short- and long-term
plasticity of glutamate transmission could involve Ca2+-
influx via presynaptic NR2B receptors. We have also shown
recently that preNMDAr are rapidly mobile and can diﬀuse
between locations near release sites and more distal locations
in the terminal membrane [82]. Traﬃcking of receptors
in the presynaptic membrane appears to be influenced by
ongoing activity levels, and exerts an intermediate (over 10
seconds of minutes) form of plasticity. Thus, presynaptic
NR2B receptors may be heavily involved in both plasticity
and metaplasticity at glutamate synapses in EC and other
cortical synapses.
In the present study, we also present evidence for
diﬀerences in pre- and postsynaptic NMDAr at layer V
synapses. Whilst preNMDAr-mediated eﬀects are exclusively
dependent on NR1/NR2B-containing diheteromers, both
NR2B and NR2A appear to contribute to postsynaptic
responses. However, the relative contributions of the two
subunits are not clear. The ability of low concentrations
of both Zn2+ and Ro 25-6981 to reduce postsynaptic
NMDAr responses could suggest that they are dependent
on a mix of NR1/NR2A and NR1/NR2B diheteromeric
receptors. However, concentrations of either blocker, that
should largely retain selectivity at the respective subtypes,
were able to almost abolish postsynaptic responses. This
could suggest that the postsynaptic receptors could be largely
triheteromeric NR1/NR2A/NR2B receptors. Although tri-
heteromeric receptors do exhibit high aﬃnity for both
NR2A and NR2B selective blockers, it seems likely that
they exhibit a reduced maximal inhibitory eﬀect to either,
and that maximal blockade requires occupation of both
sites [83]. This does not fit well with our finding that
combined application of low concentrations of Zn2+ and Ro
25-6981 could also abolish postsynaptic responses, which
would better support a mediation by a mix of NR1/NR2A
and NR1/NR2B diheteromeric receptors. It should also be
noted that the ability of NMDA antagonists to block the
receptors is not just dependent on the NR2 subunit present,
but is also modified by which splice variant of the NR1
subunit with which it combines [47, 49]. We do not know
which NR1 subunit(s) may be present in the EC. Thus,
overall it is diﬃcult to define exactly what the postsynaptic
receptor population, but the most likely scenario is a mix of
NR1/NR2A, NR1/NR2B, and NR1/NR2A/NR2B receptors.
A number of studies have suggested that NR1/NR2A,
NR1/NR2B, and NR1/NR2A/NR2B receptors may con-
tribute to postsynaptic responses at other cortical synapses
[84–86]. There is support also for synapse-specific seg-
regation of NR2A and NR2B-containing receptors (e.g.,
[87, 88]) and spatial segregation between subsynaptic and
extrasynaptic sites (e.g., [86]). The controversy over whether
subunit composition and spatial location are linked, and the
diﬃculties in defining the role of triheteromeric receptors has
been well reviewed recently [3]. We cannot make any firm
conclusions regarding these aspects in the EC, but our data
do suggest that postsynaptic NR1/NR2A, NR1/NR2B, and
NR1/NR2A/NR2B receptors all contribute to postsynaptic
responses at glutamate synapses in layer V of the EC, in
contrast to presynaptic sites where NR1/NR2B receptors may
have exclusive control. Increasing numbers of studies have
documented LTP and LTD at synapses in the EC [89–95].
The EC is clearly a pivotal site in learning and memory
functions resident in the temporal lobe. We have shown that
preNMDAr mediate short-term forms of plasticity in the EC.
In experiments employing a limited protocol of repetitive
activation, we found that this short-term plasticity may lead
to longer-term plasticity (either pre- or postsynaptically),
and the aim now is to examine in detail the relationship
between short-term eﬀects and long-term plasticity and
metaplasticity at these synapses.
ACKNOWLEDGMENTS
The authors thank the Wellcome Trust, Epilepsy Research
UK and the University of Bath for financial support, the
BBSRC and the University of Bristol for PhD scholarships for
SELC, and JY, respectively.
REFERENCES
[1] S. G. Cull-Candy, S. Brickley, and M. Farrant, “NMDA recep-
tor subunits: diversity, development and disease,” Current
Opinion in Neurobiology, vol. 11, no. 3, pp. 327–335, 2001.
[2] F. Gardoni and M. Di Luca, “New targets for pharmacological
intervention in the glutamatergic synapse,” European Journal
of Pharmacology, vol. 545, no. 1, pp. 2–10, 2006.
[3] G. Ko¨hr, “NMDA receptor function: subunit composition
versus spatial distribution,” Cell and Tissue Research, vol. 326,
no. 2, pp. 439–446, 2006.
[4] M. Llansola, A. Sanchez-Perez, O. Cauli, and V. Felipo, “Mod-
ulation of NMDA receptors in the cerebellum. 1. Properties
of the NMDA receptor that modulate its function,” The
Cerebellum, vol. 4, no. 3, pp. 154–161, 2005.
[5] P. Paoletti and J. Neyton, “NMDA receptor subunits: function
and pharmacology,” Current Opinion in Pharmacology, vol. 7,
no. 1, pp. 39–47, 2007.
[6] T. Yamakura and K. Shimoji, “Subunit- and site-specific
pharmacology of the NMDA receptor channel,” Progress in
Neurobiology, vol. 59, no. 3, pp. 279–298, 1999.
[7] S. G. Cull-Candy and D. N. Leszkiewicz, “Role of distinct
NMDA receptor subtypes at central synapses,” Science’s STKE,
vol. 2004, no. 255, p. re16, 2004.
[8] G. Bustos, J. Abarca, M. I. Forray, K. Gysling, C. W. Bradberry,
and R. H. Roth, “Regulation of excitatory amino acid release
by N-methyl-D-aspartate receptors in rat striatum: in vivo
microdialysis studies,” Brain Research, vol. 585, no. 1-2, pp.
105–115, 1992.
Sophie E. L. Chamberlain et al. 11
[9] K. Fink, H. Bo¨nisch, and M. Go¨thert, “Presynaptic NMDA
receptors stimulate noradrenaline release in the cerebral
cortex,” European Journal of Pharmacology, vol. 185, no. 1, pp.
115–117, 1990.
[10] M. O. Krebs, J. M. Desce, M. L. Kemel, et al., “Glutamatergic
control of dopamine release in the rat striatum: evidence for
presynaptic N-methyl-D-aspartate receptors on dopaminergic
nerve terminals,” Journal of Neurochemistry, vol. 56, no. 1, pp.
81–85, 1991.
[11] D. Martin, G. A. Bustos, M. A. Bowe, S. D. Bray, and J. V.
Nadler, “Autoreceptor regulation of glutamate and aspartate
release from slices of the hippocampal CA1 area,” Journal of
Neurochemistry, vol. 56, no. 5, pp. 1647–1655, 1991.
[12] C. Aoki, C. Venkatesan, C.-G. Go, J. A. Mong, and T. M.
Dawson, “Cellular and subcellular localization of NMDA-R1
subunit immunoreactivity in the visual cortex of adult and
neonatal rats,” The Journal of Neuroscience, vol. 14, no. 9, pp.
5202–5222, 1994.
[13] S. DeBiasi, A. Minelli, M. Melone, and F. Conti, “Presynaptic
NMDA receptors in the neocortex are both auto- and
heteroreceptors,” NeuroReport, vol. 7, no. 15–17, pp. 2773–
2776, 1996.
[14] R. S. Petralia, N. Yokotani, and R. J. Wenthold, “Light
and electron microscope distribution of the NMDA receptor
subunit NMDAR1 in the rat nervous system using a selective
anti-peptide antibody,” The Journal of Neuroscience, vol. 14,
no. 2, pp. 667–696, 1994.
[15] R. S. Petralia, Y. X. Wang, and R. J. Wenthold, “The NMDA
receptor subunits NR2A and NR2B show histological and
ultrastructural localization patterns similar to those of NR1,”
The Journal of Neuroscience, vol. 14, no. 10, pp. 6102–6120,
1994.
[16] N. Berretta and R. S. G. Jones, “Tonic facilitation of glutamate
release by presynaptic N-methyl-D-aspartate autoreceptors in
the entorhinal cortex,” Neuroscience, vol. 75, no. 2, pp. 339–
344, 1996.
[17] V. A. Bender, K. J. Bender, D. J. Brasier, and D. E. Feldman,
“Two coincidence detectors for spike timing-dependent plas-
ticity in somatosensory cortex,” The Journal of Neuroscience,
vol. 26, no. 16, pp. 4166–4177, 2006.
[18] A. I. M. Breukel, E. Besselsen, F. H. Lopes da Silva, and W. E. J.
M. Ghijsen, “A presynaptic N-methyl-D-aspartate autorecep-
tor in rat hippocampus modulating amino acid release from
a cytoplasmic pool,” European Journal of Neuroscience, vol. 10,
no. 1, pp. 106–114, 1998.
[19] M. Casado, S. Dieudonne´, and P. Ascher, “Presynaptic N-
methyl-D-aspartate receptors at the parallel fiber-Purkinje cell
synapse,” Proceedings of the National Academy of Sciences of
the United States of America, vol. 97, no. 21, pp. 11593–11597,
2000.
[20] Y.-H. Chen, M.-L. Wu, and W.-M. Fu, “Regulation of
presynaptic NMDA responses by external and intracellular pH
changes at developing neuromuscular synapses,” The Journal
of Neuroscience, vol. 18, no. 8, pp. 2982–2990, 1998.
[21] A. J. Cochilla and S. Alford, “NMDA receptor-mediated
control of presynaptic calcium and neurotransmitter release,”
The Journal of Neuroscience, vol. 19, no. 1, pp. 193–205, 1999.
[22] R. Corlew, Y. Wang, H. Ghermazien, A. Erisir, and B.
D. Philpot, “Developmental switch in the contribution of
presynaptic and postsynaptic NMDA receptors to long-term
depression,” The Journal of Neuroscience, vol. 27, no. 37, pp.
9835–9845, 2007.
[23] I. C. Duguid and T. G. Smart, “Retrograde activation of presy-
naptic NMDA receptors enhances GABA release at cerebellar
interneuron-Purkinje cell synapses,” Nature Neuroscience, vol.
7, no. 5, pp. 525–533, 2004.
[24] M. Glitsch and A. Marty, “Presynaptic eﬀects of NMDA in
cerebellar Purkinje cells and interneurons,” The Journal of
Neuroscience, vol. 19, no. 2, pp. 511–519, 1999.
[25] H. Huang and A. Bordey, “Glial glutamate transporters
limit spillover activation of presynaptic NMDA receptors
and influence synaptic inhibition of Purkinje neurons,” The
Journal of Neuroscience, vol. 24, no. 25, pp. 5659–5669, 2004.
[26] Y. Humeau, H. Shaban, S. Bissie`re, and A. Lu¨thi, “Presynaptic
induction of heterosynaptic associative plasticity in the mam-
malian brain,” Nature, vol. 426, no. 6968, pp. 841–845, 2003.
[27] P. Jourdain, L. H. Bergersen, K. Bhaukaurally, et al., “Gluta-
mate exocytosis from astrocytes controls synaptic strength,”
Nature Neuroscience, vol. 10, no. 3, pp. 331–339, 2007.
[28] Y.-H. Li and T.-Z. Han, “Glycine binding sites of presynaptic
NMDA receptors may tonically regulate glutamate release in
the rat visual cortex,” Journal of Neurophysiology, vol. 97, no.
1, pp. 817–823, 2007.
[29] C.-C. Lien, Y. Mu, M. Vargas-Caballero, and M. Poo, “Visual
stimuli-induced LTD of GABAergic synapses mediated by
presynaptic NMDA receptors,” Nature Neuroscience, vol. 9, no.
3, pp. 372–380, 2006.
[30] M. Mameli, M. Carta, L. D. Partridge, and C. F. Valenzuela,
“Neurosteroid-induced plasticity of immature synapses via
retrograde modulation of presynaptic NMDA receptors,” The
Journal of Neuroscience, vol. 25, no. 9, pp. 2285–2294, 2005.
[31] A. Robert, J. A. Black, and S. G. Waxman, “Endogenous
NMDA-receptor activation regulates glutamate release in
cultured spinal neurons,” The Journal of Neurophysiology, vol.
80, no. 1, pp. 196–208, 1998.
[32] R. D. Samson and D. Pare´, “Activity-dependent synaptic
plasticity in the central nucleus of the amygdala,” The Journal
of Neuroscience, vol. 25, no. 7, pp. 1847–1855, 2005.
[33] P. J. Sjo¨stro¨m, G. G. Turrigiano, and S. B. Nelson, “Neocortical
LTD via coincident activation of presynaptic NMDA and
cannabinoid receptors,” Neuron, vol. 39, no. 4, pp. 641–654,
2003.
[34] M. Casado, P. Isope, and P. Ascher, “Involvement of presynap-
tic N-methyl-D-aspartate receptors in cerebellar long-term
depression,” Neuron, vol. 33, no. 1, pp. 123–130, 2002.
[35] G. Woodhall, D. I. Evans, M. O. Cunningham, and R. S. G.
Jones, “NR2B-containing NMDA autoreceptors at synapses on
entorhinal cortical neurons,” The Journal of Neurophysiology,
vol. 86, no. 4, pp. 1644–1651, 2001.
[36] J. Yang, G. L. Woodhall, and R. S. G. Jones, “Tonic facilitation
of glutamate release by presynaptic NR2B-containing NMDA
receptors is increased in the entorhinal cortex of chronically
epileptic rats,” The Journal of Neuroscience, vol. 26, no. 2, pp.
406–410, 2006.
[37] K. Williams, “Ifenprodil discriminates subtypes of the N-
methyl-D-aspartate receptor: selectivity and mechanisms at
recombinant heteromeric receptors,” Molecular Pharmacology,
vol. 44, no. 4, pp. 851–859, 1993.
[38] G. Fischer, V. Mutel, G. Trube, et al., “Ro 25-6981, a highly
potent and selective blocker of N-methyl-D-aspartate recep-
tors containing the NR2B subunit. Characterization in vitro,”
The Journal of Pharmacology and Experimental Therapeutics,
vol. 283, no. 3, pp. 1285–1292, 1997.
12 Neural Plasticity
[39] Y. P. Auberson, H. Allgeier, S. Bischoﬀ, K. Lingenhoehl,
R. Moretti, and M. Schmutz, “5-Phosphonomethylquinox-
alinediones as competitive NMDA receptor antagonists with
a preference for the human 1A/2A, rather than 1A/2B receptor
composition,” Bioorganic & Medicinal Chemistry Letters, vol.
12, no. 7, pp. 1099–1102, 2002.
[40] D. J. Brasier and D. E. Feldman, “Synapse-specific expression
of functional presynaptic NMDA receptors in rat somatosen-
sory cortex,” The Journal of Neuroscience, vol. 28, no. 9, pp.
2199–2211, 2008.
[41] J. Neyton and P. Paoletti, “Relating NMDA receptor function
to receptor subunit composition: limitations of the pharma-
cological approach,” The Journal of Neuroscience, vol. 26, no.
5, pp. 1331–1333, 2006.
[42] J. Yang, C. Wetterstrand, and R. S. G. Jones, “Felbamate
but not phenytoin or gabapentin reduces glutamate release
by blocking presynaptic NMDA receptors in the entorhinal
cortex,” Epilepsy Research, vol. 77, no. 2-3, pp. 157–164, 2007.
[43] Y.-H. Li, T.-Z. Han, and K. Meng, “Tonic facilitation of
glutamate release by glycine binding sites on presynaptic
NR2B-containing NMDA autoreceptors in the rat visual
cortex,” Neuroscience Letters, vol. 432, no. 3, pp. 212–216,
2008.
[44] L. Liu, T. P. Wong, M. F. Pozza, et al., “Role of NMDA receptor
subtypes in governing the direction of hippocampal synaptic
plasticity,” Science, vol. 304, no. 5673, pp. 1021–1024, 2004.
[45] S. Berberich, P. Punnakkal, V. Jensen, et al., “Lack of NMDA
receptor subtype selectivity for hippocampal long-term poten-
tiation,” The Journal of Neuroscience, vol. 25, no. 29, pp. 6907–
6910, 2005.
[46] C. Weitlauf, Y. Honse, Y. P. Auberson, M. Mishina, D.
M. Lovinger, and D. G. Winder, “Activation of NR2A-
containing NMDA receptors is not obligatory for NMDA
receptor-dependent long-term potentiation,” The Journal of
Neuroscience, vol. 25, no. 37, pp. 8386–8390, 2005.
[47] P. Paoletti, P. Ascher, and J. Neyton, “High-aﬃnity zinc
inhibition of NMDA NR1-NR2A receptors,” The Journal of
Neuroscience, vol. 17, no. 15, pp. 5711–5725, 1997.
[48] J. Rachline, F. Perin-Dureau, A. Le Goﬀ, J. Neyton, and
P. Paoletti, “The micromolar zinc-binding domain on the
NMDA receptor subunit NR2B,” The Journal of Neuroscience,
vol. 25, no. 2, pp. 308–317, 2005.
[49] S. F. Traynelis, M. F. Burgess, F. Zheng, P. Lyuboslavsky, and
J. L. Powers, “Control of voltage-independent Zinc inhibition
of NMDA receptors by the NR1 subunit,” The Journal of
Neuroscience, vol. 18, no. 16, pp. 6163–6175, 1998.
[50] A. Sobczyk and K. Svoboda, “Activity-dependent plasticity of
the NMDA-receptor fractional Ca2+ current,” Neuron, vol. 53,
no. 1, pp. 17–24, 2007.
[51] M. M. Adams, S. E. Fink, W. G. M. Janssen, R. A. Shah, and
J. H. Morrison, “Estrogen modulates synaptic N-methyl-D-
aspartate receptor subunit distribution in the aged hippocam-
pus,” The Journal of Comparative Neurology, vol. 474, no. 3, pp.
419–426, 2004.
[52] F. Conti, P. Barbaresi, M. Melone, and A. Ducati, “Neuronal
and glial localization of NR1 and NR2A/B subunits of the
NMDA receptor in the human cerebral cortex,” Cerebral
Cortex, vol. 9, no. 2, pp. 110–120, 1999.
[53] V. N. Kharazia and R. J. Weinberg, “Immunogold localization
of AMPA and NMDA receptors in somatic sensory cortex of
albino rat,” The Journal of Comparative Neurology, vol. 412, no.
2, pp. 292–302, 1999.
[54] J. P. Charton, M. Herkert, C.-M. Becker, and H. Schro¨der,
“Cellular and subcellular localization of the 2B-subunit of
the NMDA receptor in the adult rat telencephalon,” Brain
Research, vol. 816, no. 2, pp. 609–617, 1999.
[55] S. Fujisawa and C. Aoki, “In vivo blockade of N-methyl-D-
aspartate receptors induces rapid traﬃcking of NR2B subunits
away from synapses and out of spines and terminals in adult
cortex,” Neuroscience, vol. 121, no. 1, pp. 51–63, 2003.
[56] V. C. Kotak, S. Fujisawa, F. A. Lee, O. Karthikeyan, C. Aoki, and
D. H. Sanes, “Hearing loss raises excitability in the auditory
cortex,” The Journal of Neuroscience, vol. 25, no. 15, pp. 3908–
3918, 2005.
[57] R. O’Donnell, S. Molon-Noblot, P. Laroque, M. Rigby, and D.
Smith, “The ultrastructural localisation of the N-methyl-D-
aspartate NR2B receptor subunit in rat lumbar spinal cord,”
Neuroscience Letters, vol. 371, no. 1, pp. 24–29, 2004.
[58] J. J. Radley, C. R. Farb, Y. He, et al., “Distribution of
NMDA and AMPA receptor subunits at thalamo-amygdaloid
dendritic spines,” Brain Research, vol. 1134, no. 1, pp. 87–94,
2007.
[59] J. G. Valtschanoﬀ, A. Burette, R. J. Wenthold, and R. J.
Weinberg, “Expression of NR2 receptor subunit in rat somatic
sensory cortex: synaptic distribution and colocalization with
NR1 and PSD-95,” The Journal of Comparative Neurology, vol.
410, no. 4, pp. 599–611, 1999.
[60] C. Aoki, S. Fujisawa, V. Mahadomrongkul, P. J. Shah, K.
Nader, and A. Erisir, “NMDA receptor blockade in intact adult
cortex increases traﬃcking of NR2A subunits into spines,
postsynaptic densities, and axon terminals,” Brain Research,
vol. 963, no. 1-2, pp. 139–149, 2003.
[61] W. G. M. Janssen, P. Vissavajjhala, G. Andrews, T. Moran, P. R.
Hof, and J. H. Morrison, “Cellular and synaptic distribution of
NR2A and NR2B in macaque monkey and rat hippocampus
as visualized with subunit-specific monoclonal antibodies,”
Experimental Neurology, vol. 191, supplement 1, pp. S28–S44,
2005.
[62] R. S. Petralia, N. Sans, Y.-X. Wang, and R. J. Wenthold,
“Ontogeny of postsynaptic density proteins at glutamatergic
synapses,” Molecular and Cellular Neuroscience, vol. 29, no. 3,
pp. 436–452, 2005.
[63] E. Luccini, V. Musante, E. Neri, M. Raiteri, and A. Pit-
taluga, “N-methyl-D-aspartate autoreceptors respond to low
and high agonist concentrations by facilitating, respectively,
exocytosis and carrier-mediated release of glutamate in rat
hippocampus,” Journal of Neuroscience Research, vol. 85, no.
16, pp. 3657–3665, 2007.
[64] D. J. Laurie and P. H. Seeburg, “Ligand aﬃnities at recom-
binant N-methyl-D-aspartate receptors depend on subunit
composition,” European Journal of Pharmacology, vol. 268, no.
3, pp. 335–345, 1994.
[65] H. Mori and M. Mishina, “Structure and function of the
NMDA receptor channel,” Neuropharmacology, vol. 34, no. 10,
pp. 1219–1237, 1995.
[66] S. G. Cull-Candy and S. G. Brickley, “NMDA receptors,” to
appear in Encyclopedia of Life Sciences, http://www.els.net.
[67] A. Sobczyk, V. Scheuss, and K. Svoboda, “NMDA receptor
subunit-dependent [Ca2+] signaling in individual hippocam-
pal dendritic spines,” The Journal of Neuroscience, vol. 25, no.
26, pp. 6037–6046, 2005.
[68] J. J. Chrobak, A. Lo¨rincz, and G. Buzsa´ki, “Physiological
patterns in the hippocampo-entorhinal cortex system,” Hip-
pocampus, vol. 10, no. 4, pp. 457–465, 2000.
Sophie E. L. Chamberlain et al. 13
[69] J. J. Chrobak and G. Buzsa´ki, “Selective activation of deep
layer (V-VI) retrohippocampal cortical neurons during hip-
pocampal sharp waves in the behaving rat,” The Journal of
Neuroscience, vol. 14, no. 10, pp. 6160–6170, 1994.
[70] M. O. Cunningham, C. H. Davies, E. H. Buhl, N. Kopell, and
M. A. Whittington, “Gamma oscillations induced by kainate
receptor activation in the entorhinal cortex in vitro,” The
Journal of Neuroscience, vol. 23, no. 30, pp. 9761–9769, 2003.
[71] M. O. Cunningham, D. D. Pervouchine, C. Racca, et al.,
“Neuronal metabolism governs cortical network response
state,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 103, no. 14, pp. 5597–5601, 2006.
[72] G. Buzsa´ki, “Theta rhythm of navigation: link between path
integration and landmark navigation, episodic and semantic
memory,” Hippocampus, vol. 15, no. 7, pp. 827–840, 2005.
[73] J. Fell, P. Klaver, H. Elfadil, C. Schaller, C. E. Elger, and
G. Ferna´ndez, “Rhinal-hippocampal theta coherence during
declarative memory formation: interaction with gamma syn-
chronization?” European Journal of Neuroscience, vol. 17, no.
5, pp. 1082–1088, 2003.
[74] R. P. Vertes, “Hippocampal theta rhythm: a tag for short-term
memory,” Hippocampus, vol. 15, no. 7, pp. 923–935, 2005.
[75] K. Alper, M. Raghavan, R. Isenhart, et al., “Localizing epilepto-
genic regions in partial epilepsy using three-dimensional sta-
tistical parametric maps of background EEG source spectra,”
NeuroImage, vol. 39, no. 3, pp. 1257–1265, 2008.
[76] N. Dericioglu and S. Saygi, “Ictal scalp EEG findings in
patients with mesial temporal lobe epilepsy,” Clinical EEG and
Neuroscience, vol. 39, no. 1, pp. 20–27, 2008.
[77] E. A. Tolner, F. Kloosterman, E. A. van Vliet, M. P. Witter, F. H.
Lopes da Silva, and J. A. Gorter, “Presubiculum stimulation
in vivo evokes distinct oscillations in superficial and deep
entorhinal cortex layers in chronic epileptic rats,” The Journal
of Neuroscience, vol. 25, no. 38, pp. 8755–8765, 2005.
[78] M. Steﬀens, H.-J. Huppertz, J. Zentner, E. Chauzit, and
T. J. Feuerstein, “Unchanged glutamine synthetase activity
and increased NMDA receptor density in epileptic human
neocortex: implications for the pathophysiology of epilepsy,”
Neurochemistry International, vol. 47, no. 6, pp. 379–384,
2005.
[79] B. Clemens, “Valproate decreases EEG synchronization in a
use-dependent manner in idiopathic generalized epilepsy,”
Seizure, vol. 17, no. 3, pp. 224–233, 2008.
[80] C. Be´la, B. Mo´nika, T. Ma´rton, and K. Istva´n, “Valproate
selectively reduces EEG activity in anterior parts of the
cortex in patients with idiopathic generalized epilepsy. A low
resolution electromagnetic tomography (LORETA) study,”
Epilepsy Research, vol. 75, no. 2-3, pp. 186–191, 2007.
[81] B. Clemens, P. Piros, M. Bessenyei, and K. Hollo´dy, “Lam-
otrigine decreases EEG synchronization in a use-dependent
manner in patients with idiopathic generalized epilepsy,”
Clinical Neurophysiology, vol. 118, no. 4, pp. 910–917, 2007.
[82] J. Yang, S. E. L. Chamberlain, G. L. Woodhall, and R. S. G.
Jones, “Mobility of NMDA autoreceptors but not postsynaptic
receptors in the rat entorhinal cortex,” The Journal of Physiol-
ogy, vol. 586, no. 20, pp. 4905–4924, 2008.
[83] C. J. Hatton and P. Paoletti, “Modulation of triheteromeric
NMDA receptors by N-terminal domain ligands,” Neuron, vol.
46, no. 2, pp. 261–274, 2005.
[84] R. A. Al-Hallaq, T. P. Conrads, T. D. Veenstra, and R.
J. Wenthold, “NMDA di-heteromeric receptor populations
and associated proteins in rat hippocampus,” The Journal of
Neuroscience, vol. 27, no. 31, pp. 8334–8343, 2007.
[85] J. Luo, Y. Wang, R. P. Yasuda, A. W. Dunah, and B. B. Wolfe,
“The majority of N-methyl-D-aspartate receptor complexes
in adult rat cerebral cortex contain at least three diﬀerent
subunits (NR1/NR2A/NR2B),” Molecular Pharmacology, vol.
51, no. 1, pp. 79–86, 1997.
[86] K. R. Tovar and G. L. Westbrook, “The incorporation
of NMDA receptors with a distinct subunit composition
at nascent hippocampal synapses in vitro,” The Journal of
Neuroscience, vol. 19, no. 10, pp. 4180–4188, 1999.
[87] I. Ito, K. Futai, H. Katagiri, et al., “Synapse-selective impair-
ment of NMDA receptor functions in mice lacking NMDA
receptor epsilon 1 or epsilon 2 subunit,” The Journal of
Physiology, vol. 500, no. 2, pp. 401–408, 1997.
[88] S. S. Kumar and J. R. Huguenard, “Pathway-specific diﬀer-
ences in subunit composition of synaptic NMDA receptors on
pyramidal neurons in neocortex,” The Journal of Neuroscience,
vol. 23, no. 31, pp. 10074–10083, 2003.
[89] A. Alonso, M. de Curtis, and R. Llina´s, “Postsynaptic Hebbian
and non-Hebbian long-term potentiation of synaptic eﬃcacy
in the entorhinal cortex in slices and in the isolated adult
guinea pig brain,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 87, no. 23, pp.
9280–9284, 1990.
[90] R. Bouras and C. A. Chapman, “Long-term synaptic depres-
sion in the adult entorhinal cortex in vivo,” Hippocampus, vol.
13, no. 7, pp. 780–790, 2003.
[91] C. A. Chapman and R. J. Racine, “Piriform cortex eﬀerents to
the entorhinal cortex in vivo: kindling-induced potentiation
and the enhancement of long-term potentiation by low-
frequency piriform cortex or medial septal stimulation,”
Hippocampus, vol. 7, no. 3, pp. 257–270, 1997.
[92] M. Y. Cheong, S. H. Yun, I. Mook-Jung, Y. Kang, and M. W.
Jung, “Induction of homosynaptic long-term depression in
entorhinal cortex,” Brain Research, vol. 954, no. 2, pp. 308–
310, 2002.
[93] Y.-H. Chen, M.-L. Wu, and W.-M. Fu, “Regulation of
presynaptic NMDA responses by external and intracellular pH
changes at developing neuromuscular synapses,” The Journal
of Neuroscience, vol. 18, no. 8, pp. 2982–2990, 1998.
[94] S. Craig and S. Commins, “Plastic and metaplastic changes in
the CA1 and subicular projections to the entorhinal cortex,”
Brain Research, vol. 1147, no. 1, pp. 124–139, 2007.
[95] J. Solger, C. Wozny, D. Manahan-Vaughan, and J. Behr, “Dis-
tinct mechanisms of bidirectional activity-dependent synaptic
plasticity in superficial and deep layers of rat entorhinal
cortex,” European Journal of Neuroscience, vol. 19, no. 7, pp.
2003–2007, 2004.
